1	1	Measles	Measles	NNP	2	nsubj	0	7	_	_
1	2	occurs	occur	VBZ	0	ROOT	8	14	_	_
1	3	worldwide	worldwide	RB	2	advmod	15	24	_	_
1	4	and	and	CC	2	cc	25	28	_	_
1	5	is	be	VBZ	6	cop	29	31	_	_
1	6	one	one	CD	2	conj	32	35	_	_
1	7	of	of	IN	12	case	36	38	_	_
1	8	the	the	DT	12	det	39	42	_	_
1	9	most	most	RBS	11	advmod	43	47	_	_
1	10	highly	highly	RB	11	advmod	48	54	_	_
1	11	communicable	communicable	JJ	12	amod	55	67	_	_
1	12	diseases	disease	NNS	6	nmod	68	76	_	_
1	13	.	.	.	2	punct	76	77	_	_

2	1	Canada	Canada	NNP	2	nsubj	78	84	B-persongroup-109940	_
2	2	has	have	VBZ	0	ROOT	85	88	_	_
2	3	imported	import	VBN	4	amod	89	97	_	_
2	4	cases	case	NNS	2	dobj	98	103	_	_
2	5	and	and	CC	4	cc	104	107	_	_
2	6	occasional	occasional	JJ	7	amod	108	118	_	_
2	7	outbreaks	outbreak	NNS	4	conj	119	128	_	_
2	8	of	of	IN	9	case	129	131	_	_
2	9	measles	measles	NNS	7	nmod	132	139	_	_
2	10	.	.	.	2	punct	139	140	_	_

3	1	MMR	mmr	NN	2	compound	142	145	_	_
3	2	vaccine	vaccine	NN	12	nsubjpass	146	153	_	_
3	3	or	or	CC	2	cc	154	156	_	_
3	4	human	human	JJ	6	amod	157	162	_	_
3	5	immune	immune	JJ	6	amod	163	169	_	_
3	6	globulin	globulin	NN	2	conj	170	178	_	_
3	7	(	(	CD	9	nummod	179	180	_	_
3	8	Ig	ig	NN	9	compound	180	182	_	_
3	9	)	)	NN	6	dep	182	183	_	_
3	10	may	may	MD	12	aux	184	187	_	_
3	11	be	be	VB	12	auxpass	188	190	_	_
3	12	used	use	VBN	0	ROOT	191	195	_	_
3	13	for	for	IN	16	case	196	199	_	_
3	14	measles	measles	NNS	16	compound	200	207	_	_
3	15	post-exposure	post-exposure	JJ	16	amod	208	221	_	_
3	16	immunization	immunization	NN	12	nmod	222	234	_	_
3	17	in	in	IN	19	case	235	237	_	_
3	18	non-immune	non-immune	JJ	19	amod	238	248	B-persongroup-109941	_
3	19	persons	person	NNS	16	nmod	249	256	I-persongroup-109941	_
3	20	.	.	.	12	punct	256	257	I-persongroup-109941	_

4	1	The	the	DT	2	det	258	261	_	_
4	2	efficacy	efficacy	NN	19	nsubjpass	262	270	_	_
4	3	of	of	IN	6	case	271	273	_	_
4	4	a	a	DT	6	det	274	275	_	_
4	5	single	single	JJ	6	amod	276	282	_	_
4	6	dose	dose	NN	2	nmod	283	287	_	_
4	7	of	of	IN	9	case	288	290	_	_
4	8	measles	measles	NNS	9	compound	291	298	_	_
4	9	vaccine	vaccine	NN	6	nmod	299	306	_	_
4	10	given	give	VBN	15	case	308	313	_	_
4	11	at	at	IN	15	case	314	316	_	_
4	12	12	12	CD	15	compound	317	319	_	_
4	13	or	or	CC	12	cc	320	322	_	_
4	14	15	15	CD	12	conj	323	325	_	_
4	15	months	month	NNS	9	nmod	326	332	_	_
4	16	of	of	IN	17	case	333	335	_	_
4	17	age	age	NN	15	nmod	336	339	_	_
4	18	is	be	VBZ	19	auxpass	340	342	_	_
4	19	estimated	estimate	VBN	0	ROOT	343	352	_	_
4	20	to	to	TO	26	mark	353	355	_	_
4	21	be	be	VB	26	cop	356	358	_	_
4	22	85	85	CD	26	compound	359	361	_	_
4	23	%	%	NN	26	dep	361	362	_	_
4	24	to	to	TO	26	dep	363	365	_	_
4	25	95	95	CD	26	compound	366	368	_	_
4	26	%	%	NN	19	xcomp	368	369	_	_
4	27	.	.	.	19	punct	369	370	_	_

5	1	With	with	IN	4	case	371	375	_	_
5	2	a	a	DT	4	det	376	377	_	_
5	3	second	second	JJ	4	amod	378	384	_	_
5	4	dose	dose	NN	10	nmod	386	390	_	_
5	5	,	,	,	10	punct	390	391	_	_
5	6	efficacy	efficacy	NN	10	nsubj	392	400	_	_
5	7	is	be	VBZ	10	cop	401	403	_	_
5	8	almost	almost	RB	9	advmod	404	410	_	_
5	9	100	100	CD	10	nummod	411	414	_	_
5	10	%	%	NN	0	ROOT	414	415	_	_
5	11	.	.	.	10	punct	415	416	_	_

6	1	Reactions	reaction	NNS	9	nsubj	417	426	_	_
6	2	to	to	TO	3	case	427	429	_	_
6	3	MMR	MMR	NNP	1	nmod	430	433	_	_
6	4	and	and	CC	3	cc	434	437	_	_
6	5	MMRV	MMRV	NNP	6	compound	438	442	_	_
6	6	vaccine	vaccine	NN	3	conj	443	450	_	_
6	7	are	be	VBP	9	cop	451	454	_	_
6	8	generally	generally	RB	9	advmod	455	464	_	_
6	9	mild	mild	JJ	0	ROOT	465	469	_	_
6	10	and	and	CC	9	cc	470	473	_	_
6	11	transient	transient	JJ	9	conj	474	483	_	_
6	12	and	and	CC	9	cc	484	487	_	_
6	13	include	include	VBP	9	conj	488	495	_	_
6	14	pain	pain	NN	13	dobj	496	500	_	_
6	15	and	and	CC	14	cc	501	504	_	_
6	16	redness	redness	NN	14	conj	505	512	_	_
6	17	at	at	IN	20	case	513	515	_	_
6	18	the	the	DT	20	det	516	519	_	_
6	19	injection	injection	NN	20	compound	520	529	_	_
6	20	site	site	NN	13	nmod	530	534	_	_
6	21	,	,	,	20	punct	534	535	_	_
6	22	low-grade	low-grade	JJ	23	amod	536	545	_	_
6	23	fever	fever	NN	20	conj	546	551	_	_
6	24	and	and	CC	20	cc	552	555	_	_
6	25	rash	rash	NN	20	conj	556	560	_	_
6	26	.	.	.	9	punct	560	561	_	_

7	1	Measles-containing	measles-containing	JJ	2	amod	564	582	_	_
7	2	vaccine	vaccine	NN	4	nsubjpass	583	590	_	_
7	3	is	be	VBZ	4	auxpass	591	593	_	_
7	4	recommended	recommend	VBN	0	ROOT	594	605	_	_
7	5	for	for	IN	7	case	607	610	_	_
7	6	routine	routine	JJ	7	amod	611	618	_	_
7	7	immunization	immunization	NN	4	nmod	619	631	_	_
7	8	of	of	IN	9	case	632	634	_	_
7	9	children	child	NNS	7	nmod	635	643	B-persongroup-109942	_
7	10	and	and	CC	7	cc	644	647	_	_
7	11	for	for	IN	12	case	648	651	_	_
7	12	immunization	immunization	NN	7	conj	652	664	_	_
7	13	of	of	IN	14	case	665	667	_	_
7	14	children	child	NNS	12	nmod	668	676	B-persongroup-109943	_
7	15	and	and	CC	14	cc	677	680	_	_
7	16	adolescents	adolescent	NNS	14	conj	682	693	B-persongroup-109944	_
7	17	who	who	WP	18	nsubj	694	697	_	_
7	18	missed	miss	VBD	12	acl:relcl	698	704	_	_
7	19	measles	measles	NNS	20	compound	705	712	_	_
7	20	immunization	immunization	NN	18	dobj	713	725	_	_
7	21	on	on	IN	24	case	726	728	_	_
7	22	the	the	DT	24	det	729	732	_	_
7	23	routine	routine	JJ	24	amod	733	740	_	_
7	24	schedule	schedule	NN	18	nmod	741	749	_	_
7	25	.	.	.	4	punct	749	750	_	_

8	1	Measles-containing	measles-containing	JJ	2	amod	751	769	_	_
8	2	vaccine	vaccine	NN	4	nsubjpass	770	777	_	_
8	3	is	be	VBZ	4	auxpass	778	780	_	_
8	4	recommended	recommend	VBN	0	ROOT	782	793	_	_
8	5	for	for	IN	7	case	794	797	_	_
8	6	susceptible	susceptible	JJ	7	amod	798	809	B-persongroup-109945	_
8	7	adults	adult	NNS	4	nmod	810	816	I-persongroup-109945	_
8	8	born	bear	VBN	7	dep	817	821	_	_
8	9	in	in	IN	10	case	822	824	_	_
8	10	1970	1970	CD	8	nmod	825	829	_	_
8	11	or	or	CC	8	cc	830	832	_	_
8	12	later	later	RB	8	conj	833	838	_	_
8	13	.	.	.	4	punct	838	839	_	_

9	1	Adults	adult	NNS	7	nsubjpass	840	846	B-persongroup-109946	_
9	2	born	bear	VBN	1	acl	847	851	_	_
9	3	before	before	IN	4	case	852	858	_	_
9	4	1970	1970	CD	2	nmod	859	863	_	_
9	5	can	can	MD	7	aux	864	867	_	_
9	6	be	be	VB	7	auxpass	868	870	_	_
9	7	presumed	presume	VBN	0	ROOT	871	879	_	_
9	8	to	to	TO	10	mark	880	882	_	_
9	9	have	have	VB	10	aux	883	887	_	_
9	10	acquired	acquire	VBN	7	xcomp	889	897	_	_
9	11	natural	natural	JJ	12	amod	898	905	_	_
9	12	immunity	immunity	NN	10	dobj	906	914	_	_
9	13	to	to	TO	14	case	915	917	_	_
9	14	measles	measles	NNS	10	nmod	918	925	_	_
9	15	;	;	:	7	punct	925	926	_	_
9	16	however	however	RB	28	advmod	927	934	_	_
9	17	,	,	,	28	punct	934	935	_	_
9	18	non-immune	non-immune	JJ	21	amod	936	946	B-persongroup-109947	_
9	19	health	health	NN	21	compound	947	953	I-persongroup-109947	_
9	20	care	care	NN	21	compound	954	958	I-persongroup-109947	_
9	21	workers	worker	NNS	28	nsubj	959	966	I-persongroup-109947	_
9	22	,	,	,	21	punct	966	967	I-persongroup-109947	_
9	23	travellers	traveller	NNS	21	conj	969	979	B-persongroup-109948	_
9	24	and	and	CC	21	cc	980	983	_	_
9	25	military	military	JJ	26	amod	984	992	B-persongroup-109949	_
9	26	personnel	personnel	NNS	21	conj	993	1002	I-persongroup-109949	_
9	27	should	should	MD	28	aux	1003	1009	_	_
9	28	receive	receive	VB	7	parataxis	1010	1017	_	_
9	29	MMR	mmr	NN	30	compound	1018	1021	_	_
9	30	vaccine	vaccine	NN	28	dobj	1022	1029	_	_
9	31	,	,	,	28	punct	1029	1030	_	_
9	32	regardless	regardless	RB	28	advmod	1031	1041	_	_
9	33	of	of	IN	34	case	1042	1044	_	_
9	34	year	year	NN	32	nmod	1046	1050	_	_
9	35	of	of	IN	36	case	1051	1053	_	_
9	36	birth	birth	NN	34	nmod	1054	1059	_	_
9	37	.	.	.	7	punct	1059	1060	_	_

10	1	Routine	routine	JJ	3	amod	1061	1068	_	_
10	2	childhood	childhood	NN	3	compound	1069	1078	_	_
10	3	immunization	immunization	NN	0	ROOT	1079	1091	_	_
10	4	:	:	:	3	punct	1091	1092	_	_
10	5	administer	administer	VB	3	dep	1093	1103	_	_
10	6	two	two	CD	7	nummod	1105	1108	_	_
10	7	doses	dose	NNS	5	dobj	1109	1114	_	_
10	8	of	of	IN	12	case	1115	1117	_	_
10	9	measles-containing	measles-containing	JJ	12	amod	1118	1136	_	_
10	10	vaccine	vaccine	NN	12	compound	1138	1145	_	_
10	11	(	(	CD	12	nummod	1146	1147	_	_
10	12	MMR	mmr	NN	7	nmod	1147	1150	_	_
10	13	or	or	CC	7	cc	1151	1153	_	_
10	14	MMRV	mmrv	NN	15	compound	1154	1158	_	_
10	15	)	)	NN	7	conj	1158	1159	_	_
10	16	;	;	:	15	punct	1159	1160	_	_
10	17	the	the	DT	19	det	1161	1164	_	_
10	18	first	first	JJ	19	amod	1165	1170	_	_
10	19	dose	dose	NN	15	dep	1171	1175	_	_
10	20	at	at	IN	24	case	1176	1178	_	_
10	21	12	12	CD	23	compound	1179	1181	_	_
10	22	to	to	TO	23	dep	1182	1184	_	_
10	23	15	15	CD	24	nummod	1185	1187	_	_
10	24	months	month	NNS	19	nmod	1188	1194	_	_
10	25	of	of	IN	26	case	1195	1197	_	_
10	26	age	age	NN	24	nmod	1198	1201	_	_
10	27	and	and	CC	24	cc	1202	1205	_	_
10	28	the	the	DT	30	det	1206	1209	_	_
10	29	second	second	JJ	30	amod	1210	1216	_	_
10	30	dose	dose	NN	24	conj	1218	1222	_	_
10	31	at	at	IN	33	case	1223	1225	_	_
10	32	18	18	CD	33	nummod	1226	1228	_	_
10	33	months	month	NNS	30	nmod	1229	1235	_	_
10	34	of	of	IN	35	case	1236	1238	_	_
10	35	age	age	NN	33	nmod	1239	1242	_	_
10	36	or	or	CC	35	cc	1243	1245	_	_
10	37	any	any	DT	38	det	1246	1249	_	_
10	38	time	time	NN	35	conj	1250	1254	_	_
10	39	thereafter	thereafter	RB	5	advmod	1255	1265	_	_
10	40	,	,	,	5	punct	1265	1266	_	_
10	41	but	but	CC	5	cc	1267	1270	_	_
10	42	should	should	MD	44	aux	1271	1277	_	_
10	43	be	be	VB	44	auxpass	1278	1280	_	_
10	44	given	give	VBN	5	conj	1281	1286	_	_
10	45	not	not	RB	46	dep	1287	1290	_	_
10	46	later	later	RB	44	advmod	1291	1296	_	_
10	47	than	than	IN	44	nmod	1297	1301	_	_
10	48	around	around	IN	50	case	1302	1308	_	_
10	49	school	school	NN	50	compound	1309	1315	_	_
10	50	entry	entry	NN	5	nmod	1316	1321	_	_
10	51	.	.	.	3	punct	1321	1322	_	_

11	1	Children	child	NNS	9	nsubj	1323	1331	B-persongroup-109950	_
11	2	and	and	CC	1	cc	1333	1336	_	_
11	3	adolescents	adolescent	NNS	1	conj	1337	1348	B-persongroup-109951	_
11	4	who	who	WP	7	nsubj	1349	1352	_	_
11	5	are	be	VBP	7	cop	1353	1356	_	_
11	6	previously	previously	RB	7	advmod	1357	1367	_	_
11	7	unimmunized	unimmunized	JJ	1	acl:relcl	1368	1379	_	_
11	8	:	:	:	7	punct	1379	1380	_	_
11	9	administer	administer	VB	0	ROOT	1381	1391	_	_
11	10	two	two	CD	11	nummod	1392	1395	_	_
11	11	doses	dose	NNS	9	dobj	1396	1401	_	_
11	12	of	of	IN	14	case	1402	1404	_	_
11	13	measles-containing	measles-containing	JJ	14	amod	1405	1423	_	_
11	14	vaccine	vaccine	NN	11	nmod	1425	1432	_	_
11	15	.	.	.	9	punct	1432	1433	_	_

12	1	The	the	DT	3	det	1434	1437	_	_
12	2	minimum	minimum	JJ	3	amod	1438	1445	_	_
12	3	interval	interval	JJ	11	nsubj	1446	1454	_	_
12	4	between	between	IN	5	case	1455	1462	_	_
12	5	doses	dose	NNS	3	nmod	1463	1468	_	_
12	6	of	of	IN	8	case	1469	1471	_	_
12	7	MMR	mmr	NN	8	compound	1472	1475	_	_
12	8	vaccine	vaccine	NN	5	nmod	1476	1483	_	_
12	9	is	be	VBZ	11	cop	1484	1486	_	_
12	10	4	4	CD	11	nummod	1487	1488	_	_
12	11	weeks	week	NNS	0	ROOT	1489	1494	_	_
12	12	.	.	.	11	punct	1494	1495	_	_

13	1	MMRV	mmrv	NN	2	compound	1496	1500	_	_
13	2	vaccine	vaccine	NN	5	nsubjpass	1502	1509	_	_
13	3	may	may	MD	5	aux	1510	1513	_	_
13	4	be	be	VB	5	auxpass	1514	1516	_	_
13	5	used	use	VBN	0	ROOT	1517	1521	_	_
13	6	in	in	IN	8	case	1522	1524	_	_
13	7	healthy	healthy	JJ	8	amod	1525	1532	B-persongroup-109952	_
13	8	children	child	NNS	5	nmod	1533	1541	I-persongroup-109952	_
13	9	aged	aged	JJ	8	amod	1543	1547	_	_
13	10	12	12	CD	11	nummod	1548	1550	_	_
13	11	months	month	NNS	9	nmod:tmod	1551	1557	_	_
13	12	to	to	TO	14	case	1558	1560	_	_
13	13	12	12	CD	14	nummod	1561	1563	_	_
13	14	years	year	NNS	5	nmod	1564	1569	_	_
13	15	.	.	.	5	punct	1569	1570	_	_

14	1	The	the	DT	3	det	1571	1574	_	_
14	2	recommended	recommend	VBN	3	amod	1575	1586	_	_
14	3	interval	interval	NN	14	nsubj	1587	1595	_	_
14	4	between	between	IN	6	case	1596	1603	_	_
14	5	2	2	CD	6	nummod	1604	1605	_	_
14	6	doses	dose	NNS	3	nmod	1606	1611	_	_
14	7	of	of	IN	9	case	1612	1614	_	_
14	8	MMRV	mmrv	NN	9	compound	1615	1619	_	_
14	9	vaccine	vaccine	NN	6	nmod	1621	1628	_	_
14	10	is	be	VBZ	14	cop	1629	1631	_	_
14	11	at	at	IN	12	case	1632	1634	_	_
14	12	least	least	JJS	13	nmod:npmod	1635	1640	_	_
14	13	3	3	CD	14	nummod	1641	1642	_	_
14	14	months	month	NNS	0	ROOT	1643	1649	_	_
14	15	;	;	:	14	punct	1649	1650	_	_
14	16	a	a	DT	18	det	1651	1652	_	_
14	17	minimum	minimum	JJ	18	amod	1653	1660	_	_
14	18	interval	interval	NN	26	nsubjpass	1661	1669	_	_
14	19	of	of	IN	21	case	1670	1672	_	_
14	20	6	6	CD	21	nummod	1673	1674	_	_
14	21	weeks	week	NNS	18	nmod	1675	1680	_	_
14	22	between	between	IN	23	case	1681	1688	_	_
14	23	doses	dose	NNS	21	nmod	1689	1694	_	_
14	24	may	may	MD	26	aux	1695	1698	_	_
14	25	be	be	VB	26	auxpass	1700	1702	_	_
14	26	used	use	VBN	14	parataxis	1703	1707	_	_
14	27	if	if	IN	33	mark	1708	1710	_	_
14	28	rapid	rapid	JJ	31	amod	1711	1716	_	_
14	29	,	,	,	31	punct	1716	1717	_	_
14	30	complete	complete	JJ	31	amod	1718	1726	_	_
14	31	protection	protection	NN	33	nsubjpass	1727	1737	_	_
14	32	is	be	VBZ	33	auxpass	1738	1740	_	_
14	33	required	require	VBN	26	advcl	1741	1749	_	_
14	34	.	.	.	14	punct	1749	1750	_	_

15	1	Susceptible	susceptible	JJ	2	amod	1752	1763	B-persongroup-109953	_
15	2	adults	adult	NNS	9	nsubj	1764	1770	I-persongroup-109953	_
15	3	born	bear	VBN	2	acl	1771	1775	_	_
15	4	in	in	IN	5	case	1776	1778	_	_
15	5	1970	1970	CD	3	dep	1779	1783	_	_
15	6	or	or	CC	5	cc	1784	1786	_	_
15	7	later	later	RB	5	conj	1787	1792	_	_
15	8	:	:	:	7	punct	1792	1793	_	_
15	9	administer	administer	VB	0	ROOT	1794	1804	_	_
15	10	one	one	CD	11	nummod	1805	1808	_	_
15	11	dose	dose	NN	9	dobj	1809	1813	_	_
15	12	of	of	IN	14	case	1814	1816	_	_
15	13	MMR	mmr	NN	14	compound	1817	1820	_	_
15	14	vaccine	vaccine	NN	11	nmod	1821	1828	_	_
15	15	.	.	.	9	punct	1828	1829	_	_

16	1	Those	those	DT	35	nsubj	1830	1835	B-persongroup-109954	_
16	2	who	who	WP	7	nsubj	1837	1840	_	_
16	3	are	be	VBP	7	cop	1841	1844	_	_
16	4	at	at	IN	7	case	1845	1847	_	_
16	5	the	the	DT	7	det	1848	1851	_	_
16	6	greatest	greatest	JJS	7	amod	1852	1860	_	_
16	7	risk	risk	NN	1	acl:relcl	1861	1865	_	_
16	8	of	of	IN	10	case	1866	1868	_	_
16	9	measles	measles	NNS	10	compound	1869	1876	_	_
16	10	exposure	exposure	NN	7	nmod	1877	1885	_	_
16	11	(	(	CD	12	nummod	1886	1887	_	_
16	12	travellers	traveller	NNS	7	advmod	1887	1897	B-persongroup-109955	_
16	13	to	to	TO	14	case	1898	1900	_	_
16	14	destinations	destination	NNS	12	nmod	1901	1913	B-persongroup-110186	_
16	15	outside	outside	IN	12	case	1915	1922	I-persongroup-110186	_
16	16	of	of	IN	18	case	1923	1925	I-persongroup-110186	_
16	17	North	North	NNP	18	compound	1926	1931	I-persongroup-110186	_
16	18	America	America	NNP	7	nmod	1932	1939	I-persongroup-110186	_
16	19	,	,	,	18	punct	1939	1940	I-persongroup-110186	_
16	20	health	health	NN	22	compound	1941	1947	B-persongroup-109956	_
16	21	care	care	NN	22	compound	1948	1952	I-persongroup-109956	_
16	22	workers	worker	NNS	18	conj	1953	1960	I-persongroup-109956	_
16	23	,	,	,	18	punct	1960	1961	I-persongroup-109956	_
16	24	students	student	NNS	18	conj	1963	1971	B-persongroup-109957	_
16	25	in	in	IN	28	case	1972	1974	_	_
16	26	post-secondary	post-secondary	JJ	28	amod	1975	1989	_	_
16	27	educational	educational	JJ	28	amod	1990	2001	_	_
16	28	settings	setting	NNS	24	nmod	2002	2010	_	_
16	29	,	,	,	18	punct	2010	2011	_	_
16	30	and	and	CC	18	cc	2012	2015	_	_
16	31	military	military	JJ	33	amod	2016	2024	B-persongroup-109958	_
16	32	personnel	personnel	NNS	33	compound	2025	2034	I-persongroup-109958	_
16	33	)	)	NN	18	conj	2034	2035	I-persongroup-109958	_
16	34	should	should	MD	35	aux	2036	2042	_	_
16	35	receive	receive	VB	0	ROOT	2044	2051	_	_
16	36	two	two	CD	37	nummod	2052	2055	_	_
16	37	doses	dose	NNS	35	dobj	2056	2061	_	_
16	38	of	of	IN	40	case	2062	2064	_	_
16	39	MMR	mmr	NN	40	compound	2065	2068	_	_
16	40	vaccine	vaccine	NN	37	nmod	2069	2076	_	_
16	41	.	.	.	35	punct	2076	2077	_	_

17	1	Non-immune	non-immune	JJ	4	amod	2079	2089	B-persongroup-109959	_
17	2	health	health	NN	4	compound	2091	2097	I-persongroup-109959	_
17	3	care	care	NN	4	compound	2098	2102	I-persongroup-109959	_
17	4	workers	worker	NNS	8	nsubj	2103	2110	I-persongroup-109959	_
17	5	and	and	CC	4	cc	2111	2114	_	_
17	6	military	military	JJ	7	amod	2115	2123	B-persongroup-109960	_
17	7	personnel	personnel	NNS	4	conj	2124	2133	I-persongroup-109960	_
17	8	born	bear	VBN	0	ROOT	2134	2138	_	_
17	9	before	before	IN	10	case	2139	2145	_	_
17	10	1970	1970	CD	8	nmod	2146	2150	_	_
17	11	:	:	:	8	punct	2150	2151	_	_
17	12	administer	administer	VB	8	parataxis	2152	2162	_	_
17	13	two	two	CD	14	nummod	2163	2166	_	_
17	14	doses	dose	NNS	12	dobj	2168	2173	_	_
17	15	of	of	IN	17	case	2174	2176	_	_
17	16	MMR	mmr	NN	17	compound	2177	2180	_	_
17	17	vaccine	vaccine	NN	14	nmod	2181	2188	_	_
17	18	at	at	IN	19	case	2189	2191	_	_
17	19	least	least	JJS	20	nmod:npmod	2192	2197	_	_
17	20	4	4	CD	21	nummod	2198	2199	_	_
17	21	weeks	week	NNS	22	nmod:npmod	2200	2205	_	_
17	22	apart	apart	RB	17	advmod	2206	2211	_	_
17	23	.	.	.	8	punct	2211	2212	_	_

18	1	Non-immune	non-immune	JJ	2	amod	2213	2223	B-persongroup-109961	_
18	2	travellers	traveller	NNS	3	nsubj	2225	2235	I-persongroup-109961	_
18	3	born	bear	VBN	0	ROOT	2236	2240	_	_
18	4	before	before	IN	5	case	2241	2247	_	_
18	5	1970	1970	CD	3	nmod	2248	2252	_	_
18	6	:	:	:	3	punct	2252	2253	_	_
18	7	administer	administer	VB	3	parataxis	2254	2264	_	_
18	8	one	one	CD	9	nummod	2265	2268	_	_
18	9	dose	dose	NN	7	dobj	2269	2273	_	_
18	10	of	of	IN	12	case	2274	2276	_	_
18	11	MMR	mmr	NN	12	compound	2277	2280	_	_
18	12	vaccine	vaccine	NN	9	nmod	2281	2288	_	_
18	13	.	.	.	3	punct	2288	2289	_	_

19	1	Non-immune	non-immune	JJ	2	amod	2291	2301	B-persongroup-109962	_
19	2	students	student	NNS	3	nsubj	2302	2310	I-persongroup-109962	_
19	3	born	bear	VBN	0	ROOT	2311	2315	_	_
19	4	before	before	IN	5	case	2316	2322	_	_
19	5	1970	1970	CD	3	nmod	2323	2327	_	_
19	6	:	:	:	3	punct	2327	2328	_	_
19	7	consider	consider	VB	3	parataxis	2329	2337	_	_
19	8	administering	administer	VBG	7	xcomp	2338	2351	_	_
19	9	one	one	CD	10	nummod	2352	2355	_	_
19	10	dose	dose	NN	8	dobj	2356	2360	_	_
19	11	of	of	IN	13	case	2361	2363	_	_
19	12	MMR	mmr	NN	13	compound	2364	2367	_	_
19	13	vaccine	vaccine	NN	10	nmod	2368	2375	_	_
19	14	.	.	.	3	punct	2375	2376	_	_

20	1	Measles	Measles	NNP	2	nsubj	2377	2384	_	_
20	2	occurs	occur	VBZ	0	ROOT	2385	2391	_	_
20	3	worldwide	worldwide	RB	2	advmod	2392	2401	_	_
20	4	and	and	CC	2	cc	2402	2405	_	_
20	5	is	be	VBZ	6	cop	2406	2408	_	_
20	6	one	one	CD	2	conj	2409	2412	_	_
20	7	of	of	IN	13	case	2413	2415	_	_
20	8	the	the	DT	13	det	2416	2419	_	_
20	9	most	most	RBS	11	advmod	2420	2424	_	_
20	10	highly	highly	RB	11	advmod	2426	2432	_	_
20	11	communicable	communicable	JJ	13	amod	2433	2445	_	_
20	12	infectious	infectious	JJ	13	amod	2446	2456	_	_
20	13	diseases	disease	NNS	6	nmod	2457	2465	_	_
20	14	.	.	.	2	punct	2465	2466	_	_

21	1	Complications	complication	NNS	5	nsubj	2468	2481	_	_
21	2	of	of	IN	4	case	2482	2484	_	_
21	3	measles	measles	NNS	4	compound	2485	2492	_	_
21	4	disease	disease	NN	1	nmod	2493	2500	_	_
21	5	occur	occur	VBP	0	ROOT	2501	2506	_	_
21	6	in	in	IN	9	case	2507	2509	_	_
21	7	about	about	RB	8	advmod	2510	2515	_	_
21	8	10	10	CD	9	nummod	2517	2519	_	_
21	9	%	%	NN	5	nmod	2519	2520	_	_
21	10	of	of	IN	12	case	2521	2523	_	_
21	11	measles	measles	NNS	12	compound	2524	2531	_	_
21	12	cases	case	NNS	9	nmod	2532	2537	_	_
21	13	.	.	.	5	punct	2537	2538	_	_

22	1	MMR	mmr	NN	4	compound	2540	2543	_	_
22	2	and	and	CC	1	cc	2544	2547	_	_
22	3	MMRV	mmrv	NN	1	conj	2548	2552	_	_
22	4	vaccines	vaccine	NNS	6	nsubj	2553	2561	_	_
22	5	are	be	VBP	6	cop	2562	2565	_	_
22	6	safe	safe	JJ	0	ROOT	2566	2570	_	_
22	7	and	and	CC	6	cc	2571	2574	_	_
22	8	effective	effective	JJ	6	conj	2575	2584	_	_
22	9	.	.	.	6	punct	2584	2585	_	_

23	1	Since	since	IN	9	case	2587	2592	_	_
23	2	the	the	DT	3	det	2593	2596	_	_
23	3	publication	publication	NN	9	compound	2597	2608	_	_
23	4	of	of	IN	8	case	2609	2611	_	_
23	5	the	the	DT	8	det	2612	2615	B-persongroup-109963	_
23	6	2006	2006	CD	8	nummod	2616	2620	I-persongroup-109963	_
23	7	Canadian	canadian	JJ	8	amod	2621	2629	I-persongroup-109963	_
23	8	Immunization	immunization	NN	3	nmod	2630	2642	I-persongroup-109963	_
23	9	Guide	Guide	NNP	15	nmod	2644	2649	I-persongroup-109963	_
23	10	:	:	:	15	punct	2649	2650	I-persongroup-109963	_
23	11	New	New	NNP	12	compound	2651	2654	_	_
23	12	recommendations	recommendation	NNS	15	nsubjpass	2655	2670	_	_
23	13	have	have	VBP	15	aux	2671	2675	_	_
23	14	been	be	VBN	15	auxpass	2682	2686	_	_
23	15	made	make	VBN	0	ROOT	2687	2691	_	_
23	16	for	for	IN	18	case	2692	2695	_	_
23	17	measles	measles	NNS	18	compound	2696	2703	_	_
23	18	vaccination	vaccination	NN	15	nmod	2704	2715	_	_
23	19	of	of	IN	22	case	2716	2718	_	_
23	20	health	health	NN	22	compound	2719	2725	B-persongroup-109964	_
23	21	care	care	NN	22	compound	2726	2730	I-persongroup-109964	_
23	22	workers	worker	NNS	18	nmod	2731	2738	I-persongroup-109964	_
23	23	,	,	,	22	punct	2738	2739	I-persongroup-109964	_
23	24	travellers	traveller	NNS	22	conj	2740	2750	B-persongroup-109965	_
23	25	and	and	CC	22	cc	2751	2754	_	_
23	26	military	military	JJ	27	amod	2755	2763	B-persongroup-109966	_
23	27	personnel	personnel	NNS	22	conj	2770	2779	I-persongroup-109966	_
23	28	.	.	.	15	punct	2779	2780	I-persongroup-109966	_

24	1	For	for	IN	3	case	2781	2784	_	_
24	2	additional	additional	JJ	3	amod	2785	2795	_	_
24	3	information	information	NN	5	nmod	2796	2807	_	_
24	4	,	,	,	5	punct	2807	2808	_	_
24	5	refer	refer	VBP	0	ROOT	2809	2814	_	_
24	6	to	to	TO	10	case	2815	2817	_	_
24	7	the	the	DT	10	det	2818	2821	B-persongroup-109967	_
24	8	National	National	NNP	10	compound	2822	2830	I-persongroup-109967	_
24	9	Advisory	Advisory	NNP	10	compound	2831	2839	I-persongroup-109967	_
24	10	Committee	Committee	NNP	5	nmod	2840	2849	I-persongroup-109967	_
24	11	on	on	IN	14	case	2850	2852	I-persongroup-109967	_
24	12	Immunization	immunization	NN	14	compound	2853	2865	I-persongroup-109967	_
24	13	(	(	CD	14	nummod	2866	2867	I-persongroup-109967	_
24	14	NACI	NACI	NNP	5	nmod	2867	2871	I-persongroup-109967	_
24	15	)	)	CD	16	nummod	2871	2872	I-persongroup-109967	_
24	16	Statements	statement	NNS	14	dep	2873	2883	_	_
24	17	:	:	:	14	punct	2883	2884	_	_
24	18	Statement	statement	NN	14	dep	2885	2894	_	_
24	19	on	on	IN	21	case	2895	2897	_	_
24	20	Measles-Mumps-Rubella-Varicella	Measles-Mumps-Rubella-Varicella	NNP	21	compound	2898	2929	_	_
24	21	Vaccine	Vaccine	NNP	18	nmod	2931	2938	_	_
24	22	and	and	CC	14	cc	2939	2942	_	_
24	23	Updated	Updated	NNP	24	compound	2943	2950	_	_
24	24	Recommendations	Recommendations	NNPS	14	conj	2952	2967	_	_
24	25	for	for	IN	27	case	2968	2971	_	_
24	26	the	the	DT	27	det	2972	2975	_	_
24	27	use	use	NN	24	nmod	2976	2979	_	_
24	28	of	of	IN	32	case	2980	2982	_	_
24	29	Varicella	varicella	NN	32	compound	2983	2992	_	_
24	30	and	and	CC	29	cc	2993	2996	_	_
24	31	MMR	mmr	NN	29	conj	2997	3000	_	_
24	32	Vaccines	vaccine	NNS	27	nmod	3001	3009	_	_
24	33	in	in	IN	35	case	3010	3012	_	_
24	34	HIV-infected	hiv-infected	JJ	35	amod	3013	3025	B-persongroup-109968	_
24	35	Individuals	individual	NNS	32	nmod	3027	3038	I-persongroup-109968	_
24	36	.	.	.	5	punct	3038	3039	I-persongroup-109968	_

25	1	Infectious	infectious	JJ	2	amod	3041	3051	_	_
25	2	agent	agent	NN	11	nsubjpass	3052	3057	_	_
25	3	Measles	Measles	NNP	5	compound	3060	3067	_	_
25	4	(	(	CD	5	nummod	3068	3069	_	_
25	5	rubeola	rubeola	NN	2	dep	3069	3076	_	_
25	6	,	,	,	2	punct	3076	3077	_	_
25	7	red	red	JJ	9	amod	3078	3081	_	_
25	8	measles	measles	NNS	9	compound	3082	3089	_	_
25	9	)	)	NN	2	appos	3089	3090	_	_
25	10	is	be	VBZ	11	auxpass	3091	3093	_	_
25	11	caused	cause	VBN	0	ROOT	3094	3100	_	_
25	12	by	by	IN	14	case	3101	3103	_	_
25	13	measles	measles	NNS	14	compound	3104	3111	_	_
25	14	virus	virus	NN	11	nmod	3112	3117	_	_
25	15	,	,	,	14	punct	3117	3118	_	_
25	16	a	a	DT	17	det	3119	3120	_	_
25	17	member	member	NN	14	appos	3122	3128	_	_
25	18	of	of	IN	21	case	3129	3131	_	_
25	19	the	the	DT	21	det	3132	3135	_	_
25	20	Paramyxoviridae	Paramyxoviridae	NNP	21	compound	3136	3151	_	_
25	21	family	family	NN	17	nmod	3152	3158	_	_
25	22	.	.	.	11	punct	3158	3159	_	_

26	1	Reservoir	Reservoir	NNP	2	compound	3160	3169	_	_
26	2	Humans	human	NNS	6	nsubj	3177	3183	_	_
26	3	Transmission	Transmission	NNP	4	compound	3184	3196	_	_
26	4	Measles	Measles	NNP	2	dep	3204	3211	_	_
26	5	is	be	VBZ	6	cop	3212	3214	_	_
26	6	one	one	CD	0	ROOT	3215	3218	_	_
26	7	of	of	IN	13	case	3219	3221	_	_
26	8	the	the	DT	13	det	3222	3225	_	_
26	9	most	most	RBS	11	advmod	3226	3230	_	_
26	10	highly	highly	RB	11	advmod	3231	3237	_	_
26	11	communicable	communicable	JJ	13	amod	3238	3250	_	_
26	12	infectious	infectious	JJ	13	amod	3251	3261	_	_
26	13	diseases	disease	NNS	6	nmod	3263	3271	_	_
26	14	with	with	IN	21	case	3272	3276	_	_
26	15	greater	greater	JJR	18	advmod	3277	3284	_	_
26	16	than	than	IN	18	advmod	3285	3289	_	_
26	17	90	90	CD	18	compound	3290	3292	_	_
26	18	%	%	NN	21	nummod	3292	3293	_	_
26	19	secondary	secondary	JJ	21	amod	3294	3303	_	_
26	20	attack	attack	NN	21	compound	3304	3310	_	_
26	21	rates	rate	NNS	13	nmod	3311	3316	_	_
26	22	among	among	IN	24	case	3317	3322	_	_
26	23	susceptible	susceptible	JJ	24	amod	3323	3334	B-persongroup-109969	_
26	24	persons	person	NNS	21	nmod	3335	3342	I-persongroup-109969	_
26	25	.	.	.	6	punct	3342	3343	I-persongroup-109969	_

27	1	The	the	DT	2	det	3345	3348	_	_
27	2	virus	virus	NN	4	nsubjpass	3349	3354	_	_
27	3	is	be	VBZ	4	auxpass	3355	3357	_	_
27	4	transmitted	transmit	VBN	0	ROOT	3358	3369	_	_
27	5	by	by	IN	8	case	3370	3372	_	_
27	6	the	the	DT	8	det	3373	3376	_	_
27	7	airborne	airborne	JJ	8	amod	3378	3386	_	_
27	8	route	route	NN	4	nmod	3387	3392	_	_
27	9	,	,	,	8	punct	3392	3393	_	_
27	10	respiratory	respiratory	JJ	11	amod	3394	3405	_	_
27	11	droplets	droplet	NNS	8	conj	3406	3414	_	_
27	12	,	,	,	8	punct	3414	3415	_	_
27	13	or	or	CC	8	cc	3416	3418	_	_
27	14	direct	direct	JJ	15	amod	3419	3425	_	_
27	15	contact	contact	NN	8	conj	3426	3433	_	_
27	16	with	with	IN	20	case	3434	3438	_	_
27	17	nasal	nasal	JJ	20	amod	3439	3444	_	_
27	18	or	or	CC	17	cc	3445	3447	_	_
27	19	throat	throat	NN	17	conj	3448	3454	_	_
27	20	secretions	secretion	NNS	4	nmod	3456	3466	_	_
27	21	of	of	IN	23	case	3467	3469	_	_
27	22	infected	infected	JJ	23	amod	3470	3478	B-persongroup-109970	_
27	23	persons	person	NNS	20	nmod	3479	3486	I-persongroup-109970	_
27	24	.	.	.	4	punct	3486	3487	I-persongroup-109970	_

28	1	The	the	DT	3	det	3488	3491	_	_
28	2	incubation	incubation	NN	3	compound	3492	3502	_	_
28	3	period	period	NN	9	nsubj	3503	3509	_	_
28	4	is	be	VBZ	9	cop	3510	3512	_	_
28	5	about	about	IN	9	case	3513	3518	_	_
28	6	10	10	CD	7	nummod	3519	3521	_	_
28	7	days	day	NNS	8	nmod:npmod	3522	3526	_	_
28	8	(	(	JJ	9	amod	3528	3529	_	_
28	9	range	range	NN	0	ROOT	3529	3534	_	_
28	10	,	,	,	9	punct	3534	3535	_	_
28	11	7	7	CD	13	compound	3536	3537	_	_
28	12	to	to	TO	13	dep	3538	3540	_	_
28	13	18	18	CD	14	nummod	3541	3543	_	_
28	14	days	day	NNS	9	appos	3544	3548	_	_
28	15	)	)	RB	9	advmod	3548	3549	_	_
28	16	.	.	.	9	punct	3549	3550	_	_

29	1	The	the	DT	2	det	3551	3554	_	_
29	2	interval	interval	NN	0	ROOT	3555	3563	_	_
29	3	from	from	IN	4	case	3564	3568	_	_
29	4	exposure	exposure	NN	2	nmod	3569	3577	_	_
29	5	to	to	TO	6	case	3578	3580	_	_
29	6	appearance	appearance	NN	2	nmod	3581	3591	_	_
29	7	of	of	IN	9	case	3592	3594	_	_
29	8	rash	rash	NN	9	compound	3595	3599	_	_
29	9	averages	average	NNS	6	nmod	3601	3609	_	_
29	10	14	14	CD	11	nummod	3610	3612	_	_
29	11	days	day	NNS	6	nmod:tmod	3613	3617	_	_
29	12	.	.	.	2	punct	3617	3618	_	_

30	1	Cases	case	NNS	3	nsubj	3619	3624	_	_
30	2	are	be	VBP	3	cop	3625	3628	_	_
30	3	infectious	infectious	JJ	0	ROOT	3629	3639	_	_
30	4	from	from	IN	6	case	3640	3644	_	_
30	5	1	1	CD	6	nummod	3645	3646	_	_
30	6	day	day	NN	3	nmod	3647	3650	_	_
30	7	before	before	IN	9	case	3651	3657	_	_
30	8	the	the	DT	9	det	3658	3661	_	_
30	9	beginning	beginning	NN	6	nmod	3662	3671	_	_
30	10	of	of	IN	13	case	3672	3674	_	_
30	11	the	the	DT	13	det	3676	3679	_	_
30	12	prodromal	prodromal	JJ	13	amod	3680	3689	_	_
30	13	period	period	NN	9	nmod	3690	3696	_	_
30	14	to	to	TO	16	case	3697	3699	_	_
30	15	4	4	CD	16	nummod	3700	3701	_	_
30	16	days	day	NNS	3	nmod	3702	3706	_	_
30	17	after	after	IN	19	case	3707	3712	_	_
30	18	rash	rash	NN	19	compound	3713	3717	_	_
30	19	onset	onset	NN	16	nmod	3718	3723	_	_
30	20	.	.	.	3	punct	3723	3724	_	_

31	1	People	people	NNS	6	nsubj	3725	3731	B-persongroup-109971	_
31	2	who	who	WP	3	nsubj	3732	3735	_	_
31	3	recover	recover	VBP	1	acl:relcl	3736	3743	_	_
31	4	from	from	IN	5	case	3744	3748	_	_
31	5	measles	measles	NNS	3	nmod	3750	3757	_	_
31	6	have	have	VBP	0	ROOT	3758	3762	_	_
31	7	permanent	permanent	JJ	8	amod	3763	3772	_	_
31	8	immunity	immunity	NN	6	dobj	3773	3781	_	_
31	9	to	to	TO	11	case	3782	3784	_	_
31	10	the	the	DT	11	det	3785	3788	_	_
31	11	disease	disease	NN	6	nmod	3789	3796	_	_
31	12	.	.	.	6	punct	3796	3797	_	_

32	1	Risk	risk	NN	2	compound	3798	3802	_	_
32	2	factors	factor	NNS	20	nsubj	3803	3810	_	_
32	3	All	all	DT	4	det	3818	3821	B-persongroup-109972	_
32	4	persons	person	NNS	2	dep	3822	3829	I-persongroup-109972	_
32	5	who	who	WP	8	nsubj	3830	3833	_	_
32	6	have	have	VBP	8	aux	3834	3838	_	_
32	7	not	not	RB	8	neg	3839	3842	_	_
32	8	had	have	VBN	2	acl:relcl	3843	3846	_	_
32	9	measles	measles	NNS	10	compound	3847	3854	_	_
32	10	disease	disease	NN	8	dobj	3855	3862	_	_
32	11	or	or	CC	10	cc	3864	3866	_	_
32	12	who	who	WP	17	nsubjpass	3867	3870	_	_
32	13	have	have	VBP	17	aux	3871	3875	_	_
32	14	not	not	RB	17	neg	3876	3879	_	_
32	15	been	be	VBN	17	auxpass	3880	3884	_	_
32	16	successfully	successfully	RB	17	advmod	3885	3897	_	_
32	17	vaccinated	vaccinate	VBN	10	conj	3898	3908	_	_
32	18	are	be	VBP	20	cop	3909	3912	_	_
32	19	at	at	IN	20	case	3913	3915	_	_
32	20	risk	risk	NN	0	ROOT	3916	3920	_	_
32	21	of	of	IN	22	case	3921	3923	_	_
32	22	infection	infection	NN	20	nmod	3924	3933	_	_
32	23	.	.	.	20	punct	3933	3934	_	_

33	1	In	in	IN	2	case	3935	3937	_	_
33	2	Canada	Canada	NNP	10	nmod	3938	3944	B-persongroup-109973	_
33	3	,	,	,	10	punct	3944	3945	I-persongroup-109973	_
33	4	adults	adult	NNS	10	nsubjpass	3947	3953	B-persongroup-109974	_
33	5	born	bear	VBN	4	acl	3954	3958	_	_
33	6	before	before	IN	7	case	3959	3965	_	_
33	7	1970	1970	CD	5	nmod	3966	3970	_	_
33	8	are	be	VBP	10	auxpass	3971	3974	_	_
33	9	generally	generally	RB	10	advmod	3975	3984	_	_
33	10	presumed	presume	VBN	0	ROOT	3985	3993	_	_
33	11	to	to	TO	13	mark	3994	3996	_	_
33	12	have	have	VB	13	aux	3997	4001	_	_
33	13	acquired	acquire	VBN	10	xcomp	4003	4011	_	_
33	14	natural	natural	JJ	15	amod	4012	4019	_	_
33	15	immunity	immunity	NN	13	dobj	4020	4028	_	_
33	16	to	to	TO	17	case	4029	4031	_	_
33	17	measles	measles	NNS	13	nmod	4032	4039	_	_
33	18	.	.	.	10	punct	4039	4040	_	_

34	1	Individuals	individual	NNS	9	nsubj	4041	4052	B-persongroup-109975	_
34	2	at	at	IN	4	case	4053	4055	_	_
34	3	greatest	greatest	JJS	4	amod	4056	4064	_	_
34	4	risk	risk	NN	1	nmod	4065	4069	_	_
34	5	of	of	IN	6	case	4070	4072	_	_
34	6	exposure	exposure	NN	1	nmod	4073	4081	_	_
34	7	to	to	TO	8	case	4083	4085	_	_
34	8	measles	measles	NNS	6	nmod	4086	4093	_	_
34	9	include	include	VBP	0	ROOT	4094	4101	_	_
34	10	travellers	traveller	NNS	9	dobj	4102	4112	B-persongroup-109976	_
34	11	to	to	TO	12	case	4113	4115	_	_
34	12	destinations	destination	NNS	9	nmod	4116	4128	B-persongroup-110185	_
34	13	outside	outside	IN	9	advmod	4129	4136	I-persongroup-110185	_
34	14	of	of	IN	16	case	4137	4139	I-persongroup-110185	_
34	15	North	North	NNP	16	compound	4140	4145	I-persongroup-110185	_
34	16	America	America	NNP	13	nmod	4148	4155	I-persongroup-110185	_
34	17	,	,	,	16	punct	4155	4156	I-persongroup-110185	_
34	18	health	health	NN	20	compound	4157	4163	B-persongroup-109977	_
34	19	care	care	NN	20	compound	4164	4168	I-persongroup-109977	_
34	20	workers	worker	NNS	16	conj	4169	4176	I-persongroup-109977	_
34	21	,	,	,	16	punct	4176	4177	I-persongroup-109977	_
34	22	students	student	NNS	16	conj	4178	4186	B-persongroup-109978	_
34	23	in	in	IN	26	case	4187	4189	_	_
34	24	post-secondary	post-secondary	JJ	26	amod	4190	4204	_	_
34	25	educational	educational	JJ	26	amod	4206	4217	_	_
34	26	settings	setting	NNS	22	nmod	4218	4226	_	_
34	27	,	,	,	16	punct	4226	4227	_	_
34	28	and	and	CC	16	cc	4228	4231	_	_
34	29	military	military	JJ	30	amod	4232	4240	B-persongroup-109979	_
34	30	personnel	personnel	NNS	16	conj	4241	4250	I-persongroup-109979	_
34	31	.	.	.	9	punct	4250	4251	I-persongroup-109979	_

35	1	Seasonal/temporal	seasonal/temporal	JJ	2	amod	4252	4269	_	_
35	2	patterns	pattern	NNS	5	nsubj	4271	4279	_	_
35	3	Historically	Historically	NNP	2	appos	4287	4299	_	_
35	4	,	,	,	5	punct	4299	4300	_	_
35	5	measles	measle	VBZ	0	ROOT	4301	4308	_	_
35	6	disease	disease	NN	7	nsubj	4309	4316	_	_
35	7	occurs	occur	VBZ	5	ccomp	4317	4323	_	_
35	8	primarily	primarily	RB	7	advmod	4324	4333	_	_
35	9	in	in	IN	11	case	4334	4336	_	_
35	10	late	late	JJ	11	amod	4337	4341	_	_
35	11	winter	winter	NN	7	nmod	4343	4349	_	_
35	12	and	and	CC	11	cc	4350	4353	_	_
35	13	spring	spring	NN	11	conj	4354	4360	_	_
35	14	in	in	IN	16	case	4361	4363	_	_
35	15	temperate	temperate	JJ	16	amod	4364	4373	_	_
35	16	zones	zone	NNS	11	nmod	4374	4379	_	_
35	17	.	.	.	5	punct	4379	4380	_	_

36	1	It	it	PRP	4	nsubj	4381	4383	_	_
36	2	is	be	VBZ	4	cop	4384	4386	_	_
36	3	now	now	RB	4	advmod	4387	4390	_	_
36	4	restricted	restricted	JJ	0	ROOT	4391	4401	_	_
36	5	to	to	TO	7	case	4402	4404	_	_
36	6	sporadic	sporadic	JJ	7	amod	4405	4413	_	_
36	7	cases	case	NNS	4	nmod	4414	4419	_	_
36	8	and	and	CC	7	cc	4421	4424	_	_
36	9	outbreaks	outbreak	NNS	7	conj	4425	4434	_	_
36	10	.	.	.	4	punct	4434	4435	_	_

37	1	Spectrum	spectrum	NN	8	nsubj	4437	4445	_	_
37	2	of	of	IN	5	case	4446	4448	_	_
37	3	clinical	clinical	JJ	5	amod	4449	4457	_	_
37	4	illness	illness	NN	5	compound	4459	4466	_	_
37	5	Symptoms	symptom	NNS	1	nmod	4474	4482	_	_
37	6	of	of	IN	7	case	4483	4485	_	_
37	7	measles	measles	NNS	5	nmod	4487	4494	_	_
37	8	include	include	VBP	0	ROOT	4495	4502	_	_
37	9	prodromal	prodromal	JJ	10	amod	4503	4512	_	_
37	10	fever	fever	NN	8	dobj	4513	4518	_	_
37	11	,	,	,	10	punct	4518	4519	_	_
37	12	cough	cough	NN	10	appos	4520	4525	_	_
37	13	,	,	,	10	punct	4525	4526	_	_
37	14	coryza	coryza	NN	10	appos	4527	4533	_	_
37	15	,	,	,	10	punct	4533	4534	_	_
37	16	conjunctivitis	conjunctivitis	NN	10	appos	4535	4549	_	_
37	17	,	,	,	10	punct	4549	4550	_	_
37	18	Koplik	Koplik	NNP	19	compound	4551	4557	_	_
37	19	spots	spot	NNS	10	appos	4558	4563	_	_
37	20	(	(	CD	22	nummod	4565	4566	_	_
37	21	white	white	JJ	22	amod	4566	4571	_	_
37	22	spots	spot	NNS	19	dep	4572	4577	_	_
37	23	on	on	IN	26	case	4578	4580	_	_
37	24	the	the	DT	26	det	4581	4584	_	_
37	25	inner	inner	JJ	26	amod	4585	4590	_	_
37	26	lining	lining	NN	10	nmod	4591	4597	_	_
37	27	of	of	IN	30	case	4598	4600	_	_
37	28	the	the	DT	30	det	4601	4604	_	_
37	29	mouth	mouth	NN	30	compound	4605	4610	_	_
37	30	)	)	NN	26	nmod	4610	4611	_	_
37	31	and	and	CC	10	cc	4612	4615	_	_
37	32	a	a	DT	33	det	4616	4617	_	_
37	33	rash	rash	NN	10	conj	4618	4622	_	_
37	34	that	that	WDT	36	nsubj	4623	4627	_	_
37	35	typically	typically	RB	36	advmod	4628	4637	_	_
37	36	begins	begin	VBZ	33	acl:relcl	4638	4644	_	_
37	37	on	on	IN	39	case	4646	4648	_	_
37	38	the	the	DT	39	det	4649	4652	_	_
37	39	face	face	NN	36	nmod	4653	4657	_	_
37	40	,	,	,	39	punct	4657	4658	_	_
37	41	advances	advance	NNS	39	appos	4659	4667	_	_
37	42	to	to	TO	44	case	4668	4670	_	_
37	43	the	the	DT	44	det	4671	4674	_	_
37	44	trunk	trunk	NN	41	nmod	4675	4680	_	_
37	45	and	and	CC	44	cc	4681	4684	_	_
37	46	then	then	RB	49	advmod	4685	4689	_	_
37	47	to	to	TO	49	case	4690	4692	_	_
37	48	the	the	DT	49	det	4693	4696	_	_
37	49	arms	arm	NNS	44	conj	4697	4701	_	_
37	50	and	and	CC	49	cc	4702	4705	_	_
37	51	legs	leg	NNS	49	conj	4706	4710	_	_
37	52	.	.	.	8	punct	4710	4711	_	_

38	1	Complications	complication	NNS	8	nsubj	4712	4725	_	_
38	2	such	such	JJ	5	case	4727	4731	_	_
38	3	as	as	IN	2	mwe	4732	4734	_	_
38	4	otitis	otitis	NN	5	compound	4735	4741	_	_
38	5	media	media	NNS	1	nmod	4742	4747	_	_
38	6	and	and	CC	5	cc	4748	4751	_	_
38	7	bronchopneumonia	bronchopneumonia	NN	5	conj	4752	4768	_	_
38	8	occur	occur	VBP	0	ROOT	4769	4774	_	_
38	9	in	in	IN	12	case	4775	4777	_	_
38	10	about	about	RB	11	advmod	4778	4783	B-persongroup-109980	_
38	11	10	10	CD	12	nummod	4784	4786	I-persongroup-109980	_
38	12	%	%	NN	8	nmod	4786	4787	I-persongroup-109980	_
38	13	of	of	IN	15	case	4788	4790	I-persongroup-109980	_
38	14	reported	report	VBN	15	amod	4791	4799	I-persongroup-109980	_
38	15	cases	case	NNS	12	nmod	4800	4805	I-persongroup-109980	_
38	16	,	,	,	12	punct	4805	4806	I-persongroup-109980	_
38	17	even	even	RB	12	conj	4808	4812	_	_
38	18	more	more	RBR	19	advmod	4813	4817	_	_
38	19	commonly	commonly	RB	21	advmod	4818	4826	_	_
38	20	in	in	IN	21	case	4827	4829	_	_
38	21	those	those	DT	12	nmod	4830	4835	_	_
38	22	who	who	WP	25	nsubj	4836	4839	_	_
38	23	are	be	VBP	25	cop	4840	4843	_	_
38	24	poorly	poorly	RB	25	advmod	4844	4850	_	_
38	25	nourished	nourish	VBN	21	acl:relcl	4851	4860	_	_
38	26	and	and	CC	25	cc	4861	4864	_	_
38	27	chronically	chronically	RB	28	advmod	4865	4876	_	_
38	28	ill	ill	RB	25	conj	4877	4880	_	_
38	29	,	,	,	12	punct	4880	4881	_	_
38	30	and	and	CC	12	cc	4882	4885	_	_
38	31	in	in	IN	32	case	4887	4889	_	_
38	32	infants	infant	NNS	12	conj	4890	4897	B-persongroup-109981	_
38	33	less	less	JJR	35	advmod	4898	4902	_	_
38	34	than	than	IN	33	mwe	4903	4907	_	_
38	35	1	1	CD	36	nummod	4908	4909	_	_
38	36	year	year	NN	32	nmod	4910	4914	_	_
38	37	of	of	IN	36	case	4915	4917	_	_
38	38	age	age	NN	36	dep	4918	4921	_	_
38	39	.	.	.	8	punct	4921	4922	_	_

39	1	Measles	Measles	NNP	2	compound	4923	4930	_	_
39	2	encephalitis	encephalitis	NN	3	nsubj	4931	4943	_	_
39	3	occurs	occur	VBZ	0	ROOT	4944	4950	_	_
39	4	in	in	IN	10	mark	4951	4953	_	_
39	5	approximately	approximately	RB	6	advmod	4955	4968	B-persongroup-109982	_
39	6	1	1	CD	10	nsubj	4969	4970	I-persongroup-109982	_
39	7	of	of	IN	9	case	4971	4973	I-persongroup-109982	_
39	8	every	every	DT	9	det	4974	4979	I-persongroup-109982	_
39	9	1,000	1,000	CD	6	nmod	4980	4985	I-persongroup-109982	_
39	10	reported	report	VBD	3	advcl	4986	4994	I-persongroup-109982	_
39	11	cases	case	NNS	10	dobj	4995	5000	I-persongroup-109982	_
39	12	and	and	CC	10	cc	5001	5004	_	_
39	13	may	may	MD	14	aux	5005	5008	_	_
39	14	result	result	VB	10	conj	5009	5015	_	_
39	15	in	in	IN	18	case	5016	5018	_	_
39	16	permanent	permanent	JJ	18	amod	5019	5028	_	_
39	17	brain	brain	NN	18	compound	5029	5034	_	_
39	18	damage	damage	NN	14	nmod	5036	5042	_	_
39	19	.	.	.	3	punct	5042	5043	_	_

40	1	Measles	Measles	NNP	2	compound	5044	5051	_	_
40	2	infection	infection	NN	4	nsubj	5052	5061	_	_
40	3	can	can	MD	4	aux	5062	5065	_	_
40	4	cause	cause	VB	0	ROOT	5066	5071	_	_
40	5	subacute	subacute	JJ	10	amod	5072	5080	_	_
40	6	sclerosing	sclerosing	NN	10	compound	5081	5091	_	_
40	7	panencephalitis	panencephalitis	NN	10	compound	5092	5107	_	_
40	8	(	(	CD	10	nummod	5108	5109	_	_
40	9	SSPE	sspe	NN	10	compound	5109	5113	_	_
40	10	)	)	NN	4	dobj	5113	5114	_	_
40	11	,	,	,	10	punct	5114	5115	_	_
40	12	a	a	DT	16	det	5117	5118	_	_
40	13	rare	rare	JJ	16	amod	5119	5123	_	_
40	14	but	but	CC	13	cc	5124	5127	_	_
40	15	fatal	fatal	JJ	13	conj	5128	5133	_	_
40	16	disease	disease	NN	10	appos	5134	5141	_	_
40	17	.	.	.	4	punct	5141	5142	_	_

41	1	Measles	Measles	NNP	4	nsubj	5143	5150	_	_
41	2	during	during	IN	3	case	5151	5157	_	_
41	3	pregnancy	pregnancy	NN	1	nmod	5158	5167	_	_
41	4	results	result	VBZ	0	ROOT	5168	5175	_	_
41	5	in	in	IN	8	case	5176	5178	_	_
41	6	a	a	DT	8	det	5179	5180	_	_
41	7	higher	higher	JJR	8	amod	5181	5187	_	_
41	8	risk	risk	NN	4	nmod	5189	5193	_	_
41	9	of	of	IN	11	case	5194	5196	_	_
41	10	premature	premature	JJ	11	amod	5197	5206	_	_
41	11	labour	labour	NN	8	nmod	5207	5213	_	_
41	12	,	,	,	11	punct	5213	5214	_	_
41	13	spontaneous	spontaneous	JJ	14	amod	5215	5226	_	_
41	14	abortion	abortion	NN	11	conj	5227	5235	_	_
41	15	and	and	CC	11	cc	5236	5239	_	_
41	16	low	low	JJ	19	amod	5240	5243	B-persongroup-109983	_
41	17	birth	birth	NN	19	compound	5244	5249	I-persongroup-109983	_
41	18	weight	weight	NN	19	compound	5250	5256	I-persongroup-109983	_
41	19	infants	infant	NNS	11	conj	5257	5264	I-persongroup-109983	_
41	20	.	.	.	4	punct	5264	5265	I-persongroup-109983	_

42	1	Measles	Measles	NNP	8	nsubj	5267	5274	_	_
42	2	in	in	IN	5	case	5275	5277	_	_
42	3	an	a	DT	5	det	5278	5280	B-persongroup-109984	_
42	4	immunocompromised	immunocompromised	JJ	5	amod	5281	5298	I-persongroup-109984	_
42	5	person	person	NN	1	nmod	5299	5305	I-persongroup-109984	_
42	6	may	may	MD	8	aux	5306	5309	_	_
42	7	be	be	VB	8	cop	5310	5312	_	_
42	8	severe	severe	JJ	0	ROOT	5313	5319	_	_
42	9	.	.	.	8	punct	5319	5320	_	_

43	1	Measles	Measles	NNP	2	nsubj	5321	5328	_	_
43	2	occurs	occur	VBZ	0	ROOT	5329	5335	_	_
43	3	worldwide	worldwide	RB	2	advmod	5336	5345	_	_
43	4	and	and	CC	2	cc	5346	5349	_	_
43	5	is	be	VBZ	6	cop	5350	5352	_	_
43	6	one	one	CD	2	conj	5353	5356	_	_
43	7	of	of	IN	13	case	5357	5359	_	_
43	8	the	the	DT	13	det	5360	5363	_	_
43	9	most	most	RBS	11	advmod	5364	5368	_	_
43	10	highly	highly	RB	11	advmod	5369	5375	_	_
43	11	communicable	communicable	JJ	13	amod	5377	5389	_	_
43	12	infectious	infectious	JJ	13	amod	5390	5400	_	_
43	13	diseases	disease	NNS	6	nmod	5401	5409	_	_
43	14	.	.	.	2	punct	5409	5410	_	_

44	1	Measles	Measles	NNP	4	nsubjpass	5421	5428	_	_
44	2	has	have	VBZ	4	aux	5429	5432	_	_
44	3	been	be	VBN	4	auxpass	5433	5437	_	_
44	4	eliminated	eliminate	VBN	0	ROOT	5438	5448	_	_
44	5	in	in	IN	6	case	5449	5451	_	_
44	6	Canada	Canada	NNP	4	nmod	5452	5458	B-persongroup-109985	_
44	7	since	since	IN	8	case	5459	5464	_	_
44	8	1998	1998	CD	4	nmod	5465	5469	_	_
44	9	;	;	:	4	punct	5469	5470	_	_
44	10	however	however	RB	13	advmod	5471	5478	_	_
44	11	,	,	,	13	punct	5478	5479	_	_
44	12	cases	case	NNS	13	nsubj	5480	5485	B-persongroup-109986	_
44	13	continue	continue	VBP	4	parataxis	5487	5495	_	_
44	14	to	to	TO	15	mark	5496	5498	_	_
44	15	occur	occur	VB	13	xcomp	5499	5504	_	_
44	16	as	as	IN	18	case	5505	5507	_	_
44	17	a	a	DT	18	det	5508	5509	_	_
44	18	result	result	NN	15	nmod	5510	5516	_	_
44	19	of	of	IN	20	case	5517	5519	_	_
44	20	importations	importation	NNS	18	nmod	5520	5532	_	_
44	21	.	.	.	4	punct	5532	5533	_	_

45	1	From	from	IN	4	case	5536	5540	_	_
45	2	1998	1998	CD	4	nummod	5541	5545	_	_
45	3	to	to	TO	4	dep	5546	5548	_	_
45	4	2013	2013	CD	7	nmod	5549	5553	_	_
45	5	,	,	,	7	punct	5553	5554	_	_
45	6	1429	1429	CD	7	nsubj	5555	5559	B-persongroup-109987	_
45	7	confirmed	confirm	VBD	0	ROOT	5560	5569	I-persongroup-109987	_
45	8	measles	measles	NNS	9	compound	5570	5577	I-persongroup-109987	_
45	9	cases	case	NNS	11	nsubjpass	5578	5583	I-persongroup-109987	_
45	10	were	be	VBD	11	auxpass	5584	5588	_	_
45	11	reported	report	VBN	7	ccomp	5589	5597	_	_
45	12	in	in	IN	13	case	5598	5600	_	_
45	13	Canada	Canada	NNP	11	nmod	5601	5607	B-persongroup-109988	_
45	14	,	,	,	11	punct	5607	5608	I-persongroup-109988	_
45	15	with	with	IN	17	case	5610	5614	_	_
45	16	a	a	DT	17	det	5615	5616	_	_
45	17	median	median	NN	11	nmod	5617	5623	_	_
45	18	of	of	IN	20	case	5624	5626	_	_
45	19	21.5	21.5	CD	20	nummod	5627	5631	B-persongroup-109989	_
45	20	cases	case	NNS	17	nmod	5632	5637	I-persongroup-109989	_
45	21	per	per	IN	24	case	5638	5641	_	_
45	22	year	year	NN	24	compound	5642	5646	_	_
45	23	(	(	NN	24	compound	5647	5648	_	_
45	24	range	range	NN	20	nmod	5648	5653	_	_
45	25	:	:	:	24	punct	5653	5654	_	_
45	26	6	6	CD	28	compound	5655	5656	_	_
45	27	to	to	TO	28	dep	5657	5659	_	_
45	28	752	752	CD	24	dep	5660	5663	_	_
45	29	)	)	CD	28	dep	5663	5664	_	_
45	30	.	.	.	7	punct	5664	5665	_	_

46	1	For	for	IN	3	case	5666	5669	_	_
46	2	more	more	JJR	3	amod	5670	5674	_	_
46	3	information	information	NN	14	nmod	5675	5686	_	_
46	4	about	about	IN	5	case	5688	5693	_	_
46	5	measles	measles	NNS	3	nmod	5694	5701	_	_
46	6	,	,	,	3	punct	5701	5702	_	_
46	7	including	include	VBG	8	case	5703	5712	_	_
46	8	disease	disease	NN	3	nmod	5713	5720	_	_
46	9	distribution	distribution	NN	14	nsubj	5721	5733	_	_
46	10	and	and	CC	9	cc	5734	5737	_	_
46	11	epidemiology	epidemiology	NN	9	conj	5738	5750	_	_
46	12	in	in	IN	13	case	5751	5753	_	_
46	13	Canada	Canada	NNP	9	nmod	5754	5760	B-persongroup-109990	_
46	14	refer	refer	VBP	0	ROOT	5761	5766	_	_
46	15	to	to	TO	19	case	5768	5770	_	_
46	16	the	the	DT	19	det	5771	5774	B-persongroup-109991	_
46	17	Public	Public	NNP	19	compound	5775	5781	I-persongroup-109991	_
46	18	Health	Health	NNP	19	compound	5782	5788	I-persongroup-109991	_
46	19	Agency	Agency	NNP	14	nmod	5789	5795	I-persongroup-109991	_
46	20	of	of	IN	22	case	5796	5798	_	_
46	21	Canada	Canada	NNP	22	compound	5799	5805	B-persongroup-109992	_
46	22	measles	measles	NNS	19	nmod	5806	5813	_	_
46	23	web	web	NN	24	compound	5814	5817	_	_
46	24	page	page	NN	22	dep	5818	5822	_	_
46	25	.	.	.	14	punct	5822	5823	_	_

47	1	Comprehensive	Comprehensive	NNP	2	compound	5825	5838	_	_
47	2	updates	update	NNS	11	nsubjpass	5839	5846	_	_
47	3	on	on	IN	5	case	5847	5849	_	_
47	4	the	the	DT	5	det	5850	5853	_	_
47	5	epidemiology	epidemiology	NN	2	nmod	5854	5866	_	_
47	6	of	of	IN	7	case	5867	5869	_	_
47	7	measles	measles	NNS	5	nmod	5870	5877	_	_
47	8	in	in	IN	9	case	5878	5880	_	_
47	9	Canada	Canada	NNP	7	nmod	5881	5887	B-persongroup-109993	_
47	10	are	be	VBP	11	auxpass	5888	5891	_	_
47	11	published	publish	VBN	0	ROOT	5892	5901	_	_
47	12	annually	annually	RB	17	advmod	5903	5911	_	_
47	13	in	in	IN	17	case	5912	5914	_	_
47	14	the	the	DT	17	det	5915	5918	B-persongroup-109994	_
47	15	Canadian	canadian	JJ	17	amod	5919	5927	I-persongroup-109994	_
47	16	Communicable	communicable	JJ	17	amod	5929	5941	I-persongroup-109994	_
47	17	Diseases	Diseases	NNPS	11	nmod	5942	5950	I-persongroup-109994	_
47	18	Report	Report	NNP	11	nmod:tmod	5951	5957	I-persongroup-109994	_
47	19	(	(	CD	18	nummod	5958	5959	I-persongroup-109994	_
47	20	CCDR	CCDR	NNP	18	dep	5959	5963	I-persongroup-109994	_
47	21	)	)	CD	20	nummod	5963	5964	I-persongroup-109994	_
47	22	.	.	.	11	punct	5964	5965	I-persongroup-109994	_

48	1	M-M-R	m-m-r	NN	2	compound	5967	5972	_	_
48	2	®	®	NN	51	dep	5972	5973	_	_
48	3	II	ii	CD	2	dep	5973	5975	_	_
48	4	:	:	:	51	punct	5975	5976	_	_
48	5	(	(	CD	6	nmod:npmod	5977	5978	_	_
48	6	live	live	JJ	8	dep	5978	5982	_	_
48	7	,	,	,	8	punct	5982	5983	_	_
48	8	attenuated	attenuate	VBD	51	dep	5984	5994	_	_
48	9	combined	combined	JJ	10	amod	5995	6003	_	_
48	10	measles	measles	NNS	8	dobj	6004	6011	_	_
48	11	,	,	,	10	punct	6011	6012	_	_
48	12	mumps	mumps	NNS	10	conj	6013	6018	_	_
48	13	and	and	CC	10	cc	6019	6022	_	_
48	14	rubella	rubella	NN	10	conj	6023	6030	_	_
48	15	vaccine	vaccine	NN	8	nsubj	6031	6038	_	_
48	16	)	)	CD	15	nummod	6038	6039	_	_
48	17	,	,	,	15	punct	6039	6040	_	_
48	18	Merck	Merck	NNP	22	compound	6041	6046	_	_
48	19	Canada	Canada	NNP	22	compound	6047	6053	_	_
48	20	Inc.	Inc.	NNP	22	compound	6054	6058	_	_
48	21	(	(	CD	22	nummod	6059	6060	_	_
48	22	MMR	MMR	NNP	15	appos	6060	6063	_	_
48	23	)	)	CD	24	nummod	6063	6064	_	_
48	24	PRIORIX	PRIORIX	NNP	22	dep	6065	6072	_	_
48	25	®	®	CD	24	nummod	6072	6073	_	_
48	26	:	:	:	51	punct	6073	6074	_	_
48	27	(	(	CD	28	nmod:npmod	6075	6076	_	_
48	28	live	live	JJ	30	dep	6076	6080	_	_
48	29	,	,	,	30	punct	6080	6081	_	_
48	30	attenuated	attenuate	VBD	51	parataxis	6082	6092	_	_
48	31	combined	combined	JJ	32	amod	6093	6101	_	_
48	32	measles	measles	NNS	30	dobj	6102	6109	_	_
48	33	,	,	,	32	punct	6109	6110	_	_
48	34	mumps	mumps	NNS	32	conj	6111	6116	_	_
48	35	and	and	CC	32	cc	6117	6120	_	_
48	36	rubella	rubella	NN	32	conj	6121	6128	_	_
48	37	vaccine	vaccine	NN	30	nsubj	6129	6136	_	_
48	38	)	)	CD	37	nummod	6136	6137	_	_
48	39	,	,	,	37	punct	6137	6138	_	_
48	40	GlaxoSmithKline	GlaxoSmithKline	NNP	43	compound	6139	6154	_	_
48	41	Inc.	Inc.	NNP	43	compound	6155	6159	_	_
48	42	(	(	CD	43	nummod	6160	6161	_	_
48	43	MMR	MMR	NNP	37	appos	6161	6164	_	_
48	44	)	)	CD	45	nummod	6164	6165	_	_
48	45	PRIORIX-TETRA	priorix-tetra	NN	43	dep	6166	6179	_	_
48	46	®	®	CD	43	dep	6179	6180	_	_
48	47	:	:	:	51	punct	6180	6181	_	_
48	48	(	(	CD	49	nmod:npmod	6182	6183	_	_
48	49	live	live	JJ	51	dep	6183	6187	_	_
48	50	,	,	,	51	punct	6187	6188	_	_
48	51	attenuated	attenuate	VBD	71	dep	6189	6199	_	_
48	52	combined	combined	JJ	53	amod	6200	6208	_	_
48	53	measles	measles	NNS	51	dobj	6209	6216	_	_
48	54	,	,	,	53	punct	6216	6217	_	_
48	55	mumps	mumps	NNS	53	conj	6218	6223	_	_
48	56	,	,	,	53	punct	6223	6224	_	_
48	57	rubella	rubella	NN	53	conj	6226	6233	_	_
48	58	and	and	CC	53	cc	6234	6237	_	_
48	59	varicella	varicella	NN	60	compound	6238	6247	_	_
48	60	vaccine	vaccine	NN	53	conj	6248	6255	_	_
48	61	)	)	CD	51	nsubj	6255	6256	_	_
48	62	,	,	,	61	punct	6256	6257	_	_
48	63	GlaxoSmithKline	GlaxoSmithKline	NNP	64	compound	6258	6273	_	_
48	64	Inc.	Inc.	NNP	61	appos	6274	6278	_	_
48	65	(	(	CD	66	nummod	6279	6280	_	_
48	66	MMRV	mmrv	NN	64	acl:relcl	6280	6284	_	_
48	67	)	)	CD	66	dep	6284	6285	_	_
48	68	In	in	IN	69	case	6286	6288	_	_
48	69	Canada	Canada	NNP	66	nmod	6290	6296	B-persongroup-109995	_
48	70	,	,	,	61	punct	6296	6297	I-persongroup-109995	_
48	71	measles	measle	VBZ	0	ROOT	6298	6305	_	_
48	72	vaccine	vaccine	NN	75	nsubj	6306	6313	_	_
48	73	is	be	VBZ	75	cop	6314	6316	_	_
48	74	only	only	RB	75	advmod	6317	6321	_	_
48	75	available	available	JJ	71	ccomp	6322	6331	_	_
48	76	in	in	IN	77	case	6332	6334	_	_
48	77	combination	combination	NN	75	nmod	6335	6346	_	_
48	78	with	with	IN	79	case	6347	6351	_	_
48	79	mumps	mumps	NNS	77	nmod	6352	6357	_	_
48	80	and	and	CC	79	cc	6358	6361	_	_
48	81	rubella	rubella	NN	82	compound	6362	6369	_	_
48	82	vaccine	vaccine	NN	79	conj	6371	6378	_	_
48	83	(	(	CD	84	nummod	6379	6380	_	_
48	84	MMR	mmr	NN	71	nsubj	6380	6383	_	_
48	85	)	)	CD	84	dep	6383	6384	_	_
48	86	or	or	CC	84	cc	6385	6387	_	_
48	87	mumps	mumps	NNS	84	conj	6388	6393	_	_
48	88	,	,	,	87	punct	6393	6394	_	_
48	89	rubella	rubella	NN	92	compound	6395	6402	_	_
48	90	and	and	CC	89	cc	6403	6406	_	_
48	91	varicella	varicella	NN	89	conj	6407	6416	_	_
48	92	vaccine	vaccine	NN	87	appos	6417	6424	_	_
48	93	(	(	CD	95	nummod	6425	6426	_	_
48	94	MMRV	mmrv	NN	95	compound	6426	6430	_	_
48	95	)	)	NN	92	dep	6430	6431	_	_
48	96	.	.	.	71	punct	6431	6432	_	_

49	1	In	in	IN	3	case	6433	6435	_	_
49	2	many	many	JJ	3	amod	6436	6440	B-persongroup-109996	_
49	3	countries	country	NNS	11	nmod	6441	6450	I-persongroup-109996	_
49	4	outside	outside	IN	3	advmod	6451	6458	I-persongroup-109996	_
49	5	of	of	IN	7	case	6459	6461	I-persongroup-109996	_
49	6	Canada	Canada	NNP	7	compound	6462	6468	I-persongroup-109996	_
49	7	measles	measles	NNS	3	nmod	6470	6477	_	_
49	8	vaccine	vaccine	NN	11	nsubjpass	6478	6485	_	_
49	9	alone	alone	RB	11	advmod	6486	6491	_	_
49	10	is	be	VBZ	11	auxpass	6492	6494	_	_
49	11	given	give	VBN	0	ROOT	6495	6500	_	_
49	12	.	.	.	11	punct	6500	6501	_	_

50	1	GamaSTAN	GamaSTAN	NNP	30	nsubj	6502	6510	_	_
50	2	®	®	CD	1	nummod	6510	6511	_	_
50	3	S/D	S/D	NNP	1	appos	6512	6515	_	_
50	4	:	:	:	1	punct	6515	6516	_	_
50	5	(	(	CD	7	nummod	6517	6518	_	_
50	6	immune	immune	JJ	7	amod	6518	6524	_	_
50	7	globulin	globulin	NN	1	dep	6525	6533	_	_
50	8	[	[	CD	11	nummod	6534	6535	_	_
50	9	human	human	JJ	11	amod	6535	6540	_	_
50	10	]	]	NN	11	compound	6540	6541	_	_
50	11	)	)	NN	7	dep	6541	6542	_	_
50	12	,	,	,	1	punct	6542	6543	_	_
50	13	Grifols	Grifols	NNP	15	compound	6544	6551	_	_
50	14	Therapeutics	Therapeutics	NNPS	15	compound	6552	6564	_	_
50	15	Inc.	Inc.	NNP	1	appos	6565	6569	_	_
50	16	(	(	CD	18	nummod	6570	6571	_	_
50	17	Ig	ig	NN	18	compound	6571	6573	_	_
50	18	)	)	NN	15	dep	6573	6574	_	_
50	19	For	for	IN	22	case	6575	6578	_	_
50	20	complete	complete	JJ	22	amod	6579	6587	_	_
50	21	prescribing	prescribe	VBG	22	amod	6588	6599	_	_
50	22	information	information	NN	30	nmod	6600	6611	_	_
50	23	,	,	,	22	punct	6611	6612	_	_
50	24	consult	consult	VB	22	conj	6613	6620	_	_
50	25	the	the	DT	27	det	6621	6624	_	_
50	26	product	product	NN	27	compound	6625	6632	_	_
50	27	leaflet	leaflet	NN	24	dobj	6633	6640	_	_
50	28	or	or	CC	22	cc	6641	6643	_	_
50	29	information	information	NN	22	conj	6644	6655	_	_
50	30	contained	contain	VBD	0	ROOT	6656	6665	_	_
50	31	within	within	IN	34	case	6666	6672	_	_
50	32	the	the	DT	34	det	6673	6676	_	_
50	33	product	product	NN	34	compound	6677	6684	_	_
50	34	monograph	monograph	NN	30	nmod	6685	6694	_	_
50	35	available	available	JJ	30	xcomp	6695	6704	_	_
50	36	through	through	IN	42	case	6705	6712	_	_
50	37	Health	Health	NNP	38	compound	6713	6719	B-persongroup-109997	_
50	38	Canada	Canada	NNP	42	nmod:poss	6720	6726	I-persongroup-109997	_
50	39	's	's	POS	38	case	6726	6728	I-persongroup-109997	_
50	40	Drug	drug	NN	42	compound	6729	6733	I-persongroup-109997	_
50	41	Product	Product	NNP	42	compound	6734	6741	I-persongroup-109997	_
50	42	Database	Database	NNP	30	nmod	6742	6750	I-persongroup-109997	_
50	43	.	.	.	30	punct	6750	6751	I-persongroup-109997	_

51	1	Refer	refer	VB	0	ROOT	6752	6757	_	_
51	2	to	to	TO	3	case	6758	6760	_	_
51	3	Contents	Contents	NNP	1	nmod	6761	6769	_	_
51	4	of	of	IN	7	case	6770	6772	_	_
51	5	Immunizing	Immunizing	NNP	7	compound	6773	6783	_	_
51	6	Agents	Agents	NNPS	7	compound	6784	6790	_	_
51	7	Available	Available	NNP	3	nmod	6791	6800	_	_
51	8	for	for	IN	9	case	6801	6804	_	_
51	9	Use	Use	NNP	7	nmod	6805	6808	_	_
51	10	in	in	IN	11	case	6809	6811	_	_
51	11	Canada	Canada	NNP	1	nmod	6812	6818	B-persongroup-109998	_
51	12	in	in	IN	13	case	6819	6821	_	_
51	13	Part	Part	NNP	11	nmod	6822	6826	_	_
51	14	1	1	CD	13	nummod	6827	6828	_	_
51	15	for	for	IN	16	case	6829	6832	_	_
51	16	lists	list	NNS	1	nmod	6833	6838	_	_
51	17	of	of	IN	18	case	6839	6841	_	_
51	18	vaccines	vaccine	NNS	16	nmod	6842	6850	_	_
51	19	and	and	CC	16	cc	6851	6854	_	_
51	20	passive	passive	JJ	22	amod	6855	6862	_	_
51	21	immunizing	immunizing	JJ	22	amod	6863	6873	_	_
51	22	agents	agent	NNS	16	conj	6874	6880	_	_
51	23	available	available	JJ	22	amod	6881	6890	_	_
51	24	for	for	IN	25	case	6891	6894	_	_
51	25	use	use	NN	23	nmod	6895	6898	_	_
51	26	in	in	IN	27	case	6899	6901	_	_
51	27	Canada	Canada	NNP	25	nmod	6902	6908	B-persongroup-109999	_
51	28	and	and	CC	27	cc	6909	6912	_	_
51	29	their	they	PRP$	30	nmod:poss	6913	6918	_	_
51	30	contents	contents	NNS	27	conj	6919	6927	_	_
51	31	.	.	.	1	punct	6927	6928	_	_

52	1	The	the	DT	2	det	6929	6932	_	_
52	2	efficacy	efficacy	NN	19	nsubjpass	6934	6942	_	_
52	3	of	of	IN	6	case	6943	6945	_	_
52	4	a	a	DT	6	det	6946	6947	_	_
52	5	single	single	JJ	6	amod	6948	6954	_	_
52	6	dose	dose	NN	2	nmod	6955	6959	_	_
52	7	of	of	IN	9	case	6960	6962	_	_
52	8	measles-containing	measles-containing	JJ	9	amod	6963	6981	_	_
52	9	vaccine	vaccine	NN	6	nmod	6982	6989	_	_
52	10	given	give	VBN	15	case	6990	6995	_	_
52	11	at	at	IN	15	case	6996	6998	_	_
52	12	12	12	CD	15	compound	6999	7001	_	_
52	13	or	or	CC	12	cc	7002	7004	_	_
52	14	15	15	CD	12	conj	7005	7007	_	_
52	15	months	month	NNS	9	nmod	7008	7014	_	_
52	16	of	of	IN	17	case	7016	7018	_	_
52	17	age	age	NN	15	nmod	7019	7022	_	_
52	18	is	be	VBZ	19	auxpass	7023	7025	_	_
52	19	estimated	estimate	VBN	0	ROOT	7026	7035	_	_
52	20	to	to	TO	26	mark	7036	7038	_	_
52	21	be	be	VB	26	cop	7039	7041	_	_
52	22	85	85	CD	26	compound	7042	7044	_	_
52	23	%	%	NN	26	dep	7044	7045	_	_
52	24	to	to	TO	26	dep	7046	7048	_	_
52	25	95	95	CD	26	compound	7049	7051	_	_
52	26	%	%	NN	19	xcomp	7051	7052	_	_
52	27	.	.	.	19	punct	7052	7053	_	_

53	1	With	with	IN	4	case	7054	7058	_	_
53	2	a	a	DT	4	det	7059	7060	_	_
53	3	second	second	JJ	4	amod	7061	7067	_	_
53	4	dose	dose	NN	9	nmod	7068	7072	_	_
53	5	,	,	,	9	punct	7072	7073	_	_
53	6	efficacy	efficacy	NN	9	nsubj	7074	7082	_	_
53	7	in	in	IN	8	case	7083	7085	_	_
53	8	children	child	NNS	6	nmod	7086	7094	B-persongroup-110000	_
53	9	approaches	approach	VBZ	0	ROOT	7095	7105	_	_
53	10	100	100	CD	11	nummod	7107	7110	_	_
53	11	%	%	NN	9	dobj	7110	7111	_	_
53	12	.	.	.	9	punct	7111	7112	_	_

54	1	However	however	RB	6	advmod	7113	7120	_	_
54	2	,	,	,	6	punct	7120	7121	_	_
54	3	measles	measles	NNS	4	compound	7122	7129	_	_
54	4	outbreaks	outbreak	NNS	6	nsubj	7130	7139	_	_
54	5	have	have	VBP	6	aux	7140	7144	_	_
54	6	occurred	occur	VBN	0	ROOT	7145	7153	_	_
54	7	in	in	IN	8	case	7154	7156	_	_
54	8	populations	population	NNS	6	nmod	7157	7168	B-persongroup-110001	_
54	9	with	with	IN	13	case	7169	7173	_	_
54	10	high	high	JJ	13	amod	7174	7178	_	_
54	11	immunization	immunization	NN	13	compound	7179	7191	_	_
54	12	coverage	coverage	NN	13	compound	7193	7201	_	_
54	13	rates	rate	NNS	8	nmod	7202	7207	_	_
54	14	.	.	.	6	punct	7207	7208	_	_

55	1	Due	due	JJ	5	case	7209	7212	_	_
55	2	to	to	TO	1	mwe	7213	7215	_	_
55	3	the	the	DT	5	det	7216	7219	_	_
55	4	high	high	JJ	5	amod	7220	7224	_	_
55	5	infectivity	infectivity	NN	17	nmod	7225	7236	_	_
55	6	of	of	IN	7	case	7237	7239	_	_
55	7	measles	measles	NNS	5	nmod	7240	7247	_	_
55	8	(	(	VBP	7	acl:relcl	7248	7249	_	_
55	9	each	each	DT	10	det	7249	7253	_	_
55	10	case	case	NN	12	nsubj	7254	7258	_	_
55	11	may	may	MD	12	aux	7259	7262	_	_
55	12	infect	infect	VB	8	ccomp	7263	7269	_	_
55	13	12	12	CD	15	compound	7270	7272	_	_
55	14	to	to	TO	15	dep	7274	7276	_	_
55	15	18	18	CD	16	nummod	7277	7279	_	_
55	16	others	other	NNS	17	nsubj	7280	7286	_	_
55	17	)	)	VBP	0	ROOT	7286	7287	_	_
55	18	at	at	IN	19	case	7288	7290	_	_
55	19	least	least	JJS	20	nmod:npmod	7291	7296	_	_
55	20	95	95	CD	21	nummod	7297	7299	B-persongroup-110002	_
55	21	%	%	NN	25	nsubj	7299	7300	I-persongroup-110002	_
55	22	of	of	IN	24	case	7301	7303	I-persongroup-110002	_
55	23	the	the	DT	24	det	7304	7307	I-persongroup-110002	_
55	24	population	population	NN	21	nmod	7308	7318	I-persongroup-110002	_
55	25	needs	need	VBZ	17	ccomp	7319	7324	_	_
55	26	to	to	TO	28	mark	7326	7328	_	_
55	27	be	be	VB	28	auxpass	7329	7331	_	_
55	28	immunized	immunize	VBN	25	xcomp	7332	7341	_	_
55	29	to	to	TO	30	mark	7342	7344	_	_
55	30	develop	develop	VB	28	xcomp	7345	7352	_	_
55	31	herd	herd	NN	32	compound	7353	7357	_	_
55	32	immunity	immunity	NN	30	dobj	7358	7366	_	_
55	33	.	.	.	17	punct	7366	7367	_	_

56	1	There	there	EX	2	expl	7368	7373	_	_
56	2	are	be	VBP	0	ROOT	7375	7378	_	_
56	3	no	no	DT	4	neg	7379	7381	_	_
56	4	data	datum	NNS	2	nsubj	7382	7386	_	_
56	5	regarding	regard	VBG	7	case	7387	7396	_	_
56	6	the	the	DT	7	det	7397	7400	_	_
56	7	efficacy	efficacy	NN	4	nmod	7401	7409	_	_
56	8	of	of	IN	10	case	7410	7412	_	_
56	9	MMRV	mmrv	NN	10	compound	7413	7417	_	_
56	10	vaccine	vaccine	NN	7	nmod	7418	7425	_	_
56	11	.	.	.	2	punct	7425	7426	_	_

57	1	In	in	IN	3	case	7427	7429	_	_
57	2	clinical	clinical	JJ	3	amod	7430	7438	_	_
57	3	studies	study	NNS	10	nmod	7439	7446	_	_
57	4	a	a	DT	6	det	7447	7448	_	_
57	5	single	single	JJ	6	amod	7449	7455	_	_
57	6	injection	injection	NN	10	nsubj	7456	7465	_	_
57	7	of	of	IN	9	case	7466	7468	_	_
57	8	MMR	mmr	NN	9	compound	7469	7472	_	_
57	9	vaccine	vaccine	NN	6	nmod	7473	7480	_	_
57	10	induced	induce	VBD	0	ROOT	7482	7489	_	_
57	11	measles	measles	NNS	12	compound	7490	7497	_	_
57	12	antibodies	antibody	NNS	10	dobj	7498	7508	_	_
57	13	in	in	IN	15	case	7509	7511	_	_
57	14	95	95	CD	15	nummod	7512	7514	_	_
57	15	%	%	NN	12	nmod	7514	7515	_	_
57	16	,	,	,	12	punct	7515	7516	_	_
57	17	mumps	mumps	NNS	18	compound	7517	7522	_	_
57	18	antibodies	antibody	NNS	12	conj	7523	7533	_	_
57	19	in	in	IN	21	case	7534	7536	_	_
57	20	96	96	CD	21	nummod	7537	7539	_	_
57	21	%	%	NN	18	nmod	7539	7540	_	_
57	22	,	,	,	12	punct	7540	7541	_	_
57	23	and	and	CC	12	cc	7542	7545	_	_
57	24	rubella	rubella	NN	25	compound	7546	7553	_	_
57	25	antibodies	antibody	NNS	12	conj	7555	7565	_	_
57	26	in	in	IN	28	case	7566	7568	_	_
57	27	99	99	CD	28	nummod	7569	7571	_	_
57	28	%	%	NN	25	nmod	7571	7572	_	_
57	29	of	of	IN	32	case	7573	7575	_	_
57	30	previously	previously	RB	31	advmod	7576	7586	B-persongroup-110003	_
57	31	seronegative	seronegative	JJ	32	amod	7587	7599	I-persongroup-110003	_
57	32	children	child	NNS	28	nmod	7600	7608	I-persongroup-110003	_
57	33	.	.	.	10	punct	7608	7609	I-persongroup-110003	_

58	1	In	in	IN	3	case	7611	7613	_	_
58	2	a	a	DT	3	det	7614	7615	_	_
58	3	study	study	NN	16	nmod	7616	7621	_	_
58	4	of	of	IN	8	case	7622	7624	_	_
58	5	12	12	CD	8	nummod	7625	7627	B-persongroup-110004	_
58	6	month	month	NN	8	compound	7628	7633	I-persongroup-110004	_
58	7	old	old	JJ	8	amod	7634	7637	I-persongroup-110004	_
58	8	children	child	NNS	3	nmod	7638	7646	I-persongroup-110004	_
58	9	,	,	,	16	punct	7646	7647	I-persongroup-110004	_
58	10	a	a	DT	12	det	7648	7649	_	_
58	11	single	single	JJ	12	amod	7650	7656	_	_
58	12	dose	dose	NN	16	nsubj	7657	7661	_	_
58	13	of	of	IN	15	case	7662	7664	_	_
58	14	MMRV	mmrv	NN	15	compound	7665	7669	_	_
58	15	vaccine	vaccine	NN	12	nmod	7670	7677	_	_
58	16	resulted	result	VBD	0	ROOT	7679	7687	_	_
58	17	in	in	IN	20	case	7688	7690	_	_
58	18	a	a	DT	20	det	7691	7692	_	_
58	19	seroconversion	seroconversion	NN	20	compound	7693	7707	_	_
58	20	rate	rate	NN	16	nmod	7708	7712	_	_
58	21	for	for	IN	22	case	7713	7716	_	_
58	22	measles	measles	NNS	20	nmod	7717	7724	_	_
58	23	,	,	,	22	punct	7724	7725	_	_
58	24	mumps	mumps	NNS	22	conj	7726	7731	_	_
58	25	,	,	,	22	punct	7731	7732	_	_
58	26	rubella	rubella	NN	22	conj	7733	7740	_	_
58	27	and	and	CC	22	cc	7741	7744	_	_
58	28	varicella	varicella	NN	22	conj	7745	7754	_	_
58	29	of	of	IN	31	case	7755	7757	_	_
58	30	98	98	CD	31	nummod	7759	7761	_	_
58	31	%	%	NN	20	nmod	7761	7762	_	_
58	32	,	,	,	31	punct	7762	7763	_	_
58	33	97	97	CD	34	nummod	7764	7766	_	_
58	34	%	%	NN	31	conj	7766	7767	_	_
58	35	,	,	,	31	punct	7767	7768	_	_
58	36	98	98	CD	37	nummod	7769	7771	_	_
58	37	%	%	NN	31	conj	7771	7772	_	_
58	38	and	and	CC	31	cc	7773	7776	_	_
58	39	93	93	CD	40	nummod	7777	7779	_	_
58	40	%	%	NN	31	conj	7779	7780	_	_
58	41	,	,	,	16	punct	7780	7781	_	_
58	42	respectively	respectively	RB	16	advmod	7782	7794	_	_
58	43	.	.	.	16	punct	7794	7795	_	_

59	1	The	the	DT	3	det	7796	7799	_	_
59	2	seroconversion	seroconversion	NN	3	compound	7800	7814	_	_
59	3	rates	rate	NNS	14	nsubj	7815	7820	_	_
59	4	and	and	CC	3	cc	7821	7824	_	_
59	5	geometric	geometric	JJ	7	amod	7825	7834	_	_
59	6	mean	mean	NN	7	compound	7836	7840	_	_
59	7	titres	titre	NNS	3	conj	7841	7847	_	_
59	8	for	for	IN	10	case	7848	7851	_	_
59	9	individual	individual	JJ	10	amod	7852	7862	_	_
59	10	components	component	NNS	7	nmod	7863	7873	_	_
59	11	were	be	VBD	14	cop	7874	7878	_	_
59	12	not	not	RB	14	neg	7879	7882	_	_
59	13	significantly	significantly	RB	14	advmod	7883	7896	_	_
59	14	different	different	JJ	0	ROOT	7897	7906	_	_
59	15	from	from	IN	16	case	7907	7911	_	_
59	16	those	those	DT	14	nmod	7913	7918	_	_
59	17	achieved	achieve	VBN	16	acl	7919	7927	_	_
59	18	after	after	IN	19	case	7928	7933	_	_
59	19	MMR	mmr	NN	17	nmod	7934	7937	_	_
59	20	plus	plus	CC	23	case	7938	7942	_	_
59	21	univalent	univalent	JJ	23	amod	7943	7952	_	_
59	22	varicella	varicella	NN	23	compound	7953	7962	_	_
59	23	vaccines	vaccine	NNS	19	nmod	7963	7971	_	_
59	24	or	or	CC	23	cc	7972	7974	_	_
59	25	MMR	mmr	NN	26	compound	7975	7978	_	_
59	26	vaccine	vaccine	NN	23	conj	7979	7986	_	_
59	27	alone	alone	RB	17	advmod	7988	7993	_	_
59	28	.	.	.	14	punct	7993	7994	_	_

60	1	A	a	DT	2	det	7995	7996	_	_
60	2	study	study	NN	17	nsubj	7997	8002	_	_
60	3	of	of	IN	4	case	8003	8005	_	_
60	4	children	child	NNS	2	nmod	8006	8014	B-persongroup-110005	_
60	5	receiving	receive	VBG	4	acl	8015	8024	_	_
60	6	two	two	CD	7	nummod	8025	8028	_	_
60	7	doses	dose	NNS	5	dobj	8029	8034	_	_
60	8	of	of	IN	10	case	8035	8037	_	_
60	9	MMRV	mmrv	NN	10	compound	8038	8042	_	_
60	10	vaccine	vaccine	NN	7	nmod	8043	8050	_	_
60	11	during	during	IN	14	case	8051	8057	_	_
60	12	the	the	DT	14	det	8058	8061	_	_
60	13	second	second	JJ	14	amod	8063	8069	_	_
60	14	year	year	NN	5	nmod	8070	8074	_	_
60	15	of	of	IN	16	case	8075	8077	_	_
60	16	life	life	NN	14	nmod	8078	8082	_	_
60	17	noted	note	VBD	0	ROOT	8083	8088	_	_
60	18	seropositivity	seropositivity	NN	17	dobj	8089	8103	_	_
60	19	for	for	IN	20	case	8104	8107	_	_
60	20	measles	measles	NNS	18	nmod	8108	8115	_	_
60	21	,	,	,	20	punct	8115	8116	_	_
60	22	mumps	mumps	NNS	20	conj	8117	8122	_	_
60	23	,	,	,	20	punct	8122	8123	_	_
60	24	rubella	rubella	NN	20	conj	8124	8131	_	_
60	25	and	and	CC	20	cc	8132	8135	_	_
60	26	varicella	varicella	NN	20	conj	8137	8146	_	_
60	27	of	of	IN	29	case	8147	8149	_	_
60	28	99	99	CD	29	nummod	8150	8152	_	_
60	29	%	%	NN	18	nmod	8152	8153	_	_
60	30	,	,	,	29	punct	8153	8154	_	_
60	31	97.4	97.4	CD	32	nummod	8155	8159	_	_
60	32	%	%	NN	29	conj	8159	8160	_	_
60	33	,	,	,	29	punct	8160	8161	_	_
60	34	100	100	CD	35	nummod	8162	8165	_	_
60	35	%	%	NN	29	conj	8165	8166	_	_
60	36	and	and	CC	29	cc	8167	8170	_	_
60	37	99.4	99.4	CD	38	nummod	8171	8175	_	_
60	38	%	%	NN	29	conj	8175	8176	_	_
60	39	respectively	respectively	RB	44	advmod	8177	8189	_	_
60	40	by	by	IN	44	case	8190	8192	_	_
60	41	the	the	DT	44	det	8193	8196	_	_
60	42	third	third	JJ	44	amod	8197	8202	_	_
60	43	year	year	NN	44	compound	8203	8207	_	_
60	44	post-vaccination	post-vaccination	NN	17	nmod	8209	8225	_	_
60	45	.	.	.	17	punct	8225	8226	_	_

61	1	Long-term	long-term	JJ	2	amod	8228	8237	_	_
61	2	persistence	persistence	NN	17	nsubj	8238	8249	_	_
61	3	of	of	IN	4	case	8250	8252	_	_
61	4	anti-measles	anti-measles	NNS	2	nmod	8253	8265	_	_
61	5	,	,	,	2	punct	8265	8266	_	_
61	6	anti-mumps	anti-mumps	NNS	2	appos	8267	8277	_	_
61	7	,	,	,	2	punct	8277	8278	_	_
61	8	anti-rubella	anti-rubella	JJ	11	amod	8279	8291	_	_
61	9	and	and	CC	8	cc	8292	8295	_	_
61	10	anti-varicella	anti-varicella	JJ	8	conj	8297	8311	_	_
61	11	antibodies	antibody	NNS	2	appos	8312	8322	_	_
61	12	following	follow	VBG	14	case	8323	8332	_	_
61	13	MMRV	mmrv	NN	14	compound	8333	8337	_	_
61	14	vaccinations	vaccination	NNS	11	nmod	8338	8350	_	_
61	15	are	be	VBP	17	cop	8351	8354	_	_
61	16	under	under	IN	17	case	8355	8360	_	_
61	17	evaluation	evaluation	NN	0	ROOT	8361	8371	_	_
61	18	.	.	.	17	punct	8371	8372	_	_

62	1	Two	two	CD	2	nummod	8373	8376	_	_
62	2	doses	dose	NNS	8	nsubjpass	8377	8382	_	_
62	3	of	of	IN	5	case	8383	8385	_	_
62	4	measles-containing	measles-containing	JJ	5	amod	8386	8404	_	_
62	5	vaccine	vaccine	NN	2	nmod	8405	8412	_	_
62	6	should	should	MD	8	aux	8413	8419	_	_
62	7	be	be	VB	8	auxpass	8420	8422	_	_
62	8	given	give	VBN	0	ROOT	8423	8428	_	_
62	9	for	for	IN	11	case	8429	8432	_	_
62	10	routine	routine	JJ	11	amod	8433	8440	_	_
62	11	immunization	immunization	NN	8	nmod	8441	8453	_	_
62	12	of	of	IN	13	case	8454	8456	_	_
62	13	children	child	NNS	11	nmod	8457	8465	B-persongroup-110006	_
62	14	and	and	CC	11	cc	8466	8469	_	_
62	15	for	for	IN	16	case	8470	8473	_	_
62	16	immunization	immunization	NN	11	conj	8474	8486	_	_
62	17	of	of	IN	18	case	8487	8489	_	_
62	18	children	child	NNS	16	nmod	8490	8498	B-persongroup-110007	_
62	19	and	and	CC	18	cc	8499	8502	_	_
62	20	adolescents	adolescent	NNS	18	conj	8503	8514	B-persongroup-110008	_
62	21	who	who	WP	23	nsubj	8515	8518	_	_
62	22	have	have	VBP	23	aux	8519	8523	_	_
62	23	missed	miss	VBN	16	acl:relcl	8524	8530	_	_
62	24	measles	measles	NNS	25	compound	8531	8538	_	_
62	25	immunization	immunization	NN	23	dobj	8539	8551	_	_
62	26	on	on	IN	29	case	8552	8554	_	_
62	27	the	the	DT	29	det	8555	8558	_	_
62	28	routine	routine	JJ	29	amod	8559	8566	_	_
62	29	schedule	schedule	NN	25	nmod	8567	8575	_	_
62	30	.	.	.	8	punct	8575	8576	_	_

63	1	MMRV	mmrv	NN	2	compound	8577	8581	_	_
63	2	vaccine	vaccine	NN	5	nsubjpass	8582	8589	_	_
63	3	may	may	MD	5	aux	8590	8593	_	_
63	4	be	be	VB	5	auxpass	8594	8596	_	_
63	5	used	use	VBN	0	ROOT	8597	8601	_	_
63	6	in	in	IN	7	case	8602	8604	_	_
63	7	children	child	NNS	5	nmod	8605	8613	B-persongroup-110009	_
63	8	aged	aged	JJ	7	amod	8614	8618	_	_
63	9	12	12	CD	10	nummod	8619	8621	_	_
63	10	months	month	NNS	8	nmod:tmod	8622	8628	_	_
63	11	to	to	TO	13	case	8629	8631	_	_
63	12	12	12	CD	13	nummod	8632	8634	_	_
63	13	years	year	NNS	5	nmod	8635	8640	_	_
63	14	.	.	.	5	punct	8640	8641	_	_

64	1	Routine	routine	JJ	2	amod	8643	8650	_	_
64	2	immunization	immunization	NN	10	nsubjpass	8651	8663	_	_
64	3	:	:	:	2	punct	8663	8664	_	_
64	4	adults	adult	NNS	2	dep	8665	8671	B-persongroup-110010	_
64	5	born	bear	VBN	4	acl	8672	8676	_	_
64	6	before	before	IN	7	case	8677	8683	_	_
64	7	1970	1970	CD	5	nmod	8684	8688	_	_
64	8	are	be	VBP	10	auxpass	8689	8692	_	_
64	9	generally	generally	RB	10	advmod	8693	8702	_	_
64	10	presumed	presume	VBN	0	ROOT	8703	8711	_	_
64	11	to	to	TO	13	mark	8712	8714	_	_
64	12	have	have	VB	13	aux	8715	8719	_	_
64	13	acquired	acquire	VBN	10	xcomp	8720	8728	_	_
64	14	natural	natural	JJ	15	amod	8729	8736	_	_
64	15	immunity	immunity	NN	13	dobj	8738	8746	_	_
64	16	to	to	TO	17	case	8747	8749	_	_
64	17	measles	measles	NNS	13	nmod	8750	8757	_	_
64	18	;	;	:	10	punct	8757	8758	_	_
64	19	however	however	RB	27	advmod	8759	8766	_	_
64	20	,	,	,	27	punct	8766	8767	_	_
64	21	some	some	DT	27	nsubj	8768	8772	_	_
64	22	of	of	IN	24	case	8773	8775	_	_
64	23	these	these	DT	24	det	8776	8781	B-persongroup-110011	_
64	24	individuals	individual	NNS	21	nmod	8782	8793	I-persongroup-110011	_
64	25	may	may	MD	27	aux	8794	8797	_	_
64	26	be	be	VB	27	cop	8798	8800	_	_
64	27	susceptible	susceptible	JJ	10	parataxis	8801	8812	_	_
64	28	.	.	.	10	punct	8812	8813	_	_

65	1	Adults	adult	NNS	38	nsubj	8814	8820	B-persongroup-110012	_
65	2	without	without	IN	3	case	8821	8828	_	_
65	3	contraindications	contraindication	NNS	1	nmod	8829	8846	_	_
65	4	,	,	,	3	punct	8846	8847	_	_
65	5	born	bear	VBN	3	acl	8848	8852	_	_
65	6	in	in	IN	7	case	8854	8856	_	_
65	7	1970	1970	CD	5	nmod	8857	8861	_	_
65	8	or	or	CC	3	cc	8862	8864	_	_
65	9	later	later	RB	3	conj	8865	8870	_	_
65	10	who	who	WP	14	nsubj	8871	8874	_	_
65	11	do	do	VBP	14	aux	8875	8877	_	_
65	12	not	not	RB	14	neg	8878	8881	_	_
65	13	have	have	VB	14	aux	8882	8886	_	_
65	14	documented	document	VBN	9	acl:relcl	8887	8897	_	_
65	15	evidence	evidence	NN	14	dobj	8898	8906	_	_
65	16	of	of	IN	17	mark	8907	8909	_	_
65	17	receiving	receive	VBG	15	acl	8910	8919	_	_
65	18	measles-containing	measles-containing	JJ	19	amod	8921	8939	_	_
65	19	vaccine	vaccine	NN	17	dobj	8940	8947	_	_
65	20	on	on	IN	25	case	8948	8950	_	_
65	21	or	or	CC	20	cc	8951	8953	_	_
65	22	after	after	IN	20	conj	8954	8959	_	_
65	23	their	they	PRP$	25	nmod:poss	8960	8965	_	_
65	24	first	first	JJ	25	amod	8966	8971	_	_
65	25	birthday	birthday	NN	17	nmod	8972	8980	_	_
65	26	,	,	,	3	punct	8980	8981	_	_
65	27	or	or	CC	3	cc	8982	8984	_	_
65	28	laboratory	laboratory	NN	29	compound	8985	8995	_	_
65	29	evidence	evidence	NN	3	conj	8997	9005	_	_
65	30	of	of	IN	31	case	9006	9008	_	_
65	31	immunity	immunity	NN	29	nmod	9009	9017	_	_
65	32	,	,	,	3	punct	9017	9018	_	_
65	33	or	or	CC	3	cc	9019	9021	_	_
65	34	a	a	DT	35	det	9022	9023	_	_
65	35	history	history	NN	3	conj	9024	9031	_	_
65	36	of	of	IN	37	case	9032	9034	_	_
65	37	laboratory	laboratory	NN	35	nmod	9035	9045	_	_
65	38	confirmed	confirm	VBD	0	ROOT	9046	9055	_	_
65	39	measles	measles	NNS	38	dobj	9056	9063	_	_
65	40	infection	infection	NN	43	nsubjpass	9064	9073	_	_
65	41	should	should	MD	43	aux	9075	9081	_	_
65	42	be	be	VB	43	auxpass	9082	9084	_	_
65	43	immunized	immunize	VBN	39	acl:relcl	9085	9094	_	_
65	44	with	with	IN	46	case	9095	9099	_	_
65	45	one	one	CD	46	nummod	9100	9103	_	_
65	46	dose	dose	NN	43	nmod	9104	9108	_	_
65	47	of	of	IN	49	case	9109	9111	_	_
65	48	MMR	mmr	NN	49	compound	9112	9115	_	_
65	49	vaccine.	vaccine.	NN	46	nmod	9116	9124	_	_
65	50	;	;	:	39	punct	9124	9125	_	_
65	51	Health	Health	NNP	53	compound	9127	9133	B-persongroup-110013	_
65	52	care	care	NN	53	compound	9134	9138	I-persongroup-110013	_
65	53	workers	worker	NNS	39	conj	9139	9146	I-persongroup-110013	_
65	54	,	,	,	53	punct	9146	9147	I-persongroup-110013	_
65	55	regardless	regardless	RB	53	advmod	9148	9158	_	_
65	56	of	of	IN	58	case	9159	9161	_	_
65	57	their	they	PRP$	58	nmod:poss	9162	9167	_	_
65	58	year	year	NN	55	nmod	9169	9173	_	_
65	59	of	of	IN	60	case	9174	9176	_	_
65	60	birth	birth	NN	58	nmod	9177	9182	_	_
65	61	,	,	,	53	punct	9182	9183	_	_
65	62	who	who	WP	66	nsubj	9184	9187	_	_
65	63	do	do	VBP	66	aux	9188	9190	_	_
65	64	not	not	RB	66	neg	9191	9194	_	_
65	65	have	have	VB	66	aux	9195	9199	_	_
65	66	documented	document	VBN	53	acl:relcl	9200	9210	_	_
65	67	evidence	evidence	NN	66	dobj	9211	9219	_	_
65	68	of	of	IN	69	mark	9220	9222	_	_
65	69	receiving	receive	VBG	67	acl	9223	9232	_	_
65	70	two	two	CD	71	nummod	9233	9236	_	_
65	71	doses	dose	NNS	69	dobj	9238	9243	_	_
65	72	of	of	IN	74	case	9244	9246	_	_
65	73	measles-containing	measles-containing	JJ	74	amod	9247	9265	_	_
65	74	vaccine	vaccine	NN	71	nmod	9266	9273	_	_
65	75	on	on	IN	80	case	9274	9276	_	_
65	76	or	or	CC	75	cc	9277	9279	_	_
65	77	after	after	IN	75	conj	9280	9285	_	_
65	78	their	they	PRP$	80	nmod:poss	9286	9291	_	_
65	79	first	first	JJ	80	amod	9292	9297	_	_
65	80	birthday	birthday	NN	69	nmod	9298	9306	_	_
65	81	,	,	,	39	punct	9306	9307	_	_
65	82	or	or	CC	39	cc	9308	9310	_	_
65	83	laboratory	laboratory	NN	84	compound	9312	9322	_	_
65	84	evidence	evidence	NN	39	conj	9323	9331	_	_
65	85	of	of	IN	86	case	9332	9334	_	_
65	86	immunity	immunity	NN	84	nmod	9335	9343	_	_
65	87	,	,	,	38	punct	9343	9344	_	_
65	88	or	or	CC	38	cc	9345	9347	_	_
65	89	a	a	DT	90	det	9348	9349	_	_
65	90	history	history	NN	93	nsubj	9350	9357	_	_
65	91	of	of	IN	92	case	9358	9360	_	_
65	92	laboratory	laboratory	NN	90	nmod	9361	9371	_	_
65	93	confirmed	confirm	VBD	38	conj	9372	9381	_	_
65	94	measles	measles	NNS	95	compound	9382	9389	_	_
65	95	disease	disease	NN	97	nsubj	9391	9398	_	_
65	96	should	should	MD	97	aux	9399	9405	_	_
65	97	receive	receive	VB	93	ccomp	9406	9413	_	_
65	98	two	two	CD	99	nummod	9414	9417	_	_
65	99	doses	dose	NNS	97	dobj	9418	9423	_	_
65	100	of	of	IN	102	case	9424	9426	_	_
65	101	MMR	mmr	NN	102	compound	9427	9430	_	_
65	102	vaccine	vaccine	NN	99	nmod	9431	9438	_	_
65	103	.	.	.	38	punct	9438	9439	_	_

66	1	Refer	refer	VB	0	ROOT	9440	9445	_	_
66	2	to	to	TO	3	case	9446	9448	_	_
66	3	Workers	worker	NNS	1	nmod	9449	9456	B-persongroup-110014	_
66	4	.	.	.	1	punct	9456	9457	I-persongroup-110014	_

67	1	Students	student	NNS	44	nsubj	9458	9466	B-persongroup-110015	_
67	2	in	in	IN	5	case	9467	9469	_	_
67	3	post-secondary	post-secondary	JJ	5	amod	9470	9484	_	_
67	4	educational	educational	JJ	5	amod	9486	9497	_	_
67	5	settings	setting	NNS	1	nmod	9498	9506	_	_
67	6	,	,	,	5	punct	9506	9507	_	_
67	7	born	bear	VBN	5	acl	9508	9512	_	_
67	8	in	in	IN	9	case	9513	9515	_	_
67	9	1970	1970	CD	7	nmod	9516	9520	_	_
67	10	or	or	CC	5	cc	9521	9523	_	_
67	11	later	later	RB	5	conj	9525	9530	_	_
67	12	,	,	,	11	punct	9530	9531	_	_
67	13	who	who	WP	17	nsubj	9532	9535	_	_
67	14	do	do	VBP	17	aux	9536	9538	_	_
67	15	not	not	RB	17	neg	9539	9542	_	_
67	16	have	have	VB	17	aux	9543	9547	_	_
67	17	documented	document	VBN	11	dep	9548	9558	_	_
67	18	evidence	evidence	NN	17	dobj	9559	9567	_	_
67	19	of	of	IN	20	mark	9568	9570	_	_
67	20	receiving	receive	VBG	18	acl	9571	9580	_	_
67	21	two	two	CD	22	nummod	9581	9584	_	_
67	22	doses	dose	NNS	20	dobj	9585	9590	_	_
67	23	of	of	IN	25	case	9591	9593	_	_
67	24	measles-containing	measles-containing	JJ	25	amod	9594	9612	_	_
67	25	vaccine	vaccine	NN	22	nmod	9613	9620	_	_
67	26	on	on	IN	31	case	9621	9623	_	_
67	27	or	or	CC	26	cc	9624	9626	_	_
67	28	after	after	IN	26	conj	9627	9632	_	_
67	29	their	they	PRP$	31	nmod:poss	9633	9638	_	_
67	30	first	first	JJ	31	amod	9639	9644	_	_
67	31	birthday	birthday	NN	20	nmod	9645	9653	_	_
67	32	,	,	,	5	punct	9653	9654	_	_
67	33	or	or	CC	5	cc	9655	9657	_	_
67	34	laboratory	laboratory	NN	35	compound	9658	9668	_	_
67	35	evidence	evidence	NN	5	conj	9670	9678	_	_
67	36	of	of	IN	37	case	9679	9681	_	_
67	37	immunity	immunity	NN	35	nmod	9682	9690	_	_
67	38	,	,	,	5	punct	9690	9691	_	_
67	39	or	or	CC	5	cc	9692	9694	_	_
67	40	a	a	DT	41	det	9695	9696	_	_
67	41	history	history	NN	5	conj	9697	9704	_	_
67	42	of	of	IN	43	case	9705	9707	_	_
67	43	laboratory	laboratory	NN	41	nmod	9708	9718	_	_
67	44	confirmed	confirm	VBD	0	ROOT	9719	9728	_	_
67	45	measles	measles	NNS	46	compound	9729	9736	_	_
67	46	disease	disease	NN	48	nsubj	9737	9744	_	_
67	47	should	should	MD	48	aux	9746	9752	_	_
67	48	receive	receive	VB	44	ccomp	9753	9760	_	_
67	49	two	two	CD	50	nummod	9761	9764	_	_
67	50	doses	dose	NNS	48	dobj	9765	9770	_	_
67	51	of	of	IN	53	case	9771	9773	_	_
67	52	MMR	mmr	NN	53	compound	9774	9777	_	_
67	53	vaccine	vaccine	NN	50	nmod	9778	9785	_	_
67	54	.	.	.	44	punct	9785	9786	_	_

68	1	In	in	IN	2	case	9787	9789	_	_
68	2	students	student	NNS	16	nmod	9790	9798	B-persongroup-110016	_
68	3	born	bear	VBN	2	acl	9799	9803	_	_
68	4	before	before	IN	5	case	9804	9810	_	_
68	5	1970	1970	CD	3	nmod	9811	9815	_	_
68	6	,	,	,	16	punct	9815	9816	_	_
68	7	administration	administration	NN	16	nsubjpass	9817	9831	_	_
68	8	of	of	IN	10	case	9832	9834	_	_
68	9	one	one	CD	10	nummod	9835	9838	_	_
68	10	dose	dose	NN	7	nmod	9839	9843	_	_
68	11	of	of	IN	13	case	9844	9846	_	_
68	12	MMR	mmr	NN	13	compound	9847	9850	_	_
68	13	vaccine	vaccine	NN	10	nmod	9851	9858	_	_
68	14	should	should	MD	16	aux	9859	9865	_	_
68	15	be	be	VB	16	auxpass	9866	9868	_	_
68	16	considered	consider	VBN	0	ROOT	9870	9880	_	_
68	17	.	.	.	16	punct	9880	9881	_	_

69	1	Military	military	JJ	2	amod	9882	9890	B-persongroup-110017	_
69	2	personnel	personnel	NNS	42	nsubj	9891	9900	I-persongroup-110017	_
69	3	,	,	,	42	punct	9900	9901	I-persongroup-110017	_
69	4	regardless	regardless	RB	42	advmod	9902	9912	_	_
69	5	of	of	IN	7	case	9913	9915	_	_
69	6	their	they	PRP$	7	nmod:poss	9916	9921	_	_
69	7	year	year	NN	4	nmod	9923	9927	_	_
69	8	of	of	IN	9	case	9928	9930	_	_
69	9	birth	birth	NN	7	nmod	9931	9936	_	_
69	10	,	,	,	9	punct	9936	9937	_	_
69	11	who	who	WP	14	nsubj	9938	9941	_	_
69	12	do	do	VBP	14	aux	9942	9944	_	_
69	13	not	not	RB	14	neg	9945	9948	_	_
69	14	have	have	VB	9	acl:relcl	9949	9953	_	_
69	15	documented	document	VBN	16	amod	9954	9964	_	_
69	16	evidence	evidence	NN	14	dobj	9965	9973	_	_
69	17	of	of	IN	18	mark	9974	9976	_	_
69	18	receiving	receive	VBG	16	acl	9977	9986	_	_
69	19	two	two	CD	20	nummod	9987	9990	_	_
69	20	doses	dose	NNS	18	dobj	9992	9997	_	_
69	21	of	of	IN	23	case	9998	10000	_	_
69	22	measles-containing	measles-containing	JJ	23	amod	10001	10019	_	_
69	23	vaccine	vaccine	NN	20	nmod	10020	10027	_	_
69	24	on	on	IN	29	case	10028	10030	_	_
69	25	or	or	CC	24	cc	10031	10033	_	_
69	26	after	after	IN	24	conj	10034	10039	_	_
69	27	their	they	PRP$	29	nmod:poss	10040	10045	_	_
69	28	first	first	JJ	29	amod	10046	10051	_	_
69	29	birthday	birthday	NN	18	nmod	10052	10060	_	_
69	30	,	,	,	16	punct	10060	10061	_	_
69	31	or	or	CC	16	cc	10062	10064	_	_
69	32	laboratory	laboratory	NN	33	compound	10066	10076	_	_
69	33	evidence	evidence	NN	16	conj	10077	10085	_	_
69	34	of	of	IN	35	case	10086	10088	_	_
69	35	immunity	immunity	NN	33	nmod	10089	10097	_	_
69	36	,	,	,	16	punct	10097	10098	_	_
69	37	or	or	CC	16	cc	10099	10101	_	_
69	38	a	a	DT	39	det	10102	10103	_	_
69	39	history	history	NN	16	conj	10104	10111	_	_
69	40	of	of	IN	41	case	10112	10114	_	_
69	41	laboratory	laboratory	NN	39	nmod	10115	10125	_	_
69	42	confirmed	confirm	VBD	0	ROOT	10126	10135	_	_
69	43	measles	measles	NNS	44	compound	10136	10143	_	_
69	44	disease	disease	NN	46	nsubj	10145	10152	_	_
69	45	should	should	MD	46	aux	10153	10159	_	_
69	46	receive	receive	VB	42	ccomp	10160	10167	_	_
69	47	two	two	CD	48	nummod	10168	10171	_	_
69	48	doses	dose	NNS	46	dobj	10172	10177	_	_
69	49	of	of	IN	51	case	10178	10180	_	_
69	50	MMR	mmr	NN	51	compound	10181	10184	_	_
69	51	vaccine	vaccine	NN	48	nmod	10185	10192	_	_
69	52	.	.	.	42	punct	10192	10193	_	_

70	1	Travellers	traveller	NNS	46	nsubj	10194	10204	B-persongroup-110018	_
70	2	to	to	TO	3	case	10205	10207	_	_
70	3	destinations	destination	NNS	1	nmod	10208	10220	B-persongroup-110184	_
70	4	outside	outside	IN	3	advmod	10221	10228	I-persongroup-110184	_
70	5	of	of	IN	7	case	10229	10231	I-persongroup-110184	_
70	6	North	North	NNP	7	compound	10232	10237	I-persongroup-110184	_
70	7	America	America	NNP	3	nmod	10238	10245	I-persongroup-110184	_
70	8	,	,	,	7	punct	10245	10246	I-persongroup-110184	_
70	9	born	bear	VBN	7	acl	10247	10251	_	_
70	10	in	in	IN	11	case	10252	10254	_	_
70	11	1970	1970	CD	9	nmod	10255	10259	_	_
70	12	or	or	CC	3	cc	10260	10262	_	_
70	13	later	later	RB	3	conj	10263	10268	_	_
70	14	,	,	,	13	punct	10268	10269	_	_
70	15	who	who	WP	19	nsubj	10270	10273	_	_
70	16	do	do	VBP	19	aux	10274	10276	_	_
70	17	not	not	RB	19	neg	10277	10280	_	_
70	18	have	have	VB	19	aux	10281	10285	_	_
70	19	documented	document	VBN	13	dep	10286	10296	_	_
70	20	evidence	evidence	NN	19	dobj	10297	10305	_	_
70	21	of	of	IN	22	mark	10306	10308	_	_
70	22	receiving	receive	VBG	20	acl	10310	10319	_	_
70	23	two	two	CD	24	nummod	10320	10323	_	_
70	24	doses	dose	NNS	22	dobj	10324	10329	_	_
70	25	of	of	IN	27	case	10330	10332	_	_
70	26	measles-containing	measles-containing	JJ	27	amod	10333	10351	_	_
70	27	vaccine	vaccine	NN	24	nmod	10352	10359	_	_
70	28	on	on	IN	33	case	10360	10362	_	_
70	29	or	or	CC	28	cc	10363	10365	_	_
70	30	after	after	IN	28	conj	10366	10371	_	_
70	31	their	they	PRP$	33	nmod:poss	10372	10377	_	_
70	32	first	first	JJ	33	amod	10378	10383	_	_
70	33	birthday	birthday	NN	22	nmod	10385	10393	_	_
70	34	,	,	,	3	punct	10393	10394	_	_
70	35	or	or	CC	3	cc	10395	10397	_	_
70	36	laboratory	laboratory	NN	37	compound	10398	10408	_	_
70	37	evidence	evidence	NN	3	conj	10409	10417	_	_
70	38	of	of	IN	39	case	10418	10420	_	_
70	39	immunity	immunity	NN	37	nmod	10421	10429	_	_
70	40	,	,	,	3	punct	10429	10430	_	_
70	41	or	or	CC	3	cc	10431	10433	_	_
70	42	a	a	DT	43	det	10434	10435	_	_
70	43	history	history	NN	3	conj	10436	10443	_	_
70	44	of	of	IN	45	case	10444	10446	_	_
70	45	laboratory	laboratory	NN	43	nmod	10447	10457	_	_
70	46	confirmed	confirm	VBD	0	ROOT	10459	10468	_	_
70	47	measles	measles	NNS	48	compound	10469	10476	_	_
70	48	disease	disease	NN	50	nsubj	10477	10484	_	_
70	49	should	should	MD	50	aux	10485	10491	_	_
70	50	receive	receive	VB	46	ccomp	10492	10499	_	_
70	51	two	two	CD	52	nummod	10500	10503	_	_
70	52	doses	dose	NNS	50	dobj	10504	10509	_	_
70	53	of	of	IN	55	case	10510	10512	_	_
70	54	measles-containing	measles-containing	JJ	55	amod	10513	10531	_	_
70	55	vaccine	vaccine	NN	52	nmod	10533	10540	_	_
70	56	.	.	.	46	punct	10540	10541	_	_

71	1	Travellers	Travellers	NNPS	2	nsubj	10542	10552	B-persongroup-110019	_
71	2	born	bear	VBN	0	ROOT	10553	10557	_	_
71	3	before	before	IN	4	case	10558	10564	_	_
71	4	1970	1970	CD	2	nmod	10565	10569	_	_
71	5	who	who	WP	8	nsubj	10570	10573	_	_
71	6	do	do	VBP	8	aux	10574	10576	_	_
71	7	not	not	RB	8	neg	10577	10580	_	_
71	8	have	have	VB	4	acl:relcl	10581	10585	_	_
71	9	documented	document	VBN	10	amod	10586	10596	_	_
71	10	evidence	evidence	NN	8	dobj	10597	10605	_	_
71	11	of	of	IN	12	mark	10606	10608	_	_
71	12	receiving	receive	VBG	10	acl	10609	10618	_	_
71	13	a	a	DT	15	det	10619	10620	_	_
71	14	measles-containing	measles-containing	JJ	15	amod	10621	10639	_	_
71	15	vaccine	vaccine	NN	12	dobj	10640	10647	_	_
71	16	on	on	IN	21	case	10649	10651	_	_
71	17	or	or	CC	16	cc	10652	10654	_	_
71	18	after	after	IN	16	conj	10655	10660	_	_
71	19	their	they	PRP$	21	nmod:poss	10661	10666	_	_
71	20	first	first	JJ	21	amod	10667	10672	_	_
71	21	birthday	birthday	NN	12	nmod	10673	10681	_	_
71	22	,	,	,	10	punct	10681	10682	_	_
71	23	or	or	CC	10	cc	10683	10685	_	_
71	24	laboratory	laboratory	NN	25	compound	10686	10696	_	_
71	25	evidence	evidence	NN	10	conj	10697	10705	_	_
71	26	of	of	IN	27	case	10706	10708	_	_
71	27	immunity	immunity	NN	25	nmod	10709	10717	_	_
71	28	,	,	,	2	punct	10717	10718	_	_
71	29	or	or	CC	2	cc	10719	10721	_	_
71	30	a	a	DT	31	det	10722	10723	_	_
71	31	history	history	NN	34	nsubj	10725	10732	_	_
71	32	of	of	IN	33	case	10733	10735	_	_
71	33	laboratory	laboratory	NN	31	nmod	10736	10746	_	_
71	34	confirmed	confirm	VBD	2	conj	10747	10756	_	_
71	35	measles	measles	NNS	36	compound	10757	10764	_	_
71	36	disease	disease	NN	38	nsubj	10765	10772	_	_
71	37	should	should	MD	38	aux	10773	10779	_	_
71	38	receive	receive	VB	34	ccomp	10780	10787	_	_
71	39	one	one	CD	40	nummod	10788	10791	_	_
71	40	dose	dose	NN	38	dobj	10792	10796	_	_
71	41	of	of	IN	43	case	10797	10799	_	_
71	42	MMR	mmr	NN	43	compound	10800	10803	_	_
71	43	vaccine	vaccine	NN	40	nmod	10805	10812	_	_
71	44	.	.	.	2	punct	10812	10813	_	_

72	1	Refer	refer	VB	0	ROOT	10814	10819	_	_
72	2	to	to	TO	3	case	10820	10822	_	_
72	3	Travellers	Travellers	NNPS	1	nmod	10823	10833	B-persongroup-110020	_
72	4	.	.	.	1	punct	10833	10834	I-persongroup-110020	_

73	1	Table	Table	NNP	3	nsubj	10835	10840	_	_
73	2	1	1	CD	1	nummod	10841	10842	_	_
73	3	provides	provide	VBZ	0	ROOT	10844	10852	_	_
73	4	a	a	DT	5	det	10853	10854	_	_
73	5	summary	summary	NN	3	dobj	10855	10862	_	_
73	6	of	of	IN	7	case	10863	10865	_	_
73	7	criteria	criterion	NNS	5	nmod	10866	10874	_	_
73	8	for	for	IN	10	case	10875	10878	_	_
73	9	measles	measles	NNS	10	compound	10879	10886	_	_
73	10	immunity	immunity	NN	7	nmod	10887	10895	_	_
73	11	.	.	.	3	punct	10895	10896	_	_

74	1	Refer	refer	VB	0	ROOT	10897	10902	_	_
74	2	to	to	TO	3	mark	10903	10905	_	_
74	3	Schedule	schedule	VB	1	xcomp	10906	10914	_	_
74	4	.	.	.	1	punct	10914	10915	_	_

75	1	Children	child	NNS	11	nsubjpass	10916	10924	B-persongroup-110021	_
75	2	and	and	CC	1	cc	10926	10929	_	_
75	3	adults	adult	NNS	1	conj	10930	10936	B-persongroup-110022	_
75	4	lacking	lack	VBG	1	acl	10937	10944	_	_
75	5	adequate	adequate	JJ	6	amod	10945	10953	_	_
75	6	documentation	documentation	NN	4	dobj	10954	10967	_	_
75	7	of	of	IN	8	case	10968	10970	_	_
75	8	immunization	immunization	NN	6	nmod	10971	10983	_	_
75	9	should	should	MD	11	aux	10984	10990	_	_
75	10	be	be	VB	11	auxpass	10991	10993	_	_
75	11	considered	consider	VBN	0	ROOT	10994	11004	_	_
75	12	unimmunized	unimmunized	JJ	11	xcomp	11006	11017	_	_
75	13	and	and	CC	11	cc	11018	11021	_	_
75	14	started	start	VBD	11	conj	11022	11029	_	_
75	15	on	on	IN	18	case	11030	11032	_	_
75	16	an	a	DT	18	det	11033	11035	_	_
75	17	immunization	immunization	NN	18	compound	11036	11048	_	_
75	18	schedule	schedule	NN	14	nmod	11049	11057	_	_
75	19	appropriate	appropriate	JJ	18	amod	11058	11069	_	_
75	20	for	for	IN	22	case	11070	11073	_	_
75	21	their	they	PRP$	22	nmod:poss	11074	11079	_	_
75	22	age	age	NN	19	nmod	11080	11083	_	_
75	23	and	and	CC	22	cc	11085	11088	_	_
75	24	risk	risk	NN	25	compound	11089	11093	_	_
75	25	factors	factor	NNS	22	conj	11094	11101	_	_
75	26	,	,	,	18	punct	11101	11102	_	_
75	27	unless	unless	IN	28	mark	11103	11109	_	_
75	28	known	know	VBN	18	dep	11110	11115	_	_
75	29	to	to	TO	31	mark	11116	11118	_	_
75	30	be	be	VB	31	cop	11119	11121	_	_
75	31	immune	immune	JJ	28	xcomp	11122	11128	_	_
75	32	based	base	VBN	35	case	11129	11134	_	_
75	33	on	on	IN	35	case	11135	11137	_	_
75	34	laboratory	laboratory	NN	35	compound	11138	11148	_	_
75	35	testing	testing	NN	31	advcl	11149	11156	_	_
75	36	.	.	.	11	punct	11156	11157	_	_

76	1	MMR	mmr	NN	4	compound	11158	11161	_	_
76	2	or	or	CC	1	cc	11162	11164	_	_
76	3	MMRV	mmrv	NN	1	conj	11166	11170	_	_
76	4	vaccine	vaccine	NN	11	nsubjpass	11171	11178	_	_
76	5	,	,	,	4	punct	11178	11179	_	_
76	6	as	as	IN	7	dep	11180	11182	_	_
76	7	appropriate	appropriate	JJ	4	amod	11183	11194	_	_
76	8	,	,	,	4	punct	11194	11195	_	_
76	9	may	may	MD	11	aux	11196	11199	_	_
76	10	be	be	VB	11	auxpass	11200	11202	_	_
76	11	given	give	VBN	0	ROOT	11203	11208	_	_
76	12	regardless	regardless	RB	11	advmod	11209	11219	_	_
76	13	of	of	IN	16	case	11220	11222	_	_
76	14	possible	possible	JJ	16	amod	11223	11231	_	_
76	15	previous	previous	JJ	16	amod	11232	11240	_	_
76	16	receipt	receipt	NN	12	nmod	11242	11249	_	_
76	17	of	of	IN	19	case	11250	11252	_	_
76	18	the	the	DT	19	det	11253	11256	_	_
76	19	vaccine	vaccine	NN	16	nmod	11257	11264	_	_
76	20	because	because	IN	31	mark	11265	11272	_	_
76	21	additional	additional	JJ	23	amod	11273	11283	_	_
76	22	adverse	adverse	JJ	23	amod	11284	11291	_	_
76	23	events	event	NNS	31	nsubjpass	11292	11298	_	_
76	24	associated	associate	VBN	23	acl	11299	11309	_	_
76	25	with	with	IN	27	case	11310	11314	_	_
76	26	repeated	repeat	VBN	27	amod	11315	11323	_	_
76	27	immunization	immunization	NN	24	nmod	11325	11337	_	_
76	28	have	have	VBP	31	aux	11338	11342	_	_
76	29	not	not	RB	31	neg	11343	11346	_	_
76	30	been	be	VBN	31	auxpass	11347	11351	_	_
76	31	demonstrated	demonstrate	VBN	11	advcl	11352	11364	_	_
76	32	.	.	.	11	punct	11364	11365	_	_

77	1	Refer	refer	VB	0	ROOT	11366	11371	_	_
77	2	to	to	TO	3	case	11372	11374	_	_
77	3	Immunization	immunization	NN	1	nmod	11375	11387	_	_
77	4	of	of	IN	5	case	11388	11390	_	_
77	5	Children	Children	NNP	3	nmod	11391	11399	B-persongroup-110023	_
77	6	and	and	CC	3	cc	11400	11403	_	_
77	7	Adults	adult	NNS	3	conj	11404	11410	B-persongroup-110024	_
77	8	with	with	IN	11	case	11411	11415	_	_
77	9	Inadequate	Inadequate	NNP	11	compound	11416	11426	_	_
77	10	Immunization	Immunization	NNP	11	compound	11427	11439	_	_
77	11	Records	Records	NNP	7	nmod	11441	11448	_	_
77	12	in	in	IN	13	case	11451	11453	_	_
77	13	Part	Part	NNP	11	nmod	11454	11458	_	_
77	14	3	3	CD	13	nummod	11459	11460	_	_
77	15	for	for	IN	18	case	11461	11464	_	_
77	16	additional	additional	JJ	18	amod	11465	11475	_	_
77	17	general	general	JJ	18	amod	11476	11483	_	_
77	18	information	information	NN	1	nmod	11484	11495	_	_
77	19	.	.	.	1	punct	11495	11496	_	_

78	1	Immunity	immunity	NN	10	nsubjpass	11497	11505	_	_
78	2	to	to	TO	3	case	11506	11508	_	_
78	3	measles	measles	NNS	1	nmod	11509	11516	_	_
78	4	,	,	,	3	punct	11516	11517	_	_
78	5	mumps	mumps	NNS	3	conj	11518	11523	_	_
78	6	and	and	CC	3	cc	11524	11527	_	_
78	7	rubella	rubella	NN	3	conj	11528	11535	_	_
78	8	should	should	MD	10	aux	11536	11542	_	_
78	9	be	be	VB	10	auxpass	11543	11545	_	_
78	10	reviewed	review	VBN	0	ROOT	11546	11554	_	_
78	11	in	in	IN	12	case	11555	11557	_	_
78	12	women	woman	NNS	10	nmod	11558	11563	_	_
78	13	of	of	IN	15	case	11564	11566	_	_
78	14	reproductive	reproductive	JJ	15	amod	11567	11579	_	_
78	15	age	age	NN	12	nmod	11580	11583	_	_
78	16	,	,	,	10	punct	11583	11584	_	_
78	17	and	and	CC	10	cc	11585	11588	_	_
78	18	vaccination	vaccination	NN	21	nsubjpass	11589	11600	_	_
78	19	should	should	MD	21	aux	11601	11607	_	_
78	20	be	be	VB	21	auxpass	11608	11610	_	_
78	21	recommended	recommend	VBN	10	conj	11611	11622	_	_
78	22	to	to	TO	25	case	11623	11625	_	_
78	23	non-pregnant	non-pregnant	JJ	25	amod	11626	11638	B-persongroup-110025	_
78	24	susceptible	susceptible	JJ	25	amod	11639	11650	I-persongroup-110025	_
78	25	women	woman	NNS	21	nmod	11651	11656	I-persongroup-110025	_
78	26	.	.	.	10	punct	11656	11657	I-persongroup-110025	_

79	1	Ideally	ideally	RB	14	advmod	11658	11665	_	_
79	2	,	,	,	14	punct	11665	11666	_	_
79	3	the	the	DT	5	det	11667	11670	_	_
79	4	immunization	immunization	NN	5	compound	11671	11683	_	_
79	5	status	status	NN	14	nsubjpass	11684	11690	_	_
79	6	of	of	IN	7	case	11691	11693	_	_
79	7	women	woman	NNS	5	nmod	11694	11699	B-persongroup-110026	_
79	8	intending	intend	VBG	7	acl	11700	11709	_	_
79	9	to	to	TO	10	mark	11710	11712	_	_
79	10	become	become	VB	8	xcomp	11713	11719	_	_
79	11	pregnant	pregnant	JJ	10	xcomp	11720	11728	_	_
79	12	should	should	MD	14	aux	11729	11735	_	_
79	13	be	be	VB	14	auxpass	11736	11738	_	_
79	14	reviewed	review	VBN	0	ROOT	11739	11747	_	_
79	15	and	and	CC	14	cc	11748	11751	_	_
79	16	vaccines	vaccine	NNS	17	nsubj	11752	11760	_	_
79	17	updated	update	VBN	14	conj	11761	11768	_	_
79	18	as	as	RB	19	advmod	11769	11771	_	_
79	19	necessary	necessary	JJ	17	xcomp	11772	11781	_	_
79	20	prior	prior	JJ	22	advmod	11782	11787	_	_
79	21	to	to	TO	22	case	11788	11790	_	_
79	22	conception	conception	NN	17	nmod	11791	11801	_	_
79	23	.	.	.	14	punct	11801	11802	_	_

80	1	Women	woman	NNS	3	nsubj	11803	11808	B-persongroup-110027	_
80	2	should	should	MD	3	aux	11809	11815	_	_
80	3	delay	delay	VB	0	ROOT	11816	11821	_	_
80	4	pregnancy	pregnancy	NN	3	dobj	11822	11831	_	_
80	5	by	by	IN	9	case	11832	11834	_	_
80	6	at	at	IN	7	case	11835	11837	_	_
80	7	least	least	JJS	8	nmod:npmod	11838	11843	_	_
80	8	28	28	CD	9	nummod	11844	11846	_	_
80	9	days	day	NNS	3	nmod	11847	11851	_	_
80	10	following	follow	VBG	11	case	11852	11861	_	_
80	11	vaccination	vaccination	NN	9	nmod	11862	11873	_	_
80	12	with	with	IN	15	case	11874	11878	_	_
80	13	a	a	DT	15	det	11879	11880	_	_
80	14	live	live	JJ	15	amod	11881	11885	_	_
80	15	vaccine	vaccine	NN	11	nmod	11886	11893	_	_
80	16	.	.	.	3	punct	11893	11894	_	_

81	1	MMR	mmr	NN	4	compound	11895	11898	_	_
81	2	and	and	CC	1	cc	11899	11902	_	_
81	3	MMRV	mmrv	NN	1	conj	11903	11907	_	_
81	4	vaccines	vaccine	NNS	9	nsubjpass	11908	11916	_	_
81	5	should	should	MD	9	aux	11917	11923	_	_
81	6	generally	generally	RB	9	advmod	11924	11933	_	_
81	7	not	not	RB	9	neg	11934	11937	_	_
81	8	be	be	VB	9	auxpass	11938	11940	_	_
81	9	given	give	VBN	0	ROOT	11941	11946	_	_
81	10	during	during	IN	11	case	11947	11953	_	_
81	11	pregnancy	pregnancy	NN	9	nmod	11954	11963	_	_
81	12	because	because	IN	16	case	11964	11971	_	_
81	13	of	of	IN	12	mwe	11972	11974	_	_
81	14	the	the	DT	16	det	11975	11978	_	_
81	15	theoretical	theoretical	JJ	16	amod	11979	11990	_	_
81	16	risk	risk	NN	9	nmod	11991	11995	_	_
81	17	of	of	IN	19	case	11996	11998	_	_
81	18	disease	disease	NN	19	compound	11999	12006	_	_
81	19	transmission	transmission	NN	16	nmod	12007	12019	_	_
81	20	to	to	TO	22	case	12020	12022	_	_
81	21	the	the	DT	22	det	12023	12026	B-persongroup-110028	_
81	22	fetus	fetus	NN	9	nmod	12027	12032	I-persongroup-110028	_
81	23	;	;	:	9	punct	12032	12033	I-persongroup-110028	_
81	24	however	however	RB	27	advmod	12034	12041	_	_
81	25	,	,	,	27	punct	12041	12042	_	_
81	26	there	there	EX	27	expl	12043	12048	_	_
81	27	is	be	VBZ	9	parataxis	12049	12051	_	_
81	28	no	no	DT	29	neg	12052	12054	_	_
81	29	evidence	evidence	NN	27	nsubj	12055	12063	_	_
81	30	demonstrating	demonstrate	VBG	29	acl	12064	12077	_	_
81	31	a	a	DT	35	det	12078	12079	_	_
81	32	teratogenic	teratogenic	JJ	35	amod	12080	12091	_	_
81	33	or	or	CC	32	cc	12092	12094	_	_
81	34	other	other	JJ	32	conj	12095	12100	_	_
81	35	risk	risk	NN	30	dobj	12101	12105	_	_
81	36	from	from	IN	38	case	12106	12110	_	_
81	37	such	such	JJ	38	amod	12111	12115	_	_
81	38	vaccines	vaccine	NNS	35	nmod	12116	12124	_	_
81	39	.	.	.	9	punct	12124	12125	_	_

82	1	There	there	EX	2	expl	12126	12131	_	_
82	2	was	be	VBD	0	ROOT	12132	12135	_	_
82	3	no	no	DT	4	neg	12136	12138	_	_
82	4	evidence	evidence	NN	2	nsubj	12139	12147	_	_
82	5	of	of	IN	8	case	12148	12150	_	_
82	6	Congenital	congenital	JJ	8	amod	12151	12161	_	_
82	7	Rubella	Rubella	NNP	8	compound	12162	12169	_	_
82	8	Syndrome	syndrome	NN	4	nmod	12170	12178	_	_
82	9	in	in	IN	10	case	12179	12181	_	_
82	10	any	any	DT	4	nmod	12182	12185	_	_
82	11	of	of	IN	13	case	12186	12188	_	_
82	12	the	the	DT	13	det	12189	12192	B-persongroup-110029	_
82	13	offspring	offspring	NN	10	nmod	12193	12202	I-persongroup-110029	_
82	14	of	of	IN	16	case	12203	12205	I-persongroup-110029	_
82	15	226	226	CD	16	nummod	12206	12209	I-persongroup-110029#B-persongroup-110030	_
82	16	women	woman	NNS	13	nmod	12210	12215	I-persongroup-110029#I-persongroup-110030	_
82	17	inadvertently	inadvertently	RB	18	advmod	12216	12229	_	_
82	18	vaccinated	vaccinate	VBN	16	acl	12230	12240	_	_
82	19	during	during	IN	20	case	12241	12247	_	_
82	20	pregnancy	pregnancy	NN	18	nmod	12248	12257	_	_
82	21	.	.	.	2	punct	12257	12258	_	_

83	1	Inadvertent	inadvertent	JJ	2	amod	12259	12270	_	_
83	2	immunization	immunization	NN	9	nsubj	12271	12283	_	_
83	3	with	with	IN	5	case	12284	12288	_	_
83	4	MMR	mmr	NN	5	compound	12289	12292	_	_
83	5	vaccine	vaccine	NN	2	nmod	12293	12300	_	_
83	6	is	be	VBZ	9	cop	12301	12303	_	_
83	7	not	not	RB	9	neg	12304	12307	_	_
83	8	a	a	DT	9	det	12308	12309	_	_
83	9	reason	reason	NN	0	ROOT	12310	12316	_	_
83	10	for	for	IN	12	case	12317	12320	_	_
83	11	pregnancy	pregnancy	NN	12	compound	12321	12330	_	_
83	12	termination	termination	NN	9	nmod	12331	12342	_	_
83	13	.	.	.	9	punct	12342	12343	_	_

84	1	In	in	IN	3	case	12344	12346	_	_
84	2	some	some	DT	3	det	12347	12351	_	_
84	3	situations	situation	NNS	11	nmod	12352	12362	_	_
84	4	,	,	,	11	punct	12362	12363	_	_
84	5	potential	potential	JJ	6	amod	12364	12373	_	_
84	6	benefits	benefit	NNS	11	nsubj	12374	12382	_	_
84	7	of	of	IN	9	case	12383	12385	_	_
84	8	MMR	mmr	NN	9	compound	12386	12389	_	_
84	9	vaccination	vaccination	NN	6	nmod	12390	12401	_	_
84	10	may	may	MD	11	aux	12402	12405	_	_
84	11	outweigh	outweigh	VB	0	ROOT	12406	12414	_	_
84	12	risks	risk	NNS	11	dobj	12415	12420	_	_
84	13	such	such	JJ	16	case	12421	12425	_	_
84	14	as	as	IN	13	mwe	12426	12428	_	_
84	15	during	during	IN	16	case	12429	12435	_	_
84	16	measles	measles	NNS	12	nmod	12436	12443	_	_
84	17	or	or	CC	16	cc	12444	12446	_	_
84	18	rubella	rubella	NN	19	compound	12447	12454	_	_
84	19	outbreaks	outbreak	NNS	16	conj	12455	12464	_	_
84	20	,	,	,	12	punct	12464	12465	_	_
84	21	in	in	IN	22	case	12466	12468	_	_
84	22	which	which	WDT	27	nmod	12469	12474	_	_
84	23	case	case	NN	24	compound	12475	12479	_	_
84	24	vaccination	vaccination	NN	27	nsubjpass	12480	12491	_	_
84	25	may	may	MD	27	aux	12492	12495	_	_
84	26	be	be	VB	27	auxpass	12496	12498	_	_
84	27	considered	consider	VBN	12	acl:relcl	12499	12509	_	_
84	28	.	.	.	11	punct	12509	12510	_	_

85	1	Women	woman	NNS	7	nsubjpass	12512	12517	B-persongroup-110031	_
85	2	who	who	WP	4	nsubj	12518	12521	_	_
85	3	are	be	VBP	4	aux	12522	12525	_	_
85	4	breastfeeding	breastfeed	VBG	1	acl:relcl	12526	12539	_	_
85	5	can	can	MD	7	aux	12540	12543	_	_
85	6	be	be	VB	7	auxpass	12544	12546	_	_
85	7	vaccinated	vaccinate	VBN	0	ROOT	12547	12557	_	_
85	8	with	with	IN	10	case	12558	12562	_	_
85	9	MMR	mmr	NN	10	compound	12563	12566	_	_
85	10	vaccine	vaccine	NN	7	nmod	12568	12575	_	_
85	11	.	.	.	7	punct	12575	12576	_	_

86	1	Refer	refer	VB	0	ROOT	12578	12583	_	_
86	2	to	to	TO	3	case	12584	12586	_	_
86	3	Contraindications	contraindication	NNS	1	nmod	12587	12604	_	_
86	4	,	,	,	3	punct	12604	12605	_	_
86	5	Precautions	precaution	NNS	3	appos	12606	12617	_	_
86	6	.	.	.	1	punct	12617	12618	_	_

87	1	Refer	refer	VB	0	ROOT	12619	12624	_	_
87	2	to	to	TO	3	case	12625	12627	_	_
87	3	Immunization	immunization	NN	1	nmod	12628	12640	_	_
87	4	in	in	IN	5	case	12641	12643	_	_
87	5	Pregnancy	Pregnancy	NNP	3	nmod	12644	12653	_	_
87	6	and	and	CC	5	cc	12654	12657	_	_
87	7	Breastfeeding	Breastfeeding	NNP	5	conj	12658	12671	_	_
87	8	in	in	IN	9	case	12673	12675	_	_
87	9	Part	Part	NNP	1	nmod	12677	12681	_	_
87	10	3	3	CD	9	nummod	12682	12683	_	_
87	11	for	for	IN	14	case	12684	12687	_	_
87	12	additional	additional	JJ	14	amod	12688	12698	_	_
87	13	general	general	JJ	14	amod	12699	12706	_	_
87	14	information	information	NN	1	nmod	12707	12718	_	_
87	15	.	.	.	1	punct	12718	12719	_	_

88	1	Susceptible	susceptible	JJ	2	amod	12720	12731	B-persongroup-110187	_
88	2	residents	resident	NNS	8	nsubj	12732	12741	I-persongroup-110187	_
88	3	of	of	IN	6	case	12742	12744	I-persongroup-110187	_
88	4	long-term	long-term	JJ	6	amod	12745	12754	I-persongroup-110187	_
88	5	care	care	NN	6	compound	12755	12759	I-persongroup-110187	_
88	6	facilities	facility	NNS	2	nmod	12760	12770	I-persongroup-110187	_
88	7	should	should	MD	8	aux	12771	12777	_	_
88	8	receive	receive	VB	0	ROOT	12778	12785	_	_
88	9	measles	measles	NNS	8	dobj	12786	12793	_	_
88	10	,	,	,	9	punct	12793	12794	_	_
88	11	mumps	mumps	NNS	9	conj	12795	12800	_	_
88	12	and	and	CC	9	cc	12801	12804	_	_
88	13	rubella-containing	rubella-containing	JJ	14	amod	12805	12823	_	_
88	14	vaccine	vaccine	NN	9	conj	12824	12831	_	_
88	15	as	as	RB	9	cc	12832	12834	_	_
88	16	well	well	RB	15	mwe	12835	12839	_	_
88	17	as	as	IN	15	mwe	12840	12842	_	_
88	18	all	all	DT	20	det	12843	12846	_	_
88	19	routine	routine	JJ	20	amod	12847	12854	_	_
88	20	immunizations	immunization	NNS	9	conj	12855	12868	_	_
88	21	appropriate	appropriate	JJ	20	amod	12869	12880	_	_
88	22	for	for	IN	24	case	12881	12884	_	_
88	23	their	they	PRP$	24	nmod:poss	12885	12890	_	_
88	24	age	age	NN	21	nmod	12891	12894	_	_
88	25	and	and	CC	24	cc	12895	12898	_	_
88	26	risk	risk	NN	27	compound	12899	12903	_	_
88	27	factors	factor	NNS	24	conj	12904	12911	_	_
88	28	.	.	.	8	punct	12911	12912	_	_

89	1	Refer	refer	VB	0	ROOT	12913	12918	_	_
89	2	to	to	TO	3	case	12919	12921	_	_
89	3	Immunization	immunization	NN	1	nmod	12922	12934	_	_
89	4	of	of	IN	5	case	12935	12937	_	_
89	5	Patients	patient	NNS	3	nmod	12938	12946	B-persongroup-110032	_
89	6	in	in	IN	9	case	12947	12949	_	_
89	7	Health	Health	NNP	9	compound	12950	12956	B-persongroup-110033	_
89	8	Care	Care	NNP	9	compound	12957	12961	I-persongroup-110033	_
89	9	Institutions	Institutions	NNP	5	nmod	12962	12974	I-persongroup-110033	_
89	10	in	in	IN	11	case	12976	12978	_	_
89	11	Part	Part	NNP	9	nmod	12979	12983	_	_
89	12	3	3	CD	11	nummod	12984	12985	_	_
89	13	for	for	IN	16	case	12986	12989	_	_
89	14	additional	additional	JJ	16	amod	12990	13000	_	_
89	15	general	general	JJ	16	amod	13001	13008	_	_
89	16	information	information	NN	1	nmod	13009	13020	_	_
89	17	.	.	.	1	punct	13020	13021	_	_

90	1	In	in	IN	2	case	13022	13024	_	_
90	2	general	general	JJ	8	advcl	13025	13032	_	_
90	3	,	,	,	8	punct	13032	13033	_	_
90	4	immunocompromised	immunocompromised	JJ	5	amod	13034	13051	B-persongroup-110034	_
90	5	persons	person	NNS	8	nsubj	13052	13059	I-persongroup-110034	_
90	6	should	should	MD	8	aux	13060	13066	_	_
90	7	not	not	RB	8	neg	13067	13070	_	_
90	8	receive	receive	VB	0	ROOT	13071	13078	_	_
90	9	live	live	JJ	10	amod	13079	13083	_	_
90	10	vaccines	vaccine	NNS	8	dobj	13084	13092	_	_
90	11	because	because	IN	14	case	13093	13100	_	_
90	12	of	of	IN	11	mwe	13101	13103	_	_
90	13	the	the	DT	14	det	13104	13107	_	_
90	14	risk	risk	NN	8	nmod	13108	13112	_	_
90	15	of	of	IN	16	case	13113	13115	_	_
90	16	disease	disease	NN	14	nmod	13116	13123	_	_
90	17	caused	cause	VBN	16	acl	13124	13130	_	_
90	18	by	by	IN	21	case	13131	13133	_	_
90	19	the	the	DT	21	det	13134	13137	_	_
90	20	vaccine	vaccine	NN	21	compound	13138	13145	_	_
90	21	strains	strain	NNS	17	nmod	13146	13153	_	_
90	22	.	.	.	8	punct	13153	13154	_	_

91	1	When	when	WRB	2	advmod	13155	13159	_	_
91	2	considering	consider	VBG	21	advcl	13160	13171	_	_
91	3	immunization	immunization	NN	2	dobj	13172	13184	_	_
91	4	of	of	IN	7	case	13185	13187	_	_
91	5	an	a	DT	7	det	13188	13190	B-persongroup-110035	_
91	6	immunocompromised	immunocompromised	JJ	7	amod	13191	13208	I-persongroup-110035	_
91	7	person	person	NN	3	nmod	13209	13215	I-persongroup-110035	_
91	8	with	with	IN	11	case	13216	13220	_	_
91	9	a	a	DT	11	det	13221	13222	_	_
91	10	live	live	JJ	11	amod	13223	13227	_	_
91	11	vaccine	vaccine	NN	2	nmod	13228	13235	_	_
91	12	,	,	,	21	punct	13235	13236	_	_
91	13	approval	approval	NN	21	nsubjpass	13237	13245	_	_
91	14	from	from	IN	16	case	13246	13250	_	_
91	15	the	the	DT	16	det	13251	13254	B-persongroup-110036	_
91	16	individualís	individualís	NNS	13	nmod	13255	13267	I-persongroup-110036	_
91	17	attending	attend	VBG	16	acl	13268	13277	I-persongroup-110036	_
91	18	physician	physician	NN	17	dobj	13278	13287	I-persongroup-110036	_
91	19	should	should	MD	21	aux	13288	13294	_	_
91	20	be	be	VB	21	auxpass	13295	13297	_	_
91	21	obtained	obtain	VBN	0	ROOT	13298	13306	_	_
91	22	before	before	IN	23	case	13307	13313	_	_
91	23	vaccination	vaccination	NN	21	nmod	13314	13325	_	_
91	24	.	.	.	21	punct	13325	13326	_	_

92	1	For	for	IN	3	case	13327	13330	_	_
92	2	complex	complex	JJ	3	amod	13331	13338	_	_
92	3	cases	case	NNS	16	nmod	13339	13344	_	_
92	4	,	,	,	16	punct	13344	13345	_	_
92	5	referral	referral	NN	16	nsubjpass	13346	13354	_	_
92	6	to	to	TO	8	case	13355	13357	_	_
92	7	a	a	DT	8	det	13358	13359	B-persongroup-110037	_
92	8	consultant	consultant	NN	5	nmod	13360	13370	I-persongroup-110037	_
92	9	with	with	IN	10	case	13371	13375	_	_
92	10	expertise	expertise	NN	8	nmod	13376	13385	_	_
92	11	in	in	IN	12	case	13386	13388	_	_
92	12	immunization	immunization	NN	10	nmod	13389	13401	_	_
92	13	or	or	CC	12	cc	13402	13404	_	_
92	14	immunodeficiency	immunodeficiency	NN	12	conj	13405	13421	_	_
92	15	is	be	VBZ	16	auxpass	13422	13424	_	_
92	16	advised	advise	VBN	0	ROOT	13425	13432	_	_
92	17	.	.	.	16	punct	13432	13433	_	_

93	1	People	people	NNS	10	nsubj	13434	13440	B-persongroup-110038	_
93	2	who	who	WP	3	nsubj	13441	13444	_	_
93	3	have	have	VBP	1	acl:relcl	13445	13449	_	_
93	4	a	a	DT	6	det	13450	13451	_	_
93	5	suspicious	suspicious	JJ	6	amod	13452	13462	_	_
93	6	history	history	NN	3	dobj	13463	13470	_	_
93	7	for	for	IN	9	case	13471	13474	_	_
93	8	immunodeficiency	immunodeficiency	NN	9	compound	13475	13491	_	_
93	9	disorders	disorder	NNS	6	nmod	13492	13501	_	_
93	10	(	(	VBP	0	ROOT	13502	13503	_	_
93	11	e.g.	e.g.	FW	10	dobj	13503	13507	_	_
93	12	,	,	,	10	punct	13507	13508	_	_
93	13	known	know	VBN	10	dep	13509	13514	_	_
93	14	or	or	CC	13	cc	13515	13517	_	_
93	15	suspected	suspect	VBN	13	conj	13518	13527	_	_
93	16	family	family	NN	17	compound	13528	13534	_	_
93	17	history	history	NN	13	dobj	13535	13542	_	_
93	18	of	of	IN	21	case	13543	13545	_	_
93	19	congenital	congenital	JJ	21	amod	13546	13556	_	_
93	20	immunodeficiency	immunodeficiency	NN	21	compound	13557	13573	_	_
93	21	disorder	disorder	NN	17	nmod	13574	13582	_	_
93	22	or	or	CC	21	cc	13583	13585	_	_
93	23	HIV	hiv	NN	24	compound	13586	13589	_	_
93	24	infection	infection	NN	21	conj	13590	13599	_	_
93	25	,	,	,	17	punct	13599	13600	_	_
93	26	or	or	CC	17	cc	13601	13603	_	_
93	27	history	history	NN	17	conj	13604	13611	_	_
93	28	of	of	IN	29	case	13612	13614	_	_
93	29	failure	failure	NN	27	nmod	13615	13622	_	_
93	30	to	to	TO	31	mark	13623	13625	_	_
93	31	thrive	thrive	VB	10	xcomp	13626	13632	_	_
93	32	and	and	CC	10	cc	13633	13636	_	_
93	33	recurrent	recurrent	JJ	34	amod	13637	13646	_	_
93	34	infections	infection	NNS	35	nsubj	13647	13657	_	_
93	35	)	)	VBP	10	conj	13657	13658	_	_
93	36	should	should	MD	39	aux	13659	13665	_	_
93	37	not	not	RB	39	neg	13666	13669	_	_
93	38	be	be	VB	39	auxpass	13670	13672	_	_
93	39	immunized	immunize	VBN	35	ccomp	13673	13682	_	_
93	40	with	with	IN	43	case	13683	13687	_	_
93	41	a	a	DT	43	det	13688	13689	_	_
93	42	live	live	JJ	43	amod	13690	13694	_	_
93	43	vaccine	vaccine	NN	39	nmod	13695	13702	_	_
93	44	until	until	IN	49	mark	13703	13708	_	_
93	45	they	they	PRP	49	nsubjpass	13709	13713	_	_
93	46	have	have	VBP	49	aux	13714	13718	_	_
93	47	been	be	VBN	49	auxpass	13719	13723	_	_
93	48	fully	fully	RB	49	advmod	13724	13729	_	_
93	49	investigated	investigate	VBN	39	advcl	13730	13742	_	_
93	50	and	and	CC	49	cc	13743	13746	_	_
93	51	T	t	NN	53	compound	13747	13748	_	_
93	52	cell	cell	NN	53	compound	13749	13753	_	_
93	53	dysfunction	dysfunction	NN	54	nsubj	13754	13765	_	_
93	54	ruled	rule	VBD	49	conj	13766	13771	_	_
93	55	out	out	RP	54	compound:prt	13772	13775	_	_
93	56	.	.	.	10	punct	13775	13776	_	_

94	1	Immunodeficiency	immunodeficiency	NN	2	compound	13777	13793	B-persongroup-110039	_
94	2	states	state	NNS	5	nsubj	13794	13800	I-persongroup-110039	_
94	3	may	may	MD	5	aux	13801	13804	_	_
94	4	be	be	VB	5	cop	13805	13807	_	_
94	5	undiagnosed	undiagnosed	JJ	0	ROOT	13808	13819	_	_
94	6	in	in	IN	8	case	13820	13822	_	_
94	7	young	young	JJ	8	amod	13823	13828	B-persongroup-110040	_
94	8	children	child	NNS	5	nmod	13829	13837	I-persongroup-110040	_
94	9	presenting	present	VBG	8	acl	13838	13848	_	_
94	10	for	for	IN	12	case	13849	13852	_	_
94	11	routine	routine	JJ	12	amod	13853	13860	_	_
94	12	immunizations	immunization	NNS	9	nmod	13861	13874	_	_
94	13	,	,	,	12	punct	13874	13875	_	_
94	14	which	which	WDT	15	nsubj	13876	13881	_	_
94	15	include	include	VBP	12	acl:relcl	13882	13889	_	_
94	16	live	live	JJ	17	amod	13890	13894	_	_
94	17	vaccines	vaccine	NNS	15	dobj	13895	13903	_	_
94	18	.	.	.	5	punct	13903	13904	_	_

95	1	This	this	DT	4	nsubj	13905	13909	_	_
95	2	is	be	VBZ	4	cop	13910	13912	_	_
95	3	particularly	particularly	RB	4	advmod	13913	13925	_	_
95	4	important	important	JJ	0	ROOT	13926	13935	_	_
95	5	to	to	TO	6	mark	13936	13938	_	_
95	6	consider	consider	VB	4	xcomp	13939	13947	_	_
95	7	in	in	IN	8	case	13948	13950	_	_
95	8	infants	infant	NNS	6	nmod	13951	13958	B-persongroup-110041	_
95	9	receiving	receive	VBG	8	acl	13959	13968	_	_
95	10	live	live	JJ	11	amod	13969	13973	_	_
95	11	vaccines	vaccine	NNS	9	dobj	13974	13982	_	_
95	12	before	before	IN	14	case	13983	13989	_	_
95	13	12	12	CD	14	nummod	13990	13992	_	_
95	14	months	month	NNS	9	nmod	13993	13999	_	_
95	15	of	of	IN	16	case	14000	14002	_	_
95	16	age	age	NN	14	nmod	14003	14006	_	_
95	17	.	.	.	4	punct	14006	14007	_	_

96	1	A	a	DT	2	det	14008	14009	_	_
96	2	history	history	NN	15	nsubjpass	14010	14017	_	_
96	3	of	of	IN	6	case	14018	14020	_	_
96	4	negative	negative	JJ	6	amod	14021	14029	_	_
96	5	prenatal	prenatal	JJ	6	amod	14030	14038	_	_
96	6	screening	screening	NN	2	nmod	14039	14048	_	_
96	7	of	of	IN	10	case	14049	14051	_	_
96	8	the	the	DT	10	det	14052	14055	B-persongroup-110042	_
96	9	infantís	infantís	NNS	10	compound	14056	14064	I-persongroup-110042	_
96	10	mother	mother	NN	6	nmod	14065	14071	I-persongroup-110042	_
96	11	for	for	IN	12	case	14072	14075	_	_
96	12	HIV	hiv	NN	10	nmod	14076	14079	_	_
96	13	should	should	MD	15	aux	14080	14086	_	_
96	14	be	be	VB	15	auxpass	14087	14089	_	_
96	15	obtained	obtain	VBN	0	ROOT	14090	14098	_	_
96	16	before	before	IN	17	mark	14099	14105	_	_
96	17	administering	administer	VBG	15	advcl	14106	14119	_	_
96	18	a	a	DT	20	det	14120	14121	_	_
96	19	live	live	JJ	20	amod	14122	14126	_	_
96	20	vaccine	vaccine	NN	17	dobj	14127	14134	_	_
96	21	.	.	.	15	punct	14134	14135	_	_

97	1	If	if	IN	6	mark	14136	14138	_	_
97	2	a	a	DT	3	det	14139	14140	B-persongroup-110043	_
97	3	mother	mother	NN	6	nsubj	14141	14147	I-persongroup-110043	_
97	4	has	have	VBZ	6	aux	14148	14151	_	_
97	5	not	not	RB	6	neg	14152	14155	_	_
97	6	received	receive	VBN	21	advcl	14156	14164	_	_
97	7	routine	routine	JJ	9	amod	14165	14172	_	_
97	8	prenatal	prenatal	JJ	9	amod	14173	14181	_	_
97	9	care	care	NN	6	dobj	14182	14186	_	_
97	10	in	in	IN	11	case	14187	14189	_	_
97	11	Canada	Canada	NNP	9	nmod	14190	14196	B-persongroup-110044	_
97	12	,	,	,	21	punct	14196	14197	I-persongroup-110044	_
97	13	the	the	DT	14	det	14198	14201	_	_
97	14	possibility	possibility	NN	21	nsubjpass	14202	14213	_	_
97	15	of	of	IN	18	case	14214	14216	_	_
97	16	undiagnosed	undiagnosed	JJ	18	amod	14217	14228	_	_
97	17	HIV	hiv	NN	18	compound	14229	14232	_	_
97	18	infection	infection	NN	14	nmod	14233	14242	_	_
97	19	should	should	MD	21	aux	14243	14249	_	_
97	20	be	be	VB	21	auxpass	14250	14252	_	_
97	21	considered	consider	VBN	0	ROOT	14253	14263	_	_
97	22	.	.	.	21	punct	14263	14264	_	_

98	1	Live	live	VB	0	ROOT	14265	14269	_	_
98	2	vaccines	vaccine	NNS	1	dobj	14270	14278	_	_
98	3	are	be	VBP	6	auxpass	14279	14282	_	_
98	4	generally	generally	RB	6	advmod	14283	14292	_	_
98	5	not	not	RB	6	neg	14293	14296	_	_
98	6	recommended	recommend	VBN	2	acl:relcl	14297	14308	_	_
98	7	for	for	IN	8	case	14309	14312	_	_
98	8	people	people	NNS	6	nmod	14314	14320	B-persongroup-110045	_
98	9	with	with	IN	12	case	14321	14325	_	_
98	10	congenital	congenital	JJ	12	amod	14326	14336	_	_
98	11	immunodeficiency	immunodeficiency	NN	12	compound	14337	14353	_	_
98	12	states	state	NNS	8	nmod	14354	14360	_	_
98	13	although	although	IN	16	mark	14361	14369	_	_
98	14	some	some	DT	15	det	14370	14374	_	_
98	15	exceptions	exception	NNS	16	nsubj	14375	14385	_	_
98	16	exist	exist	VBP	1	advcl	14387	14392	_	_
98	17	.	.	.	1	punct	14392	14393	_	_

99	1	B	b	NN	5	compound	14394	14395	_	_
99	2	cell	cell	NN	5	compound	14396	14400	_	_
99	3	deficiency	deficiency	NN	5	compound	14401	14411	_	_
99	4	MMR	mmr	NN	5	compound	14413	14416	_	_
99	5	vaccine	vaccine	NN	14	nsubjpass	14417	14424	_	_
99	6	,	,	,	8	punct	14424	14425	_	_
99	7	as	as	IN	8	mark	14426	14428	_	_
99	8	appropriate	appropriate	JJ	5	dep	14430	14441	_	_
99	9	for	for	IN	10	case	14442	14445	_	_
99	10	age	age	NN	8	nmod	14446	14449	_	_
99	11	,	,	,	8	punct	14449	14450	_	_
99	12	should	should	MD	14	aux	14451	14457	_	_
99	13	be	be	VB	14	auxpass	14458	14460	_	_
99	14	considered	consider	VBN	0	ROOT	14461	14471	_	_
99	15	if	if	IN	20	mark	14472	14474	_	_
99	16	the	the	DT	17	det	14475	14478	B-persongroup-110046	_
99	17	individual	individual	NN	20	nsubj	14479	14489	I-persongroup-110046	_
99	18	is	be	VBZ	20	aux	14490	14492	_	_
99	19	not	not	RB	20	neg	14493	14496	_	_
99	20	receiving	receive	VBG	14	advcl	14497	14506	_	_
99	21	regular	regular	JJ	25	amod	14508	14515	_	_
99	22	immune	immune	JJ	25	amod	14516	14522	_	_
99	23	globulin	globulin	NN	25	compound	14523	14531	_	_
99	24	replacement	replacement	NN	25	compound	14532	14543	_	_
99	25	therapy	therapy	NN	20	dobj	14544	14551	_	_
99	26	which	which	WDT	28	nsubj	14552	14557	_	_
99	27	may	may	MD	28	aux	14558	14561	_	_
99	28	affect	affect	VB	25	acl:relcl	14562	14568	_	_
99	29	the	the	DT	30	det	14569	14572	_	_
99	30	efficacy	efficacy	NN	28	dobj	14573	14581	_	_
99	31	of	of	IN	33	case	14582	14584	_	_
99	32	the	the	DT	33	det	14586	14589	_	_
99	33	vaccine	vaccine	NN	30	nmod	14590	14597	_	_
99	34	.	.	.	14	punct	14597	14598	_	_

100	1	T	t	NN	2	compound	14600	14601	_	_
100	2	cell	cell	NN	15	nsubj	14602	14606	_	_
100	3	,	,	,	2	punct	14606	14607	_	_
100	4	natural	natural	JJ	7	amod	14609	14616	_	_
100	5	killer	killer	NN	7	compound	14617	14623	_	_
100	6	T	t	NN	7	compound	14624	14625	_	_
100	7	cell	cell	NN	2	appos	14626	14630	_	_
100	8	,	,	,	2	punct	14630	14631	_	_
100	9	and	and	CC	2	cc	14632	14635	_	_
100	10	mixed	mixed	JJ	11	amod	14636	14641	_	_
100	11	cellular	cellular	JJ	2	conj	14642	14650	_	_
100	12	and	and	CC	11	cc	14651	14654	_	_
100	13	antibody	antibody	NN	14	compound	14655	14663	_	_
100	14	defects	defect	NNS	11	conj	14664	14671	_	_
100	15	(	(	VBP	0	ROOT	14672	14673	_	_
100	16	e.g.	e.g.	FW	36	nsubjpass	14673	14677	_	_
100	17	,	,	,	16	punct	14677	14678	_	_
100	18	Severe	severe	JJ	24	amod	14679	14685	_	_
100	19	Combined	combined	JJ	24	amod	14687	14695	_	_
100	20	Immune	immune	JJ	24	amod	14696	14702	_	_
100	21	Deficiency	deficiency	NN	24	compound	14703	14713	_	_
100	22	[	[	CD	24	nummod	14714	14715	_	_
100	23	SCID	scid	NN	24	compound	14715	14719	_	_
100	24	]	]	NN	16	appos	14719	14720	_	_
100	25	)	)	CD	28	nummod	14720	14721	_	_
100	26	All	all	DT	28	compound	14722	14725	_	_
100	27	live	live	JJ	28	amod	14726	14730	_	_
100	28	vaccines	vaccine	NNS	24	dep	14731	14739	_	_
100	29	,	,	,	16	punct	14739	14740	_	_
100	30	including	include	VBG	31	case	14741	14750	_	_
100	31	MMR	MMR	NNP	16	nmod	14751	14754	_	_
100	32	and	and	CC	31	cc	14755	14758	_	_
100	33	MMRV	MMRV	NNP	31	conj	14759	14763	_	_
100	34	,	,	,	16	punct	14763	14764	_	_
100	35	are	be	VBP	36	auxpass	14765	14768	_	_
100	36	contraindicated	contraindicate	VBN	15	ccomp	14770	14785	_	_
100	37	in	in	IN	38	case	14786	14788	_	_
100	38	people	people	NNS	36	nmod	14789	14795	B-persongroup-110047	_
100	39	with	with	IN	40	case	14796	14800	_	_
100	40	defects	defect	NNS	38	nmod	14801	14808	_	_
100	41	in	in	IN	44	case	14809	14811	_	_
100	42	T	t	NN	44	compound	14812	14813	_	_
100	43	cell	cell	NN	44	compound	14814	14818	_	_
100	44	function	function	NN	40	nmod	14819	14827	_	_
100	45	.	.	.	15	punct	14827	14828	_	_

101	1	Phagocytic	phagocytic	JJ	4	amod	14829	14839	_	_
101	2	and	and	CC	1	cc	14841	14844	_	_
101	3	neutrophil	neutrophil	NN	1	conj	14845	14855	_	_
101	4	disorders	disorder	NNS	5	nsubj	14856	14865	_	_
101	5	(	(	VBP	29	ccomp	14866	14867	_	_
101	6	e.g.	e.g.	FW	5	dobj	14867	14871	_	_
101	7	,	,	,	6	punct	14871	14872	_	_
101	8	congenital	congenital	JJ	9	amod	14873	14883	_	_
101	9	neutropenia	neutropenia	NN	6	conj	14884	14895	_	_
101	10	,	,	,	6	punct	14895	14896	_	_
101	11	leukocyte	leukocyte	NN	12	compound	14897	14906	_	_
101	12	adhesion	adhesion	NN	6	conj	14907	14915	_	_
101	13	and	and	CC	6	cc	14916	14919	_	_
101	14	migration	migration	NN	15	compound	14921	14930	_	_
101	15	defects	defect	NNS	6	conj	14931	14938	_	_
101	16	,	,	,	29	punct	14938	14939	_	_
101	17	chronic	chronic	JJ	21	amod	14940	14947	_	_
101	18	granulomatous	granulomatous	JJ	21	amod	14948	14961	_	_
101	19	disease	disease	NN	21	compound	14962	14969	_	_
101	20	)	)	CD	21	nummod	14969	14970	_	_
101	21	Children	child	NNS	29	nsubjpass	14972	14980	B-persongroup-110048	_
101	22	with	with	IN	26	case	14981	14985	_	_
101	23	phagocytic	phagocytic	JJ	26	amod	14986	14996	_	_
101	24	or	or	CC	23	cc	14997	14999	_	_
101	25	neutrophil	neutrophil	NN	23	conj	15000	15010	_	_
101	26	disorders	disorder	NNS	21	nmod	15011	15020	_	_
101	27	may	may	MD	29	aux	15022	15025	_	_
101	28	be	be	VB	29	auxpass	15026	15028	_	_
101	29	vaccinated	vaccinate	VBN	0	ROOT	15029	15039	_	_
101	30	with	with	IN	32	case	15040	15044	_	_
101	31	MMR	mmr	NN	32	compound	15045	15048	_	_
101	32	vaccine	vaccine	NN	29	nmod	15049	15056	_	_
101	33	as	as	IN	34	case	15057	15059	_	_
101	34	appropriate	appropriate	JJ	29	advcl	15060	15071	_	_
101	35	for	for	IN	36	case	15072	15075	_	_
101	36	age	age	NN	29	nmod	15076	15079	_	_
101	37	.	.	.	29	punct	15079	15080	_	_

102	1	Complement	complement	NN	2	compound	15081	15091	_	_
102	2	deficiency	deficiency	NN	4	nsubj	15092	15102	_	_
102	3	There	there	EX	4	expl	15103	15108	_	_
102	4	are	be	VBP	0	ROOT	15109	15112	_	_
102	5	no	no	DT	6	neg	15113	15115	_	_
102	6	contraindications	contraindication	NNS	4	nsubj	15116	15133	_	_
102	7	to	to	TO	9	case	15134	15136	_	_
102	8	the	the	DT	9	det	15137	15140	_	_
102	9	use	use	NN	6	nmod	15141	15144	_	_
102	10	of	of	IN	12	case	15145	15147	_	_
102	11	MMR	mmr	NN	12	compound	15148	15151	_	_
102	12	vaccine	vaccine	NN	9	nmod	15152	15159	_	_
102	13	in	in	IN	14	case	15160	15162	_	_
102	14	individuals	individual	NNS	12	nmod	15163	15174	_	_
102	15	with	with	IN	18	case	15175	15179	_	_
102	16	complement	complement	NN	18	compound	15180	15190	_	_
102	17	deficiency	deficiency	NN	18	compound	15191	15201	_	_
102	18	disorders	disorder	NNS	14	nmod	15202	15211	_	_
102	19	.	.	.	4	punct	15211	15212	_	_

103	1	Immunity	immunity	NN	3	nsubj	15213	15221	_	_
103	2	can	can	MD	3	aux	15222	15225	_	_
103	3	decrease	decrease	VB	0	ROOT	15226	15234	_	_
103	4	over	over	IN	5	case	15235	15239	_	_
103	5	time	time	NN	3	nmod	15240	15244	_	_
103	6	.	.	.	3	punct	15244	15245	_	_

104	1	Measurement	measurement	NN	13	nsubjpass	15246	15257	_	_
104	2	of	of	IN	4	case	15258	15260	_	_
104	3	antibody	antibody	NN	4	compound	15261	15269	_	_
104	4	titres	titre	NNS	1	nmod	15270	15276	_	_
104	5	and	and	CC	4	cc	15277	15280	_	_
104	6	re-immunization	re-immunization	NN	4	conj	15281	15296	_	_
104	7	,	,	,	1	punct	15296	15297	_	_
104	8	if	if	IN	9	mark	15298	15300	_	_
104	9	needed	need	VBN	1	dep	15301	15307	_	_
104	10	,	,	,	1	punct	15307	15308	_	_
104	11	should	should	MD	13	aux	15309	15315	_	_
104	12	be	be	VB	13	auxpass	15316	15318	_	_
104	13	considered	consider	VBN	0	ROOT	15319	15329	_	_
104	14	.	.	.	13	punct	15329	15330	_	_

105	1	Malignant	malignant	JJ	4	amod	15331	15340	_	_
105	2	hematologic	hematologic	JJ	4	amod	15342	15353	_	_
105	3	disorders	disorder	NNS	4	compound	15354	15363	_	_
105	4	MMR	mmr	NN	9	nsubjpass	15364	15367	_	_
105	5	and	and	CC	4	cc	15368	15371	_	_
105	6	MMRV	mmrv	NN	7	compound	15372	15376	_	_
105	7	vaccines	vaccine	NNS	4	conj	15377	15385	_	_
105	8	are	be	VBP	9	auxpass	15386	15389	_	_
105	9	contraindicated	contraindicate	VBN	0	ROOT	15390	15405	_	_
105	10	in	in	IN	11	case	15406	15408	_	_
105	11	individuals	individual	NNS	9	nmod	15409	15420	B-persongroup-110049	_
105	12	with	with	IN	14	case	15421	15425	_	_
105	13	severe	severe	JJ	14	amod	15426	15432	_	_
105	14	immunodeficiency	immunodeficiency	NN	9	nmod	15433	15449	_	_
105	15	due	due	JJ	14	amod	15450	15453	_	_
105	16	to	to	TO	18	case	15454	15456	_	_
105	17	blood	blood	NN	18	compound	15457	15462	_	_
105	18	dyscrasias	dyscrasia	NNS	15	nmod	15463	15473	_	_
105	19	,	,	,	14	punct	15473	15474	_	_
105	20	lymphomas	lymphoma	NNS	14	conj	15475	15484	_	_
105	21	,	,	,	14	punct	15484	15485	_	_
105	22	leukemias	leukemia	NNS	14	conj	15486	15495	_	_
105	23	of	of	IN	25	case	15496	15498	_	_
105	24	any	any	DT	25	det	15499	15502	_	_
105	25	type	type	NN	22	nmod	15503	15507	_	_
105	26	,	,	,	14	punct	15507	15508	_	_
105	27	or	or	CC	14	cc	15509	15511	_	_
105	28	other	other	JJ	30	amod	15512	15517	_	_
105	29	malignant	malignant	JJ	30	amod	15518	15527	_	_
105	30	neoplasms	neoplasm	NNS	14	conj	15528	15537	_	_
105	31	affecting	affect	VBG	30	acl	15538	15547	_	_
105	32	the	the	DT	34	det	15548	15551	_	_
105	33	bone	bone	NN	34	compound	15552	15556	_	_
105	34	marrow	marrow	NN	31	dobj	15557	15563	_	_
105	35	or	or	CC	34	cc	15564	15566	_	_
105	36	lymphatic	lymphatic	JJ	37	amod	15567	15576	_	_
105	37	systems	system	NNS	34	conj	15577	15584	_	_
105	38	and	and	CC	14	cc	15585	15588	_	_
105	39	in	in	IN	40	case	15589	15591	_	_
105	40	people	people	NNS	14	conj	15592	15598	B-persongroup-110051	_
105	41	undergoing	undergo	VBG	40	acl	15599	15609	_	_
105	42	immunosuppressive	immunosuppressive	JJ	43	amod	15610	15627	_	_
105	43	treatment	treatment	NN	41	dobj	15628	15637	_	_
105	44	for	for	IN	45	case	15638	15641	_	_
105	45	malignancy	malignancy	NN	41	nmod	15642	15652	_	_
105	46	.	.	.	9	punct	15652	15653	_	_

106	1	Children	child	NNS	11	nmod:tmod	15654	15662	B-persongroup-110050	_
106	2	with	with	IN	5	case	15663	15667	_	_
106	3	Acute	acute	JJ	5	amod	15668	15673	_	_
106	4	Lymphocytic	lymphocytic	JJ	5	amod	15674	15685	_	_
106	5	Leukemia	leukemia	NN	1	nmod	15686	15694	_	_
106	6	(	(	CD	8	nummod	15695	15696	_	_
106	7	ALL	all	NN	8	compound	15696	15699	_	_
106	8	)	)	NN	11	nsubjpass	15699	15700	_	_
106	9	may	may	MD	11	aux	15701	15704	_	_
106	10	be	be	VB	11	auxpass	15705	15707	_	_
106	11	vaccinated	vaccinate	VBN	0	ROOT	15708	15718	_	_
106	12	with	with	IN	14	case	15719	15723	_	_
106	13	MMR	mmr	NN	14	compound	15724	15727	_	_
106	14	vaccine	vaccine	NN	11	nmod	15728	15735	_	_
106	15	if	if	IN	21	mark	15736	15738	_	_
106	16	the	the	DT	17	det	15739	15742	_	_
106	17	disease	disease	NN	21	nsubj	15743	15750	_	_
106	18	has	have	VBZ	21	aux	15751	15754	_	_
106	19	been	be	VBN	21	cop	15755	15759	_	_
106	20	in	in	IN	21	case	15760	15762	_	_
106	21	remission	remission	NN	11	advcl	15763	15772	_	_
106	22	for	for	IN	26	case	15773	15776	_	_
106	23	at	at	IN	24	case	15777	15779	_	_
106	24	least	least	JJS	25	nmod:npmod	15780	15785	_	_
106	25	12	12	CD	26	nummod	15786	15788	_	_
106	26	months	month	NNS	21	nmod	15789	15795	_	_
106	27	,	,	,	11	punct	15795	15796	_	_
106	28	the	the	DT	29	det	15797	15800	_	_
106	29	child	child	NN	33	nmod:poss	15801	15806	B-persongroup-110052	_
106	30	's	's	POS	29	case	15806	15808	I-persongroup-110052	_
106	31	total	total	JJ	33	amod	15809	15814	_	_
106	32	lymphocyte	lymphocyte	NN	33	compound	15815	15825	_	_
106	33	count	count	NN	39	nsubj	15826	15831	_	_
106	34	is	be	VBZ	39	cop	15832	15834	_	_
106	35	at	at	IN	36	case	15835	15837	_	_
106	36	least	least	JJS	38	nmod:npmod	15838	15843	_	_
106	37	1.2	1.2	CD	38	compound	15844	15847	_	_
106	38	×	×	CD	39	nummod	15848	15849	_	_
106	39	109/L	109/l	NN	11	ccomp	15850	15855	_	_
106	40	,	,	,	11	punct	15855	15856	_	_
106	41	the	the	DT	42	det	15857	15860	B-persongroup-110188	_
106	42	child	child	NN	45	nsubj	15861	15866	I-persongroup-110188	_
106	43	is	be	VBZ	45	aux	15867	15869	_	_
106	44	not	not	RB	45	neg	15870	15873	_	_
106	45	receiving	receive	VBG	11	ccomp	15874	15883	_	_
106	46	radiation	radiation	NN	47	compound	15884	15893	_	_
106	47	therapy	therapy	NN	45	dobj	15894	15901	_	_
106	48	,	,	,	11	punct	15901	15902	_	_
106	49	and	and	CC	11	cc	15903	15906	_	_
106	50	maintenance	maintenance	NN	51	compound	15907	15918	_	_
106	51	chemotherapy	chemotherapy	NN	54	nsubjpass	15919	15931	_	_
106	52	can	can	MD	54	aux	15932	15935	_	_
106	53	be	be	VB	54	auxpass	15936	15938	_	_
106	54	withheld	withhold	VBN	11	conj	15939	15947	_	_
106	55	for	for	IN	58	case	15948	15951	_	_
106	56	at	at	IN	57	case	15952	15954	_	_
106	57	least	least	JJS	58	nmod:npmod	15955	15960	_	_
106	58	1	1	CD	54	nmod	15961	15962	_	_
106	59	week	week	NN	54	nmod:tmod	15963	15967	_	_
106	60	before	before	IN	63	case	15968	15974	_	_
106	61	to	to	TO	63	case	15975	15977	_	_
106	62	1	1	CD	63	nummod	15978	15979	_	_
106	63	week	week	NN	54	nmod	15980	15984	_	_
106	64	after	after	IN	65	case	15985	15990	_	_
106	65	immunization	immunization	NN	63	nmod	15991	16003	_	_
106	66	.	.	.	11	punct	16003	16004	_	_

107	1	Malignant	malignant	JJ	4	amod	16005	16014	_	_
107	2	solid	solid	JJ	4	amod	16015	16020	_	_
107	3	tumours	tumour	NNS	4	compound	16021	16028	_	_
107	4	MMR	mmr	NN	9	nsubjpass	16029	16032	_	_
107	5	and	and	CC	4	cc	16033	16036	_	_
107	6	MMRV	mmrv	NN	7	compound	16037	16041	_	_
107	7	vaccines	vaccine	NNS	4	conj	16042	16050	_	_
107	8	are	be	VBP	9	auxpass	16051	16054	_	_
107	9	contraindicated	contraindicate	VBN	0	ROOT	16055	16070	_	_
107	10	in	in	IN	11	case	16071	16073	_	_
107	11	people	people	NNS	9	nmod	16074	16080	B-persongroup-110053	_
107	12	undergoing	undergo	VBG	11	acl	16081	16091	_	_
107	13	immunosuppressive	immunosuppressive	JJ	14	amod	16092	16109	_	_
107	14	treatment	treatment	NN	12	dobj	16110	16119	_	_
107	15	for	for	IN	19	case	16120	16123	_	_
107	16	any	any	DT	19	det	16124	16127	_	_
107	17	malignant	malignant	JJ	19	amod	16128	16137	_	_
107	18	solid	solid	JJ	19	amod	16138	16143	_	_
107	19	tumours	tumour	NNS	12	nmod	16144	16151	_	_
107	20	.	.	.	9	punct	16151	16152	_	_

108	1	Hematopoietic	hematopoietic	JJ	4	amod	16153	16166	_	_
108	2	stem	stem	NN	4	compound	16168	16172	_	_
108	3	cell	cell	NN	4	compound	16173	16177	_	_
108	4	transplantation	transplantation	NN	0	ROOT	16178	16193	_	_
108	5	(	(	CD	6	nummod	16194	16195	_	_
108	6	HSCT	HSCT	NNP	4	dep	16195	16199	_	_
108	7	–	–	CD	6	nummod	16200	16201	_	_
108	8	autologous	autologous	JJ	12	amod	16202	16212	_	_
108	9	or	or	CC	8	cc	16213	16215	_	_
108	10	allogeneic	allogeneic	JJ	8	conj	16216	16226	_	_
108	11	)	)	NN	12	compound	16226	16227	_	_
108	12	Pre-transplantation	pre-transplantation	NN	6	dep	16228	16247	_	_
108	13	:	:	:	4	punct	16247	16248	_	_
108	14	People	people	NNS	4	dep	16249	16255	B-persongroup-110054	_
108	15	awaiting	await	VBG	14	acl	16256	16264	_	_
108	16	HSCT	HSCT	NNP	19	nsubj	16265	16269	_	_
108	17	should	should	MD	19	aux	16270	16276	_	_
108	18	not	not	RB	19	neg	16277	16280	_	_
108	19	receive	receive	VB	15	ccomp	16281	16288	_	_
108	20	measles	measles	NNS	19	dobj	16289	16296	_	_
108	21	,	,	,	20	punct	16296	16297	_	_
108	22	mumps	mumps	NNS	20	conj	16299	16304	_	_
108	23	and	and	CC	20	cc	16305	16308	_	_
108	24	rubella-containing	rubella-containing	JJ	25	amod	16309	16327	_	_
108	25	vaccine	vaccine	NN	20	conj	16328	16335	_	_
108	26	.	.	.	4	punct	16335	16336	_	_

109	1	Vaccination	vaccination	NN	11	nsubjpass	16337	16348	_	_
109	2	of	of	IN	3	case	16349	16351	_	_
109	3	donors	donor	NNS	1	nmod	16352	16358	B-persongroup-110055	_
109	4	immediately	immediately	RB	3	advmod	16359	16370	_	_
109	5	before	before	IN	8	case	16371	16377	_	_
109	6	stem	stem	NN	8	compound	16379	16383	_	_
109	7	cell	cell	NN	8	compound	16384	16388	_	_
109	8	harvest	harvest	NN	4	nmod	16389	16396	_	_
109	9	is	be	VBZ	11	auxpass	16397	16399	_	_
109	10	not	not	RB	11	neg	16400	16403	_	_
109	11	recommended	recommend	VBN	0	ROOT	16404	16415	_	_
109	12	as	as	IN	14	mark	16416	16418	_	_
109	13	there	there	EX	14	expl	16419	16424	_	_
109	14	is	be	VBZ	11	advcl	16425	16427	_	_
109	15	no	no	DT	16	neg	16428	16430	_	_
109	16	evidence	evidence	NN	14	nsubj	16431	16439	_	_
109	17	that	that	IN	21	mark	16440	16444	_	_
109	18	immunity	immunity	NN	21	nsubjpass	16445	16453	_	_
109	19	can	can	MD	21	aux	16454	16457	_	_
109	20	be	be	VB	21	auxpass	16459	16461	_	_
109	21	transferred	transfer	VBN	14	ccomp	16462	16473	_	_
109	22	from	from	IN	24	case	16474	16478	_	_
109	23	the	the	DT	24	det	16479	16482	B-persongroup-110056	_
109	24	donor	donor	NN	21	nmod	16483	16488	I-persongroup-110056	_
109	25	to	to	TO	27	case	16489	16491	_	_
109	26	the	the	DT	27	det	16492	16495	B-persongroup-110057	_
109	27	recipient	recipient	JJ	21	nmod	16496	16505	I-persongroup-110057	_
109	28	and	and	CC	21	cc	16506	16509	_	_
109	29	there	there	EX	30	expl	16510	16515	_	_
109	30	are	be	VBP	21	conj	16516	16519	_	_
109	31	no	no	DT	33	neg	16520	16522	_	_
109	32	safety	safety	NN	33	compound	16523	16529	_	_
109	33	data	datum	NNS	30	nsubj	16530	16534	_	_
109	34	.	.	.	11	punct	16534	16535	_	_

110	1	Post-transplantation	post-transplantation	NN	0	ROOT	16536	16556	_	_
110	2	:	:	:	1	punct	16556	16557	_	_
110	3	Antibody	antibody	NN	4	compound	16558	16566	_	_
110	4	titres	titre	NNS	8	nsubj	16567	16573	_	_
110	5	to	to	TO	7	case	16574	16576	_	_
110	6	vaccine-preventable	vaccine-preventable	JJ	7	amod	16577	16596	_	_
110	7	diseases	disease	NNS	4	nmod	16597	16605	_	_
110	8	decline	decline	VBP	1	appos	16606	16613	_	_
110	9	after	after	IN	10	case	16614	16619	_	_
110	10	HSCT	HSCT	NNP	8	nmod	16620	16624	_	_
110	11	if	if	IN	16	mark	16625	16627	_	_
110	12	the	the	DT	13	det	16628	16631	B-persongroup-110058	_
110	13	recipient	recipient	JJ	16	nsubjpass	16632	16641	I-persongroup-110058	_
110	14	is	be	VBZ	16	auxpass	16642	16644	_	_
110	15	not	not	RB	16	neg	16645	16648	_	_
110	16	re-vaccinated	re-vaccinate	VBN	8	advcl	16649	16662	_	_
110	17	.	.	.	1	punct	16662	16663	_	_

111	1	Vaccination	vaccination	NN	7	nsubjpass	16664	16675	_	_
111	2	with	with	IN	4	case	16676	16680	_	_
111	3	MMR	mmr	NN	4	compound	16681	16684	_	_
111	4	vaccine	vaccine	NN	1	nmod	16685	16692	_	_
111	5	may	may	MD	7	aux	16693	16696	_	_
111	6	be	be	VB	7	auxpass	16697	16699	_	_
111	7	considered	consider	VBN	0	ROOT	16700	16710	_	_
111	8	24	24	CD	9	nummod	16711	16713	_	_
111	9	months	month	NNS	7	nmod:tmod	16714	16720	_	_
111	10	after	after	IN	11	case	16721	16726	_	_
111	11	transplantation	transplantation	NN	7	nmod	16727	16742	_	_
111	12	provided	provide	VBN	11	acl	16743	16751	_	_
111	13	there	there	EX	14	expl	16752	16757	_	_
111	14	is	be	VBZ	12	ccomp	16758	16760	_	_
111	15	no	no	DT	16	neg	16761	16763	_	_
111	16	evidence	evidence	NN	14	nsubj	16764	16772	_	_
111	17	of	of	IN	20	case	16773	16775	_	_
111	18	chronic	chronic	JJ	20	amod	16776	16783	_	_
111	19	graft-versus-host	graft-versus-host	JJ	20	amod	16784	16801	_	_
111	20	disease	disease	NN	16	nmod	16802	16809	_	_
111	21	,	,	,	25	punct	16809	16810	_	_
111	22	immunosuppression	immunosuppression	NN	25	nsubjpass	16811	16828	_	_
111	23	has	have	VBZ	25	aux	16829	16832	_	_
111	24	been	be	VBN	25	auxpass	16833	16837	_	_
111	25	discontinued	discontinue	VBN	7	dep	16838	16850	_	_
111	26	for	for	IN	30	case	16851	16854	_	_
111	27	at	at	IN	28	case	16855	16857	_	_
111	28	least	least	JJS	29	nmod:npmod	16858	16863	_	_
111	29	3	3	CD	30	nummod	16864	16865	_	_
111	30	months	month	NNS	25	nmod	16866	16872	_	_
111	31	,	,	,	25	punct	16872	16873	_	_
111	32	and	and	CC	7	cc	16874	16877	_	_
111	33	the	the	DT	34	det	16878	16881	B-persongroup-110059	_
111	34	person	person	NN	36	nsubjpass	16882	16888	I-persongroup-110059	_
111	35	is	be	VBZ	36	auxpass	16889	16891	_	_
111	36	considered	consider	VBN	7	conj	16892	16902	_	_
111	37	immunocompetent	immunocompetent	JJ	36	xcomp	16903	16918	_	_
111	38	by	by	IN	41	case	16919	16921	_	_
111	39	a	a	DT	41	det	16922	16923	B-persongroup-110060	_
111	40	transplant	transplant	NN	41	compound	16924	16934	I-persongroup-110060	_
111	41	specialist	specialist	NN	36	nmod	16935	16945	I-persongroup-110060	_
111	42	.	.	.	7	punct	16945	16946	I-persongroup-110060	_

112	1	Serologic	serologic	JJ	2	amod	16947	16956	_	_
112	2	response	response	NN	5	nsubjpass	16957	16965	_	_
112	3	should	should	MD	5	aux	16966	16972	_	_
112	4	be	be	VB	5	auxpass	16973	16975	_	_
112	5	checked	check	VBN	0	ROOT	16976	16983	_	_
112	6	after	after	IN	9	case	16984	16989	_	_
112	7	the	the	DT	9	det	16990	16993	_	_
112	8	first	first	JJ	9	amod	16994	16999	_	_
112	9	dose	dose	NN	5	nmod	17000	17004	_	_
112	10	of	of	IN	12	case	17005	17007	_	_
112	11	MMR	mmr	NN	12	compound	17008	17011	_	_
112	12	vaccine	vaccine	NN	9	nmod	17012	17019	_	_
112	13	and	and	CC	5	cc	17020	17023	_	_
112	14	a	a	DT	16	det	17024	17025	_	_
112	15	second	second	JJ	16	amod	17026	17032	_	_
112	16	dose	dose	NN	19	nsubjpass	17033	17037	_	_
112	17	should	should	MD	19	aux	17038	17044	_	_
112	18	be	be	VB	19	auxpass	17045	17047	_	_
112	19	given	give	VBN	5	conj	17048	17053	_	_
112	20	3	3	CD	21	nummod	17054	17055	_	_
112	21	months	month	NNS	19	nmod:tmod	17056	17062	_	_
112	22	or	or	CC	23	cc	17063	17065	_	_
112	23	more	more	JJR	19	dobj	17066	17070	_	_
112	24	after	after	IN	27	case	17071	17076	_	_
112	25	the	the	DT	27	det	17077	17080	_	_
112	26	first	first	JJ	27	amod	17081	17086	_	_
112	27	dose	dose	NN	23	nmod	17087	17091	_	_
112	28	if	if	IN	30	mark	17092	17094	_	_
112	29	there	there	EX	30	expl	17095	17100	_	_
112	30	is	be	VBZ	5	dep	17101	17103	_	_
112	31	no	no	DT	32	neg	17104	17106	_	_
112	32	seroconversion	seroconversion	NN	30	nsubj	17107	17121	_	_
112	33	.	.	.	5	punct	17121	17122	_	_

113	1	Solid	solid	JJ	3	amod	17123	17128	_	_
113	2	organ	organ	NN	3	compound	17130	17135	_	_
113	3	transplantation	transplantation	NN	25	nsubjpass	17136	17151	_	_
113	4	If	if	IN	15	mark	17152	17154	_	_
113	5	possible	possible	JJ	15	dep	17155	17163	_	_
113	6	,	,	,	15	punct	17163	17164	_	_
113	7	individuals	individual	NNS	15	nsubj	17165	17176	B-persongroup-110061	_
113	8	being	be	VBG	9	auxpass	17177	17182	_	_
113	9	considered	consider	VBN	7	acl	17183	17193	_	_
113	10	for	for	IN	13	case	17194	17197	_	_
113	11	solid	solid	JJ	13	amod	17198	17203	_	_
113	12	organ	organ	NN	13	compound	17204	17209	_	_
113	13	transplantation	transplantation	NN	9	nmod	17210	17225	_	_
113	14	should	should	MD	15	aux	17226	17232	_	_
113	15	receive	receive	VB	25	dep	17233	17240	_	_
113	16	immunizations	immunization	NNS	15	dobj	17241	17254	_	_
113	17	recommended	recommend	VBN	16	acl	17255	17266	_	_
113	18	for	for	IN	20	case	17267	17270	_	_
113	19	their	they	PRP$	20	nmod:poss	17271	17276	_	_
113	20	age	age	NN	17	nmod	17277	17280	_	_
113	21	before	before	IN	23	case	17281	17287	_	_
113	22	the	the	DT	23	det	17288	17291	_	_
113	23	transplantation	transplantation	NN	17	nmod	17292	17307	_	_
113	24	is	be	VBZ	25	auxpass	17308	17310	_	_
113	25	performed	perform	VBN	0	ROOT	17311	17320	_	_
113	26	.	.	.	25	punct	17320	17321	_	_

114	1	MMR	mmr	NN	2	compound	17322	17325	_	_
114	2	vaccine	vaccine	NN	5	nsubjpass	17326	17333	_	_
114	3	may	may	MD	5	aux	17334	17337	_	_
114	4	be	be	VB	5	auxpass	17338	17340	_	_
114	5	given	give	VBN	0	ROOT	17341	17346	_	_
114	6	to	to	TO	7	case	17347	17349	_	_
114	7	infants	infant	NNS	5	nmod	17350	17357	B-persongroup-110062	_
114	8	as	as	IN	9	case	17358	17360	_	_
114	9	early	early	JJ	7	nmod	17361	17366	_	_
114	10	as	as	IN	12	case	17367	17369	_	_
114	11	6	6	CD	12	nummod	17370	17371	_	_
114	12	months	month	NNS	9	nmod	17372	17378	_	_
114	13	of	of	IN	14	case	17379	17381	_	_
114	14	age	age	NN	12	nmod	17382	17385	_	_
114	15	if	if	IN	18	mark	17386	17388	_	_
114	16	transplantation	transplantation	NN	18	nsubjpass	17389	17404	_	_
114	17	is	be	VBZ	18	auxpass	17405	17407	_	_
114	18	anticipated	anticipate	VBN	5	advcl	17408	17419	_	_
114	19	before	before	IN	23	case	17420	17426	_	_
114	20	12	12	CD	22	compound	17427	17429	_	_
114	21	to	to	TO	22	dep	17430	17432	_	_
114	22	15	15	CD	23	nummod	17433	17435	_	_
114	23	months	month	NNS	18	nmod	17436	17442	_	_
114	24	of	of	IN	25	case	17443	17445	_	_
114	25	age	age	NN	23	nmod	17446	17449	_	_
114	26	.	.	.	5	punct	17449	17450	_	_

115	1	MMR	mmr	NN	2	compound	17451	17454	_	_
115	2	vaccine	vaccine	NN	5	nsubjpass	17455	17462	_	_
115	3	should	should	MD	5	aux	17463	17469	_	_
115	4	be	be	VB	5	auxpass	17470	17472	_	_
115	5	given	give	VBN	0	ROOT	17473	17478	_	_
115	6	at	at	IN	7	case	17479	17481	_	_
115	7	least	least	JJS	8	nmod:npmod	17482	17487	_	_
115	8	4	4	CD	9	nummod	17488	17489	_	_
115	9	weeks	week	NNS	5	nmod:tmod	17490	17495	_	_
115	10	before	before	IN	13	case	17496	17502	_	_
115	11	solid	solid	JJ	13	amod	17503	17508	_	_
115	12	organ	organ	NN	13	compound	17509	17514	_	_
115	13	transplantation	transplantation	NN	5	nmod	17515	17530	_	_
115	14	and	and	CC	5	cc	17531	17534	_	_
115	15	,	,	,	17	punct	17534	17535	_	_
115	16	in	in	IN	17	case	17536	17538	_	_
115	17	general	general	JJ	5	dep	17539	17546	_	_
115	18	,	,	,	17	punct	17546	17547	_	_
115	19	is	be	VBZ	21	auxpass	17548	17550	_	_
115	20	not	not	RB	21	neg	17551	17554	_	_
115	21	recommended	recommend	VBN	5	conj	17555	17566	_	_
115	22	after	after	IN	23	case	17567	17572	_	_
115	23	transplantation	transplantation	NN	21	nmod	17573	17588	_	_
115	24	.	.	.	5	punct	17588	17589	_	_

116	1	Immunosuppressive	immunosuppressive	JJ	4	amod	17592	17609	_	_
116	2	therapy	therapy	NN	4	compound	17611	17618	_	_
116	3	Vaccination	vaccination	NN	4	compound	17619	17630	_	_
116	4	status	status	NN	13	nsubjpass	17631	17637	_	_
116	5	for	for	IN	6	case	17638	17641	_	_
116	6	measles	measles	NNS	4	nmod	17642	17649	_	_
116	7	,	,	,	6	punct	17649	17650	_	_
116	8	mumps	mumps	NNS	6	conj	17651	17656	_	_
116	9	and	and	CC	6	cc	17657	17660	_	_
116	10	rubella	rubella	NN	6	conj	17661	17668	_	_
116	11	should	should	MD	13	aux	17669	17675	_	_
116	12	be	be	VB	13	auxpass	17676	17678	_	_
116	13	reviewed	review	VBN	0	ROOT	17679	17687	_	_
116	14	for	for	IN	16	case	17688	17691	_	_
116	15	immunocompetent	immunocompetent	JJ	16	amod	17692	17707	B-persongroup-110063	_
116	16	persons	person	NNS	13	nmod	17708	17715	I-persongroup-110063	_
116	17	who	who	WP	20	nsubj	17716	17719	_	_
116	18	might	might	MD	20	aux	17720	17725	_	_
116	19	be	be	VB	20	aux	17726	17728	_	_
116	20	anticipating	anticipate	VBG	13	dep	17729	17741	_	_
116	21	initiation	initiation	NN	20	dobj	17742	17752	_	_
116	22	of	of	IN	24	case	17753	17755	_	_
116	23	immunosuppressive	immunosuppressive	JJ	24	amod	17756	17773	_	_
116	24	treatments	treatment	NNS	21	nmod	17774	17784	_	_
116	25	or	or	CC	20	cc	17785	17787	_	_
116	26	who	who	WP	27	nsubj	17788	17791	_	_
116	27	have	have	VBP	20	conj	17792	17796	_	_
116	28	diseases	disease	NNS	27	dobj	17797	17805	_	_
116	29	that	that	WDT	31	nsubj	17806	17810	_	_
116	30	might	might	MD	31	aux	17811	17816	_	_
116	31	lead	lead	VB	28	acl:relcl	17817	17821	_	_
116	32	to	to	TO	33	case	17822	17824	_	_
116	33	immunodeficiency	immunodeficiency	NN	31	nmod	17825	17841	_	_
116	34	.	.	.	13	punct	17841	17842	_	_

117	1	Refer	refer	VB	0	ROOT	17843	17848	_	_
117	2	to	to	TO	3	case	17849	17851	_	_
117	3	Immunization	immunization	NN	1	nmod	17852	17864	_	_
117	4	of	of	IN	6	case	17865	17867	_	_
117	5	Immunocompromised	immunocompromised	JJ	6	amod	17868	17885	B-persongroup-110064	_
117	6	Persons	person	NNS	3	nmod	17886	17893	I-persongroup-110064	_
117	7	in	in	IN	8	case	17894	17896	_	_
117	8	Part	Part	NNP	6	nmod	17897	17901	_	_
117	9	3	3	CD	8	nummod	17902	17903	_	_
117	10	for	for	IN	12	case	17904	17907	_	_
117	11	a	a	DT	12	det	17908	17909	_	_
117	12	list	list	NN	1	nmod	17910	17914	_	_
117	13	of	of	IN	15	case	17915	17917	_	_
117	14	immunosuppressive	immunosuppressive	JJ	15	amod	17918	17935	_	_
117	15	medications	medication	NNS	12	nmod	17936	17947	_	_
117	16	.	.	.	1	punct	17947	17948	_	_

118	1	If	if	IN	2	mark	17950	17952	_	_
118	2	indicated	indicate	VBN	8	advcl	17953	17962	_	_
118	3	,	,	,	8	punct	17962	17963	_	_
118	4	MMR	mmr	NN	5	compound	17964	17967	_	_
118	5	vaccine	vaccine	NN	8	nsubjpass	17968	17975	_	_
118	6	should	should	MD	8	aux	17976	17982	_	_
118	7	be	be	VB	8	auxpass	17983	17985	_	_
118	8	administered	administer	VBN	0	ROOT	17986	17998	_	_
118	9	at	at	IN	10	case	17999	18001	_	_
118	10	least	least	JJS	11	nmod:npmod	18002	18007	_	_
118	11	4	4	CD	12	nummod	18008	18009	_	_
118	12	weeks	week	NNS	8	nmod	18010	18015	_	_
118	13	before	before	IN	12	case	18016	18022	_	_
118	14	the	the	DT	15	det	18023	18026	_	_
118	15	initiation	initiation	NN	12	dep	18027	18037	_	_
118	16	of	of	IN	18	case	18038	18040	_	_
118	17	immunosuppressive	immunosuppressive	JJ	18	amod	18041	18058	_	_
118	18	therapy	therapy	NN	15	nmod	18059	18066	_	_
118	19	to	to	TO	20	mark	18067	18069	_	_
118	20	reduce	reduce	VB	15	acl	18070	18076	_	_
118	21	the	the	DT	22	det	18077	18080	_	_
118	22	risk	risk	NN	20	dobj	18081	18085	_	_
118	23	of	of	IN	24	case	18086	18088	_	_
118	24	disease	disease	NN	22	nmod	18089	18096	_	_
118	25	caused	cause	VBN	24	acl	18097	18103	_	_
118	26	by	by	IN	29	case	18104	18106	_	_
118	27	the	the	DT	29	det	18107	18110	_	_
118	28	vaccine	vaccine	NN	29	compound	18111	18118	_	_
118	29	strain	strain	NN	25	nmod	18119	18125	_	_
118	30	.	.	.	8	punct	18125	18126	_	_

119	1	If	if	IN	7	mark	18127	18129	_	_
119	2	MMR	mmr	NN	3	compound	18130	18133	_	_
119	3	vaccine	vaccine	NN	7	nsubjpass	18134	18141	_	_
119	4	can	can	MD	7	aux	18142	18145	_	_
119	5	not	not	RB	7	neg	18145	18148	_	_
119	6	be	be	VB	7	auxpass	18149	18151	_	_
119	7	given	give	VBN	23	advcl	18152	18157	_	_
119	8	prior	prior	RB	10	advmod	18158	18163	_	_
119	9	to	to	TO	10	case	18164	18166	_	_
119	10	initiation	initiation	NN	7	advcl	18167	18177	_	_
119	11	of	of	IN	13	case	18178	18180	_	_
119	12	immunosuppressive	immunosuppressive	JJ	13	amod	18181	18198	_	_
119	13	therapy	therapy	NN	10	nmod	18199	18206	_	_
119	14	,	,	,	23	punct	18206	18207	_	_
119	15	a	a	DT	16	det	18208	18209	_	_
119	16	period	period	NN	23	nsubj	18210	18216	_	_
119	17	of	of	IN	21	case	18217	18219	_	_
119	18	at	at	IN	19	case	18220	18222	_	_
119	19	least	least	JJS	20	nmod:npmod	18223	18228	_	_
119	20	3	3	CD	21	nummod	18229	18230	_	_
119	21	months	month	NNS	16	nmod	18231	18237	_	_
119	22	should	should	MD	23	aux	18238	18244	_	_
119	23	elapse	elapse	VB	0	ROOT	18245	18251	_	_
119	24	after	after	IN	27	mark	18252	18257	_	_
119	25	immunosuppressive	immunosuppressive	JJ	26	amod	18258	18275	_	_
119	26	drugs	drug	NNS	27	nsubj	18276	18281	_	_
119	27	(	(	VBP	23	advcl	18282	18283	_	_
119	28	except	except	IN	35	mark	18283	18289	_	_
119	29	high-dose	high-dose	JJ	31	amod	18290	18299	_	_
119	30	systemic	systemic	JJ	31	amod	18300	18308	_	_
119	31	corticosteroids	corticosteroid	NNS	35	nsubjpass	18309	18324	_	_
119	32	)	)	RB	35	advmod	18324	18325	_	_
119	33	have	have	VBP	35	aux	18326	18330	_	_
119	34	been	be	VBN	35	auxpass	18331	18335	_	_
119	35	stopped	stop	VBN	27	advcl	18336	18343	_	_
119	36	before	before	RB	37	advmod	18344	18350	_	_
119	37	administration	administration	NN	35	nmod	18351	18365	_	_
119	38	of	of	IN	40	case	18366	18368	_	_
119	39	live	live	JJ	40	amod	18369	18373	_	_
119	40	vaccines	vaccine	NNS	37	nmod	18374	18382	_	_
119	41	to	to	TO	42	mark	18383	18385	_	_
119	42	reduce	reduce	VB	35	xcomp	18386	18392	_	_
119	43	the	the	DT	44	det	18393	18396	_	_
119	44	risk	risk	NN	42	dobj	18397	18401	_	_
119	45	of	of	IN	46	case	18402	18404	_	_
119	46	disease	disease	NN	44	nmod	18405	18412	_	_
119	47	caused	cause	VBN	46	acl	18413	18419	_	_
119	48	by	by	IN	51	case	18420	18422	_	_
119	49	the	the	DT	51	det	18423	18426	_	_
119	50	vaccine	vaccine	NN	51	compound	18427	18434	_	_
119	51	strain	strain	NN	47	nmod	18435	18441	_	_
119	52	.	.	.	23	punct	18441	18442	_	_

120	1	A	a	DT	2	det	18443	18444	_	_
120	2	period	period	NN	9	nsubj	18445	18451	_	_
120	3	of	of	IN	7	case	18452	18454	_	_
120	4	at	at	IN	5	case	18455	18457	_	_
120	5	least	least	JJS	6	nmod:npmod	18458	18463	_	_
120	6	4	4	CD	7	nummod	18464	18465	_	_
120	7	weeks	week	NNS	2	nmod	18466	18471	_	_
120	8	should	should	MD	9	aux	18472	18478	_	_
120	9	elapse	elapse	VB	0	ROOT	18479	18485	_	_
120	10	between	between	IN	11	case	18486	18493	_	_
120	11	discontinuation	discontinuation	NN	9	nmod	18494	18509	_	_
120	12	of	of	IN	15	case	18510	18512	_	_
120	13	high-dose	high-dose	JJ	15	amod	18513	18522	_	_
120	14	systemic	systemic	JJ	15	amod	18523	18531	_	_
120	15	steroids	steroid	NNS	11	nmod	18532	18540	_	_
120	16	and	and	CC	11	cc	18541	18544	_	_
120	17	the	the	DT	18	det	18545	18548	_	_
120	18	administration	administration	NN	11	conj	18549	18563	_	_
120	19	of	of	IN	21	case	18564	18566	_	_
120	20	MMR	mmr	NN	21	compound	18567	18570	_	_
120	21	vaccine	vaccine	NN	18	nmod	18571	18578	_	_
120	22	.	.	.	9	punct	18578	18579	_	_

121	1	The	the	DT	2	det	18580	18583	_	_
121	2	interval	interval	NN	13	nsubj	18584	18592	_	_
121	3	between	between	IN	4	case	18593	18600	_	_
121	4	discontinuation	discontinuation	NN	2	nmod	18601	18616	_	_
121	5	of	of	IN	7	case	18617	18619	_	_
121	6	immunosuppressive	immunosuppressive	JJ	7	amod	18620	18637	_	_
121	7	drugs	drug	NNS	4	nmod	18638	18643	_	_
121	8	and	and	CC	7	cc	18644	18647	_	_
121	9	MMR	mmr	NN	11	compound	18648	18651	_	_
121	10	vaccine	vaccine	NN	11	compound	18652	18659	_	_
121	11	administration	administration	NN	7	conj	18660	18674	_	_
121	12	may	may	MD	13	aux	18675	18678	_	_
121	13	vary	vary	VB	0	ROOT	18679	18683	_	_
121	14	with	with	IN	16	case	18684	18688	_	_
121	15	the	the	DT	16	det	18689	18692	_	_
121	16	intensity	intensity	NN	13	nmod	18693	18702	_	_
121	17	of	of	IN	20	case	18703	18705	_	_
121	18	the	the	DT	20	det	18706	18709	_	_
121	19	immunosuppressive	immunosuppressive	JJ	20	amod	18710	18727	_	_
121	20	therapy	therapy	NN	16	nmod	18728	18735	_	_
121	21	,	,	,	20	punct	18735	18736	_	_
121	22	underlying	underlie	VBG	23	amod	18737	18747	_	_
121	23	disease	disease	NN	20	conj	18748	18755	_	_
121	24	and	and	CC	20	cc	18756	18759	_	_
121	25	other	other	JJ	26	amod	18760	18765	_	_
121	26	factors	factor	NNS	20	conj	18766	18773	_	_
121	27	.	.	.	13	punct	18773	18774	_	_

122	1	If	if	IN	7	mark	18775	18777	_	_
122	2	immunosuppressive	immunosuppressive	JJ	3	amod	18778	18795	_	_
122	3	therapy	therapy	NN	7	nsubjpass	18796	18803	_	_
122	4	can	can	MD	7	aux	18804	18807	_	_
122	5	not	not	RB	7	neg	18807	18810	_	_
122	6	be	be	VB	7	auxpass	18811	18813	_	_
122	7	stopped	stop	VBN	9	advcl	18814	18821	_	_
122	8	,	,	,	9	punct	18821	18822	_	_
122	9	live	live	VB	0	ROOT	18823	18827	_	_
122	10	vaccines	vaccine	NNS	13	nsubjpass	18828	18836	_	_
122	11	are	be	VBP	13	auxpass	18837	18840	_	_
122	12	generally	generally	RB	13	advmod	18841	18850	_	_
122	13	contraindicated	contraindicate	VBN	9	ccomp	18851	18866	_	_
122	14	,	,	,	13	punct	18866	18867	_	_
122	15	although	although	IN	20	mark	18868	18876	_	_
122	16	the	the	DT	18	det	18877	18880	_	_
122	17	risk-to-benefit	risk-to-benefit	JJ	18	amod	18881	18896	_	_
122	18	ratio	ratio	NN	20	nsubj	18897	18902	_	_
122	19	may	may	MD	20	aux	18903	18906	_	_
122	20	favour	favour	VB	13	advcl	18907	18913	_	_
122	21	immunization	immunization	NN	20	dobj	18914	18926	_	_
122	22	if	if	IN	30	mark	18927	18929	_	_
122	23	only	only	RB	25	advmod	18930	18934	_	_
122	24	low	low	JJ	25	amod	18935	18938	_	_
122	25	doses	dose	NNS	30	nsubjpass	18939	18944	_	_
122	26	of	of	IN	28	case	18945	18947	_	_
122	27	immunosuppressive	immunosuppressive	JJ	28	amod	18948	18965	_	_
122	28	drugs	drug	NNS	25	nmod	18966	18971	_	_
122	29	are	be	VBP	30	auxpass	18972	18975	_	_
122	30	required	require	VBN	20	advcl	18976	18984	_	_
122	31	and	and	CC	30	cc	18985	18988	_	_
122	32	there	there	EX	33	expl	18989	18994	_	_
122	33	is	be	VBZ	30	conj	18995	18997	_	_
122	34	significant	significant	JJ	35	amod	18998	19009	_	_
122	35	risk	risk	NN	33	nsubj	19010	19014	_	_
122	36	of	of	IN	37	case	19015	19017	_	_
122	37	development	development	NN	35	nmod	19018	19029	_	_
122	38	of	of	IN	39	case	19030	19032	_	_
122	39	disease	disease	NN	37	nmod	19033	19040	_	_
122	40	.	.	.	9	punct	19040	19041	_	_

123	1	The	the	DT	2	det	19042	19045	_	_
123	2	safety	safety	NN	8	nsubj	19046	19052	_	_
123	3	and	and	CC	2	cc	19053	19056	_	_
123	4	efficacy	efficacy	NN	2	conj	19057	19065	_	_
123	5	of	of	IN	6	case	19066	19068	_	_
123	6	live	live	JJ	2	nmod	19069	19073	_	_
123	7	,	,	,	8	punct	19073	19074	_	_
123	8	attenuated	attenuate	VBD	0	ROOT	19075	19085	_	_
123	9	vaccines	vaccine	NNS	8	dobj	19086	19094	_	_
123	10	during	during	IN	12	case	19095	19101	_	_
123	11	low	low	JJ	12	amod	19102	19105	_	_
123	12	dose	dose	NN	8	nmod	19106	19110	_	_
123	13	intermittent	intermittent	JJ	16	amod	19111	19123	_	_
123	14	or	or	CC	13	cc	19124	19126	_	_
123	15	maintenance	maintenance	NN	13	conj	19127	19138	_	_
123	16	therapy	therapy	NN	20	nsubj	19139	19146	_	_
123	17	with	with	IN	19	case	19147	19151	_	_
123	18	immunosuppressive	immunosuppressive	JJ	19	amod	19152	19169	_	_
123	19	drugs	drug	NNS	16	nmod	19170	19175	_	_
123	20	(	(	VBP	12	acl:relcl	19176	19177	_	_
123	21	other	other	JJ	20	xcomp	19177	19182	_	_
123	22	than	than	IN	23	case	19183	19187	_	_
123	23	corticosteroids	corticosteroid	NNS	21	nmod	19188	19203	_	_
123	24	)	)	CD	26	nsubj	19203	19204	_	_
123	25	are	be	VBP	26	cop	19205	19208	_	_
123	26	unknown	unknown	JJ	23	acl:relcl	19209	19216	_	_
123	27	.	.	.	8	punct	19216	19217	_	_

124	1	Immunosuppressive	immunosuppressive	JJ	2	amod	19218	19235	_	_
124	2	drugs	drug	NNS	5	nsubjpass	19236	19241	_	_
124	3	have	have	VBP	5	aux	19242	19246	_	_
124	4	been	be	VBN	5	auxpass	19247	19251	_	_
124	5	reported	report	VBN	0	ROOT	19252	19260	_	_
124	6	to	to	TO	7	mark	19261	19263	_	_
124	7	cause	cause	VB	5	xcomp	19264	19269	_	_
124	8	reactivation	reactivation	NN	7	dobj	19270	19282	_	_
124	9	of	of	IN	12	case	19283	19285	_	_
124	10	latent	latent	JJ	11	dep	19286	19292	_	_
124	11	tuberculosis	tuberculosis	NN	12	amod	19293	19305	_	_
124	12	infection	infection	NN	8	nmod	19306	19315	_	_
124	13	and	and	CC	12	cc	19316	19319	_	_
124	14	predisposition	predisposition	NN	12	conj	19320	19334	_	_
124	15	to	to	TO	18	case	19335	19337	_	_
124	16	other	other	JJ	18	amod	19338	19343	_	_
124	17	opportunistic	opportunistic	JJ	18	amod	19344	19357	_	_
124	18	infections	infection	NNS	7	nmod	19358	19368	_	_
124	19	.	.	.	5	punct	19368	19369	_	_

125	1	Therefore	therefore	RB	24	advmod	19370	19379	_	_
125	2	,	,	,	24	punct	19379	19380	_	_
125	3	until	until	IN	6	mark	19381	19386	_	_
125	4	additional	additional	JJ	5	amod	19387	19397	_	_
125	5	information	information	NN	6	nsubj	19398	19409	_	_
125	6	becomes	become	VBZ	24	advcl	19410	19417	_	_
125	7	available	available	JJ	6	xcomp	19418	19427	_	_
125	8	,	,	,	24	punct	19427	19428	_	_
125	9	avoidance	avoidance	NN	24	nsubj	19429	19438	_	_
125	10	of	of	IN	12	case	19439	19441	_	_
125	11	MMR	mmr	NN	12	compound	19442	19445	_	_
125	12	vaccines	vaccine	NNS	9	nmod	19446	19454	_	_
125	13	during	during	IN	14	case	19455	19461	_	_
125	14	intermittent	intermittent	JJ	12	nmod	19462	19474	_	_
125	15	or	or	CC	12	cc	19475	19477	_	_
125	16	low	low	JJ	18	amod	19478	19481	_	_
125	17	dose	dose	NN	18	compound	19482	19486	_	_
125	18	chemotherapy	chemotherapy	NN	12	conj	19487	19499	_	_
125	19	or	or	CC	18	cc	19500	19502	_	_
125	20	other	other	JJ	22	amod	19503	19508	_	_
125	21	immunosuppressive	immunosuppressive	JJ	22	amod	19509	19526	_	_
125	22	therapy	therapy	NN	18	conj	19527	19534	_	_
125	23	is	be	VBZ	24	cop	19535	19537	_	_
125	24	prudent	prudent	JJ	0	ROOT	19538	19545	_	_
125	25	.	.	.	24	punct	19545	19546	_	_

126	1	Corticosteroid	corticosteroid	NN	2	compound	19548	19562	_	_
126	2	therapy	therapy	NN	6	nsubj	19563	19570	_	_
126	3	is	be	VBZ	6	cop	19571	19573	_	_
126	4	not	not	RB	6	neg	19574	19577	_	_
126	5	a	a	DT	6	det	19578	19579	_	_
126	6	contraindication	contraindication	NN	0	ROOT	19580	19596	_	_
126	7	to	to	TO	8	mark	19597	19599	_	_
126	8	administering	administer	VBG	6	acl	19600	19613	_	_
126	9	live	live	JJ	10	amod	19614	19618	_	_
126	10	vaccine	vaccine	NN	8	dobj	19619	19626	_	_
126	11	when	when	WRB	17	advmod	19627	19631	_	_
126	12	steroid	steroid	NN	13	compound	19632	19639	_	_
126	13	therapy	therapy	NN	17	nsubj	19640	19647	_	_
126	14	is	be	VBZ	17	cop	19648	19650	_	_
126	15	short-term	short-term	JJ	17	advmod	19651	19661	_	_
126	16	(	(	CD	15	dep	19662	19663	_	_
126	17	i.e.	i.e.	FW	10	acl:relcl	19663	19667	_	_
126	18	,	,	,	17	punct	19667	19668	_	_
126	19	less	less	JJR	21	advmod	19669	19673	_	_
126	20	than	than	IN	19	mwe	19674	19678	_	_
126	21	14	14	CD	22	nummod	19679	19681	_	_
126	22	days	day	NNS	23	nmod:npmod	19682	19686	_	_
126	23	)	)	RB	17	amod	19686	19687	_	_
126	24	;	;	:	17	punct	19687	19688	_	_
126	25	or	or	CC	10	cc	19689	19691	_	_
126	26	a	a	DT	29	det	19692	19693	_	_
126	27	low-to-moderate	low-to-moderate	JJ	29	amod	19694	19709	_	_
126	28	dose	dose	NN	29	compound	19710	19714	_	_
126	29	(	(	NN	10	conj	19715	19716	_	_
126	30	less	less	JJR	32	advmod	19716	19720	_	_
126	31	than	than	IN	30	mwe	19721	19725	_	_
126	32	2	2	CD	33	nummod	19726	19727	_	_
126	33	mg/kg/day	mg/kg/day	NN	29	dep	19728	19737	_	_
126	34	for	for	IN	36	case	19738	19741	_	_
126	35	a	a	DT	36	det	19742	19743	B-persongroup-110065	_
126	36	child	child	NN	33	nmod	19744	19749	I-persongroup-110065	_
126	37	or	or	CC	36	cc	19750	19752	_	_
126	38	less	less	JJR	40	advmod	19753	19757	_	_
126	39	than	than	IN	38	mwe	19758	19762	_	_
126	40	20	20	CD	41	nummod	19763	19765	_	_
126	41	mg/day	mg/day	NN	36	conj	19766	19772	_	_
126	42	of	of	IN	43	case	19773	19775	_	_
126	43	prednisone	prednisone	NN	41	nmod	19776	19786	_	_
126	44	or	or	CC	36	cc	19787	19789	_	_
126	45	its	its	PRP$	48	nmod:poss	19790	19793	_	_
126	46	equivalent	equivalent	JJ	48	amod	19794	19804	_	_
126	47	per	per	IN	46	nmod	19805	19808	_	_
126	48	day	day	NN	36	conj	19809	19812	_	_
126	49	for	for	IN	52	case	19813	19816	_	_
126	50	an	a	DT	52	det	19817	19819	B-persongroup-110066	_
126	51	adult	adult	JJ	52	amod	19820	19825	I-persongroup-110066	_
126	52	)	)	NN	48	nmod	19825	19826	I-persongroup-110066	_
126	53	;	;	:	36	punct	19826	19827	_	_
126	54	or	or	CC	36	cc	19828	19830	_	_
126	55	long-term	long-term	JJ	58	amod	19831	19840	_	_
126	56	,	,	,	58	punct	19840	19841	_	_
126	57	alternate-day	alternate-day	JJ	58	amod	19842	19855	_	_
126	58	treatment	treatment	NN	36	conj	19856	19865	_	_
126	59	with	with	IN	61	case	19866	19870	_	_
126	60	short-acting	short-acting	JJ	61	amod	19871	19883	_	_
126	61	preparations	preparation	NNS	58	nmod	19884	19896	_	_
126	62	;	;	:	10	punct	19896	19897	_	_
126	63	or	or	CC	10	cc	19898	19900	_	_
126	64	maintenance	maintenance	NN	10	conj	19901	19912	_	_
126	65	physiologic	physiologic	JJ	67	amod	19913	19924	_	_
126	66	replacement	replacement	NN	67	compound	19925	19936	_	_
126	67	therapy	therapy	NN	64	dep	19937	19944	_	_
126	68	;	;	:	6	punct	19944	19945	_	_
126	69	or	or	CC	6	cc	19946	19948	_	_
126	70	administered	administer	VBN	6	conj	19949	19961	_	_
126	71	topically	topically	RB	70	advmod	19962	19971	_	_
126	72	,	,	,	70	punct	19971	19972	_	_
126	73	inhaled	inhale	VBN	70	parataxis	19973	19980	_	_
126	74	,	,	,	6	punct	19980	19981	_	_
126	75	or	or	CC	6	cc	19982	19984	_	_
126	76	locally	locally	RB	77	advmod	19985	19992	_	_
126	77	injected	inject	VBD	6	conj	19993	20001	_	_
126	78	(	(	CD	77	dobj	20002	20003	_	_
126	79	e.g.	e.g.	FW	77	nsubj	20003	20007	_	_
126	80	,	,	,	79	punct	20007	20008	_	_
126	81	joint	joint	JJ	83	amod	20009	20014	_	_
126	82	injection	injection	NN	83	compound	20015	20024	_	_
126	83	)	)	NN	79	appos	20024	20025	_	_
126	84	.	.	.	6	punct	20025	20026	_	_

127	1	In	in	IN	2	case	20028	20030	_	_
127	2	general	general	JJ	5	advcl	20031	20038	_	_
127	3	,	,	,	5	punct	20038	20039	_	_
127	4	live	live	JJ	5	nsubj	20040	20044	_	_
127	5	attenuated	attenuate	VBD	0	ROOT	20045	20055	_	_
127	6	vaccines	vaccine	NNS	8	nsubjpass	20056	20064	_	_
127	7	are	be	VBP	8	auxpass	20065	20068	_	_
127	8	contraindicated	contraindicate	VBN	5	ccomp	20069	20084	_	_
127	9	during	during	IN	12	case	20085	20091	_	_
127	10	monoclonal	monoclonal	JJ	12	amod	20092	20102	_	_
127	11	antibody	antibody	NN	12	compound	20103	20111	_	_
127	12	treatment	treatment	NN	8	nmod	20112	20121	_	_
127	13	or	or	CC	12	cc	20122	20124	_	_
127	14	in	in	IN	15	case	20125	20127	_	_
127	15	infants	infant	NNS	12	conj	20128	20135	B-persongroup-110067	_
127	16	exposed	expose	VBN	15	acl	20136	20143	_	_
127	17	to	to	TO	19	case	20144	20146	_	_
127	18	monoclonal	monoclonal	JJ	19	amod	20147	20157	_	_
127	19	antibodies	antibody	NNS	16	nmod	20158	20168	_	_
127	20	.	.	.	5	punct	20168	20169	_	_

128	1	Monoclonal	monoclonal	JJ	2	amod	20170	20180	_	_
128	2	antibodies	antibody	NNS	8	nsubjpass	20181	20191	_	_
128	3	taken	take	VBN	2	acl	20192	20197	_	_
128	4	during	during	IN	5	case	20198	20204	_	_
128	5	pregnancy	pregnancy	NN	3	nmod	20205	20214	_	_
128	6	will	will	MD	8	aux	20215	20219	_	_
128	7	be	be	VB	8	auxpass	20220	20222	_	_
128	8	transferred	transfer	VBN	0	ROOT	20223	20234	_	_
128	9	to	to	TO	11	case	20235	20237	_	_
128	10	the	the	DT	11	det	20238	20241	B-persongroup-110068	_
128	11	fetus	fetus	NN	8	nmod	20242	20247	I-persongroup-110068	_
128	12	and	and	CC	8	cc	20248	20251	_	_
128	13	their	they	PRP$	14	nmod:poss	20252	20257	_	_
128	14	effects	effect	NNS	16	nsubj	20258	20265	_	_
128	15	may	may	MD	16	aux	20266	20269	_	_
128	16	persist	persist	VB	8	conj	20270	20277	_	_
128	17	after	after	IN	18	case	20278	20283	_	_
128	18	birth	birth	NN	16	nmod	20284	20289	_	_
128	19	.	.	.	8	punct	20289	20290	_	_

129	1	Infants	infant	NNS	18	nsubj	20291	20298	B-persongroup-110069	_
129	2	who	who	WP	5	nsubjpass	20299	20302	_	_
129	3	have	have	VBP	5	aux	20303	20307	_	_
129	4	been	be	VBN	5	auxpass	20308	20312	_	_
129	5	exposed	expose	VBN	1	acl:relcl	20313	20320	_	_
129	6	to	to	TO	8	case	20321	20323	_	_
129	7	monoclonal	monoclonal	JJ	8	amod	20324	20334	_	_
129	8	antibodies	antibody	NNS	5	nmod	20335	20345	_	_
129	9	,	,	,	8	punct	20345	20346	_	_
129	10	either	either	CC	8	cc:preconj	20347	20353	_	_
129	11	during	during	IN	12	case	20354	20360	_	_
129	12	pregnancy	pregnancy	NN	8	conj	20361	20370	_	_
129	13	or	or	CC	8	cc	20371	20373	_	_
129	14	from	from	IN	8	conj	20374	20378	_	_
129	15	breastfeeding	breastfeed	VBG	5	xcomp	20379	20392	_	_
129	16	,	,	,	18	punct	20392	20393	_	_
129	17	should	should	MD	18	aux	20394	20400	_	_
129	18	have	have	VB	0	ROOT	20401	20405	_	_
129	19	B-cell	b-cell	NN	20	compound	20406	20412	_	_
129	20	enumeration	enumeration	NN	18	dobj	20413	20424	_	_
129	21	.	.	.	18	punct	20424	20425	_	_

130	1	B	b	NN	3	compound	20426	20427	_	_
130	2	cell	cell	NN	3	compound	20428	20432	_	_
130	3	enumeration	enumeration	NN	6	nsubj	20433	20444	_	_
130	4	should	should	MD	6	aux	20445	20451	_	_
130	5	be	be	VB	6	cop	20452	20454	_	_
130	6	normal	normal	JJ	0	ROOT	20455	20461	_	_
130	7	before	before	IN	8	case	20462	20468	_	_
130	8	vaccination	vaccination	NN	6	nmod	20469	20480	_	_
130	9	with	with	IN	11	case	20481	20485	_	_
130	10	live	live	JJ	11	amod	20486	20490	_	_
130	11	vaccines	vaccine	NNS	6	nmod	20491	20499	_	_
130	12	.	.	.	6	punct	20499	20500	_	_

131	1	Consultation	consultation	NN	6	nsubjpass	20501	20513	_	_
131	2	with	with	IN	4	case	20514	20518	_	_
131	3	an	a	DT	4	det	20519	20521	B-persongroup-110070	_
131	4	immunologist	immunologist	NN	1	nmod	20522	20534	I-persongroup-110070	_
131	5	is	be	VBZ	6	auxpass	20535	20537	_	_
131	6	advised	advise	VBN	0	ROOT	20538	20545	_	_
131	7	.	.	.	6	punct	20545	20546	_	_

132	1	Vaccination	vaccination	NN	2	compound	20547	20558	_	_
132	2	status	status	NN	5	nsubjpass	20559	20565	_	_
132	3	should	should	MD	5	aux	20566	20572	_	_
132	4	be	be	VB	5	auxpass	20573	20575	_	_
132	5	reviewed	review	VBN	0	ROOT	20576	20584	_	_
132	6	prior	prior	RB	5	advmod	20585	20590	_	_
132	7	to	to	TO	8	mark	20591	20593	_	_
132	8	commencing	commence	VBG	6	advcl	20594	20604	_	_
132	9	monoclonal	monoclonal	JJ	10	amod	20605	20615	_	_
132	10	antibodies	antibody	NNS	8	dobj	20616	20626	_	_
132	11	.	.	.	5	punct	20626	20627	_	_

133	1	HIV-infected	hiv-infected	JJ	5	amod	20629	20641	_	_
133	2	An	a	DT	5	det	20642	20644	B-persongroup-110071	_
133	3	infectious	infectious	JJ	5	amod	20645	20655	I-persongroup-110071	_
133	4	disease	disease	NN	5	compound	20656	20663	I-persongroup-110071	_
133	5	specialist/immunologist	specialist/immunologist	NN	8	nsubjpass	20664	20687	I-persongroup-110071	_
133	6	should	should	MD	8	aux	20689	20695	_	_
133	7	be	be	VB	8	auxpass	20696	20698	_	_
133	8	consulted	consult	VBN	0	ROOT	20699	20708	_	_
133	9	for	for	IN	10	case	20709	20712	_	_
133	10	advice	advice	NN	8	nmod	20713	20719	_	_
133	11	on	on	IN	13	case	20720	20722	_	_
133	12	MMR	mmr	NN	13	compound	20723	20726	_	_
133	13	immunization	immunization	NN	8	nmod	20727	20739	_	_
133	14	in	in	IN	16	case	20740	20742	_	_
133	15	HIV-infected	hiv-infected	JJ	16	amod	20743	20755	B-persongroup-110072	_
133	16	people	people	NNS	13	nmod	20756	20762	I-persongroup-110072	_
133	17	.	.	.	8	punct	20762	20763	_	_

134	1	There	there	EX	2	expl	20764	20769	_	_
134	2	are	be	VBP	0	ROOT	20770	20773	_	_
134	3	no	no	DT	4	neg	20774	20776	_	_
134	4	contraindications	contraindication	NNS	2	nsubj	20777	20794	_	_
134	5	to	to	TO	7	case	20795	20797	_	_
134	6	the	the	DT	7	det	20798	20801	_	_
134	7	use	use	NN	4	nmod	20803	20806	_	_
134	8	of	of	IN	10	case	20807	20809	_	_
134	9	MMR	mmr	NN	10	compound	20810	20813	_	_
134	10	vaccine	vaccine	NN	7	nmod	20814	20821	_	_
134	11	early	early	RB	2	advmod	20822	20827	_	_
134	12	in	in	IN	14	case	20828	20830	_	_
134	13	the	the	DT	14	det	20831	20834	_	_
134	14	course	course	NN	11	nmod	20835	20841	_	_
134	15	of	of	IN	16	case	20842	20844	_	_
134	16	illness	illness	NN	14	nmod	20845	20852	_	_
134	17	;	;	:	2	punct	20852	20853	_	_
134	18	however	however	RB	23	advmod	20854	20861	_	_
134	19	,	,	,	23	punct	20861	20862	_	_
134	20	MMR	mmr	NN	21	compound	20863	20866	_	_
134	21	vaccine	vaccine	NN	23	nsubjpass	20867	20874	_	_
134	22	is	be	VBZ	23	auxpass	20875	20877	_	_
134	23	contraindicated	contraindicate	VBN	2	parataxis	20878	20893	_	_
134	24	in	in	IN	25	case	20894	20896	_	_
134	25	persons	person	NNS	23	nmod	20897	20904	B-persongroup-110073	_
134	26	with	with	IN	28	case	20906	20910	_	_
134	27	advanced	advanced	JJ	28	amod	20911	20919	_	_
134	28	HIV/AIDS	hiv/aids	NN	25	nmod	20920	20928	_	_
134	29	.	.	.	2	punct	20928	20929	_	_

135	1	The	the	DT	2	det	20931	20934	_	_
135	2	safety	safety	NN	14	nsubjpass	20935	20941	_	_
135	3	and	and	CC	2	cc	20942	20945	_	_
135	4	immunogenicity	immunogenicity	NN	2	conj	20946	20960	_	_
135	5	of	of	IN	7	case	20961	20963	_	_
135	6	MMRV	mmrv	NN	7	compound	20964	20968	_	_
135	7	vaccine	vaccine	NN	2	nmod	20969	20976	_	_
135	8	in	in	IN	10	case	20977	20979	_	_
135	9	HIV-infected	hiv-infected	JJ	10	amod	20980	20992	B-persongroup-110074	_
135	10	individuals	individual	NNS	7	nmod	20993	21004	I-persongroup-110074	_
135	11	has	have	VBZ	14	aux	21005	21008	_	_
135	12	not	not	RB	14	neg	21010	21013	_	_
135	13	been	be	VBN	14	auxpass	21014	21018	_	_
135	14	evaluated	evaluate	VBN	0	ROOT	21019	21028	_	_
135	15	,	,	,	14	punct	21028	21029	_	_
135	16	and	and	CC	14	cc	21030	21033	_	_
135	17	MMRV	mmrv	NN	18	compound	21034	21038	_	_
135	18	vaccine	vaccine	NN	23	nsubjpass	21039	21046	_	_
135	19	can	can	MD	23	aux	21047	21050	_	_
135	20	not	not	RB	23	neg	21050	21053	_	_
135	21	be	be	VB	23	auxpass	21054	21056	_	_
135	22	routinely	routinely	RB	23	advmod	21057	21066	_	_
135	23	recommended	recommend	VBN	14	conj	21067	21078	_	_
135	24	.	.	.	14	punct	21078	21079	_	_

136	1	Children	child	NNS	0	ROOT	21080	21088	B-persongroup-110075	_
136	2	:	:	:	1	punct	21088	21089	I-persongroup-110075	_
136	3	HIV-infected	hiv-infected	JJ	4	amod	21090	21102	B-persongroup-110076	_
136	4	children	child	NNS	1	dep	21103	21111	I-persongroup-110076	_
136	5	12	12	CD	6	nummod	21112	21114	_	_
136	6	months	month	NNS	4	nmod	21116	21122	_	_
136	7	of	of	IN	6	case	21123	21125	_	_
136	8	age	age	NN	6	dep	21126	21129	_	_
136	9	and	and	CC	8	cc	21130	21133	_	_
136	10	older	older	JJR	8	conj	21134	21139	_	_
136	11	,	,	,	4	punct	21139	21140	_	_
136	12	and	and	CC	4	cc	21141	21144	_	_
136	13	with	with	IN	14	case	21145	21149	_	_
136	14	Centers	Centers	NNPS	4	nmod	21150	21157	B-persongroup-110077	_
136	15	for	for	IN	17	case	21158	21161	I-persongroup-110077	_
136	16	Disease	Disease	NNP	17	compound	21162	21169	I-persongroup-110077	_
136	17	Control	Control	NNP	14	nmod	21170	21177	I-persongroup-110077	_
136	18	and	and	CC	17	cc	21178	21181	I-persongroup-110077	_
136	19	Prevention	Prevention	NNP	21	compound	21182	21192	I-persongroup-110077	_
136	20	(	(	CD	21	nummod	21193	21194	I-persongroup-110077	_
136	21	CDC	CDC	NNP	17	conj	21194	21197	I-persongroup-110077	_
136	22	)	)	CD	25	nummod	21197	21198	I-persongroup-110077	_
136	23	clinical	clinical	JJ	25	amod	21199	21207	_	_
136	24	category	category	NN	25	compound	21208	21216	_	_
136	25	N	n	NN	17	dep	21217	21218	_	_
136	26	,	,	,	25	punct	21218	21219	_	_
136	27	A	a	NN	25	appos	21220	21221	_	_
136	28	,	,	,	25	punct	21221	21222	_	_
136	29	or	or	CC	17	cc	21223	21225	_	_
136	30	B	b	NN	17	conj	21226	21227	_	_
136	31	and	and	CC	30	cc	21228	21231	_	_
136	32	immunologic	immunologic	JJ	33	amod	21233	21244	_	_
136	33	category	category	NN	30	conj	21245	21253	_	_
136	34	1	1	CD	4	conj	21254	21255	_	_
136	35	or	or	CC	34	cc	21256	21258	_	_
136	36	2	2	CD	37	nummod	21259	21260	_	_
136	37	(	(	CD	34	conj	21261	21262	_	_
136	38	i.e.	i.e.	FW	34	dep	21262	21266	_	_
136	39	,	,	,	4	punct	21266	21267	_	_
136	40	CD4	cd4	NN	41	nsubj	21268	21271	_	_
136	41	counts	count	VBZ	4	acl:relcl	21272	21278	_	_
136	42	≥	≥	CD	43	compound	21279	21280	_	_
136	43	15	15	CD	44	nummod	21280	21282	_	_
136	44	%	%	NN	41	dobj	21282	21283	_	_
136	45	)	)	CD	47	nsubj	21283	21284	_	_
136	46	may	may	MD	47	aux	21285	21288	_	_
136	47	receive	receive	VB	44	acl:relcl	21289	21296	_	_
136	48	two	two	CD	49	nummod	21297	21300	_	_
136	49	doses	dose	NNS	47	dobj	21301	21306	_	_
136	50	of	of	IN	52	case	21307	21309	_	_
136	51	MMR	mmr	NN	52	compound	21311	21314	_	_
136	52	vaccine	vaccine	NN	49	nmod	21315	21322	_	_
136	53	3	3	CD	55	compound	21323	21324	_	_
136	54	to	to	TO	55	dep	21325	21327	_	_
136	55	6	6	CD	56	nummod	21328	21329	_	_
136	56	months	month	NNS	57	nmod:npmod	21330	21336	_	_
136	57	apart	apart	RB	47	advmod	21337	21342	_	_
136	58	.	.	.	1	punct	21342	21343	_	_

137	1	Univalent	univalent	JJ	3	amod	21344	21353	_	_
137	2	varicella	varicella	NN	3	compound	21354	21363	_	_
137	3	vaccine	vaccine	NN	6	nsubjpass	21364	21371	_	_
137	4	may	may	MD	6	aux	21372	21375	_	_
137	5	be	be	VB	6	auxpass	21376	21378	_	_
137	6	administered	administer	VBN	0	ROOT	21380	21392	_	_
137	7	concomitantly	concomitantly	RB	6	advmod	21393	21406	_	_
137	8	with	with	IN	10	case	21407	21411	_	_
137	9	MMR	mmr	NN	10	compound	21412	21415	_	_
137	10	vaccine	vaccine	NN	6	nmod	21416	21423	_	_
137	11	at	at	IN	14	case	21424	21426	_	_
137	12	different	different	JJ	14	amod	21427	21436	_	_
137	13	injection	injection	NN	14	compound	21437	21446	_	_
137	14	sites	site	NNS	6	nmod	21447	21452	_	_
137	15	using	use	VBG	6	xcomp	21453	21458	_	_
137	16	separate	separate	JJ	17	amod	21459	21467	_	_
137	17	needles	needle	NNS	15	dobj	21468	21475	_	_
137	18	and	and	CC	17	cc	21477	21480	_	_
137	19	syringes	syringe	NNS	17	conj	21481	21489	_	_
137	20	.	.	.	6	punct	21489	21490	_	_

138	1	Adolescents	adolescent	NNS	17	nsubjpass	21491	21502	B-persongroup-110078	_
138	2	and	and	CC	1	cc	21503	21506	_	_
138	3	adults	adult	NNS	1	conj	21507	21513	B-persongroup-110079	_
138	4	:	:	:	1	punct	21513	21514	I-persongroup-110079	_
138	5	immunization	immunization	NN	1	dep	21515	21527	_	_
138	6	with	with	IN	8	case	21528	21532	_	_
138	7	two	two	CD	8	nummod	21533	21536	_	_
138	8	doses	dose	NNS	5	nmod	21537	21542	_	_
138	9	of	of	IN	10	case	21543	21545	_	_
138	10	MMR	mmr	NN	8	nmod	21546	21549	_	_
138	11	administered	administer	VBN	10	acl	21550	21562	_	_
138	12	3	3	CD	13	nummod	21563	21564	_	_
138	13	months	month	NNS	14	nmod:npmod	21565	21571	_	_
138	14	apart	apart	RB	11	advmod	21572	21577	_	_
138	15	may	may	MD	17	aux	21578	21581	_	_
138	16	be	be	VB	17	auxpass	21582	21584	_	_
138	17	considered	consider	VBN	0	ROOT	21585	21595	_	_
138	18	for	for	IN	21	case	21596	21599	_	_
138	19	susceptible	susceptible	JJ	20	amod	21600	21611	B-persongroup-110080	_
138	20	HIV-infected	hiv-infected	JJ	21	amod	21612	21624	I-persongroup-110080	_
138	21	adolescents	adolescent	NNS	17	nmod	21625	21636	I-persongroup-110080	_
138	22	and	and	CC	21	cc	21637	21640	_	_
138	23	adults	adult	NNS	21	conj	21641	21647	B-persongroup-110081	_
138	24	with	with	IN	27	case	21648	21652	_	_
138	25	CD4	cd4	NN	27	compound	21653	21656	_	_
138	26	cell	cell	NN	27	compound	21657	21661	_	_
138	27	count	count	NN	21	nmod	21662	21667	_	_
138	28	≥	≥	CD	29	compound	21668	21669	_	_
138	29	200	200	CD	31	nummod	21669	21672	_	_
138	30	x	x	NN	31	compound	21673	21674	_	_
138	31	106/L	106/l	NN	27	dep	21675	21680	_	_
138	32	and	and	CC	27	cc	21681	21684	_	_
138	33	CD4	cd4	NN	34	compound	21685	21688	_	_
138	34	percentage	percentage	NN	27	conj	21689	21699	_	_
138	35	≥	≥	CD	36	compound	21700	21701	_	_
138	36	15	15	CD	37	nummod	21701	21703	_	_
138	37	%	%	NN	34	dep	21703	21704	_	_
138	38	.	.	.	17	punct	21704	21705	_	_

139	1	Susceptible	susceptible	JJ	3	amod	21706	21717	B-persongroup-110082	_
139	2	household	household	NN	3	compound	21718	21727	I-persongroup-110082	_
139	3	contacts	contact	NNS	8	nsubj	21728	21736	I-persongroup-110082	_
139	4	of	of	IN	6	case	21737	21739	I-persongroup-110082	_
139	5	immunocompromised	immunocompromised	JJ	6	amod	21740	21757	I-persongroup-110082	_
139	6	people	people	NNS	3	nmod	21759	21765	I-persongroup-110082	_
139	7	should	should	MD	8	aux	21766	21772	_	_
139	8	receive	receive	VB	0	ROOT	21773	21780	_	_
139	9	a	a	DT	11	det	21781	21782	_	_
139	10	measles-containing	measles-containing	JJ	11	amod	21783	21801	_	_
139	11	vaccine	vaccine	NN	8	dobj	21802	21809	_	_
139	12	as	as	IN	18	case	21810	21812	_	_
139	13	appropriate	appropriate	JJ	18	amod	21813	21824	_	_
139	14	for	for	IN	15	case	21825	21828	_	_
139	15	age	age	NN	13	nmod	21829	21832	_	_
139	16	and	and	CC	15	cc	21833	21836	_	_
139	17	risk	risk	NN	15	conj	21838	21842	_	_
139	18	factors	factor	NNS	8	nmod	21843	21850	_	_
139	19	.	.	.	8	punct	21850	21851	_	_

140	1	Refer	refer	VB	0	ROOT	21852	21857	_	_
140	2	to	to	TO	3	case	21858	21860	_	_
140	3	Contraindications	contraindication	NNS	1	nmod	21861	21878	_	_
140	4	and	and	CC	3	cc	21879	21882	_	_
140	5	Precautions	precaution	NNS	3	conj	21883	21894	_	_
140	6	.	.	.	1	punct	21894	21895	_	_

141	1	Refer	refer	VB	0	ROOT	21896	21901	_	_
141	2	to	to	TO	3	case	21902	21904	_	_
141	3	Immunization	immunization	NN	1	nmod	21905	21917	_	_
141	4	of	of	IN	6	case	21918	21920	_	_
141	5	Immunocompromised	immunocompromised	JJ	6	amod	21921	21938	B-persongroup-110083	_
141	6	Persons	person	NNS	3	nmod	21939	21946	I-persongroup-110083	_
141	7	in	in	IN	8	case	21947	21949	_	_
141	8	Part	Part	NNP	6	nmod	21950	21954	_	_
141	9	3	3	CD	8	nummod	21955	21956	_	_
141	10	for	for	IN	12	case	21957	21960	_	_
141	11	additional	additional	JJ	12	amod	21961	21971	_	_
141	12	information	information	NN	1	nmod	21972	21983	_	_
141	13	.	.	.	1	punct	21983	21984	_	_

142	1	Hyposplenic	hyposplenic	JJ	4	amod	21985	21996	B-persongroup-110084	_
142	2	or	or	CC	1	cc	21998	22000	I-persongroup-110084	_
142	3	asplenic	asplenic	JJ	1	conj	22001	22009	I-persongroup-110084	_
142	4	(	(	NN	23	nsubj	22010	22011	_	_
142	5	congenital	congenital	JJ	12	amod	22011	22021	_	_
142	6	absence	absence	NN	9	compound	22022	22029	_	_
142	7	,	,	,	9	punct	22029	22030	_	_
142	8	surgical	surgical	JJ	9	amod	22031	22039	_	_
142	9	removal	removal	NN	12	compound	22040	22047	_	_
142	10	or	or	CC	9	cc	22048	22050	I-persongroup-110084	_
142	11	functional	functional	JJ	9	conj	22051	22061	_	_
142	12	[	[	NN	4	dep	22063	22064	_	_
142	13	e.g.	e.g.	FW	4	dep	22064	22068	_	_
142	14	,	,	,	4	punct	22068	22069	_	_
142	15	sickle	sickle	JJ	17	amod	22070	22076	_	_
142	16	cell	cell	NN	17	compound	22077	22081	_	_
142	17	disease	disease	NN	4	appos	22082	22089	_	_
142	18	]	]	CD	19	compound	22089	22090	_	_
142	19	)	)	CD	20	nummod	22090	22091	_	_
142	20	individuals	individual	NNS	17	dep	22092	22103	I-persongroup-110084	_
142	21	should	should	MD	23	aux	22104	22110	_	_
142	22	be	be	VB	23	cop	22111	22113	_	_
142	23	immune	immune	JJ	0	ROOT	22114	22120	_	_
142	24	to	to	TO	25	case	22121	22123	_	_
142	25	measles	measles	NNS	23	nmod	22124	22131	_	_
142	26	,	,	,	25	punct	22131	22132	_	_
142	27	mumps	mumps	NNS	25	conj	22133	22138	_	_
142	28	and	and	CC	25	cc	22139	22142	_	_
142	29	rubella	rubella	NN	25	conj	22143	22150	_	_
142	30	or	or	CC	23	cc	22151	22153	_	_
142	31	should	should	MD	32	aux	22154	22160	_	_
142	32	receive	receive	VB	23	conj	22161	22168	_	_
142	33	MMR	mmr	NN	36	compound	22170	22173	_	_
142	34	or	or	CC	33	cc	22174	22176	_	_
142	35	MMRV	mmrv	NN	33	conj	22177	22181	_	_
142	36	vaccine	vaccine	NN	32	dobj	22182	22189	_	_
142	37	as	as	IN	38	case	22190	22192	_	_
142	38	appropriate	appropriate	JJ	32	advcl	22193	22204	_	_
142	39	.	.	.	23	punct	22204	22205	_	_

143	1	Individuals	individual	NNS	11	nsubj	22206	22217	B-persongroup-110085	_
143	2	with	with	IN	5	case	22218	22222	_	_
143	3	chronic	chronic	JJ	5	amod	22223	22230	_	_
143	4	renal	renal	JJ	5	amod	22231	22236	_	_
143	5	disease	disease	NN	1	nmod	22237	22244	_	_
143	6	or	or	CC	5	cc	22245	22247	_	_
143	7	undergoing	undergo	VBG	5	conj	22249	22259	_	_
143	8	dialysis	dialysis	NN	7	dobj	22260	22268	_	_
143	9	should	should	MD	11	aux	22269	22275	_	_
143	10	be	be	VB	11	cop	22276	22278	_	_
143	11	immune	immune	JJ	0	ROOT	22279	22285	_	_
143	12	to	to	TO	13	case	22286	22288	_	_
143	13	measles	measles	NNS	11	nmod	22289	22296	_	_
143	14	,	,	,	13	punct	22296	22297	_	_
143	15	mumps	mumps	NNS	13	conj	22298	22303	_	_
143	16	and	and	CC	13	cc	22304	22307	_	_
143	17	rubella	rubella	NN	13	conj	22308	22315	_	_
143	18	or	or	CC	11	cc	22316	22318	_	_
143	19	should	should	MD	20	aux	22319	22325	_	_
143	20	receive	receive	VB	11	conj	22327	22334	_	_
143	21	MMR	mmr	NN	24	compound	22335	22338	_	_
143	22	or	or	CC	21	cc	22339	22341	_	_
143	23	MMRV	mmrv	NN	21	conj	22342	22346	_	_
143	24	vaccine	vaccine	NN	20	dobj	22347	22354	_	_
143	25	as	as	IN	26	case	22355	22357	_	_
143	26	appropriate	appropriate	JJ	20	advcl	22358	22369	_	_
143	27	.	.	.	11	punct	22369	22370	_	_

144	1	People	people	NNS	12	nsubj	22371	22377	B-persongroup-110086	_
144	2	with	with	IN	3	case	22378	22382	_	_
144	3	conditions	condition	NNS	1	nmod	22383	22393	_	_
144	4	such	such	JJ	8	case	22394	22398	_	_
144	5	as	as	IN	4	mwe	22399	22401	_	_
144	6	autism	autism	NN	8	compound	22402	22408	_	_
144	7	spectrum	spectrum	NN	8	compound	22409	22417	_	_
144	8	disorders	disorder	NNS	3	nmod	22418	22427	_	_
144	9	or	or	CC	8	cc	22428	22430	_	_
144	10	demyelinating	demyelinating	JJ	11	amod	22431	22444	_	_
144	11	disorders	disorder	NNS	8	conj	22445	22454	_	_
144	12	(	(	VBP	0	ROOT	22455	22456	_	_
144	13	including	include	VBG	16	case	22456	22465	_	_
144	14	multiple	multiple	JJ	16	amod	22466	22474	_	_
144	15	sclerosis	sclerosis	NN	16	compound	22475	22484	_	_
144	16	)	)	NN	12	nmod	22484	22485	_	_
144	17	should	should	MD	18	aux	22486	22492	_	_
144	18	receive	receive	VB	16	acl:relcl	22493	22500	_	_
144	19	all	all	DT	18	dobj	22501	22504	_	_
144	20	routinely	routinely	RB	21	advmod	22505	22514	_	_
144	21	recommended	recommend	VBN	19	acl	22515	22526	_	_
144	22	immunizations	immunization	NNS	21	dobj	22527	22540	_	_
144	23	,	,	,	16	punct	22540	22541	_	_
144	24	including	include	VBG	28	case	22542	22551	_	_
144	25	MMR	mmr	NN	28	compound	22552	22555	_	_
144	26	or	or	CC	25	cc	22556	22558	_	_
144	27	MMRV	mmrv	NN	25	conj	22559	22563	_	_
144	28	vaccine	vaccine	NN	16	nmod	22564	22571	_	_
144	29	as	as	IN	30	case	22572	22574	_	_
144	30	appropriate	appropriate	JJ	28	acl	22575	22586	_	_
144	31	.	.	.	12	punct	22586	22587	_	_

145	1	Individuals	individual	NNS	13	nsubjpass	22590	22601	B-persongroup-110087	_
145	2	with	with	IN	4	case	22602	22606	_	_
145	3	autoimmune	autoimmune	JJ	4	amod	22607	22617	_	_
145	4	disease	disease	NN	1	nmod	22618	22625	_	_
145	5	not	not	RB	7	neg	22626	22629	_	_
145	6	being	be	VBG	7	auxpass	22630	22635	_	_
145	7	treated	treat	VBN	4	acl	22636	22643	_	_
145	8	with	with	IN	10	case	22644	22648	_	_
145	9	immunosuppressive	immunosuppressive	JJ	10	amod	22649	22666	_	_
145	10	drugs	drug	NNS	7	nmod	22667	22672	_	_
145	11	are	be	VBP	13	auxpass	22673	22676	_	_
145	12	not	not	RB	13	neg	22677	22680	_	_
145	13	considered	consider	VBN	0	ROOT	22681	22691	_	_
145	14	significantly	significantly	RB	15	advmod	22692	22705	_	_
145	15	immunocompromised	immunocompromised	JJ	13	xcomp	22706	22723	_	_
145	16	and	and	CC	13	cc	22724	22727	_	_
145	17	should	should	MD	18	aux	22728	22734	_	_
145	18	receive	receive	VB	13	conj	22735	22742	_	_
145	19	MMR	mmr	NN	20	compound	22743	22746	_	_
145	20	immunization	immunization	NN	18	dobj	22747	22759	_	_
145	21	following	follow	VBG	22	case	22760	22769	_	_
145	22	consultation	consultation	NN	20	nmod	22770	22782	_	_
145	23	with	with	IN	25	case	22783	22787	_	_
145	24	their	they	PRP$	25	nmod:poss	22788	22793	B-persongroup-110088	_
145	25	physician	physician	NN	22	nmod	22794	22803	I-persongroup-110088	_
145	26	.	.	.	13	punct	22803	22804	I-persongroup-110088	_

146	1	Rheumatic	rheumatic	JJ	2	amod	22805	22814	_	_
146	2	disease	disease	NN	16	nsubjpass	22815	22822	_	_
146	3	modifying	modify	VBG	2	acl	22823	22832	_	_
146	4	agents	agent	NNS	3	dobj	22833	22839	_	_
146	5	such	such	JJ	7	case	22840	22844	_	_
146	6	as	as	IN	5	mwe	22845	22847	_	_
146	7	hydroxychloroquine	hydroxychloroquine	NN	4	nmod	22848	22866	_	_
146	8	,	,	,	7	punct	22866	22867	_	_
146	9	sulfasalazine	sulfasalazine	NN	7	conj	22868	22881	_	_
146	10	,	,	,	7	punct	22881	22882	_	_
146	11	or	or	CC	7	cc	22883	22885	_	_
146	12	auranofin	auranofin	NN	7	conj	22886	22895	_	_
146	13	are	be	VBP	16	auxpass	22896	22899	_	_
146	14	not	not	RB	16	neg	22900	22903	_	_
146	15	generally	generally	RB	16	advmod	22904	22913	_	_
146	16	identified	identify	VBN	0	ROOT	22914	22924	_	_
146	17	as	as	IN	18	case	22925	22927	_	_
146	18	immunosuppressive	immunosuppressive	JJ	16	advcl	22928	22945	_	_
146	19	.	.	.	16	punct	22945	22946	_	_

147	1	Refer	refer	VB	0	ROOT	22948	22953	_	_
147	2	to	to	TO	3	case	22954	22956	_	_
147	3	Immunization	immunization	NN	1	nmod	22957	22969	_	_
147	4	of	of	IN	5	case	22970	22972	_	_
147	5	Persons	person	NNS	3	nmod	22973	22980	B-persongroup-110089	_
147	6	with	with	IN	8	case	22981	22985	_	_
147	7	Chronic	chronic	JJ	8	amod	22986	22993	_	_
147	8	Diseases	disease	NNS	5	nmod	22994	23002	_	_
147	9	in	in	IN	10	case	23004	23006	_	_
147	10	Part	Part	NNP	8	nmod	23008	23012	_	_
147	11	3	3	CD	10	nummod	23013	23014	_	_
147	12	for	for	IN	15	case	23015	23018	_	_
147	13	additional	additional	JJ	15	amod	23019	23029	_	_
147	14	general	general	JJ	15	amod	23030	23037	_	_
147	15	information	information	NN	1	nmod	23038	23049	_	_
147	16	.	.	.	1	punct	23049	23050	_	_

148	1	Protection	protection	NN	6	nsubj	23051	23061	_	_
148	2	against	against	IN	3	case	23062	23069	_	_
148	3	measles	measles	NNS	1	nmod	23070	23077	_	_
148	4	is	be	VBZ	6	cop	23078	23080	_	_
148	5	especially	especially	RB	6	advmod	23081	23091	_	_
148	6	important	important	JJ	0	ROOT	23092	23101	_	_
148	7	for	for	IN	8	case	23102	23105	_	_
148	8	people	people	NNS	6	nmod	23106	23112	B-persongroup-110090	_
148	9	planning	plan	VBG	6	xcomp	23113	23121	_	_
148	10	travel	travel	NN	9	dobj	23122	23128	_	_
148	11	to	to	TO	12	case	23129	23131	_	_
148	12	destinations	destination	NNS	9	nmod	23132	23144	B-persongroup-110092	_
148	13	outside	outside	IN	12	advmod	23145	23152	I-persongroup-110092	_
148	14	of	of	IN	16	case	23153	23155	I-persongroup-110092	_
148	15	North	North	NNP	16	compound	23156	23161	I-persongroup-110092	_
148	16	America	America	NNP	13	nmod	23162	23169	I-persongroup-110092	_
148	17	.	.	.	6	punct	23169	23170	I-persongroup-110092	_

149	1	Travellers	Travellers	NNPS	2	nsubj	23171	23181	B-persongroup-110091	_
149	2	born	bear	VBN	0	ROOT	23182	23186	_	_
149	3	in	in	IN	4	case	23187	23189	_	_
149	4	1970	1970	CD	2	dep	23190	23194	_	_
149	5	or	or	CC	4	cc	23195	23197	_	_
149	6	later	later	RB	4	conj	23198	23203	_	_
149	7	who	who	WP	10	nsubj	23204	23207	_	_
149	8	do	do	VBP	10	aux	23208	23210	_	_
149	9	not	not	RB	10	neg	23211	23214	_	_
149	10	have	have	VB	4	conj	23215	23219	_	_
149	11	documented	document	VBN	12	amod	23220	23230	_	_
149	12	evidence	evidence	NN	10	dobj	23231	23239	_	_
149	13	of	of	IN	14	mark	23240	23242	_	_
149	14	receiving	receive	VBG	12	acl	23243	23252	_	_
149	15	two	two	CD	16	nummod	23253	23256	_	_
149	16	doses	dose	NNS	14	dobj	23257	23262	_	_
149	17	of	of	IN	19	case	23263	23265	_	_
149	18	measles-containing	measles-containing	JJ	19	amod	23266	23284	_	_
149	19	vaccine	vaccine	NN	16	nmod	23285	23292	_	_
149	20	on	on	IN	25	case	23293	23295	_	_
149	21	or	or	CC	20	cc	23296	23298	_	_
149	22	after	after	IN	20	conj	23299	23304	_	_
149	23	their	they	PRP$	25	nmod:poss	23305	23310	_	_
149	24	first	first	JJ	25	amod	23311	23316	_	_
149	25	birthday	birthday	NN	14	nmod	23317	23325	_	_
149	26	,	,	,	12	punct	23325	23326	_	_
149	27	or	or	CC	12	cc	23327	23329	_	_
149	28	laboratory	laboratory	NN	29	compound	23330	23340	_	_
149	29	evidence	evidence	NN	12	conj	23341	23349	_	_
149	30	of	of	IN	31	case	23350	23352	_	_
149	31	immunity	immunity	NN	29	nmod	23353	23361	_	_
149	32	,	,	,	2	punct	23361	23362	_	_
149	33	or	or	CC	2	cc	23363	23365	_	_
149	34	a	a	DT	35	det	23366	23367	_	_
149	35	history	history	NN	38	nsubj	23368	23375	_	_
149	36	of	of	IN	37	case	23376	23378	_	_
149	37	laboratory	laboratory	NN	35	nmod	23379	23389	_	_
149	38	confirmed	confirm	VBD	2	conj	23390	23399	_	_
149	39	measles	measles	NNS	40	compound	23400	23407	_	_
149	40	disease	disease	NN	42	nsubj	23408	23415	_	_
149	41	should	should	MD	42	aux	23416	23422	_	_
149	42	receive	receive	VB	38	ccomp	23423	23430	_	_
149	43	two	two	CD	44	nummod	23431	23434	_	_
149	44	doses	dose	NNS	42	dobj	23435	23440	_	_
149	45	of	of	IN	47	case	23441	23443	_	_
149	46	measles-containing	measles-containing	JJ	47	amod	23444	23462	_	_
149	47	vaccine	vaccine	NN	44	nmod	23463	23470	_	_
149	48	.	.	.	2	punct	23470	23471	_	_

150	1	Measles	Measles	NNP	2	compound	23473	23480	_	_
150	2	vaccine	vaccine	NN	5	nsubjpass	23481	23488	_	_
150	3	should	should	MD	5	aux	23489	23495	_	_
150	4	be	be	VB	5	auxpass	23496	23498	_	_
150	5	given	give	VBN	0	ROOT	23499	23504	_	_
150	6	at	at	IN	9	case	23505	23507	_	_
150	7	an	a	DT	9	det	23508	23510	_	_
150	8	earlier	earlier	JJR	9	amod	23511	23518	_	_
150	9	age	age	NN	5	nmod	23519	23522	_	_
150	10	than	than	IN	11	case	23523	23527	_	_
150	11	usual	usual	JJ	9	acl	23528	23533	_	_
150	12	for	for	IN	13	case	23534	23537	_	_
150	13	children	child	NNS	5	nmod	23538	23546	B-persongroup-110093	_
150	14	travelling	travel	VBG	13	acl	23547	23557	_	_
150	15	to	to	TO	16	case	23558	23560	_	_
150	16	countries	country	NNS	14	nmod	23561	23570	_	_
150	17	outside	outside	IN	16	advmod	23571	23578	B-persongroup-110094	_
150	18	of	of	IN	20	case	23579	23581	I-persongroup-110094	_
150	19	North	North	NNP	20	compound	23582	23587	I-persongroup-110094	_
150	20	America	America	NNP	17	nmod	23588	23595	I-persongroup-110094	_
150	21	.	.	.	5	punct	23595	23596	I-persongroup-110094	_

151	1	MMR	mmr	NN	2	compound	23597	23600	_	_
151	2	vaccine	vaccine	NN	5	nsubjpass	23601	23608	_	_
151	3	may	may	MD	5	aux	23609	23612	_	_
151	4	be	be	VB	5	auxpass	23613	23615	_	_
151	5	given	give	VBN	0	ROOT	23616	23621	_	_
151	6	as	as	RB	7	advmod	23622	23624	_	_
151	7	early	early	RB	5	advmod	23625	23630	_	_
151	8	as	as	IN	10	case	23631	23633	_	_
151	9	6	6	CD	10	nummod	23634	23635	_	_
151	10	months	month	NNS	5	nmod	23636	23642	_	_
151	11	of	of	IN	12	case	23643	23645	_	_
151	12	age	age	NN	10	nmod	23646	23649	_	_
151	13	;	;	:	5	punct	23649	23650	_	_
151	14	however	however	RB	24	advmod	23651	23658	_	_
151	15	,	,	,	24	punct	23658	23659	_	_
151	16	two	two	CD	18	nummod	23660	23663	_	_
151	17	additional	additional	JJ	18	amod	23664	23674	_	_
151	18	doses	dose	NNS	24	nsubjpass	23675	23680	_	_
151	19	of	of	IN	21	case	23681	23683	_	_
151	20	measles-containing	measles-containing	JJ	21	amod	23684	23702	_	_
151	21	vaccine	vaccine	NN	18	nmod	23703	23710	_	_
151	22	must	must	MD	24	aux	23711	23715	_	_
151	23	be	be	VB	24	auxpass	23716	23718	_	_
151	24	administered	administer	VBN	5	parataxis	23719	23731	_	_
151	25	after	after	IN	31	mark	23732	23737	_	_
151	26	the	the	DT	27	det	23738	23741	B-persongroup-110095	_
151	27	child	child	NN	31	nsubj	23742	23747	I-persongroup-110095	_
151	28	is	be	VBZ	31	cop	23748	23750	_	_
151	29	12	12	CD	30	nummod	23751	23753	_	_
151	30	months	month	NNS	31	nmod:npmod	23754	23760	_	_
151	31	old	old	JJ	24	advcl	23761	23764	_	_
151	32	to	to	TO	33	mark	23765	23767	_	_
151	33	ensure	ensure	VB	31	xcomp	23768	23774	_	_
151	34	long	long	JJ	36	amod	23775	23779	_	_
151	35	lasting	lasting	JJ	36	amod	23780	23787	_	_
151	36	immunity	immunity	NN	33	dobj	23788	23796	_	_
151	37	to	to	TO	38	case	23797	23799	_	_
151	38	measles	measles	NNS	33	nmod	23800	23807	_	_
151	39	.	.	.	5	punct	23807	23808	_	_

152	1	Travellers	Travellers	NNPS	2	nsubj	23810	23820	B-persongroup-110096	_
152	2	born	bear	VBN	0	ROOT	23821	23825	_	_
152	3	before	before	IN	4	case	23826	23832	_	_
152	4	1970	1970	CD	2	nmod	23833	23837	_	_
152	5	,	,	,	4	punct	23837	23838	_	_
152	6	who	who	WP	9	nsubj	23839	23842	_	_
152	7	do	do	VBP	9	aux	23843	23845	_	_
152	8	not	not	RB	9	neg	23846	23849	_	_
152	9	have	have	VB	4	acl:relcl	23850	23854	_	_
152	10	documented	document	VBN	11	amod	23855	23865	_	_
152	11	evidence	evidence	NN	9	dobj	23866	23874	_	_
152	12	of	of	IN	13	mark	23875	23877	_	_
152	13	receiving	receive	VBG	11	acl	23879	23888	_	_
152	14	measles-containing	measles-containing	JJ	15	amod	23889	23907	_	_
152	15	vaccine	vaccine	NN	13	dobj	23908	23915	_	_
152	16	on	on	IN	21	case	23916	23918	_	_
152	17	or	or	CC	16	cc	23919	23921	_	_
152	18	after	after	IN	16	conj	23922	23927	_	_
152	19	their	they	PRP$	21	nmod:poss	23928	23933	_	_
152	20	first	first	JJ	21	amod	23934	23939	_	_
152	21	birthday	birthday	NN	13	nmod	23940	23948	_	_
152	22	,	,	,	11	punct	23948	23949	_	_
152	23	or	or	CC	11	cc	23950	23952	_	_
152	24	laboratory	laboratory	NN	25	compound	23953	23963	_	_
152	25	evidence	evidence	NN	11	conj	23964	23972	_	_
152	26	of	of	IN	27	case	23973	23975	_	_
152	27	immunity	immunity	NN	25	nmod	23976	23984	_	_
152	28	,	,	,	2	punct	23984	23985	_	_
152	29	or	or	CC	2	cc	23986	23988	_	_
152	30	a	a	DT	31	det	23989	23990	_	_
152	31	history	history	NN	34	nsubj	23991	23998	_	_
152	32	of	of	IN	33	case	23999	24001	_	_
152	33	laboratory	laboratory	NN	31	nmod	24002	24012	_	_
152	34	confirmed	confirm	VBD	2	conj	24013	24022	_	_
152	35	measles	measles	NNS	36	compound	24023	24030	_	_
152	36	disease	disease	NN	38	nsubj	24031	24038	_	_
152	37	should	should	MD	38	aux	24039	24045	_	_
152	38	receive	receive	VB	34	ccomp	24046	24053	_	_
152	39	one	one	CD	40	nummod	24054	24057	_	_
152	40	dose	dose	NN	38	dobj	24058	24062	_	_
152	41	of	of	IN	43	case	24063	24065	_	_
152	42	MMR	mmr	NN	43	compound	24066	24069	_	_
152	43	vaccine	vaccine	NN	40	nmod	24070	24077	_	_
152	44	.	.	.	2	punct	24077	24078	_	_

153	1	Measles	Measles	NNP	3	nsubj	24081	24088	_	_
153	2	is	be	VBZ	3	cop	24089	24091	_	_
153	3	endemic	endemic	JJ	0	ROOT	24092	24099	_	_
153	4	in	in	IN	6	case	24100	24102	_	_
153	5	many	many	JJ	6	amod	24103	24107	B-persongroup-110098	_
153	6	countries	country	NNS	3	nmod	24108	24117	I-persongroup-110098	_
153	7	.	.	.	3	punct	24117	24118	I-persongroup-110098	_

154	1	Refer	refer	VB	0	ROOT	24119	24124	_	_
154	2	to	to	TO	5	case	24125	24127	_	_
154	3	measles	measles	NNS	5	compound	24128	24135	_	_
154	4	incidence	incidence	NN	5	compound	24136	24145	_	_
154	5	rates	rate	NNS	1	nmod	24146	24151	_	_
154	6	in	in	IN	7	case	24152	24154	_	_
154	7	WHO	who	WP	5	nmod	24155	24158	B-persongroup-110097	_
154	8	member	member	NN	9	compound	24159	24165	I-persongroup-110097	_
154	9	countries	country	NNS	1	nmod	24166	24175	I-persongroup-110097	_
154	10	for	for	IN	9	case	24176	24179	_	_
154	11	additional	additional	JJ	12	amod	24180	24190	_	_
154	12	information	information	NN	9	dep	24191	24202	_	_
154	13	.	.	.	1	punct	24202	24203	_	_

155	1	Refer	refer	VB	0	ROOT	24204	24209	_	_
155	2	to	to	TO	3	case	24210	24212	_	_
155	3	Immunization	immunization	NN	1	nmod	24213	24225	_	_
155	4	of	of	IN	5	case	24226	24228	_	_
155	5	Travellers	Travellers	NNPS	3	nmod	24229	24239	B-persongroup-110099	_
155	6	in	in	IN	7	case	24240	24242	_	_
155	7	Part	Part	NNP	1	nmod	24243	24247	_	_
155	8	3	3	CD	7	nummod	24248	24249	_	_
155	9	for	for	IN	12	case	24250	24253	_	_
155	10	additional	additional	JJ	12	amod	24254	24264	_	_
155	11	general	general	JJ	12	amod	24265	24272	_	_
155	12	information	information	NN	1	nmod	24273	24284	_	_
155	13	.	.	.	1	punct	24284	24285	_	_

156	1	Health	Health	NNP	3	compound	24287	24293	B-persongroup-110100	_
156	2	care	care	NN	3	compound	24294	24298	I-persongroup-110100	_
156	3	providers	provider	NNS	12	nsubj	24299	24308	I-persongroup-110100	_
156	4	who	who	WP	5	nsubj	24309	24312	_	_
156	5	see	see	VBP	3	acl:relcl	24313	24316	_	_
156	6	persons	person	NNS	5	dobj	24317	24324	B-persongroup-110101	_
156	7	newly	newly	RB	8	advmod	24325	24330	_	_
156	8	arrived	arrive	VBN	6	acl	24331	24338	_	_
156	9	in	in	IN	10	case	24339	24341	_	_
156	10	Canada	Canada	NNP	8	nmod	24342	24348	B-persongroup-110102	_
156	11	should	should	MD	12	aux	24349	24355	_	_
156	12	review	review	VB	0	ROOT	24356	24362	_	_
156	13	the	the	DT	15	det	24363	24366	_	_
156	14	immunization	immunization	NN	15	compound	24367	24379	_	_
156	15	status	status	NN	12	dobj	24380	24386	_	_
156	16	and	and	CC	12	cc	24387	24390	_	_
156	17	update	update	VB	12	conj	24391	24397	_	_
156	18	immunization	immunization	NN	17	dobj	24398	24410	_	_
156	19	for	for	IN	21	case	24411	24414	_	_
156	20	these	these	DT	21	det	24415	24420	B-persongroup-110103	_
156	21	individuals	individual	NNS	17	nmod	24421	24432	I-persongroup-110103	_
156	22	.	.	.	12	punct	24432	24433	I-persongroup-110103	_

157	1	In	in	IN	3	case	24434	24436	_	_
157	2	many	many	JJ	3	amod	24437	24441	B-persongroup-110104	_
157	3	countries	country	NNS	15	nmod	24442	24451	I-persongroup-110104	_
157	4	outside	outside	IN	3	advmod	24452	24459	I-persongroup-110104	_
157	5	of	of	IN	6	case	24460	24462	I-persongroup-110104	_
157	6	Canada	Canada	NNP	3	nmod	24463	24469	I-persongroup-110104	_
157	7	,	,	,	15	punct	24469	24470	I-persongroup-110104	_
157	8	mumps	mumps	NNS	15	nsubj	24471	24476	_	_
157	9	and	and	CC	8	cc	24477	24480	_	_
157	10	rubella	rubella	NN	11	compound	24481	24488	_	_
157	11	vaccines	vaccine	NNS	8	conj	24489	24497	_	_
157	12	are	be	VBP	15	cop	24498	24501	_	_
157	13	in	in	IN	15	case	24502	24504	_	_
157	14	limited	limited	JJ	15	amod	24505	24512	_	_
157	15	use	use	NN	0	ROOT	24513	24516	_	_
157	16	and	and	CC	15	cc	24517	24520	_	_
157	17	measles	measles	NNS	18	compound	24521	24528	_	_
157	18	vaccine	vaccine	NN	21	nsubjpass	24529	24536	_	_
157	19	alone	alone	RB	21	advmod	24537	24542	_	_
157	20	is	be	VBZ	21	auxpass	24543	24545	_	_
157	21	given	give	VBN	15	conj	24546	24551	_	_
157	22	.	.	.	15	punct	24551	24552	_	_

158	1	A	a	DT	3	det	24553	24554	_	_
158	2	Canadian	canadian	JJ	3	amod	24555	24563	_	_
158	3	study	study	NN	4	nsubj	24564	24569	_	_
158	4	showed	show	VBD	0	ROOT	24570	24576	_	_
158	5	that	that	IN	19	mark	24577	24581	_	_
158	6	more	more	JJR	8	advmod	24582	24586	B-persongroup-110105	_
158	7	than	than	IN	6	mwe	24587	24591	I-persongroup-110105	_
158	8	one-third	one-third	NN	19	nsubj	24592	24601	I-persongroup-110105	_
158	9	of	of	IN	11	case	24602	24604	I-persongroup-110105	_
158	10	new	new	JJ	11	amod	24605	24608	I-persongroup-110105	_
158	11	immigrants	immigrant	NNS	8	nmod	24609	24619	I-persongroup-110105	_
158	12	and	and	CC	11	cc	24620	24623	I-persongroup-110105	_
158	13	refugees	refugee	NNS	11	conj	24624	24632	I-persongroup-110105	_
158	14	,	,	,	8	punct	24632	24633	I-persongroup-110105	_
158	15	particularly	particularly	RB	16	advmod	24634	24646	_	_
158	16	women	woman	NNS	8	appos	24647	24652	B-persongroup-110106	_
158	17	,	,	,	8	punct	24652	24653	I-persongroup-110106	_
158	18	were	be	VBD	19	cop	24654	24658	_	_
158	19	susceptible	susceptible	JJ	4	ccomp	24659	24670	_	_
158	20	to	to	TO	21	case	24671	24673	_	_
158	21	measles	measles	NNS	19	nmod	24674	24681	_	_
158	22	,	,	,	21	punct	24681	24682	_	_
158	23	mumps	mumps	NNS	21	conj	24683	24688	_	_
158	24	,	,	,	21	punct	24688	24689	_	_
158	25	or	or	CC	21	cc	24690	24692	_	_
158	26	rubella	rubella	NN	21	conj	24693	24700	_	_
158	27	.	.	.	4	punct	24700	24701	_	_

159	1	Refer	refer	VB	0	ROOT	24702	24707	_	_
159	2	to	to	TO	3	case	24708	24710	_	_
159	3	Immunization	immunization	NN	1	nmod	24711	24723	_	_
159	4	of	of	IN	6	case	24724	24726	_	_
159	5	Persons	Persons	NNPS	6	compound	24727	24734	B-persongroup-110107	_
159	6	New	New	NNP	3	nmod	24735	24738	_	_
159	7	to	to	TO	8	case	24739	24741	_	_
159	8	Canada	Canada	NNP	1	nmod	24742	24748	B-persongroup-110108	_
159	9	in	in	IN	10	case	24749	24751	_	_
159	10	Part	Part	NNP	8	nmod	24752	24756	_	_
159	11	3	3	CD	10	nummod	24757	24758	_	_
159	12	for	for	IN	15	case	24759	24762	_	_
159	13	additional	additional	JJ	15	amod	24763	24773	_	_
159	14	general	general	JJ	15	amod	24774	24781	_	_
159	15	information	information	NN	1	nmod	24782	24793	_	_
159	16	.	.	.	1	punct	24793	24794	_	_

160	1	It	it	PRP	3	nsubjpass	24795	24797	_	_
160	2	is	be	VBZ	3	auxpass	24798	24800	_	_
160	3	recommended	recommend	VBN	0	ROOT	24801	24812	_	_
160	4	that	that	IN	10	mark	24814	24818	_	_
160	5	all	all	DT	8	det	24819	24822	B-persongroup-110109	_
160	6	health	health	NN	8	compound	24823	24829	I-persongroup-110109	_
160	7	care	care	NN	8	compound	24830	24834	I-persongroup-110109	_
160	8	workers	worker	NNS	10	nsubj	24835	24842	I-persongroup-110109	_
160	9	be	be	VB	10	cop	24843	24845	_	_
160	10	immune	immune	JJ	3	ccomp	24846	24852	_	_
160	11	to	to	TO	12	case	24853	24855	_	_
160	12	measles	measles	NNS	10	nmod	24856	24863	_	_
160	13	.	.	.	3	punct	24863	24864	_	_

161	1	Health	Health	NNP	3	compound	24865	24871	B-persongroup-110110	_
161	2	care	care	NN	3	compound	24872	24876	I-persongroup-110110	_
161	3	workers	worker	NNS	43	nsubj	24877	24884	I-persongroup-110110	_
161	4	,	,	,	43	punct	24884	24885	I-persongroup-110110	_
161	5	regardless	regardless	RB	43	advmod	24886	24896	_	_
161	6	of	of	IN	8	case	24897	24899	_	_
161	7	their	they	PRP$	8	nmod:poss	24901	24906	_	_
161	8	year	year	NN	5	nmod	24907	24911	_	_
161	9	of	of	IN	10	case	24912	24914	_	_
161	10	birth	birth	NN	8	nmod	24915	24920	_	_
161	11	,	,	,	10	punct	24920	24921	_	_
161	12	who	who	WP	15	nsubj	24922	24925	_	_
161	13	do	do	VBP	15	aux	24926	24928	_	_
161	14	not	not	RB	15	neg	24929	24932	_	_
161	15	have	have	VB	10	acl:relcl	24933	24937	_	_
161	16	documented	document	VBN	17	amod	24938	24948	_	_
161	17	evidence	evidence	NN	15	dobj	24949	24957	_	_
161	18	of	of	IN	19	mark	24958	24960	_	_
161	19	receiving	receive	VBG	17	acl	24961	24970	_	_
161	20	two	two	CD	21	nummod	24971	24974	_	_
161	21	doses	dose	NNS	19	dobj	24976	24981	_	_
161	22	of	of	IN	24	case	24982	24984	_	_
161	23	measles-containing	measles-containing	JJ	24	amod	24985	25003	_	_
161	24	vaccine	vaccine	NN	21	nmod	25004	25011	_	_
161	25	on	on	IN	30	case	25012	25014	_	_
161	26	or	or	CC	25	cc	25015	25017	_	_
161	27	after	after	IN	25	conj	25018	25023	_	_
161	28	their	they	PRP$	30	nmod:poss	25024	25029	_	_
161	29	first	first	JJ	30	amod	25030	25035	_	_
161	30	birthday	birthday	NN	19	nmod	25036	25044	_	_
161	31	,	,	,	17	punct	25044	25045	_	_
161	32	or	or	CC	17	cc	25046	25048	_	_
161	33	laboratory	laboratory	NN	34	compound	25050	25060	_	_
161	34	evidence	evidence	NN	17	conj	25061	25069	_	_
161	35	of	of	IN	36	case	25070	25072	_	_
161	36	immunity	immunity	NN	34	nmod	25073	25081	_	_
161	37	,	,	,	17	punct	25081	25082	_	_
161	38	or	or	CC	17	cc	25083	25085	_	_
161	39	a	a	DT	40	det	25086	25087	_	_
161	40	history	history	NN	17	conj	25088	25095	_	_
161	41	of	of	IN	42	case	25096	25098	_	_
161	42	laboratory	laboratory	NN	40	nmod	25099	25109	_	_
161	43	confirmed	confirm	VBD	0	ROOT	25110	25119	_	_
161	44	measles	measles	NNS	45	compound	25120	25127	_	_
161	45	disease	disease	NN	48	nsubjpass	25129	25136	_	_
161	46	should	should	MD	48	aux	25137	25143	_	_
161	47	be	be	VB	48	auxpass	25144	25146	_	_
161	48	vaccinated	vaccinate	VBN	43	ccomp	25147	25157	_	_
161	49	accordingly	accordingly	RB	48	advmod	25158	25169	_	_
161	50	so	so	RB	54	mark	25170	25172	_	_
161	51	that	that	IN	50	mwe	25173	25177	_	_
161	52	they	they	PRP	54	nsubj	25178	25182	_	_
161	53	have	have	VBP	54	aux	25183	25187	_	_
161	54	received	receive	VBN	48	advcl	25188	25196	_	_
161	55	two	two	CD	56	nummod	25197	25200	_	_
161	56	doses	dose	NNS	54	dobj	25201	25206	_	_
161	57	of	of	IN	59	case	25207	25209	_	_
161	58	MMR	mmr	NN	59	compound	25211	25214	_	_
161	59	vaccine	vaccine	NN	56	nmod	25215	25222	_	_
161	60	.	.	.	43	punct	25222	25223	_	_

162	1	Refer	refer	VB	0	ROOT	25224	25229	_	_
162	2	to	to	TO	3	case	25230	25232	_	_
162	3	Immunization	immunization	NN	1	nmod	25233	25245	_	_
162	4	of	of	IN	5	case	25246	25248	_	_
162	5	Workers	worker	NNS	3	nmod	25249	25256	B-persongroup-110111	_
162	6	in	in	IN	7	case	25257	25259	_	_
162	7	Part	Part	NNP	5	nmod	25260	25264	_	_
162	8	3	3	CD	7	nummod	25265	25266	_	_
162	9	for	for	IN	12	case	25267	25270	_	_
162	10	additional	additional	JJ	12	amod	25271	25281	_	_
162	11	general	general	JJ	12	amod	25282	25289	_	_
162	12	information	information	NN	1	nmod	25290	25301	_	_
162	13	.	.	.	1	punct	25301	25302	_	_

163	1	Measles	Measles	NNP	3	nsubj	25303	25310	_	_
163	2	may	may	MD	3	aux	25311	25314	_	_
163	3	continue	continue	VB	0	ROOT	25315	25323	_	_
163	4	to	to	TO	6	mark	25324	25326	_	_
163	5	be	be	VB	6	auxpass	25327	25329	_	_
163	6	imported	import	VBN	3	xcomp	25330	25338	_	_
163	7	into	into	IN	8	case	25339	25343	_	_
163	8	Canada	Canada	NNP	6	nmod	25344	25350	B-persongroup-110112	_
163	9	.	.	.	3	punct	25350	25351	I-persongroup-110112	_

164	1	Outbreaks	outbreak	NNS	3	nsubj	25352	25361	_	_
164	2	may	may	MD	3	aux	25362	25365	_	_
164	3	occur	occur	VB	0	ROOT	25366	25371	_	_
164	4	in	in	IN	6	case	25372	25374	_	_
164	5	susceptible	susceptible	JJ	6	amod	25375	25386	B-persongroup-110113	_
164	6	populations	population	NNS	3	nmod	25387	25398	I-persongroup-110113	_
164	7	.	.	.	3	punct	25398	25399	I-persongroup-110113	_

165	1	For	for	IN	3	case	25400	25403	_	_
165	2	practical	practical	JJ	3	amod	25404	25413	_	_
165	3	purposes	purpose	NNS	15	nmod	25414	25422	_	_
165	4	,	,	,	15	punct	25422	25423	_	_
165	5	all	all	DT	6	det	25424	25427	B-persongroup-110114	_
165	6	individuals	individual	NNS	15	nsubjpass	25428	25439	I-persongroup-110114	_
165	7	attending	attend	VBG	6	acl	25440	25449	_	_
165	8	the	the	DT	10	det	25450	25453	B-persongroup-110115	_
165	9	same	same	JJ	10	amod	25454	25458	I-persongroup-110115	_
165	10	school	school	NN	7	dobj	25459	25465	I-persongroup-110115	_
165	11	or	or	CC	10	cc	25466	25468	_	_
165	12	facility	facility	NN	10	conj	25469	25477	B-persongroup-110116	_
165	13	should	should	MD	15	aux	25478	25484	_	_
165	14	be	be	VB	15	auxpass	25485	25487	_	_
165	15	considered	consider	VBN	0	ROOT	25488	25498	_	_
165	16	contacts	contact	NNS	15	dobj	25499	25507	B-persongroup-110117	_
165	17	.	.	.	15	punct	25507	25508	I-persongroup-110117	_

166	1	Susceptible	susceptible	JJ	4	amod	25509	25520	B-persongroup-110118	_
166	2	,	,	,	4	punct	25520	25521	I-persongroup-110118	_
166	3	immunocompetent	immunocompetent	JJ	4	amod	25522	25537	I-persongroup-110118	_
166	4	individuals	individual	NNS	18	nsubjpass	25538	25549	I-persongroup-110118	_
166	5	12	12	CD	6	nummod	25550	25552	_	_
166	6	months	month	NNS	4	amod	25553	25559	_	_
166	7	of	of	IN	8	case	25560	25562	_	_
166	8	age	age	NN	6	nmod	25563	25566	_	_
166	9	and	and	CC	6	cc	25567	25570	_	_
166	10	older	older	JJR	6	conj	25571	25576	_	_
166	11	who	who	WP	13	nsubjpass	25577	25580	_	_
166	12	are	be	VBP	13	auxpass	25581	25584	_	_
166	13	exposed	expose	VBN	4	acl:relcl	25585	25592	_	_
166	14	to	to	TO	15	case	25593	25595	_	_
166	15	measles	measles	NNS	13	nmod	25596	25603	_	_
166	16	may	may	MD	18	aux	25604	25607	_	_
166	17	be	be	VB	18	auxpass	25608	25610	_	_
166	18	protected	protect	VBN	0	ROOT	25611	25620	_	_
166	19	from	from	IN	21	case	25621	25625	_	_
166	20	measles	measles	NNS	21	compound	25626	25633	_	_
166	21	disease	disease	NN	18	nmod	25634	25641	_	_
166	22	if	if	IN	25	mark	25642	25644	_	_
166	23	they	they	PRP	25	nsubjpass	25645	25649	B-persongroup-110119	_
166	24	are	be	VBP	25	auxpass	25650	25653	_	_
166	25	given	give	VBN	18	advcl	25654	25659	_	_
166	26	MMR	MMR	NNP	27	compound	25660	25663	_	_
166	27	vaccine	vaccine	NN	25	dobj	25664	25671	_	_
166	28	within	within	IN	30	case	25672	25678	_	_
166	29	72	72	CD	30	nummod	25679	25681	_	_
166	30	hours	hour	NNS	25	nmod	25682	25687	_	_
166	31	of	of	IN	33	case	25688	25690	_	_
166	32	their	they	PRP$	33	nmod:poss	25691	25696	_	_
166	33	exposure	exposure	NN	30	nmod	25697	25705	_	_
166	34	.	.	.	18	punct	25705	25706	_	_

167	1	MMR	mmr	NN	2	compound	25707	25710	_	_
167	2	vaccine	vaccine	NN	5	nsubjpass	25711	25718	_	_
167	3	may	may	MD	5	aux	25719	25722	_	_
167	4	be	be	VB	5	auxpass	25723	25725	_	_
167	5	recommended	recommend	VBN	0	ROOT	25726	25737	_	_
167	6	for	for	IN	7	case	25738	25741	_	_
167	7	children	child	NNS	5	nmod	25742	25750	B-persongroup-110120	_
167	8	between	between	IN	10	case	25751	25758	_	_
167	9	6	6	CD	10	nummod	25759	25760	_	_
167	10	months	month	NNS	7	nmod	25761	25767	_	_
167	11	to	to	TO	15	case	25768	25770	_	_
167	12	less	less	JJR	14	advmod	25771	25775	_	_
167	13	than	than	IN	12	mwe	25776	25780	_	_
167	14	12	12	CD	15	nummod	25781	25783	_	_
167	15	months	month	NNS	5	nmod	25784	25790	_	_
167	16	of	of	IN	17	case	25791	25793	_	_
167	17	age	age	NN	15	nmod	25794	25797	_	_
167	18	for	for	IN	20	case	25798	25801	_	_
167	19	post-exposure	post-exposure	JJ	20	amod	25802	25815	_	_
167	20	management	management	NN	17	nmod	25816	25826	_	_
167	21	if	if	IN	24	mark	25827	25829	_	_
167	22	it	it	PRP	24	nsubjpass	25830	25832	_	_
167	23	is	be	VBZ	24	auxpass	25833	25835	_	_
167	24	given	give	VBN	5	advcl	25836	25841	_	_
167	25	within	within	IN	27	case	25842	25848	_	_
167	26	72	72	CD	27	nummod	25849	25851	_	_
167	27	hours	hour	NNS	24	nmod	25852	25857	_	_
167	28	of	of	IN	29	case	25858	25860	_	_
167	29	exposure	exposure	NN	27	nmod	25861	25869	_	_
167	30	;	;	:	5	punct	25869	25870	_	_
167	31	however	however	RB	41	advmod	25871	25878	_	_
167	32	,	,	,	41	punct	25878	25879	_	_
167	33	two	two	CD	35	nummod	25880	25883	_	_
167	34	additional	additional	JJ	35	amod	25884	25894	_	_
167	35	doses	dose	NNS	41	nsubjpass	25895	25900	_	_
167	36	of	of	IN	38	case	25901	25903	_	_
167	37	measles-containing	measles-containing	JJ	38	amod	25904	25922	_	_
167	38	vaccine	vaccine	NN	35	nmod	25923	25930	_	_
167	39	must	must	MD	41	aux	25931	25935	_	_
167	40	be	be	VB	41	auxpass	25936	25938	_	_
167	41	administered	administer	VBN	5	parataxis	25939	25951	_	_
167	42	after	after	IN	49	mark	25952	25957	_	_
167	43	the	the	DT	44	det	25958	25961	B-persongroup-110121	_
167	44	child	child	NN	49	nsubj	25962	25967	I-persongroup-110121	_
167	45	is	be	VBZ	49	cop	25968	25970	_	_
167	46	12	12	CD	47	nummod	25971	25973	_	_
167	47	months	month	NNS	48	nmod:npmod	25974	25980	_	_
167	48	old	old	JJ	49	amod	25981	25984	_	_
167	49	(	(	NN	41	advcl	25985	25986	_	_
167	50	and	and	CC	49	cc	25986	25989	_	_
167	51	at	at	IN	52	case	25990	25992	_	_
167	52	least	least	JJS	49	advmod	25993	25998	_	_
167	53	28	28	CD	54	nummod	25999	26001	_	_
167	54	days	day	NNS	49	conj	26002	26006	_	_
167	55	from	from	IN	59	case	26007	26011	_	_
167	56	the	the	DT	59	det	26012	26015	_	_
167	57	previous	previous	JJ	59	amod	26016	26024	_	_
167	58	dose	dose	NN	59	compound	26025	26029	_	_
167	59	)	)	NN	54	nmod	26029	26030	_	_
167	60	to	to	TO	61	mark	26031	26033	_	_
167	61	ensure	ensure	VB	54	acl	26034	26040	_	_
167	62	long	long	JJ	64	amod	26041	26045	_	_
167	63	lasting	lasting	JJ	64	amod	26046	26053	_	_
167	64	immunity	immunity	NN	61	dobj	26054	26062	_	_
167	65	to	to	TO	66	case	26063	26065	_	_
167	66	measles	measles	NNS	61	nmod	26066	26073	_	_
167	67	.	.	.	5	punct	26073	26074	_	_

168	1	Prophylactic	prophylactic	JJ	2	amod	26077	26089	_	_
168	2	use	use	NN	7	nsubjpass	26090	26093	_	_
168	3	of	of	IN	4	case	26094	26096	_	_
168	4	Ig	ig	NN	2	nmod	26097	26099	_	_
168	5	has	have	VBZ	7	aux	26100	26103	_	_
168	6	been	be	VBN	7	auxpass	26104	26108	_	_
168	7	shown	show	VBN	0	ROOT	26109	26114	_	_
168	8	to	to	TO	10	mark	26115	26117	_	_
168	9	be	be	VB	10	cop	26118	26120	_	_
168	10	effective	effective	JJ	7	xcomp	26121	26130	_	_
168	11	in	in	IN	12	mark	26131	26133	_	_
168	12	modifying	modify	VBG	10	advcl	26134	26143	_	_
168	13	or	or	CC	12	cc	26144	26146	_	_
168	14	preventing	prevent	VBG	12	conj	26147	26157	_	_
168	15	disease	disease	NN	12	dobj	26158	26165	_	_
168	16	if	if	IN	31	mark	26166	26168	_	_
168	17	administered	administer	VBN	31	advcl	26169	26181	_	_
168	18	within	within	IN	20	case	26182	26188	_	_
168	19	6	6	CD	20	nummod	26189	26190	_	_
168	20	days	day	NNS	17	nmod	26191	26195	_	_
168	21	after	after	IN	22	case	26196	26201	_	_
168	22	exposure	exposure	NN	20	nmod	26202	26210	_	_
168	23	to	to	TO	24	case	26211	26213	_	_
168	24	measles	measles	NNS	17	nmod	26214	26221	_	_
168	25	,	,	,	17	punct	26221	26222	_	_
168	26	however	however	RB	17	advmod	26223	26230	_	_
168	27	,	,	,	31	punct	26230	26231	_	_
168	28	it	it	PRP	31	nsubjpass	26232	26234	_	_
168	29	should	should	MD	31	aux	26235	26241	_	_
168	30	be	be	VB	31	auxpass	26242	26244	_	_
168	31	given	give	VBN	10	advcl	26245	26250	_	_
168	32	as	as	RB	33	advmod	26251	26253	_	_
168	33	soon	soon	RB	31	advmod	26254	26258	_	_
168	34	as	as	IN	35	case	26259	26261	_	_
168	35	possible	possible	JJ	33	advcl	26262	26270	_	_
168	36	after	after	IN	37	case	26271	26276	_	_
168	37	exposure	exposure	NN	31	nmod	26277	26285	_	_
168	38	when	when	WRB	39	advmod	26286	26290	_	_
168	39	indicated	indicate	VBN	31	advcl	26291	26300	_	_
168	40	.	.	.	7	punct	26300	26301	_	_

169	1	Ig	ig	NN	4	nsubjpass	26302	26304	_	_
169	2	should	should	MD	4	aux	26305	26311	_	_
169	3	be	be	VB	4	auxpass	26312	26314	_	_
169	4	considered	consider	VBN	0	ROOT	26315	26325	_	_
169	5	for	for	IN	6	case	26326	26329	_	_
169	6	contacts	contact	NNS	4	nmod	26330	26338	B-persongroup-110122	_
169	7	of	of	IN	8	case	26339	26341	_	_
169	8	measles	measles	NNS	6	nmod	26342	26349	_	_
169	9	who	who	WP	13	nsubj	26350	26353	_	_
169	10	are	be	VBP	13	cop	26354	26357	_	_
169	11	:	:	:	13	punct	26357	26358	_	_
169	12	Measles-containing	measles-containing	JJ	13	amod	26360	26378	_	_
169	13	vaccine	vaccine	NN	8	acl:relcl	26379	26386	_	_
169	14	is	be	VBZ	15	auxpass	26387	26389	_	_
169	15	contraindicated	contraindicate	VBN	13	acl:relcl	26390	26405	_	_
169	16	in	in	IN	17	case	26406	26408	_	_
169	17	groups	group	NNS	15	nmod	26409	26415	_	_
169	18	1	1	CD	17	nummod	26416	26417	_	_
169	19	and	and	CC	17	cc	26418	26421	_	_
169	20	2	2	CD	17	conj	26422	26423	_	_
169	21	and	and	CC	4	cc	26424	26427	_	_
169	22	effectiveness	effectiveness	NN	28	nsubjpass	26428	26441	_	_
169	23	and	and	CC	22	cc	26442	26445	_	_
169	24	safety	safety	NN	22	conj	26446	26452	_	_
169	25	has	have	VBZ	28	aux	26453	26456	_	_
169	26	not	not	RB	28	neg	26457	26460	_	_
169	27	been	be	VBN	28	auxpass	26461	26465	_	_
169	28	established	establish	VBN	4	conj	26466	26477	_	_
169	29	in	in	IN	30	case	26478	26480	_	_
169	30	group	group	NN	28	nmod	26481	26486	_	_
169	31	3	3	CD	30	nummod	26487	26488	_	_
169	32	.	.	.	4	punct	26488	26489	_	_

170	1	Ig	ig	NN	5	nsubjpass	26490	26492	_	_
170	2	should	should	MD	5	aux	26493	26499	_	_
170	3	also	also	RB	5	advmod	26500	26504	_	_
170	4	be	be	VB	5	auxpass	26505	26507	_	_
170	5	considered	consider	VBN	0	ROOT	26508	26518	_	_
170	6	for	for	IN	9	case	26519	26522	_	_
170	7	susceptible	susceptible	JJ	8	amod	26523	26534	B-persongroup-110123	_
170	8	immunocompetent	immunocompetent	JJ	9	amod	26535	26550	I-persongroup-110123	_
170	9	contacts	contact	NNS	5	nmod	26551	26559	I-persongroup-110123	_
170	10	of	of	IN	11	case	26560	26562	_	_
170	11	measles	measles	NNS	9	nmod	26563	26570	_	_
170	12	who	who	WP	15	nsubj	26571	26574	_	_
170	13	are	be	VBP	15	cop	26575	26578	_	_
170	14	6	6	CD	15	nummod	26579	26580	_	_
170	15	months	month	NNS	11	acl:relcl	26581	26587	_	_
170	16	of	of	IN	17	case	26588	26590	_	_
170	17	age	age	NN	15	nmod	26591	26594	_	_
170	18	and	and	CC	17	cc	26595	26598	_	_
170	19	older	older	JJR	17	conj	26599	26604	_	_
170	20	and	and	CC	15	cc	26605	26608	_	_
170	21	who	who	WP	22	nsubj	26609	26612	_	_
170	22	present	present	VBP	15	conj	26613	26620	_	_
170	23	more	more	JJR	25	advmod	26621	26625	_	_
170	24	than	than	IN	23	mwe	26626	26630	_	_
170	25	72	72	CD	26	nummod	26631	26633	_	_
170	26	hours	hour	NNS	22	dobj	26634	26639	_	_
170	27	after	after	IN	28	case	26640	26645	_	_
170	28	exposure	exposure	NN	22	nmod	26646	26654	_	_
170	29	(	(	CD	28	nummod	26655	26656	_	_
170	30	when	when	WRB	35	advmod	26656	26660	_	_
170	31	MMR	mmr	NN	32	compound	26661	26664	_	_
170	32	vaccine	vaccine	NN	35	nsubj	26665	26672	_	_
170	33	no	no	RB	34	neg	26673	26675	_	_
170	34	longer	longer	RB	35	advmod	26676	26682	_	_
170	35	provides	provide	VBZ	15	advcl	26683	26691	_	_
170	36	post-exposure	post-exposure	JJ	38	amod	26692	26705	_	_
170	37	protection	protection	NN	38	compound	26706	26716	_	_
170	38	)	)	NN	35	dobj	26716	26717	_	_
170	39	but	but	CC	42	cc	26718	26721	_	_
170	40	within	within	IN	42	case	26722	26728	_	_
170	41	6	6	CD	42	nummod	26729	26730	_	_
170	42	days	day	NNS	35	nmod	26731	26735	_	_
170	43	after	after	IN	44	case	26736	26741	_	_
170	44	exposure	exposure	NN	42	nmod	26742	26750	_	_
170	45	(	(	CD	44	nummod	26751	26752	_	_
170	46	when	when	WRB	50	advmod	26752	26756	_	_
170	47	Ig	ig	NN	50	nsubj	26757	26759	_	_
170	48	may	may	MD	50	aux	26760	26763	_	_
170	49	still	still	RB	50	advmod	26764	26769	_	_
170	50	provide	provide	VB	35	advcl	26770	26777	_	_
170	51	post-exposure	post-exposure	JJ	53	amod	26778	26791	_	_
170	52	protection	protection	NN	53	compound	26792	26802	_	_
170	53	)	)	NN	50	dobj	26802	26803	_	_
170	54	.	.	.	5	punct	26803	26804	_	_

171	1	In	in	IN	4	case	26807	26809	_	_
171	2	HIV	hiv	NN	4	compound	26810	26813	B-persongroup-110124	_
171	3	infected	infected	JJ	4	amod	26814	26822	I-persongroup-110124	_
171	4	individuals	individual	NNS	10	nmod	26823	26834	I-persongroup-110124	_
171	5	,	,	,	10	punct	26834	26835	I-persongroup-110124	_
171	6	measles	measles	NNS	10	nsubjpass	26836	26843	_	_
171	7	antibody	antibody	NN	8	compound	26844	26852	_	_
171	8	titre	titre	NN	6	dep	26853	26858	_	_
171	9	is	be	VBZ	10	auxpass	26859	26861	_	_
171	10	known	know	VBN	0	ROOT	26862	26867	_	_
171	11	to	to	TO	12	mark	26868	26870	_	_
171	12	decline	decline	VB	10	xcomp	26871	26878	_	_
171	13	more	more	RBR	14	advmod	26879	26883	_	_
171	14	rapidly	rapidly	RB	12	advmod	26884	26891	_	_
171	15	over	over	IN	16	case	26892	26896	_	_
171	16	time	time	NN	14	nmod	26897	26901	_	_
171	17	as	as	IN	16	amod	26902	26904	_	_
171	18	compared	compare	VBN	20	case	26905	26913	_	_
171	19	to	to	TO	20	case	26914	26916	_	_
171	20	those	those	DT	12	advcl	26917	26922	B-persongroup-110125	_
171	21	who	who	WP	23	nsubj	26923	26926	_	_
171	22	are	be	VBP	23	cop	26927	26930	_	_
171	23	HIV	hiv	NN	20	acl:relcl	26931	26934	_	_
171	24	uninfected	uninfected	JJ	23	amod	26935	26945	_	_
171	25	.	.	.	10	punct	26945	26946	_	_

172	1	A	a	DT	2	det	26947	26948	_	_
172	2	dose	dose	NN	7	nsubjpass	26949	26953	_	_
172	3	of	of	IN	4	case	26954	26956	_	_
172	4	Ig	ig	NN	2	nmod	26957	26959	_	_
172	5	should	should	MD	7	aux	26960	26966	_	_
172	6	be	be	VB	7	auxpass	26967	26969	_	_
172	7	considered	consider	VBN	0	ROOT	26970	26980	_	_
172	8	in	in	IN	11	case	26981	26983	_	_
172	9	HIV	hiv	NN	11	compound	26984	26987	B-persongroup-110126	_
172	10	infected	infected	JJ	11	amod	26988	26996	I-persongroup-110126	_
172	11	individuals	individual	NNS	7	nmod	26997	27008	I-persongroup-110126	_
172	12	with	with	IN	14	case	27009	27013	_	_
172	13	severe	severe	JJ	14	amod	27014	27020	_	_
172	14	immunosuppression	immunosuppression	NN	11	nmod	27021	27038	_	_
172	15	after	after	IN	18	case	27039	27044	_	_
172	16	a	a	DT	18	det	27045	27046	_	_
172	17	known	known	JJ	18	amod	27047	27052	_	_
172	18	exposure	exposure	NN	7	nmod	27053	27061	_	_
172	19	to	to	TO	20	mark	27062	27064	_	_
172	20	confirmed	confirm	VBN	7	xcomp	27065	27074	_	_
172	21	measles	measles	NNS	20	dobj	27075	27082	_	_
172	22	,	,	,	7	punct	27082	27083	_	_
172	23	even	even	RB	28	advmod	27084	27088	_	_
172	24	with	with	IN	28	case	27089	27093	_	_
172	25	documented	document	VBN	28	amod	27094	27104	_	_
172	26	previous	previous	JJ	28	amod	27105	27113	_	_
172	27	MMR	mmr	NN	28	compound	27114	27117	_	_
172	28	immunization	immunization	NN	7	nmod	27118	27130	_	_
172	29	.	.	.	7	punct	27130	27131	_	_

173	1	Regardless	regardless	RB	5	advmod	27132	27142	_	_
173	2	of	of	IN	4	case	27143	27145	_	_
173	3	vaccination	vaccination	NN	4	compound	27146	27157	_	_
173	4	status	status	NN	1	nmod	27158	27164	_	_
173	5	pre-transplant	pre-transplant	JJ	11	ccomp	27165	27179	_	_
173	6	,	,	,	11	punct	27179	27180	_	_
173	7	Ig	ig	NN	11	nsubjpass	27181	27183	_	_
173	8	should	should	MD	11	aux	27184	27190	_	_
173	9	also	also	RB	11	advmod	27191	27195	_	_
173	10	be	be	VB	11	auxpass	27196	27198	_	_
173	11	considered	consider	VBN	0	ROOT	27199	27209	_	_
173	12	for	for	IN	16	case	27210	27213	_	_
173	13	hematopoietic	hematopoietic	JJ	16	amod	27214	27227	B-persongroup-110127	_
173	14	stem	stem	NN	16	compound	27228	27232	I-persongroup-110127	_
173	15	cell	cell	NN	16	compound	27233	27237	I-persongroup-110127	_
173	16	transplantation	transplantation	NN	11	nmod	27238	27253	I-persongroup-110127	_
173	17	(	(	CD	20	nummod	27254	27255	I-persongroup-110127	_
173	18	HSCT	hsct	NN	20	compound	27255	27259	I-persongroup-110127	_
173	19	)	)	NN	20	compound	27259	27260	I-persongroup-110127	_
173	20	recipients	recipient	NNS	11	nmod:tmod	27261	27271	I-persongroup-110127	_
173	21	,	,	,	20	punct	27271	27272	I-persongroup-110127	_
173	22	unless	unless	IN	23	mark	27273	27279	_	_
173	23	vaccinated	vaccinate	VBN	20	dep	27280	27290	_	_
173	24	post	post	NN	25	compound	27291	27295	_	_
173	25	HSCT	hsct	NN	23	dobj	27296	27300	_	_
173	26	and	and	CC	23	cc	27301	27304	_	_
173	27	known	know	VBN	23	conj	27305	27310	_	_
173	28	to	to	TO	29	mark	27311	27313	_	_
173	29	have	have	VB	27	xcomp	27314	27318	_	_
173	30	an	a	DT	34	det	27319	27321	_	_
173	31	adequate	adequate	JJ	34	amod	27322	27330	_	_
173	32	measles	measles	NNS	34	compound	27331	27338	_	_
173	33	antibody	antibody	NN	34	compound	27339	27347	_	_
173	34	titre	titre	NN	29	dobj	27348	27353	_	_
173	35	.	.	.	11	punct	27353	27354	_	_

174	1	In	in	IN	2	mark	27356	27358	_	_
174	2	assessing	assess	VBG	21	advcl	27359	27368	_	_
174	3	the	the	DT	4	det	27369	27372	_	_
174	4	extent	extent	NN	2	dobj	27373	27379	_	_
174	5	of	of	IN	7	case	27380	27382	_	_
174	6	measles	measles	NNS	7	compound	27383	27390	_	_
174	7	exposure	exposure	NN	4	nmod	27391	27399	_	_
174	8	and	and	CC	2	cc	27400	27403	_	_
174	9	deciding	decide	VBG	2	conj	27404	27412	_	_
174	10	between	between	IN	12	case	27413	27420	_	_
174	11	MMR	MMR	NNP	12	compound	27421	27424	_	_
174	12	vaccine	vaccine	NN	9	nmod	27425	27432	_	_
174	13	and	and	CC	12	cc	27433	27436	_	_
174	14	Ig	ig	NN	12	conj	27437	27439	_	_
174	15	for	for	IN	17	case	27440	27443	_	_
174	16	post-exposure	post-exposure	JJ	17	amod	27444	27457	_	_
174	17	management	management	NN	12	nmod	27458	27468	_	_
174	18	,	,	,	21	punct	27468	27469	_	_
174	19	it	it	PRP	21	nsubj	27470	27472	_	_
174	20	is	be	VBZ	21	cop	27473	27475	_	_
174	21	important	important	JJ	0	ROOT	27476	27485	_	_
174	22	to	to	TO	23	mark	27486	27488	_	_
174	23	consider	consider	VB	21	xcomp	27489	27497	_	_
174	24	that	that	DT	25	det	27498	27502	_	_
174	25	Ig	ig	NN	27	nsubj	27503	27505	_	_
174	26	only	only	RB	27	advmod	27506	27510	_	_
174	27	provides	provide	VBZ	23	ccomp	27511	27519	_	_
174	28	short-term	short-term	JJ	29	amod	27520	27530	_	_
174	29	protection	protection	NN	27	dobj	27531	27541	_	_
174	30	and	and	CC	27	cc	27542	27545	_	_
174	31	requires	require	VBZ	27	conj	27546	27554	_	_
174	32	postponing	postpone	VBG	31	xcomp	27555	27565	_	_
174	33	the	the	DT	34	det	27566	27569	_	_
174	34	administration	administration	NN	32	dobj	27570	27584	_	_
174	35	of	of	IN	37	case	27585	27587	_	_
174	36	MMR	mmr	NN	37	compound	27588	27591	_	_
174	37	vaccine	vaccine	NN	34	nmod	27592	27599	_	_
174	38	for	for	IN	42	case	27600	27603	_	_
174	39	5	5	CD	41	compound	27604	27605	_	_
174	40	to	to	TO	41	dep	27606	27608	_	_
174	41	6	6	CD	42	nummod	27609	27610	_	_
174	42	months	month	NNS	37	nmod	27611	27617	_	_
174	43	.	.	.	21	punct	27617	27618	_	_

175	1	If	if	IN	9	mark	27619	27621	_	_
175	2	longer	longer	JJR	7	amod	27622	27628	_	_
175	3	-	-	:	2	punct	27628	27629	_	_
175	4	term	term	NN	5	compound	27630	27634	_	_
175	5	protection	protection	NN	2	dep	27635	27645	_	_
175	6	against	against	IN	5	acl	27646	27653	_	_
175	7	measles	measles	NNS	9	nsubjpass	27654	27661	_	_
175	8	is	be	VBZ	9	auxpass	27662	27664	_	_
175	9	required	require	VBN	25	advcl	27665	27673	_	_
175	10	because	because	IN	14	case	27674	27681	_	_
175	11	of	of	IN	10	mwe	27682	27684	_	_
175	12	ongoing	ongoing	JJ	14	amod	27685	27692	_	_
175	13	measles	measles	NNS	14	compound	27693	27700	_	_
175	14	transmission	transmission	NN	9	nmod	27701	27713	_	_
175	15	in	in	IN	17	case	27714	27716	_	_
175	16	the	the	DT	17	det	27717	27720	B-persongroup-110128	_
175	17	community	community	NN	14	nmod	27721	27730	I-persongroup-110128	_
175	18	,	,	,	25	punct	27730	27731	I-persongroup-110128	_
175	19	MMR	mmr	NN	20	compound	27732	27735	_	_
175	20	vaccine	vaccine	NN	25	nsubj	27736	27743	_	_
175	21	may	may	MD	25	aux	27744	27747	_	_
175	22	be	be	VB	25	cop	27748	27750	_	_
175	23	the	the	DT	25	det	27751	27754	_	_
175	24	preferred	preferred	JJ	25	amod	27755	27764	_	_
175	25	choice	choice	NN	0	ROOT	27765	27771	_	_
175	26	.	.	.	25	punct	27771	27772	_	_

176	1	It	it	PRP	3	nsubj	27773	27775	_	_
176	2	is	be	VBZ	3	cop	27776	27778	_	_
176	3	important	important	JJ	0	ROOT	27779	27788	_	_
176	4	to	to	TO	5	mark	27789	27791	_	_
176	5	note	note	VB	3	xcomp	27792	27796	_	_
176	6	that	that	IN	23	mark	27797	27801	_	_
176	7	despite	despite	IN	9	case	27802	27809	_	_
176	8	the	the	DT	9	det	27810	27813	_	_
176	9	use	use	NN	23	nmod	27814	27817	_	_
176	10	of	of	IN	12	case	27818	27820	_	_
176	11	MMR	mmr	NN	12	compound	27821	27824	_	_
176	12	vaccine	vaccine	NN	9	nmod	27825	27832	_	_
176	13	or	or	CC	12	cc	27833	27835	_	_
176	14	Ig	ig	NN	12	conj	27836	27838	_	_
176	15	for	for	IN	17	case	27839	27842	_	_
176	16	post-exposure	post-exposure	JJ	17	amod	27843	27856	_	_
176	17	management	management	NN	9	nmod	27857	27867	_	_
176	18	,	,	,	23	punct	27867	27868	_	_
176	19	measles	measles	NNS	20	compound	27869	27876	_	_
176	20	infection	infection	NN	23	nsubj	27877	27886	_	_
176	21	may	may	MD	23	aux	27887	27890	_	_
176	22	still	still	RB	23	advmod	27891	27896	_	_
176	23	occur	occur	VB	5	ccomp	27897	27902	_	_
176	24	.	.	.	3	punct	27902	27903	_	_

177	1	Exposed	expose	VBN	5	dep	27904	27911	B-persongroup-110129	_
177	2	individuals	individual	NNS	5	nsubjpass	27912	27923	I-persongroup-110129	_
177	3	should	should	MD	5	aux	27924	27930	_	_
177	4	be	be	VB	5	auxpass	27931	27933	_	_
177	5	counseled	counsel	VBN	0	ROOT	27934	27943	_	_
177	6	regarding	regard	VBG	7	case	27944	27953	_	_
177	7	signs	sign	NNS	5	nmod	27954	27959	_	_
177	8	and	and	CC	7	cc	27960	27963	_	_
177	9	symptoms	symptom	NNS	7	conj	27964	27972	_	_
177	10	of	of	IN	11	case	27973	27975	_	_
177	11	measles	measles	NNS	7	nmod	27976	27983	_	_
177	12	;	;	:	5	punct	27983	27984	_	_
177	13	counseling	counseling	NN	15	nsubj	27985	27995	_	_
177	14	should	should	MD	15	aux	27996	28002	_	_
177	15	include	include	VB	5	parataxis	28004	28011	_	_
177	16	avoiding	avoid	VBG	15	xcomp	28012	28020	_	_
177	17	contact	contact	NN	16	dobj	28021	28028	_	_
177	18	with	with	IN	19	case	28029	28033	_	_
177	19	others	other	NNS	16	nmod	28034	28040	B-persongroup-110130	_
177	20	should	should	MD	22	dep	28041	28047	_	_
177	21	they	they	PRP	22	nsubj	28048	28052	B-persongroup-110131	_
177	22	become	become	VB	15	ccomp	28053	28059	_	_
177	23	ill	ill	RB	22	advmod	28060	28063	_	_
177	24	with	with	IN	25	case	28064	28068	_	_
177	25	symptoms	symptom	NNS	22	nmod	28069	28077	_	_
177	26	compatible	compatible	JJ	25	amod	28078	28088	_	_
177	27	with	with	IN	28	case	28089	28093	_	_
177	28	measles	measles	NNS	26	nmod	28094	28101	_	_
177	29	and	and	CC	28	cc	28102	28105	_	_
177	30	the	the	DT	31	det	28106	28109	_	_
177	31	need	need	NN	28	conj	28110	28114	_	_
177	32	to	to	TO	33	mark	28115	28117	_	_
177	33	seek	seek	VB	26	xcomp	28118	28122	_	_
177	34	medical	medical	JJ	35	amod	28123	28130	_	_
177	35	care	care	NN	33	dobj	28131	28135	_	_
177	36	,	,	,	35	punct	28135	28136	_	_
177	37	including	include	VBG	38	case	28137	28146	_	_
177	38	advising	advise	VBG	35	acl	28147	28155	_	_
177	39	health	health	NN	41	compound	28156	28162	B-persongroup-110133	_
177	40	care	care	NN	41	compound	28163	28167	I-persongroup-110133	_
177	41	workers	worker	NNS	38	dobj	28168	28175	I-persongroup-110133	_
177	42	of	of	IN	44	case	28176	28178	_	_
177	43	the	the	DT	44	det	28179	28182	_	_
177	44	possibility	possibility	NN	41	nmod	28183	28194	_	_
177	45	of	of	IN	46	case	28195	28197	_	_
177	46	measles	measles	NNS	44	nmod	28198	28205	_	_
177	47	before	before	IN	48	mark	28206	28212	_	_
177	48	going	go	VBG	38	advcl	28213	28218	_	_
177	49	to	to	TO	52	case	28219	28221	_	_
177	50	a	a	DT	52	det	28222	28223	B-persongroup-110132	_
177	51	health	health	NN	52	compound	28224	28230	I-persongroup-110132	_
177	52	care	care	NN	48	nmod	28231	28235	I-persongroup-110132	_
177	53	setting	set	VBG	52	acl	28236	28243	I-persongroup-110132	_
177	54	so	so	RB	53	advmod	28244	28246	_	_
177	55	that	that	IN	60	mark	28247	28251	_	_
177	56	appropriate	appropriate	JJ	57	amod	28252	28263	_	_
177	57	precautions	precaution	NNS	60	nsubjpass	28264	28275	_	_
177	58	can	can	MD	60	aux	28276	28279	_	_
177	59	be	be	VB	60	auxpass	28280	28282	_	_
177	60	taken	take	VBN	26	ccomp	28283	28288	_	_
177	61	.	.	.	5	punct	28288	28289	_	_

178	1	For	for	IN	10	dep	28290	28293	_	_
178	2	detailed	detailed	JJ	3	amod	28294	28302	_	_
178	3	information	information	NN	10	nsubj	28303	28314	_	_
178	4	regarding	regard	VBG	6	case	28315	28324	_	_
178	5	infection	infection	NN	6	compound	28325	28334	_	_
178	6	prevention	prevention	NN	3	nmod	28335	28345	_	_
178	7	and	and	CC	6	cc	28346	28349	_	_
178	8	control	control	NN	6	conj	28350	28357	_	_
178	9	,	,	,	3	punct	28357	28358	_	_
178	10	refer	refer	VBP	0	ROOT	28359	28364	_	_
178	11	to	to	TO	13	case	28365	28367	_	_
178	12	the	the	DT	13	det	28368	28371	_	_
178	13	Guidelines	guideline	NNS	10	nmod	28372	28382	_	_
178	14	for	for	IN	16	case	28383	28386	_	_
178	15	the	the	DT	16	det	28387	28390	_	_
178	16	Prevention	Prevention	NNP	13	nmod	28391	28401	_	_
178	17	and	and	CC	16	cc	28402	28405	_	_
178	18	Control	Control	NNP	16	conj	28406	28413	_	_
178	19	of	of	IN	21	case	28414	28416	_	_
178	20	Measles	Measles	NNP	21	compound	28417	28424	_	_
178	21	Outbreaks	Outbreaks	NNPS	13	nmod	28425	28434	_	_
178	22	in	in	IN	23	case	28435	28437	_	_
178	23	Canada	Canada	NNP	21	nmod	28438	28444	B-persongroup-110134	_
178	24	.	.	.	10	punct	28444	28445	I-persongroup-110134	_

179	1	The	the	DT	3	det	28447	28450	_	_
179	2	recommended	recommend	VBN	3	amod	28451	28462	_	_
179	3	dose	dose	NN	14	nsubj	28463	28467	_	_
179	4	of	of	IN	5	case	28468	28470	_	_
179	5	Ig	ig	NN	3	nmod	28471	28473	_	_
179	6	for	for	IN	8	case	28474	28477	_	_
179	7	healthy	healthy	JJ	8	amod	28478	28485	_	_
179	8	individuals	individual	NNS	5	nmod	28486	28497	_	_
179	9	exposed	expose	VBN	8	acl	28498	28505	_	_
179	10	to	to	TO	11	case	28506	28508	_	_
179	11	measles	measles	NNS	9	nmod	28509	28516	_	_
179	12	is	be	VBZ	14	cop	28517	28519	_	_
179	13	0.25	0.25	CD	14	nummod	28520	28524	_	_
179	14	mL/kg	ml/kg	NN	0	ROOT	28525	28530	_	_
179	15	of	of	IN	17	case	28531	28533	_	_
179	16	body	body	NN	17	compound	28534	28538	_	_
179	17	weight	weight	NN	14	nmod	28539	28545	_	_
179	18	given	give	VBN	22	case	28546	28551	_	_
179	19	by	by	IN	22	case	28552	28554	_	_
179	20	the	the	DT	22	det	28555	28558	_	_
179	21	IM	im	NN	22	compound	28559	28561	_	_
179	22	route	route	NN	17	nmod	28562	28567	_	_
179	23	.	.	.	14	punct	28567	28568	_	_

180	1	The	the	DT	2	det	28569	28572	_	_
180	2	dose	dose	NN	11	nsubj	28573	28577	_	_
180	3	for	for	IN	5	case	28578	28581	_	_
180	4	exposed	expose	VBN	5	amod	28582	28589	B-persongroup-110135	_
180	5	individuals	individual	NNS	2	nmod	28590	28601	I-persongroup-110135	_
180	6	who	who	WP	8	nsubjpass	28602	28605	_	_
180	7	are	be	VBP	8	auxpass	28606	28609	_	_
180	8	immunocompromised	immunocompromise	VBN	5	acl:relcl	28610	28627	_	_
180	9	is	be	VBZ	11	cop	28628	28630	_	_
180	10	0.5	0.5	CD	11	nummod	28631	28634	_	_
180	11	mL/kg	ml/kg	NN	0	ROOT	28635	28640	_	_
180	12	of	of	IN	14	case	28641	28643	_	_
180	13	body	body	NN	14	compound	28644	28648	_	_
180	14	weight	weight	NN	11	nmod	28649	28655	_	_
180	15	.	.	.	11	punct	28655	28656	_	_

181	1	A	a	DT	3	det	28657	28658	_	_
181	2	maximum	maximum	NN	3	compound	28659	28666	_	_
181	3	dose	dose	NN	10	nsubjpass	28667	28671	_	_
181	4	of	of	IN	6	case	28672	28674	_	_
181	5	15	15	CD	6	nummod	28675	28677	_	_
181	6	mL	ml	NN	3	nmod	28678	28680	_	_
181	7	should	should	MD	10	aux	28681	28687	_	_
181	8	not	not	RB	10	neg	28688	28691	_	_
181	9	be	be	VB	10	auxpass	28692	28694	_	_
181	10	exceeded	exceed	VBN	0	ROOT	28695	28703	_	_
181	11	.	.	.	10	punct	28703	28704	_	_

182	1	For	for	IN	2	case	28705	28708	_	_
182	2	complete	complete	JJ	6	nmod	28709	28717	_	_
182	3	prescribing	prescribe	VBG	2	acl	28718	28729	_	_
182	4	information	information	NN	3	dobj	28730	28741	_	_
182	5	,	,	,	6	punct	28741	28742	_	_
182	6	consult	consult	VB	0	ROOT	28743	28750	_	_
182	7	the	the	DT	9	det	28751	28754	_	_
182	8	product	product	NN	9	compound	28755	28762	_	_
182	9	leaflet	leaflet	NN	12	nsubj	28763	28770	_	_
182	10	or	or	CC	9	cc	28771	28773	_	_
182	11	information	information	NN	9	conj	28774	28785	_	_
182	12	contained	contain	VBD	6	ccomp	28786	28795	_	_
182	13	within	within	IN	16	case	28796	28802	_	_
182	14	the	the	DT	16	det	28803	28806	_	_
182	15	product	product	NN	16	compound	28807	28814	_	_
182	16	monograph	monograph	NN	12	nmod	28815	28824	_	_
182	17	available	available	JJ	12	xcomp	28825	28834	_	_
182	18	through	through	IN	23	case	28835	28842	_	_
182	19	Health	Health	NNP	23	compound	28843	28849	_	_
182	20	Canadaís	Canadaís	NNP	23	compound	28850	28858	_	_
182	21	Drug	Drug	NNP	23	compound	28859	28863	_	_
182	22	Product	Product	NNP	23	compound	28864	28871	_	_
182	23	Database	Database	NNP	12	nmod	28872	28880	_	_
182	24	.	.	.	6	punct	28880	28881	_	_

183	1	Individuals	individual	NNS	15	nsubjpass	28883	28894	B-persongroup-110136	_
183	2	receiving	receive	VBG	1	acl	28895	28904	_	_
183	3	replacement	replacement	NN	5	compound	28905	28916	_	_
183	4	IVIg	ivig	NN	5	compound	28917	28921	_	_
183	5	(	(	NN	7	nsubj	28922	28923	_	_
183	6	400	400	CD	7	nummod	28923	28926	_	_
183	7	mg/kg	mg/kg	NN	2	xcomp	28927	28932	_	_
183	8	of	of	IN	10	case	28933	28935	_	_
183	9	body	body	NN	10	compound	28936	28940	_	_
183	10	weight	weight	NN	7	nmod	28941	28947	_	_
183	11	or	or	CC	10	cc	28948	28950	_	_
183	12	higher	higher	JJR	13	amod	28951	28957	_	_
183	13	)	)	NN	10	conj	28957	28958	_	_
183	14	are	be	VBP	15	auxpass	28959	28962	_	_
183	15	considered	consider	VBN	0	ROOT	28963	28973	_	_
183	16	protected	protected	JJ	15	ccomp	28974	28983	_	_
183	17	and	and	CC	15	cc	28984	28987	_	_
183	18	do	do	VBP	20	aux	28988	28990	_	_
183	19	not	not	RB	20	neg	28991	28994	_	_
183	20	require	require	VB	15	conj	28995	29002	_	_
183	21	Ig	ig	NN	20	dobj	29003	29005	_	_
183	22	if	if	IN	29	mark	29006	29008	_	_
183	23	the	the	DT	25	det	29009	29012	_	_
183	24	last	last	JJ	25	amod	29013	29017	_	_
183	25	dose	dose	NN	29	nsubjpass	29018	29022	_	_
183	26	of	of	IN	27	case	29023	29025	_	_
183	27	IVIg	ivig	NN	25	nmod	29026	29030	_	_
183	28	was	be	VBD	29	auxpass	29031	29034	_	_
183	29	received	receive	VBN	20	advcl	29035	29043	_	_
183	30	within	within	IN	33	case	29044	29050	_	_
183	31	the	the	DT	33	det	29051	29054	_	_
183	32	three	three	CD	33	nummod	29055	29060	_	_
183	33	weeks	week	NNS	29	nmod	29061	29066	_	_
183	34	prior	prior	RB	37	advmod	29067	29072	_	_
183	35	to	to	TO	37	case	29073	29075	_	_
183	36	measles	measles	NNS	37	compound	29076	29083	_	_
183	37	exposure	exposure	NN	29	advcl	29084	29092	_	_
183	38	.	.	.	15	punct	29092	29093	_	_

184	1	Unless	unless	IN	4	mark	29094	29100	_	_
184	2	it	it	PRP	4	nsubjpass	29101	29103	_	_
184	3	is	be	VBZ	4	auxpass	29104	29106	_	_
184	4	contraindicated	contraindicate	VBN	25	advcl	29107	29122	_	_
184	5	,	,	,	25	punct	29122	29123	_	_
184	6	individuals	individual	NNS	25	nsubj	29124	29135	B-persongroup-110137	_
184	7	who	who	WP	8	nsubj	29136	29139	_	_
184	8	receive	receive	VBP	6	acl:relcl	29140	29147	_	_
184	9	Ig	ig	NN	11	nsubj	29148	29150	_	_
184	10	should	should	MD	11	aux	29151	29157	_	_
184	11	receive	receive	VB	8	ccomp	29158	29165	_	_
184	12	measles-containing	measles-containing	JJ	13	amod	29166	29184	_	_
184	13	vaccine	vaccine	NN	11	dobj	29185	29192	_	_
184	14	after	after	IN	16	case	29193	29198	_	_
184	15	specified	specify	VBN	16	amod	29199	29208	_	_
184	16	intervals	interval	NNS	13	nmod	29209	29218	_	_
184	17	,	,	,	13	punct	29218	29219	_	_
184	18	once	once	RB	21	advmod	29220	29224	_	_
184	19	the	the	DT	21	det	29225	29228	_	_
184	20	measles	measles	NNS	21	compound	29229	29236	_	_
184	21	antibodies	antibody	NNS	13	appos	29237	29247	_	_
184	22	administered	administer	VBN	21	acl	29248	29260	_	_
184	23	passively	passively	RB	22	advmod	29261	29270	_	_
184	24	have	have	VBP	25	aux	29271	29275	_	_
184	25	degraded	degrade	VBN	0	ROOT	29276	29284	_	_
184	26	.	.	.	25	punct	29284	29285	_	_

185	1	For	for	IN	2	case	29286	29289	_	_
185	2	recommendations	recommendation	NNS	21	nmod	29290	29305	_	_
185	3	on	on	IN	5	case	29306	29308	_	_
185	4	the	the	DT	5	det	29309	29312	_	_
185	5	interval	interval	NN	21	nmod	29313	29321	_	_
185	6	between	between	IN	7	case	29322	29329	_	_
185	7	administration	administration	NN	5	nmod	29330	29344	_	_
185	8	of	of	IN	11	case	29345	29347	_	_
185	9	an	a	DT	11	det	29348	29350	_	_
185	10	Ig	ig	NN	11	compound	29351	29353	_	_
185	11	preparation	preparation	NN	7	nmod	29354	29365	_	_
185	12	or	or	CC	11	cc	29366	29368	_	_
185	13	blood	blood	NN	14	compound	29369	29374	_	_
185	14	product	product	NN	11	conj	29375	29382	_	_
185	15	and	and	CC	7	cc	29383	29386	_	_
185	16	vaccination	vaccination	NN	7	conj	29387	29398	_	_
185	17	with	with	IN	19	case	29399	29403	_	_
185	18	measles-containing	measles-containing	JJ	19	amod	29404	29422	_	_
185	19	vaccine	vaccine	NN	16	nmod	29423	29430	_	_
185	20	,	,	,	21	punct	29430	29431	_	_
185	21	refer	refer	VBP	0	ROOT	29432	29437	_	_
185	22	to	to	TO	24	case	29438	29440	_	_
185	23	Blood	Blood	NNP	24	compound	29441	29446	_	_
185	24	Products	Products	NNPS	21	nmod	29447	29455	_	_
185	25	,	,	,	24	punct	29455	29456	_	_
185	26	Human	human	JJ	28	amod	29457	29462	_	_
185	27	Immune	immune	JJ	28	amod	29463	29469	_	_
185	28	Globulin	globulin	NN	24	conj	29470	29478	_	_
185	29	and	and	CC	24	cc	29479	29482	_	_
185	30	Timing	timing	NN	24	conj	29483	29489	_	_
185	31	of	of	IN	32	case	29490	29492	_	_
185	32	Immunization	immunization	NN	30	nmod	29493	29505	_	_
185	33	in	in	IN	34	case	29506	29508	_	_
185	34	Part	Part	NNP	21	nmod	29509	29513	_	_
185	35	1	1	CD	34	nummod	29514	29515	_	_
185	36	.	.	.	21	punct	29515	29516	_	_

186	1	Refer	refer	VB	0	ROOT	29518	29523	_	_
186	2	to	to	TO	5	case	29524	29526	_	_
186	3	Passive	passive	JJ	5	amod	29527	29534	_	_
186	4	Immunizing	immunizing	JJ	5	amod	29535	29545	_	_
186	5	Agents	agent	NNS	1	nmod	29546	29552	_	_
186	6	in	in	IN	7	case	29553	29555	_	_
186	7	Part	Part	NNP	5	nmod	29556	29560	_	_
186	8	5	5	CD	7	nummod	29561	29562	_	_
186	9	for	for	IN	12	case	29563	29566	_	_
186	10	additional	additional	JJ	12	amod	29567	29577	_	_
186	11	general	general	JJ	12	amod	29578	29585	_	_
186	12	information	information	NN	1	nmod	29586	29597	_	_
186	13	.	.	.	1	punct	29597	29598	_	_

187	1	Immunization	immunization	NN	8	nsubj	29600	29612	_	_
187	2	with	with	IN	4	case	29613	29617	_	_
187	3	MMR	mmr	NN	4	compound	29618	29621	_	_
187	4	vaccine	vaccine	NN	1	nmod	29622	29629	_	_
187	5	is	be	VBZ	8	cop	29630	29632	_	_
187	6	an	a	DT	8	det	29633	29635	_	_
187	7	integral	integral	JJ	8	amod	29636	29644	_	_
187	8	element	element	NN	0	ROOT	29645	29652	_	_
187	9	of	of	IN	14	case	29653	29655	_	_
187	10	a	a	DT	14	det	29656	29657	_	_
187	11	comprehensive	comprehensive	JJ	14	amod	29658	29671	_	_
187	12	measles	measles	NNS	14	compound	29672	29679	_	_
187	13	outbreak	outbreak	NN	14	compound	29680	29688	_	_
187	14	prevention	prevention	NN	8	nmod	29689	29699	_	_
187	15	and	and	CC	14	cc	29700	29703	_	_
187	16	management	management	NN	17	compound	29704	29714	_	_
187	17	strategy	strategy	NN	14	conj	29715	29723	_	_
187	18	.	.	.	8	punct	29723	29724	_	_

188	1	In	in	IN	4	case	29725	29727	_	_
188	2	a	a	DT	4	det	29728	29729	_	_
188	3	measles	measles	NNS	4	compound	29730	29737	_	_
188	4	outbreak	outbreak	NN	10	nmod	29738	29746	_	_
188	5	,	,	,	10	punct	29746	29747	_	_
188	6	MMR	mmr	NN	7	compound	29748	29751	_	_
188	7	vaccine	vaccine	NN	10	nsubjpass	29752	29759	_	_
188	8	can	can	MD	10	aux	29760	29763	_	_
188	9	be	be	VB	10	auxpass	29764	29766	_	_
188	10	provided	provide	VBN	0	ROOT	29767	29775	_	_
188	11	at	at	IN	13	case	29776	29778	_	_
188	12	any	any	DT	13	det	29779	29782	_	_
188	13	time	time	NN	10	nmod	29783	29787	_	_
188	14	starting	start	VBG	17	case	29788	29796	_	_
188	15	from	from	IN	17	case	29797	29801	_	_
188	16	6	6	CD	17	nummod	29802	29803	_	_
188	17	months	month	NNS	10	advcl	29804	29810	_	_
188	18	of	of	IN	19	case	29811	29813	_	_
188	19	age	age	NN	17	nmod	29814	29817	_	_
188	20	.	.	.	10	punct	29817	29818	_	_

189	1	However	however	RB	23	advmod	29819	29826	_	_
189	2	if	if	IN	23	mark	29827	29829	_	_
189	3	given	give	VBN	6	case	29830	29835	_	_
189	4	between	between	IN	6	case	29836	29843	_	_
189	5	6	6	CD	6	nummod	29844	29845	_	_
189	6	months	month	NNS	23	advcl	29846	29852	_	_
189	7	and	and	CC	6	cc	29853	29856	_	_
189	8	less	less	JJR	10	advmod	29857	29861	_	_
189	9	than	than	IN	8	mwe	29862	29866	_	_
189	10	12	12	CD	11	nummod	29867	29869	_	_
189	11	months	month	NNS	6	conj	29870	29876	_	_
189	12	of	of	IN	13	case	29877	29879	_	_
189	13	age	age	NN	11	nmod	29880	29883	_	_
189	14	,	,	,	23	punct	29883	29884	_	_
189	15	two	two	CD	17	nummod	29885	29888	_	_
189	16	additional	additional	JJ	17	amod	29889	29899	_	_
189	17	doses	dose	NNS	23	nsubjpass	29900	29905	_	_
189	18	of	of	IN	20	case	29906	29908	_	_
189	19	measles-containing	measles-containing	JJ	20	amod	29909	29927	_	_
189	20	vaccine	vaccine	NN	17	nmod	29928	29935	_	_
189	21	must	must	MD	23	aux	29936	29940	_	_
189	22	be	be	VB	23	auxpass	29941	29943	_	_
189	23	administered	administer	VBN	31	csubj	29944	29956	_	_
189	24	after	after	IN	26	case	29957	29962	_	_
189	25	the	the	DT	26	det	29963	29966	B-persongroup-110138	_
189	26	child	child	NN	23	nmod	29967	29972	I-persongroup-110138	_
189	27	is	be	VBZ	31	cop	29973	29975	_	_
189	28	12	12	CD	29	nummod	29976	29978	_	_
189	29	months	month	NNS	30	nmod:npmod	29979	29985	_	_
189	30	old	old	JJ	31	amod	29986	29989	_	_
189	31	(	(	NN	0	ROOT	29990	29991	_	_
189	32	and	and	CC	31	cc	29991	29994	_	_
189	33	at	at	IN	34	case	29995	29997	_	_
189	34	least	least	JJS	31	advmod	29998	30003	_	_
189	35	28	28	CD	36	nummod	30004	30006	_	_
189	36	days	day	NNS	31	conj	30007	30011	_	_
189	37	from	from	IN	41	case	30012	30016	_	_
189	38	the	the	DT	41	det	30017	30020	_	_
189	39	previous	previous	JJ	41	amod	30021	30029	_	_
189	40	dose	dose	NN	41	compound	30030	30034	_	_
189	41	)	)	NN	36	nmod	30034	30035	_	_
189	42	to	to	TO	43	mark	30036	30038	_	_
189	43	ensure	ensure	VB	36	acl	30039	30045	_	_
189	44	long	long	JJ	46	amod	30046	30050	_	_
189	45	lasting	lasting	JJ	46	amod	30051	30058	_	_
189	46	immunity	immunity	NN	43	dobj	30059	30067	_	_
189	47	to	to	TO	48	case	30068	30070	_	_
189	48	measles	measles	NNS	43	nmod	30071	30078	_	_
189	49	.	.	.	31	punct	30078	30079	_	_

190	1	For	for	IN	3	case	30080	30083	_	_
190	2	detailed	detailed	JJ	3	amod	30084	30092	_	_
190	3	information	information	NN	8	nmod	30093	30104	_	_
190	4	on	on	IN	6	case	30105	30107	_	_
190	5	outbreak	outbreak	NN	6	compound	30108	30116	_	_
190	6	control	control	NN	8	nmod	30117	30124	_	_
190	7	,	,	,	8	punct	30124	30125	_	_
190	8	refer	refer	VBP	0	ROOT	30126	30131	_	_
190	9	to	to	TO	11	case	30132	30134	_	_
190	10	the	the	DT	11	det	30135	30138	_	_
190	11	Guidelines	guideline	NNS	8	nmod	30139	30149	_	_
190	12	for	for	IN	14	case	30150	30153	_	_
190	13	the	the	DT	14	det	30154	30157	_	_
190	14	Prevention	Prevention	NNP	11	nmod	30158	30168	_	_
190	15	and	and	CC	14	cc	30169	30172	_	_
190	16	Control	Control	NNP	14	conj	30173	30180	_	_
190	17	of	of	IN	19	case	30181	30183	_	_
190	18	Measles	Measles	NNP	19	compound	30184	30191	_	_
190	19	Outbreaks	Outbreaks	NNPS	11	nmod	30192	30201	_	_
190	20	in	in	IN	21	case	30202	30204	_	_
190	21	Canada	Canada	NNP	19	nmod	30205	30211	B-persongroup-110139	_
190	22	.	.	.	8	punct	30211	30212	I-persongroup-110139	_

191	1	Dose	dose	NN	6	nsubj	30213	30217	_	_
191	2	Each	each	DT	3	det	30219	30223	_	_
191	3	dose	dose	NN	1	dep	30225	30229	_	_
191	4	is	be	VBZ	6	cop	30230	30232	_	_
191	5	0.5	0.5	CD	6	nummod	30233	30236	_	_
191	6	mL	ml	NN	0	ROOT	30237	30239	_	_
191	7	.	.	.	6	punct	30239	30240	_	_

192	1	Route	route	NN	8	nsubjpass	30242	30247	_	_
192	2	of	of	IN	5	case	30248	30250	_	_
192	3	administration	administration	NN	5	compound	30251	30265	_	_
192	4	MMR	mmr	NN	5	compound	30267	30270	_	_
192	5	vaccine	vaccine	NN	1	nmod	30271	30278	_	_
192	6	should	should	MD	8	aux	30279	30285	_	_
192	7	be	be	VB	8	auxpass	30286	30288	_	_
192	8	administered	administer	VBN	0	ROOT	30289	30301	_	_
192	9	subcutaneously	subcutaneously	RB	8	advmod	30302	30316	_	_
192	10	;	;	:	8	punct	30316	30317	_	_
192	11	MMRV	mmrv	NN	14	nsubjpass	30318	30322	_	_
192	12	can	can	MD	14	aux	30323	30326	_	_
192	13	be	be	VB	14	auxpass	30327	30329	_	_
192	14	administered	administer	VBN	8	parataxis	30330	30342	_	_
192	15	subcutaneously	subcutaneously	RB	16	advmod	30343	30357	_	_
192	16	or	or	CC	14	advmod	30358	30360	_	_
192	17	intramuscularly	intramuscularly	RB	16	advmod	30361	30376	_	_
192	18	.	.	.	8	punct	30376	30377	_	_

193	1	Refer	refer	VB	0	ROOT	30378	30383	_	_
193	2	to	to	TO	5	case	30384	30386	_	_
193	3	Vaccine	Vaccine	NNP	5	compound	30387	30394	_	_
193	4	Administration	Administration	NNP	5	compound	30395	30409	_	_
193	5	Practices	Practices	NNPS	1	nmod	30410	30419	_	_
193	6	in	in	IN	7	case	30420	30422	_	_
193	7	Part	Part	NNP	5	nmod	30423	30427	_	_
193	8	1	1	CD	7	nummod	30428	30429	_	_
193	9	for	for	IN	11	case	30430	30433	_	_
193	10	additional	additional	JJ	11	amod	30434	30444	_	_
193	11	information	information	NN	1	nmod	30445	30456	_	_
193	12	.	.	.	1	punct	30456	30457	_	_

194	1	Children	child	NNS	2	nsubj	30459	30467	B-persongroup-110140	_
194	2	(	(	VBP	0	ROOT	30468	30469	_	_
194	3	12	12	CD	4	nummod	30469	30471	_	_
194	4	months	month	NNS	2	nmod:tmod	30472	30478	_	_
194	5	to	to	TO	7	case	30479	30481	_	_
194	6	12	12	CD	7	nummod	30482	30484	_	_
194	7	years	year	NNS	2	nmod	30485	30490	_	_
194	8	of	of	IN	10	case	30491	30493	_	_
194	9	age	age	NN	10	compound	30494	30497	_	_
194	10	)	)	NN	7	nmod	30497	30498	_	_
194	11	For	for	IN	13	case	30500	30503	_	_
194	12	routine	routine	JJ	13	amod	30504	30511	_	_
194	13	immunization	immunization	NN	10	nmod	30512	30524	_	_
194	14	of	of	IN	15	case	30525	30527	_	_
194	15	children	child	NNS	13	nmod	30528	30536	B-persongroup-110141	_
194	16	aged	aged	JJ	2	advmod	30537	30541	_	_
194	17	12	12	CD	18	nummod	30542	30544	_	_
194	18	months	month	NNS	16	dep	30545	30551	_	_
194	19	to	to	TO	21	case	30552	30554	_	_
194	20	12	12	CD	21	nummod	30555	30557	_	_
194	21	years	year	NNS	16	nmod	30558	30563	_	_
194	22	,	,	,	21	punct	30563	30564	_	_
194	23	two	two	CD	24	nummod	30565	30568	_	_
194	24	doses	dose	NNS	21	appos	30569	30574	_	_
194	25	of	of	IN	27	case	30575	30577	_	_
194	26	measles-containing	measles-containing	JJ	27	amod	30578	30596	_	_
194	27	vaccine	vaccine	NN	24	nmod	30597	30604	_	_
194	28	(	(	CD	29	nummod	30605	30606	_	_
194	29	MMR	mmr	NN	35	nsubjpass	30606	30609	_	_
194	30	or	or	CC	29	cc	30610	30612	_	_
194	31	MMRV	mmrv	NN	32	compound	30613	30617	_	_
194	32	)	)	NN	29	conj	30617	30618	_	_
194	33	should	should	MD	35	aux	30619	30625	_	_
194	34	be	be	VB	35	auxpass	30626	30628	_	_
194	35	administered	administer	VBN	27	acl:relcl	30629	30641	_	_
194	36	.	.	.	2	punct	30641	30642	_	_

195	1	The	the	DT	3	det	30643	30646	_	_
195	2	first	first	JJ	3	amod	30647	30652	_	_
195	3	dose	dose	NN	9	nsubjpass	30653	30657	_	_
195	4	of	of	IN	6	case	30658	30660	_	_
195	5	measles-containing	measles-containing	JJ	6	amod	30661	30679	_	_
195	6	vaccine	vaccine	NN	3	nmod	30680	30687	_	_
195	7	should	should	MD	9	aux	30688	30694	_	_
195	8	be	be	VB	9	auxpass	30695	30697	_	_
195	9	administered	administer	VBN	0	ROOT	30698	30710	_	_
195	10	at	at	IN	14	case	30711	30713	_	_
195	11	12	12	CD	13	compound	30714	30716	_	_
195	12	to	to	TO	13	dep	30717	30719	_	_
195	13	15	15	CD	14	nummod	30720	30722	_	_
195	14	months	month	NNS	9	nmod	30723	30729	_	_
195	15	of	of	IN	16	case	30730	30732	_	_
195	16	age	age	NN	14	nmod	30733	30736	_	_
195	17	and	and	CC	14	cc	30737	30740	_	_
195	18	the	the	DT	20	det	30741	30744	_	_
195	19	second	second	JJ	20	amod	30745	30751	_	_
195	20	dose	dose	NN	14	conj	30752	30756	_	_
195	21	at	at	IN	23	case	30757	30759	_	_
195	22	18	18	CD	23	nummod	30760	30762	_	_
195	23	months	month	NNS	20	nmod	30763	30769	_	_
195	24	of	of	IN	25	case	30770	30772	_	_
195	25	age	age	NN	23	nmod	30773	30776	_	_
195	26	or	or	CC	25	cc	30777	30779	_	_
195	27	any	any	DT	28	det	30780	30783	_	_
195	28	time	time	NN	25	conj	30784	30788	_	_
195	29	thereafter	thereafter	RB	9	advmod	30789	30799	_	_
195	30	,	,	,	9	punct	30799	30800	_	_
195	31	but	but	CC	9	cc	30801	30804	_	_
195	32	should	should	MD	34	aux	30805	30811	_	_
195	33	be	be	VB	34	auxpass	30812	30814	_	_
195	34	given	give	VBN	9	conj	30815	30820	_	_
195	35	no	no	RB	36	neg	30821	30823	_	_
195	36	later	later	RB	34	advmod	30824	30829	_	_
195	37	than	than	IN	36	case	30830	30834	_	_
195	38	around	around	IN	40	case	30835	30841	_	_
195	39	school	school	NN	40	compound	30842	30848	_	_
195	40	entry	entry	NN	36	nmod	30849	30854	_	_
195	41	.	.	.	9	punct	30854	30855	_	_

196	1	The	the	DT	4	det	30856	30859	_	_
196	2	recommended	recommend	VBN	4	amod	30860	30871	_	_
196	3	minimum	minimum	NN	4	compound	30872	30879	_	_
196	4	interval	interval	NN	12	nsubj	30881	30889	_	_
196	5	between	between	IN	6	case	30890	30897	_	_
196	6	doses	dose	NNS	4	nmod	30898	30903	_	_
196	7	of	of	IN	9	case	30904	30906	_	_
196	8	MMR	mmr	NN	9	compound	30907	30910	_	_
196	9	vaccine	vaccine	NN	6	nmod	30911	30918	_	_
196	10	is	be	VBZ	12	cop	30919	30921	_	_
196	11	4	4	CD	12	nummod	30922	30923	_	_
196	12	weeks	week	NNS	0	ROOT	30924	30929	_	_
196	13	.	.	.	12	punct	30929	30930	_	_

197	1	Children	child	NNS	12	nsubj	30931	30939	B-persongroup-110142	_
197	2	who	who	WP	4	nsubj	30940	30943	_	_
197	3	previously	previously	RB	4	advmod	30944	30954	_	_
197	4	received	receive	VBD	1	acl:relcl	30956	30964	_	_
197	5	a	a	DT	7	det	30965	30966	_	_
197	6	single	single	JJ	7	amod	30967	30973	_	_
197	7	dose	dose	NN	4	dobj	30974	30978	_	_
197	8	of	of	IN	10	case	30979	30981	_	_
197	9	MMR	mmr	NN	10	compound	30982	30985	_	_
197	10	vaccine	vaccine	NN	7	nmod	30986	30993	_	_
197	11	should	should	MD	12	aux	30994	31000	_	_
197	12	receive	receive	VB	0	ROOT	31001	31008	_	_
197	13	a	a	DT	15	det	31009	31010	_	_
197	14	second	second	JJ	15	amod	31011	31017	_	_
197	15	dose	dose	NN	12	dobj	31018	31022	_	_
197	16	at	at	IN	17	case	31023	31025	_	_
197	17	least	least	JJS	18	nmod:npmod	31026	31031	_	_
197	18	4	4	CD	19	nummod	31032	31033	_	_
197	19	weeks	week	NNS	12	nmod	31035	31040	_	_
197	20	after	after	IN	19	case	31041	31046	_	_
197	21	the	the	DT	23	det	31047	31050	_	_
197	22	first	first	JJ	23	amod	31051	31056	_	_
197	23	dose	dose	NN	19	dep	31057	31061	_	_
197	24	.	.	.	12	punct	31061	31062	_	_

198	1	The	the	DT	3	det	31063	31066	_	_
198	2	recommended	recommend	VBN	3	amod	31067	31078	_	_
198	3	interval	interval	NN	14	nsubj	31079	31087	_	_
198	4	between	between	IN	6	case	31088	31095	_	_
198	5	two	two	CD	6	nummod	31096	31099	_	_
198	6	doses	dose	NNS	3	nmod	31101	31106	_	_
198	7	of	of	IN	9	case	31107	31109	_	_
198	8	MMRV	mmrv	NN	9	compound	31110	31114	_	_
198	9	vaccine	vaccine	NN	6	nmod	31116	31123	_	_
198	10	is	be	VBZ	14	cop	31124	31126	_	_
198	11	at	at	IN	12	case	31127	31129	_	_
198	12	least	least	JJS	13	nmod:npmod	31130	31135	_	_
198	13	3	3	CD	14	nummod	31136	31137	_	_
198	14	months	month	NNS	0	ROOT	31138	31144	_	_
198	15	;	;	:	14	punct	31144	31145	_	_
198	16	a	a	DT	18	det	31146	31147	_	_
198	17	minimum	minimum	JJ	18	amod	31148	31155	_	_
198	18	interval	interval	NN	26	nsubjpass	31156	31164	_	_
198	19	of	of	IN	21	case	31165	31167	_	_
198	20	6	6	CD	21	nummod	31168	31169	_	_
198	21	weeks	week	NNS	18	nmod	31170	31175	_	_
198	22	between	between	IN	23	case	31176	31183	_	_
198	23	doses	dose	NNS	21	nmod	31184	31189	_	_
198	24	may	may	MD	26	aux	31190	31193	_	_
198	25	be	be	VB	26	auxpass	31195	31197	_	_
198	26	used	use	VBN	14	parataxis	31198	31202	_	_
198	27	if	if	IN	33	mark	31203	31205	_	_
198	28	rapid	rapid	JJ	31	amod	31206	31211	_	_
198	29	,	,	,	31	punct	31211	31212	_	_
198	30	complete	complete	JJ	31	amod	31213	31221	_	_
198	31	protection	protection	NN	33	nsubjpass	31222	31232	_	_
198	32	is	be	VBZ	33	auxpass	31233	31235	_	_
198	33	required	require	VBN	26	advcl	31236	31244	_	_
198	34	.	.	.	14	punct	31244	31245	_	_

199	1	Adolescents	adolescent	NNS	2	nsubj	31247	31258	B-persongroup-110143	_
199	2	(	(	VBP	13	dep	31259	31260	_	_
199	3	13	13	CD	5	compound	31260	31262	_	_
199	4	to	to	TO	5	dep	31263	31265	_	_
199	5	17	17	CD	6	nummod	31266	31268	_	_
199	6	years	year	NNS	2	dobj	31269	31274	_	_
199	7	of	of	IN	8	case	31275	31277	_	_
199	8	age	age	NN	6	nmod	31278	31281	_	_
199	9	)	)	CD	11	nummod	31281	31282	_	_
199	10	Measles-susceptible	measles-susceptible	JJ	11	amod	31285	31304	B-persongroup-110144	_
199	11	adolescents	adolescent	NNS	13	nsubj	31305	31316	I-persongroup-110144	_
199	12	should	should	MD	13	aux	31317	31323	_	_
199	13	receive	receive	VB	0	ROOT	31324	31331	_	_
199	14	two	two	CD	15	nummod	31333	31336	_	_
199	15	doses	dose	NNS	13	dobj	31337	31342	_	_
199	16	of	of	IN	18	case	31343	31345	_	_
199	17	MMR	mmr	NN	18	compound	31346	31349	_	_
199	18	vaccine	vaccine	NN	15	nmod	31350	31357	_	_
199	19	given	give	VBN	18	acl	31358	31363	_	_
199	20	at	at	IN	21	case	31365	31367	_	_
199	21	least	least	JJS	22	nmod:npmod	31368	31373	_	_
199	22	4	4	CD	23	nummod	31374	31375	_	_
199	23	weeks	week	NNS	24	nmod:npmod	31376	31381	_	_
199	24	apart	apart	RB	19	advmod	31382	31387	_	_
199	25	.	.	.	13	punct	31387	31388	_	_

200	1	Adults	adult	NNS	2	nsubj	31389	31395	B-persongroup-110145	_
200	2	(	(	VBP	0	ROOT	31396	31397	_	_
200	3	18	18	CD	4	nummod	31397	31399	_	_
200	4	years	year	NNS	28	nsubj	31400	31405	_	_
200	5	of	of	IN	6	case	31406	31408	_	_
200	6	age	age	NN	4	nmod	31409	31412	_	_
200	7	and	and	CC	4	cc	31413	31416	_	_
200	8	older	older	JJR	27	amod	31418	31423	_	_
200	9	)	)	CD	11	nummod	31423	31424	_	_
200	10	Measles-susceptible	measles-susceptible	JJ	11	amod	31427	31446	B-persongroup-110146	_
200	11	adults	adult	NNS	13	nsubj	31448	31454	I-persongroup-110146	_
200	12	should	should	MD	13	aux	31455	31461	_	_
200	13	receive	receive	VB	8	ccomp	31462	31469	_	_
200	14	one	one	CD	17	compound	31470	31473	_	_
200	15	or	or	CC	14	cc	31474	31476	_	_
200	16	two	two	CD	14	conj	31477	31480	_	_
200	17	doses	dose	NNS	13	dobj	31481	31486	_	_
200	18	of	of	IN	20	case	31487	31489	_	_
200	19	MMR	mmr	NN	20	compound	31490	31493	_	_
200	20	vaccine	vaccine	NN	17	nmod	31494	31501	_	_
200	21	as	as	IN	22	case	31502	31504	_	_
200	22	appropriate	appropriate	JJ	8	advcl	31505	31516	_	_
200	23	for	for	IN	24	case	31517	31520	_	_
200	24	age	age	NN	8	nmod	31521	31524	_	_
200	25	and	and	CC	24	cc	31526	31529	_	_
200	26	risk	risk	NN	24	conj	31530	31534	_	_
200	27	factors	factor	NNS	4	conj	31535	31542	_	_
200	28	(	(	VBP	2	ccomp	31543	31544	_	_
200	29	refer	refer	VB	28	xcomp	31544	31549	_	_
200	30	to	to	TO	31	case	31550	31552	_	_
200	31	Table	Table	NNP	29	nmod	31553	31558	_	_
200	32	1	1	CD	33	compound	31559	31560	_	_
200	33	)	)	CD	29	dobj	31560	31561	_	_
200	34	.	.	.	2	punct	31561	31562	_	_

201	1	If	if	IN	5	mark	31563	31565	_	_
201	2	two	two	CD	3	nummod	31566	31569	_	_
201	3	doses	dose	NNS	5	nsubjpass	31570	31575	_	_
201	4	are	be	VBP	5	auxpass	31576	31579	_	_
201	5	needed	need	VBN	11	advcl	31580	31586	_	_
201	6	,	,	,	11	punct	31586	31587	_	_
201	7	MMR	mmr	NN	8	compound	31588	31591	_	_
201	8	vaccine	vaccine	NN	11	nsubjpass	31592	31599	_	_
201	9	should	should	MD	11	aux	31600	31606	_	_
201	10	be	be	VB	11	auxpass	31607	31609	_	_
201	11	administered	administer	VBN	0	ROOT	31610	31622	_	_
201	12	with	with	IN	15	case	31623	31627	_	_
201	13	a	a	DT	15	det	31628	31629	_	_
201	14	minimum	minimum	JJ	15	amod	31630	31637	_	_
201	15	interval	interval	NN	11	nmod	31639	31647	_	_
201	16	of	of	IN	18	case	31648	31650	_	_
201	17	4	4	CD	18	nummod	31651	31652	_	_
201	18	weeks	week	NNS	15	nmod	31653	31658	_	_
201	19	between	between	IN	20	case	31659	31666	_	_
201	20	doses	dose	NNS	18	nmod	31667	31672	_	_
201	21	.	.	.	11	punct	31672	31673	_	_

202	1	Re-immunization	re-immunization	NN	13	nsubj	31675	31690	_	_
202	2	with	with	IN	4	case	31691	31695	_	_
202	3	measles-containing	measles-containing	JJ	4	amod	31696	31714	_	_
202	4	vaccine	vaccine	NN	1	nmod	31715	31722	_	_
202	5	after	after	IN	10	case	31723	31728	_	_
202	6	age	age	NN	10	compound	31729	31732	_	_
202	7	and	and	CC	6	cc	31733	31736	_	_
202	8	risk	risk	NN	6	conj	31737	31741	_	_
202	9	appropriate	appropriate	JJ	10	amod	31742	31753	_	_
202	10	vaccination	vaccination	NN	4	nmod	31754	31765	_	_
202	11	is	be	VBZ	13	cop	31766	31768	_	_
202	12	not	not	RB	13	neg	31769	31772	_	_
202	13	necessary	necessary	JJ	0	ROOT	31773	31782	_	_
202	14	.	.	.	13	punct	31782	31783	_	_

203	1	Serological	serological	JJ	2	amod	31785	31796	_	_
203	2	testing	testing	NN	5	nsubjpass	31797	31804	_	_
203	3	may	may	MD	5	aux	31805	31808	_	_
203	4	be	be	VB	5	auxpass	31809	31811	_	_
203	5	indicated	indicate	VBN	0	ROOT	31812	31821	_	_
203	6	to	to	TO	7	mark	31822	31824	_	_
203	7	confirm	confirm	VB	5	ccomp	31825	31832	_	_
203	8	the	the	DT	9	det	31833	31836	_	_
203	9	diagnosis	diagnosis	NN	7	dobj	31837	31846	_	_
203	10	of	of	IN	11	case	31847	31849	_	_
203	11	measles	measles	NNS	9	nmod	31850	31857	_	_
203	12	or	or	CC	7	cc	31858	31860	_	_
203	13	to	to	TO	14	mark	31861	31863	_	_
203	14	determine	determine	VB	7	conj	31864	31873	_	_
203	15	immune	immune	JJ	16	amod	31874	31880	_	_
203	16	status	status	NN	14	dobj	31881	31887	_	_
203	17	.	.	.	5	punct	31887	31888	_	_

204	1	Serologic	serologic	JJ	2	amod	31889	31898	_	_
204	2	testing	testing	NN	5	nsubjpass	31899	31906	_	_
204	3	is	be	VBZ	5	auxpass	31907	31909	_	_
204	4	not	not	RB	5	neg	31910	31913	_	_
204	5	recommended	recommend	VBN	0	ROOT	31914	31925	_	_
204	6	before	before	IN	9	mark	31926	31932	_	_
204	7	or	or	CC	6	cc	31933	31935	_	_
204	8	after	after	IN	6	conj	31936	31941	_	_
204	9	receiving	receive	VBG	5	advcl	31942	31951	_	_
204	10	measles-containing	measles-containing	JJ	11	amod	31952	31970	_	_
204	11	vaccine	vaccine	NN	9	dobj	31971	31978	_	_
204	12	.	.	.	5	punct	31978	31979	_	_

205	1	If	if	IN	5	mark	31980	31982	_	_
205	2	serology	serology	NN	5	nsubjpass	31983	31991	_	_
205	3	is	be	VBZ	5	auxpass	31992	31994	_	_
205	4	inadvertently	inadvertently	RB	5	advmod	31995	32008	_	_
205	5	done	do	VBN	21	advcl	32009	32013	_	_
205	6	subsequent	subsequent	JJ	10	amod	32014	32024	_	_
205	7	to	to	TO	9	case	32025	32027	_	_
205	8	appropriate	appropriate	JJ	9	amod	32028	32039	_	_
205	9	measles	measles	NNS	6	nmod	32040	32047	_	_
205	10	immunization	immunization	NN	5	dobj	32048	32060	_	_
205	11	and	and	CC	5	cc	32061	32064	_	_
205	12	does	do	VBZ	14	aux	32065	32069	_	_
205	13	not	not	RB	14	neg	32070	32073	_	_
205	14	demonstrate	demonstrate	VB	5	conj	32074	32085	_	_
205	15	immunity	immunity	NN	14	dobj	32086	32094	_	_
205	16	,	,	,	5	punct	32094	32095	_	_
205	17	measles	measle	VBZ	5	dep	32096	32103	_	_
205	18	re-immunization	re-immunization	NN	21	nsubj	32104	32119	_	_
205	19	is	be	VBZ	21	cop	32120	32122	_	_
205	20	not	not	RB	21	neg	32123	32126	_	_
205	21	necessary	necessary	JJ	0	ROOT	32127	32136	_	_
205	22	.	.	.	21	punct	32136	32137	_	_

206	1	M-M-R	m-m-r	NN	2	compound	32138	32143	_	_
206	2	®	®	NN	0	ROOT	32143	32144	_	_
206	3	II	ii	CD	2	dep	32145	32147	_	_
206	4	:	:	:	2	punct	32147	32148	_	_
206	5	Maintain	maintain	VB	2	dep	32149	32157	_	_
206	6	vaccine	vaccine	NN	5	dobj	32158	32165	_	_
206	7	at	at	IN	9	case	32166	32168	_	_
206	8	+10	+10	CD	9	nummod	32170	32173	_	_
206	9	°C	°c	NN	5	nmod	32173	32175	_	_
206	10	or	or	CC	9	cc	32176	32178	_	_
206	11	colder	colder	JJR	9	conj	32179	32185	_	_
206	12	during	during	IN	13	case	32186	32192	_	_
206	13	shipment	shipment	NN	5	nmod	32193	32201	_	_
206	14	.	.	.	2	punct	32201	32202	_	_

207	1	Freezing	freezing	NN	6	nsubj	32203	32211	_	_
207	2	during	during	IN	3	case	32212	32218	_	_
207	3	shipment	shipment	NN	1	nmod	32219	32227	_	_
207	4	will	will	MD	6	aux	32228	32232	_	_
207	5	not	not	RB	6	neg	32233	32236	_	_
207	6	affect	affect	VB	0	ROOT	32237	32243	_	_
207	7	potency	potency	NN	6	dobj	32245	32252	_	_
207	8	of	of	IN	10	case	32253	32255	_	_
207	9	the	the	DT	10	det	32256	32259	_	_
207	10	vaccine	vaccine	NN	7	nmod	32260	32267	_	_
207	11	.	.	.	6	punct	32267	32268	_	_

208	1	Protect	protect	VB	0	ROOT	32269	32276	_	_
208	2	the	the	DT	3	det	32277	32280	_	_
208	3	vaccine	vaccine	NN	1	dobj	32281	32288	_	_
208	4	from	from	IN	5	case	32289	32293	_	_
208	5	light	light	NN	1	nmod	32294	32299	_	_
208	6	.	.	.	1	punct	32299	32300	_	_

209	1	Before	before	IN	2	case	32301	32307	_	_
209	2	reconstitution	reconstitution	NN	4	nmod	32308	32322	_	_
209	3	,	,	,	4	punct	32322	32323	_	_
209	4	store	store	VBP	0	ROOT	32325	32330	_	_
209	5	the	the	DT	6	det	32331	32334	_	_
209	6	vial	vial	NN	4	dobj	32335	32339	_	_
209	7	of	of	IN	8	case	32340	32342	_	_
209	8	vaccine	vaccine	NN	6	nmod	32343	32350	_	_
209	9	at	at	IN	11	case	32351	32353	_	_
209	10	+2	+2	CD	11	nummod	32354	32356	_	_
209	11	°C	°c	NN	8	nmod	32356	32358	_	_
209	12	to	to	TO	14	case	32359	32361	_	_
209	13	+8	+8	CD	14	nummod	32362	32364	_	_
209	14	°C	°c	NN	4	nmod	32364	32366	_	_
209	15	or	or	CC	14	cc	32367	32369	_	_
209	16	colder	colder	JJR	14	conj	32370	32376	_	_
209	17	.	.	.	4	punct	32376	32377	_	_

210	1	The	the	DT	2	det	32378	32381	_	_
210	2	diluent	diluent	NN	5	nsubjpass	32382	32389	_	_
210	3	may	may	MD	5	aux	32390	32393	_	_
210	4	be	be	VB	5	auxpass	32394	32396	_	_
210	5	stored	store	VBN	0	ROOT	32397	32403	_	_
210	6	in	in	IN	8	case	32404	32406	_	_
210	7	the	the	DT	8	det	32407	32410	_	_
210	8	refrigerator	refrigerator	NN	5	nmod	32411	32423	_	_
210	9	or	or	CC	8	cc	32424	32426	_	_
210	10	at	at	IN	12	case	32427	32429	_	_
210	11	room	room	NN	12	compound	32430	32434	_	_
210	12	temperature	temperature	NN	8	conj	32435	32446	_	_
210	13	and	and	CC	5	cc	32447	32450	_	_
210	14	must	must	MD	17	aux	32452	32456	_	_
210	15	not	not	RB	17	neg	32457	32460	_	_
210	16	be	be	VB	17	auxpass	32461	32463	_	_
210	17	frozen	freeze	VBN	5	conj	32464	32470	_	_
210	18	.	.	.	5	punct	32470	32471	_	_

211	1	PRIORIX	PRIORIX	NNP	0	ROOT	32473	32480	_	_
211	2	®	®	CD	1	nummod	32480	32481	_	_
211	3	:	:	:	1	punct	32481	32482	_	_
211	4	Store	Store	NNP	1	dep	32483	32488	_	_
211	5	in	in	IN	7	case	32489	32491	_	_
211	6	a	a	DT	7	det	32492	32493	_	_
211	7	refrigerator	refrigerator	NN	4	nmod	32494	32506	_	_
211	8	at	at	IN	10	case	32507	32509	_	_
211	9	+2	+2	CD	10	nummod	32510	32512	_	_
211	10	°C	°c	NN	7	nmod	32512	32514	_	_
211	11	to	to	TO	13	case	32515	32517	_	_
211	12	+8	+8	CD	13	nummod	32518	32520	_	_
211	13	°C	°c	NN	10	nmod	32520	32522	_	_
211	14	.	.	.	1	punct	32522	32523	_	_

212	1	The	the	DT	2	det	32524	32527	_	_
212	2	diluent	diluent	NN	5	nsubjpass	32529	32536	_	_
212	3	may	may	MD	5	aux	32537	32540	_	_
212	4	be	be	VB	5	auxpass	32541	32543	_	_
212	5	stored	store	VBN	0	ROOT	32544	32550	_	_
212	6	separately	separately	RB	5	advmod	32551	32561	_	_
212	7	at	at	IN	9	case	32562	32564	_	_
212	8	room	room	NN	9	compound	32565	32569	_	_
212	9	temperature	temperature	NN	5	nmod	32570	32581	_	_
212	10	.	.	.	5	punct	32581	32582	_	_

213	1	Protect	protect	VB	0	ROOT	32583	32590	_	_
213	2	from	from	IN	3	case	32591	32595	_	_
213	3	light	light	NN	1	nmod	32596	32601	_	_
213	4	.	.	.	1	punct	32601	32602	_	_

214	1	PRIORIX-TETRA	priorix-tetra	NN	6	nsubj	32604	32617	_	_
214	2	®	®	CD	1	nummod	32617	32618	_	_
214	3	:	:	:	1	punct	32618	32619	_	_
214	4	Store	Store	NNP	1	dep	32620	32625	_	_
214	5	the	the	DT	6	det	32626	32629	_	_
214	6	vaccine	vaccine	NN	0	ROOT	32630	32637	_	_
214	7	and	and	CC	6	cc	32638	32641	_	_
214	8	diluent	diluent	NN	6	conj	32642	32649	_	_
214	9	in	in	IN	11	case	32650	32652	_	_
214	10	a	a	DT	11	det	32653	32654	_	_
214	11	refrigerator	refrigerator	NN	6	nmod	32655	32667	_	_
214	12	at	at	IN	14	case	32668	32670	_	_
214	13	+2	+2	CD	14	nummod	32672	32674	_	_
214	14	°C	°c	NN	11	nmod	32674	32676	_	_
214	15	to	to	TO	17	case	32677	32679	_	_
214	16	+8	+8	CD	17	nummod	32680	32682	_	_
214	17	°C	°c	NN	6	nmod	32682	32684	_	_
214	18	and	and	CC	6	cc	32685	32688	_	_
214	19	do	do	VBP	21	aux	32689	32691	_	_
214	20	not	not	RB	21	neg	32692	32695	_	_
214	21	freeze	freeze	VB	6	conj	32696	32702	_	_
214	22	.	.	.	6	punct	32702	32703	_	_

215	1	Protect	protect	VB	0	ROOT	32704	32711	_	_
215	2	the	the	DT	3	det	32712	32715	_	_
215	3	vaccine	vaccine	NN	1	dobj	32716	32723	_	_
215	4	from	from	IN	5	case	32724	32728	_	_
215	5	light	light	NN	1	nmod	32729	32734	_	_
215	6	.	.	.	1	punct	32734	32735	_	_

216	1	Refer	refer	VB	0	ROOT	32737	32742	_	_
216	2	to	to	TO	3	case	32743	32745	_	_
216	3	Storage	Storage	NNP	1	nmod	32746	32753	_	_
216	4	and	and	CC	3	cc	32754	32757	_	_
216	5	Handling	Handling	NNP	3	conj	32758	32766	_	_
216	6	of	of	IN	8	case	32767	32769	_	_
216	7	Immunizing	Immunizing	NNP	8	compound	32770	32780	_	_
216	8	Agents	Agents	NNPS	3	nmod	32781	32787	_	_
216	9	in	in	IN	10	case	32788	32790	_	_
216	10	Part	Part	NNP	8	nmod	32791	32795	_	_
216	11	1	1	CD	10	nummod	32796	32797	_	_
216	12	for	for	IN	15	case	32798	32801	_	_
216	13	additional	additional	JJ	15	amod	32802	32812	_	_
216	14	general	general	JJ	15	amod	32813	32820	_	_
216	15	information	information	NN	1	nmod	32821	32832	_	_
216	16	.	.	.	1	punct	32832	32833	_	_

217	1	Refer	refer	VB	0	ROOT	32834	32839	_	_
217	2	to	to	TO	6	case	32840	32842	_	_
217	3	Passive	Passive	NNP	6	compound	32843	32850	_	_
217	4	Immunizing	Immunizing	NNP	6	compound	32851	32861	_	_
217	5	Agents	Agents	NNPS	6	compound	32862	32868	_	_
217	6	Part	Part	NNP	1	nmod	32869	32873	_	_
217	7	5	5	CD	1	nmod	32874	32875	_	_
217	8	for	for	IN	7	case	32876	32879	_	_
217	9	information	information	NN	7	dep	32880	32891	_	_
217	10	regarding	regard	VBG	13	case	32892	32901	_	_
217	11	Ig	ig	NN	13	compound	32902	32904	_	_
217	12	storage	storage	NN	13	compound	32905	32912	_	_
217	13	requirements	requirement	NNS	9	nmod	32913	32925	_	_
217	14	.	.	.	1	punct	32925	32926	_	_

218	1	Live	live	VB	10	csubjpass	32928	32932	_	_
218	2	vaccines	vaccine	NNS	1	dobj	32933	32941	_	_
218	3	given	give	VBN	7	case	32942	32947	_	_
218	4	by	by	IN	7	case	32948	32950	_	_
218	5	the	the	DT	7	det	32951	32954	_	_
218	6	parenteral	parenteral	JJ	7	amod	32955	32965	_	_
218	7	route	route	NN	1	advcl	32966	32971	_	_
218	8	may	may	MD	10	aux	32972	32975	_	_
218	9	be	be	VB	10	auxpass	32976	32978	_	_
218	10	administered	administer	VBN	0	ROOT	32979	32991	_	_
218	11	concomitantly	concomitantly	RB	10	advmod	32992	33005	_	_
218	12	with	with	IN	15	case	33006	33010	_	_
218	13	all	all	DT	15	det	33011	33014	_	_
218	14	other	other	JJ	15	amod	33015	33020	_	_
218	15	vaccines	vaccine	NNS	10	nmod	33021	33029	_	_
218	16	during	during	IN	19	case	33030	33036	_	_
218	17	the	the	DT	19	det	33037	33040	_	_
218	18	same	same	JJ	19	amod	33041	33045	_	_
218	19	visit	visit	NN	10	nmod	33046	33051	_	_
218	20	using	use	VBG	19	acl	33052	33057	_	_
218	21	different	different	JJ	23	amod	33058	33067	_	_
218	22	injection	injection	NN	23	compound	33068	33077	_	_
218	23	sites	site	NNS	20	dobj	33078	33083	_	_
218	24	and	and	CC	23	cc	33084	33087	_	_
218	25	separate	separate	JJ	26	amod	33088	33096	_	_
218	26	needles	needle	NNS	23	conj	33097	33104	_	_
218	27	and	and	CC	23	cc	33105	33108	_	_
218	28	syringes	syringe	NNS	23	conj	33109	33117	_	_
218	29	.	.	.	10	punct	33117	33118	_	_

219	1	In	in	IN	2	case	33119	33121	_	_
219	2	general	general	JJ	18	advcl	33122	33129	_	_
219	3	,	,	,	18	punct	33129	33130	_	_
219	4	if	if	IN	11	mark	33131	33133	_	_
219	5	two	two	CD	8	nummod	33134	33137	_	_
219	6	live	live	JJ	8	amod	33138	33142	_	_
219	7	parenteral	parenteral	JJ	8	amod	33143	33153	_	_
219	8	vaccines	vaccine	NNS	11	nsubjpass	33154	33162	_	_
219	9	are	be	VBP	11	auxpass	33163	33166	_	_
219	10	not	not	RB	11	neg	33167	33170	_	_
219	11	administered	administer	VBN	18	advcl	33171	33183	_	_
219	12	concomitantly	concomitantly	RB	11	advmod	33184	33197	_	_
219	13	,	,	,	18	punct	33197	33198	_	_
219	14	there	there	EX	18	expl	33199	33204	_	_
219	15	should	should	MD	18	aux	33205	33211	_	_
219	16	be	be	VB	18	cop	33212	33214	_	_
219	17	a	a	DT	18	det	33215	33216	_	_
219	18	period	period	NN	0	ROOT	33217	33223	_	_
219	19	of	of	IN	23	case	33224	33226	_	_
219	20	at	at	IN	21	case	33227	33229	_	_
219	21	least	least	JJS	22	nmod:npmod	33230	33235	_	_
219	22	4	4	CD	23	nummod	33236	33237	_	_
219	23	weeks	week	NNS	18	nmod	33238	33243	_	_
219	24	before	before	IN	31	mark	33244	33250	_	_
219	25	the	the	DT	29	det	33251	33254	_	_
219	26	second	second	JJ	29	amod	33255	33261	_	_
219	27	live	live	JJ	29	amod	33262	33266	_	_
219	28	parenteral	parenteral	JJ	29	amod	33267	33277	_	_
219	29	vaccine	vaccine	NN	31	nsubjpass	33278	33285	_	_
219	30	is	be	VBZ	31	auxpass	33286	33288	_	_
219	31	given	give	VBN	18	advcl	33289	33294	_	_
219	32	.	.	.	18	punct	33294	33295	_	_

220	1	Exceptions	exception	NNS	4	nsubj	33296	33306	_	_
220	2	are	be	VBP	4	cop	33307	33310	_	_
220	3	varicella-containing	varicella-containing	JJ	4	amod	33311	33331	_	_
220	4	vaccines	vaccine	NNS	0	ROOT	33332	33340	_	_
220	5	,	,	,	4	punct	33340	33341	_	_
220	6	such	such	JJ	9	case	33342	33346	_	_
220	7	as	as	IN	6	mwe	33347	33349	_	_
220	8	MMRV	mmrv	NN	9	compound	33350	33354	_	_
220	9	vaccine	vaccine	NN	4	nmod	33355	33362	_	_
220	10	:	:	:	9	punct	33362	33363	_	_
220	11	administer	administer	VB	9	dep	33364	33374	_	_
220	12	doses	dose	NNS	11	dobj	33375	33380	_	_
220	13	of	of	IN	15	case	33381	33383	_	_
220	14	varicella-containing	varicella-containing	JJ	15	amod	33384	33404	_	_
220	15	vaccine	vaccine	NN	12	nmod	33405	33412	_	_
220	16	at	at	IN	17	case	33413	33415	_	_
220	17	least	least	JJS	18	nmod:npmod	33416	33421	_	_
220	18	3	3	CD	19	nummod	33422	33423	_	_
220	19	months	month	NNS	20	nmod:npmod	33424	33430	_	_
220	20	apart	apart	RB	11	advmod	33431	33436	_	_
220	21	for	for	IN	22	case	33437	33440	_	_
220	22	children	child	NNS	11	nmod	33441	33449	_	_
220	23	1	1	CD	25	compound	33450	33451	_	_
220	24	to	to	TO	25	dep	33452	33454	_	_
220	25	12	12	CD	26	nummod	33455	33457	_	_
220	26	years	year	NNS	22	nmod	33458	33463	_	_
220	27	of	of	IN	26	case	33464	33466	_	_
220	28	age	age	NN	26	dep	33467	33470	_	_
220	29	.	.	.	4	punct	33470	33471	_	_

221	1	If	if	IN	9	mark	33472	33474	_	_
221	2	rapid	rapid	JJ	5	amod	33475	33480	_	_
221	3	,	,	,	5	punct	33480	33481	_	_
221	4	complete	complete	JJ	5	amod	33482	33490	_	_
221	5	protection	protection	NN	9	nsubjpass	33491	33501	_	_
221	6	against	against	IN	7	case	33502	33509	_	_
221	7	varicella	varicella	NN	5	nmod	33510	33519	_	_
221	8	is	be	VBZ	9	auxpass	33520	33522	_	_
221	9	required	require	VBN	22	advcl	33523	33531	_	_
221	10	,	,	,	22	punct	33531	33532	_	_
221	11	a	a	DT	13	det	33533	33534	_	_
221	12	minimum	minimum	JJ	13	amod	33535	33542	_	_
221	13	interval	interval	NN	22	nsubjpass	33543	33551	_	_
221	14	of	of	IN	16	case	33552	33554	_	_
221	15	6	6	CD	16	nummod	33555	33556	_	_
221	16	weeks	week	NNS	13	nmod	33557	33562	_	_
221	17	between	between	IN	19	case	33563	33570	_	_
221	18	2	2	CD	19	nummod	33571	33572	_	_
221	19	doses	dose	NNS	16	nmod	33573	33578	_	_
221	20	may	may	MD	22	aux	33579	33582	_	_
221	21	be	be	VB	22	auxpass	33583	33585	_	_
221	22	used	use	VBN	0	ROOT	33586	33590	_	_
221	23	for	for	IN	24	case	33591	33594	_	_
221	24	children	child	NNS	22	nmod	33595	33603	B-persongroup-110147	_
221	25	1	1	CD	27	compound	33604	33605	_	_
221	26	to	to	TO	27	dep	33606	33608	_	_
221	27	12	12	CD	28	nummod	33609	33611	_	_
221	28	years	year	NNS	24	nmod	33612	33617	_	_
221	29	of	of	IN	28	case	33618	33620	_	_
221	30	age	age	NN	28	dep	33621	33624	_	_
221	31	.	.	.	22	punct	33624	33625	_	_

222	1	do	do	VB	4	aux	33626	33628	_	_
222	2	not	not	RB	4	neg	33629	33632	_	_
222	3	concomitantly	concomitantly	RB	4	advmod	33633	33646	_	_
222	4	administer	administer	VB	0	ROOT	33647	33657	_	_
222	5	varicella-containing	varicella-containing	JJ	6	amod	33658	33678	_	_
222	6	vaccines	vaccine	NNS	4	dobj	33679	33687	_	_
222	7	with	with	IN	9	case	33688	33692	_	_
222	8	smallpox	smallpox	NN	9	compound	33693	33701	_	_
222	9	vaccine	vaccine	NN	4	nmod	33702	33709	_	_
222	10	;	;	:	4	punct	33709	33710	_	_
222	11	administer	administer	VB	4	dep	33711	33721	_	_
222	12	varicella-containing	varicella-containing	JJ	13	amod	33722	33742	_	_
222	13	vaccine	vaccine	NN	11	dobj	33743	33750	_	_
222	14	and	and	CC	13	cc	33751	33754	_	_
222	15	smallpox	smallpox	NN	16	compound	33755	33763	_	_
222	16	vaccine	vaccine	NN	13	conj	33764	33771	_	_
222	17	at	at	IN	18	case	33772	33774	_	_
222	18	least	least	JJS	19	nmod:npmod	33775	33780	_	_
222	19	4	4	CD	20	nummod	33781	33782	_	_
222	20	weeks	week	NNS	13	nmod:tmod	33783	33788	_	_
222	21	apart	apart	RB	11	advmod	33789	33794	_	_
222	22	.	.	.	4	punct	33794	33795	_	_

223	1	Oral	oral	JJ	4	amod	33796	33800	_	_
223	2	and	and	CC	1	cc	33801	33804	_	_
223	3	intranasal	intranasal	JJ	1	conj	33805	33815	_	_
223	4	vaccines	vaccine	NNS	7	nsubjpass	33816	33824	_	_
223	5	can	can	MD	7	aux	33825	33828	_	_
223	6	be	be	VB	7	auxpass	33829	33831	_	_
223	7	given	give	VBN	0	ROOT	33832	33837	_	_
223	8	at	at	IN	11	case	33838	33840	_	_
223	9	the	the	DT	11	det	33841	33844	_	_
223	10	same	same	JJ	11	amod	33845	33849	_	_
223	11	time	time	NN	7	nmod	33850	33854	_	_
223	12	as	as	IN	16	mark	33855	33857	_	_
223	13	,	,	,	16	punct	33857	33858	_	_
223	14	or	or	CC	16	cc	33859	33861	_	_
223	15	any	any	DT	16	det	33862	33865	_	_
223	16	time	time	NN	11	dep	33866	33870	_	_
223	17	before	before	IN	23	case	33871	33877	_	_
223	18	or	or	CC	17	cc	33878	33880	_	_
223	19	after	after	IN	17	conj	33881	33886	_	_
223	20	any	any	DT	23	det	33887	33890	_	_
223	21	other	other	JJ	23	amod	33891	33896	_	_
223	22	live	live	JJ	23	amod	33897	33901	_	_
223	23	vaccine	vaccine	NN	16	nmod	33902	33909	_	_
223	24	,	,	,	23	punct	33909	33910	_	_
223	25	regardless	regardless	RB	23	advmod	33911	33921	_	_
223	26	of	of	IN	28	case	33922	33924	_	_
223	27	the	the	DT	28	det	33925	33928	_	_
223	28	route	route	NN	25	nmod	33929	33934	_	_
223	29	of	of	IN	30	case	33935	33937	_	_
223	30	administration	administration	NN	28	nmod	33938	33952	_	_
223	31	of	of	IN	35	case	33953	33955	_	_
223	32	the	the	DT	35	det	33956	33959	_	_
223	33	other	other	JJ	35	amod	33960	33965	_	_
223	34	live	live	JJ	35	amod	33966	33970	_	_
223	35	vaccine	vaccine	NN	30	nmod	33971	33978	_	_
223	36	.	.	.	7	punct	33978	33979	_	_

224	1	Refer	refer	VB	0	ROOT	33980	33985	_	_
224	2	to	to	TO	3	case	33986	33988	_	_
224	3	Timing	timing	NN	1	nmod	33989	33995	_	_
224	4	of	of	IN	6	case	33996	33998	_	_
224	5	Vaccine	Vaccine	NNP	6	compound	33999	34006	_	_
224	6	Administration	Administration	NNP	3	nmod	34007	34021	_	_
224	7	in	in	IN	8	case	34022	34024	_	_
224	8	Part	Part	NNP	6	nmod	34025	34029	_	_
224	9	1	1	CD	8	nummod	34030	34031	_	_
224	10	for	for	IN	13	case	34032	34035	_	_
224	11	additional	additional	JJ	13	amod	34036	34046	_	_
224	12	general	general	JJ	13	amod	34047	34054	_	_
224	13	information	information	NN	1	nmod	34055	34066	_	_
224	14	.	.	.	1	punct	34066	34067	_	_

225	1	Refer	refer	VB	0	ROOT	34068	34073	_	_
225	2	to	to	TO	5	case	34074	34076	_	_
225	3	Vaccine	Vaccine	NNP	5	compound	34077	34084	_	_
225	4	Safety	Safety	NNP	5	compound	34085	34091	_	_
225	5	Part	Part	NNP	1	nmod	34092	34096	_	_
225	6	2	2	CD	5	nummod	34097	34098	_	_
225	7	for	for	IN	10	case	34099	34102	_	_
225	8	additional	additional	JJ	10	amod	34103	34113	_	_
225	9	general	general	JJ	10	amod	34114	34121	_	_
225	10	information	information	NN	5	nmod	34122	34133	_	_
225	11	.	.	.	1	punct	34133	34134	_	_

226	1	Adverse	adverse	JJ	2	amod	34136	34143	_	_
226	2	events	event	NNS	6	nsubj	34144	34150	_	_
226	3	following	follow	VBG	5	case	34151	34160	_	_
226	4	MMR	mmr	NN	5	compound	34161	34164	_	_
226	5	immunization	immunization	NN	2	nmod	34165	34177	_	_
226	6	occur	occur	VBP	0	ROOT	34178	34183	_	_
226	7	less	less	RBR	8	advmod	34184	34188	_	_
226	8	frequently	frequently	RB	6	advmod	34189	34199	_	_
226	9	and	and	CC	6	cc	34200	34203	_	_
226	10	are	be	VBP	12	cop	34204	34207	_	_
226	11	less	less	RBR	12	advmod	34208	34212	_	_
226	12	severe	severe	JJ	6	conj	34213	34219	_	_
226	13	than	than	IN	14	case	34220	34224	_	_
226	14	those	those	DT	12	nmod	34225	34230	_	_
226	15	associated	associate	VBN	14	acl	34231	34241	_	_
226	16	with	with	IN	18	case	34242	34246	_	_
226	17	natural	natural	JJ	18	amod	34247	34254	_	_
226	18	disease	disease	NN	15	nmod	34255	34262	_	_
226	19	.	.	.	6	punct	34262	34263	_	_

227	1	Adverse	adverse	JJ	2	amod	34264	34271	_	_
227	2	reactions	reaction	NNS	5	nsubj	34272	34281	_	_
227	3	are	be	VBP	5	cop	34282	34285	_	_
227	4	less	less	RBR	5	advmod	34286	34290	_	_
227	5	frequent	frequent	JJ	0	ROOT	34291	34299	_	_
227	6	after	after	IN	9	case	34300	34305	_	_
227	7	the	the	DT	9	det	34306	34309	_	_
227	8	second	second	JJ	9	amod	34310	34316	_	_
227	9	dose	dose	NN	5	nmod	34317	34321	_	_
227	10	of	of	IN	11	case	34322	34324	_	_
227	11	vaccine	vaccine	NN	9	nmod	34325	34332	_	_
227	12	and	and	CC	5	cc	34333	34336	_	_
227	13	tend	tend	VB	5	conj	34337	34341	_	_
227	14	to	to	TO	15	mark	34342	34344	_	_
227	15	occur	occur	VB	13	xcomp	34345	34350	_	_
227	16	only	only	RB	15	advmod	34351	34355	_	_
227	17	in	in	IN	18	case	34356	34358	_	_
227	18	those	those	DT	15	nmod	34359	34364	_	_
227	19	not	not	RB	20	neg	34365	34368	_	_
227	20	protected	protect	VBN	18	acl	34369	34378	_	_
227	21	by	by	IN	24	case	34379	34381	_	_
227	22	the	the	DT	24	det	34382	34385	_	_
227	23	first	first	JJ	24	amod	34386	34391	_	_
227	24	dose	dose	NN	20	nmod	34392	34396	_	_
227	25	.	.	.	5	punct	34396	34397	_	_

228	1	Six	six	CD	3	compound	34398	34401	_	_
228	2	to	to	TO	3	dep	34402	34404	_	_
228	3	23	23	CD	4	nummod	34405	34407	_	_
228	4	days	day	NNS	15	nsubj	34408	34412	_	_
228	5	after	after	IN	7	case	34413	34418	_	_
228	6	MMR	mmr	NN	7	compound	34419	34422	_	_
228	7	immunization	immunization	NN	4	nmod	34423	34435	_	_
228	8	,	,	,	15	punct	34435	34436	_	_
228	9	approximately	approximately	RB	10	advmod	34437	34450	B-persongroup-110148	_
228	10	5	5	CD	11	nummod	34451	34452	I-persongroup-110148	_
228	11	%	%	NN	15	nsubj	34452	34453	I-persongroup-110148	_
228	12	of	of	IN	14	case	34454	34456	I-persongroup-110148	_
228	13	immunized	immunized	JJ	14	amod	34457	34466	I-persongroup-110148	_
228	14	children	child	NNS	11	nmod	34467	34475	I-persongroup-110148	_
228	15	experience	experience	VBP	0	ROOT	34476	34486	_	_
228	16	malaise	malaise	NN	19	compound	34487	34494	_	_
228	17	and	and	CC	16	cc	34495	34498	_	_
228	18	fever	fever	NN	16	conj	34499	34504	_	_
228	19	(	(	NN	15	dobj	34505	34506	_	_
228	20	with	with	IN	24	case	34506	34510	_	_
228	21	or	or	CC	20	cc	34511	34513	_	_
228	22	without	without	IN	20	conj	34514	34521	_	_
228	23	rash	rash	JJ	24	amod	34522	34526	_	_
228	24	)	)	NN	15	nmod	34526	34527	_	_
228	25	lasting	last	VBG	15	xcomp	34528	34535	_	_
228	26	up	up	RP	25	compound:prt	34536	34538	_	_
228	27	to	to	TO	29	case	34539	34541	_	_
228	28	3	3	CD	29	nummod	34542	34543	_	_
228	29	days	day	NNS	25	nmod	34544	34548	_	_
228	30	.	.	.	15	punct	34548	34549	_	_

229	1	Parotitis	Parotitis	NNP	11	nsubj	34550	34559	_	_
229	2	,	,	,	1	punct	34559	34560	_	_
229	3	rash	rash	NN	1	conj	34561	34565	_	_
229	4	,	,	,	1	punct	34565	34566	_	_
229	5	lymphadenopathy	lymphadenopathy	NN	1	conj	34567	34582	_	_
229	6	,	,	,	1	punct	34582	34583	_	_
229	7	and	and	CC	1	cc	34584	34587	_	_
229	8	joint	joint	JJ	9	amod	34588	34593	_	_
229	9	symptoms	symptom	NNS	1	conj	34594	34602	_	_
229	10	also	also	RB	11	advmod	34603	34607	_	_
229	11	occur	occur	VBP	0	ROOT	34608	34613	_	_
229	12	occasionally	occasionally	RB	11	advmod	34614	34626	_	_
229	13	after	after	IN	15	case	34627	34632	_	_
229	14	MMR	mmr	NN	15	compound	34633	34636	_	_
229	15	immunization	immunization	NN	11	nmod	34637	34649	_	_
229	16	.	.	.	11	punct	34649	34650	_	_

230	1	Pain	pain	NN	11	nsubj	34652	34656	_	_
230	2	and	and	CC	1	cc	34657	34660	_	_
230	3	redness	redness	NN	1	conj	34661	34668	_	_
230	4	at	at	IN	7	case	34669	34671	_	_
230	5	the	the	DT	7	det	34672	34675	_	_
230	6	injection	injection	NN	7	compound	34676	34685	_	_
230	7	site	site	NN	1	nmod	34686	34690	_	_
230	8	or	or	CC	7	cc	34691	34693	_	_
230	9	low-grade	low-grade	JJ	10	amod	34694	34703	_	_
230	10	fever	fever	NN	7	conj	34704	34709	_	_
230	11	occur	occur	VBP	0	ROOT	34710	34715	_	_
230	12	in	in	IN	14	case	34716	34718	_	_
230	13	10	10	CD	14	nummod	34719	34721	_	_
230	14	%	%	NN	11	nmod	34721	34722	_	_
230	15	or	or	CC	14	cc	34723	34725	_	_
230	16	more	more	JJR	14	conj	34726	34730	_	_
230	17	of	of	IN	18	case	34731	34733	_	_
230	18	vaccinees	vaccinee	NNS	14	nmod	34734	34743	_	_
230	19	.	.	.	11	punct	34743	34744	_	_

231	1	Rash	Rash	NNP	28	nsubj	34745	34749	_	_
231	2	,	,	,	28	punct	34749	34750	_	_
231	3	including	include	VBG	28	advcl	34751	34760	_	_
231	4	measles-like	measles-like	JJ	9	amod	34761	34773	_	_
231	5	,	,	,	4	punct	34773	34774	_	_
231	6	rubella-like	rubella-like	JJ	4	conj	34775	34787	_	_
231	7	and	and	CC	4	cc	34788	34791	_	_
231	8	varicella-like	varicella-like	JJ	4	conj	34792	34806	_	_
231	9	rash	rash	NN	3	dobj	34807	34811	_	_
231	10	,	,	,	3	punct	34811	34812	_	_
231	11	as	as	RB	3	cc	34813	34815	_	_
231	12	well	well	RB	11	mwe	34816	34820	_	_
231	13	as	as	IN	11	mwe	34821	34823	_	_
231	14	swelling	swell	VBG	3	conj	34824	34832	_	_
231	15	at	at	IN	18	case	34833	34835	_	_
231	16	the	the	DT	18	det	34836	34839	_	_
231	17	injection	injection	NN	18	compound	34840	34849	_	_
231	18	site	site	NN	14	nmod	34850	34854	_	_
231	19	and	and	CC	18	cc	34855	34858	_	_
231	20	moderate	moderate	JJ	21	amod	34859	34867	_	_
231	21	fever	fever	NN	18	conj	34868	34873	_	_
231	22	(	(	RB	23	advmod	34874	34875	_	_
231	23	greater	greater	JJR	18	amod	34875	34882	_	_
231	24	than	than	IN	26	case	34883	34887	_	_
231	25	39	39	CD	26	nummod	34888	34890	_	_
231	26	°C	°c	NN	14	nmod	34890	34892	_	_
231	27	)	)	CD	3	dobj	34892	34893	_	_
231	28	occur	occur	VBP	0	ROOT	34894	34899	_	_
231	29	in	in	IN	31	case	34900	34902	_	_
231	30	1	1	CD	31	nummod	34903	34904	B-persongroup-110149	_
231	31	%	%	NN	28	nmod	34904	34905	I-persongroup-110149	_
231	32	to	to	TO	36	case	34906	34908	I-persongroup-110149	_
231	33	less	less	JJR	35	advmod	34909	34913	I-persongroup-110149	_
231	34	than	than	IN	33	mwe	34914	34918	I-persongroup-110149	_
231	35	10	10	CD	36	nummod	34919	34921	I-persongroup-110149	_
231	36	%	%	NN	28	nmod	34921	34922	I-persongroup-110149	_
231	37	of	of	IN	38	case	34923	34925	I-persongroup-110149	_
231	38	vaccinees	vaccinee	NNS	36	nmod	34926	34935	I-persongroup-110149	_
231	39	.	.	.	28	punct	34935	34936	I-persongroup-110149	_

232	1	As	as	IN	3	case	34937	34939	_	_
232	2	varicella-like	varicella-like	JJ	3	amod	34940	34954	_	_
232	3	rashes	rash	NNS	24	nmod	34955	34961	_	_
232	4	that	that	WDT	5	nsubj	34962	34966	_	_
232	5	occur	occur	VBP	3	acl:relcl	34967	34972	_	_
232	6	within	within	IN	10	case	34973	34979	_	_
232	7	the	the	DT	10	det	34980	34983	_	_
232	8	first	first	JJ	10	amod	34984	34989	_	_
232	9	two	two	CD	10	nummod	34990	34993	_	_
232	10	weeks	week	NNS	5	nmod	34994	34999	_	_
232	11	after	after	IN	15	mark	35000	35005	_	_
232	12	immunization	immunization	NN	15	nsubjpass	35006	35018	_	_
232	13	may	may	MD	15	aux	35019	35022	_	_
232	14	be	be	VB	15	auxpass	35023	35025	_	_
232	15	caused	cause	VBN	5	advcl	35026	35032	_	_
232	16	by	by	IN	18	case	35033	35035	_	_
232	17	wild-type	wild-type	JJ	18	amod	35036	35045	_	_
232	18	virus	virus	NN	15	nmod	35046	35051	_	_
232	19	,	,	,	24	punct	35051	35052	_	_
232	20	health	health	NN	22	compound	35053	35059	B-persongroup-110150	_
232	21	care	care	NN	22	compound	35060	35064	I-persongroup-110150	_
232	22	providers	provider	NNS	24	nsubj	35065	35074	I-persongroup-110150	_
232	23	should	should	MD	24	aux	35075	35081	_	_
232	24	obtain	obtain	VB	0	ROOT	35082	35088	_	_
232	25	specimens	specimen	NNS	24	dobj	35089	35098	_	_
232	26	using	use	VBG	25	acl	35099	35104	_	_
232	27	viral	viral	JJ	29	amod	35105	35110	_	_
232	28	transport	transport	NN	29	compound	35111	35120	_	_
232	29	media	media	NNS	26	dobj	35121	35126	_	_
232	30	from	from	IN	32	case	35127	35131	_	_
232	31	a	a	DT	32	det	35132	35133	_	_
232	32	lesion	lesion	NN	26	nmod	35134	35140	_	_
232	33	to	to	TO	34	mark	35141	35143	_	_
232	34	ensure	ensure	VB	32	acl	35144	35150	_	_
232	35	varicella	varicella	NN	36	compound	35151	35160	_	_
232	36	disease	disease	NN	39	nsubjpass	35161	35168	_	_
232	37	is	be	VBZ	39	auxpass	35169	35171	_	_
232	38	not	not	RB	39	neg	35172	35175	_	_
232	39	confused	confuse	VBN	34	ccomp	35176	35184	_	_
232	40	with	with	IN	42	case	35185	35189	_	_
232	41	a	a	DT	42	det	35190	35191	_	_
232	42	reaction	reaction	NN	39	nmod	35192	35200	_	_
232	43	to	to	TO	44	case	35201	35203	_	_
232	44	vaccination	vaccination	NN	39	nmod	35204	35215	_	_
232	45	.	.	.	24	punct	35215	35216	_	_

233	1	Acute	acute	JJ	3	amod	35217	35222	_	_
233	2	transient	transient	JJ	3	amod	35223	35232	_	_
233	3	arthritis	arthritis	NN	7	nsubj	35233	35242	_	_
233	4	or	or	CC	3	cc	35243	35245	_	_
233	5	arthralgia	arthralgia	NN	3	conj	35246	35256	_	_
233	6	may	may	MD	7	aux	35257	35260	_	_
233	7	occur	occur	VB	0	ROOT	35261	35266	_	_
233	8	1	1	CD	10	compound	35267	35268	_	_
233	9	to	to	TO	10	dep	35269	35271	_	_
233	10	3	3	CD	11	nummod	35272	35273	_	_
233	11	weeks	week	NNS	7	nmod:tmod	35274	35279	_	_
233	12	after	after	IN	13	case	35280	35285	_	_
233	13	immunization	immunization	NN	7	nmod	35286	35298	_	_
233	14	with	with	IN	16	case	35299	35303	_	_
233	15	rubella-containing	rubella-containing	JJ	16	amod	35304	35322	_	_
233	16	vaccine	vaccine	NN	7	nmod	35323	35330	_	_
233	17	,	,	,	7	punct	35330	35331	_	_
233	18	lasts	last	VBZ	7	conj	35332	35337	_	_
233	19	for	for	IN	24	case	35338	35341	_	_
233	20	about	about	IN	24	case	35342	35347	_	_
233	21	1	1	CD	23	compound	35348	35349	_	_
233	22	to	to	TO	23	dep	35350	35352	_	_
233	23	3	3	CD	24	nummod	35353	35354	_	_
233	24	weeks	week	NNS	18	nmod	35355	35360	_	_
233	25	,	,	,	7	punct	35360	35361	_	_
233	26	and	and	CC	7	cc	35362	35365	_	_
233	27	rarely	rarely	RB	28	advmod	35366	35372	_	_
233	28	recurs	recur	VBZ	7	conj	35373	35379	_	_
233	29	.	.	.	7	punct	35379	35380	_	_

234	1	This	this	DT	4	nsubj	35381	35385	_	_
234	2	is	be	VBZ	4	cop	35386	35388	_	_
234	3	more	more	RBR	4	advmod	35389	35393	_	_
234	4	common	common	JJ	0	ROOT	35394	35400	_	_
234	5	in	in	IN	7	case	35401	35403	_	_
234	6	post-pubertal	post-pubertal	JJ	7	amod	35404	35417	B-persongroup-110151	_
234	7	females	female	NNS	4	nmod	35418	35425	I-persongroup-110151	_
234	8	,	,	,	4	punct	35425	35426	I-persongroup-110151	_
234	9	among	among	IN	12	mark	35427	35432	_	_
234	10	whom	whom	WP	12	dobj	35433	35437	_	_
234	11	arthralgia	arthralgia	FW	12	nsubj	35438	35448	_	_
234	12	develops	develop	VBZ	4	advcl	35449	35457	_	_
234	13	in	in	IN	15	case	35458	35460	_	_
234	14	25	25	CD	15	nummod	35461	35463	B-persongroup-110152	_
234	15	%	%	NN	12	nmod	35463	35464	I-persongroup-110152	_
234	16	and	and	CC	15	cc	35465	35468	_	_
234	17	arthritis	arthritis	NN	15	conj	35469	35478	_	_
234	18	in	in	IN	20	case	35479	35481	_	_
234	19	10	10	CD	20	nummod	35482	35484	B-persongroup-110153	_
234	20	%	%	NN	17	nmod	35484	35485	I-persongroup-110153	_
234	21	after	after	IN	22	case	35486	35491	_	_
234	22	immunization	immunization	NN	12	nmod	35492	35504	_	_
234	23	with	with	IN	25	case	35505	35509	_	_
234	24	rubella-containing	rubella-containing	JJ	25	amod	35510	35528	_	_
234	25	vaccine	vaccine	NN	22	nmod	35529	35536	_	_
234	26	.	.	.	4	punct	35536	35537	_	_

235	1	There	there	EX	2	expl	35538	35543	_	_
235	2	is	be	VBZ	0	ROOT	35544	35546	_	_
235	3	no	no	DT	4	neg	35547	35549	_	_
235	4	evidence	evidence	NN	2	nsubj	35550	35558	_	_
235	5	of	of	IN	7	case	35559	35561	_	_
235	6	increased	increase	VBN	7	amod	35562	35571	_	_
235	7	risk	risk	NN	4	nmod	35572	35576	_	_
235	8	of	of	IN	10	case	35577	35579	_	_
235	9	new	new	JJ	10	amod	35580	35583	_	_
235	10	onset	onset	NN	7	nmod	35584	35589	_	_
235	11	,	,	,	10	punct	35589	35590	_	_
235	12	chronic	chronic	JJ	13	amod	35591	35598	_	_
235	13	arthropathies	arthropathy	NNS	10	conj	35599	35612	_	_
235	14	or	or	CC	10	cc	35613	35615	_	_
235	15	neurologic	neurologic	JJ	16	amod	35616	35626	_	_
235	16	conditions	condition	NNS	10	conj	35627	35637	_	_
235	17	.	.	.	2	punct	35637	35638	_	_

236	1	Injection	injection	NN	3	compound	35639	35648	_	_
236	2	site	site	NN	3	compound	35649	35653	_	_
236	3	pain	pain	NN	12	nsubj	35654	35658	_	_
236	4	and	and	CC	3	cc	35659	35662	_	_
236	5	tenderness	tenderness	NN	3	conj	35663	35673	_	_
236	6	,	,	,	5	punct	35673	35674	_	_
236	7	urticaria	urticaria	NN	5	conj	35676	35685	_	_
236	8	,	,	,	5	punct	35685	35686	_	_
236	9	and	and	CC	5	cc	35687	35690	_	_
236	10	angioedema	angioedema	NN	5	conj	35691	35701	_	_
236	11	may	may	MD	12	aux	35702	35705	_	_
236	12	occur	occur	VB	0	ROOT	35706	35711	_	_
236	13	.	.	.	12	punct	35711	35712	_	_

237	1	Serious	serious	JJ	3	amod	35713	35720	_	_
237	2	adverse	adverse	JJ	3	amod	35721	35728	_	_
237	3	events	event	NNS	5	nsubj	35729	35735	_	_
237	4	are	be	VBP	5	cop	35736	35739	_	_
237	5	rare	rare	JJ	0	ROOT	35740	35744	_	_
237	6	following	follow	VBG	7	case	35745	35754	_	_
237	7	immunization	immunization	NN	5	nmod	35755	35767	_	_
237	8	and	and	CC	5	cc	35768	35771	_	_
237	9	,	,	,	5	punct	35771	35772	_	_
237	10	in	in	IN	12	case	35774	35776	_	_
237	11	most	most	JJS	12	amod	35777	35781	B-persongroup-110154	_
237	12	cases	case	NNS	16	nmod	35782	35787	I-persongroup-110154	_
237	13	,	,	,	16	punct	35787	35788	I-persongroup-110154	_
237	14	data	datum	NNS	16	nsubj	35789	35793	_	_
237	15	are	be	VBP	16	cop	35794	35797	_	_
237	16	insufficient	insufficient	JJ	5	conj	35798	35810	_	_
237	17	to	to	TO	18	mark	35811	35813	_	_
237	18	determine	determine	VB	16	xcomp	35814	35823	_	_
237	19	a	a	DT	21	det	35824	35825	_	_
237	20	causal	causal	JJ	21	amod	35826	35832	_	_
237	21	association	association	NN	18	dobj	35833	35844	_	_
237	22	.	.	.	5	punct	35844	35845	_	_

238	1	As	as	IN	4	case	35846	35848	_	_
238	2	with	with	IN	4	case	35849	35853	_	_
238	3	other	other	JJ	4	amod	35855	35860	_	_
238	4	vaccines	vaccine	NNS	15	nmod	35861	35869	_	_
238	5	,	,	,	15	punct	35869	35870	_	_
238	6	anaphylaxis	anaphylaxis	NN	8	compound	35871	35882	_	_
238	7	following	follow	VBG	8	amod	35883	35892	_	_
238	8	vaccination	vaccination	NN	15	nsubj	35893	35904	_	_
238	9	with	with	IN	13	case	35905	35909	_	_
238	10	MMR	mmr	NN	13	compound	35910	35913	_	_
238	11	or	or	CC	10	cc	35914	35916	_	_
238	12	MMRV	mmrv	NN	10	conj	35917	35921	_	_
238	13	vaccine	vaccine	NN	8	nmod	35922	35929	_	_
238	14	may	may	MD	15	aux	35930	35933	_	_
238	15	occur	occur	VB	0	ROOT	35935	35940	_	_
238	16	but	but	CC	15	cc	35941	35944	_	_
238	17	is	be	VBZ	19	cop	35945	35947	_	_
238	18	very	very	RB	19	advmod	35948	35952	_	_
238	19	rare	rare	JJ	15	conj	35953	35957	_	_
238	20	.	.	.	15	punct	35957	35958	_	_

239	1	Immune	immune	JJ	5	amod	35959	35965	_	_
239	2	Thrombocytopenic	Thrombocytopenic	NNP	5	compound	35967	35983	_	_
239	3	Purpura	Purpura	NNP	5	compound	35984	35991	_	_
239	4	(	(	CD	5	nummod	35992	35993	_	_
239	5	ITP	ITP	NNP	10	nsubj	35993	35996	_	_
239	6	)	)	CD	5	nmod:tmod	35996	35997	_	_
239	7	Rarely	rarely	RB	6	advmod	36000	36006	_	_
239	8	,	,	,	5	punct	36006	36007	_	_
239	9	ITP	itp	NN	5	appos	36008	36011	_	_
239	10	occurs	occur	VBZ	0	ROOT	36012	36018	_	_
239	11	within	within	IN	13	case	36019	36025	_	_
239	12	6	6	CD	13	nummod	36026	36027	_	_
239	13	weeks	week	NNS	10	nmod	36028	36033	_	_
239	14	after	after	IN	15	case	36034	36039	_	_
239	15	immunization	immunization	NN	10	nmod	36040	36052	_	_
239	16	with	with	IN	20	case	36053	36057	_	_
239	17	MMR	mmr	NN	20	compound	36059	36062	_	_
239	18	or	or	CC	17	cc	36063	36065	_	_
239	19	MMRV	mmrv	NN	17	conj	36066	36070	_	_
239	20	vaccine	vaccine	NN	15	nmod	36071	36078	_	_
239	21	.	.	.	10	punct	36078	36079	_	_

240	1	In	in	IN	3	case	36080	36082	_	_
240	2	most	most	JJS	3	amod	36083	36087	B-persongroup-110155	_
240	3	children	child	NNS	7	nmod	36088	36096	I-persongroup-110155	_
240	4	,	,	,	7	punct	36096	36097	I-persongroup-110155	_
240	5	post-immunization	post-immunization	JJ	6	amod	36098	36115	_	_
240	6	thrombocytopenia	thrombocytopenia	NN	7	nsubj	36116	36132	_	_
240	7	resolves	resolve	VBZ	0	ROOT	36134	36142	_	_
240	8	within	within	IN	10	case	36143	36149	_	_
240	9	three	three	CD	10	nummod	36150	36155	_	_
240	10	months	month	NNS	7	nmod	36156	36162	_	_
240	11	without	without	IN	13	case	36163	36170	_	_
240	12	serious	serious	JJ	13	amod	36171	36178	_	_
240	13	complications	complication	NNS	7	nmod	36179	36192	_	_
240	14	.	.	.	7	punct	36192	36193	_	_

241	1	In	in	IN	2	case	36194	36196	_	_
241	2	individuals	individual	NNS	19	nmod	36197	36208	B-persongroup-110157	_
241	3	who	who	WP	4	nsubj	36209	36212	_	_
241	4	experienced	experience	VBD	2	acl:relcl	36213	36224	_	_
241	5	ITP	itp	NN	4	dobj	36225	36228	_	_
241	6	with	with	IN	9	case	36229	36233	_	_
241	7	the	the	DT	9	det	36234	36237	_	_
241	8	first	first	JJ	9	amod	36239	36244	_	_
241	9	dose	dose	NN	4	nmod	36245	36249	_	_
241	10	of	of	IN	11	case	36250	36252	_	_
241	11	MMR	mmr	NN	9	nmod	36253	36256	_	_
241	12	or	or	CC	11	cc	36257	36259	_	_
241	13	MMRV	mmrv	NN	11	conj	36260	36264	_	_
241	14	,	,	,	19	punct	36264	36265	_	_
241	15	serologic	serologic	JJ	16	amod	36266	36275	_	_
241	16	status	status	NN	19	nsubjpass	36276	36282	_	_
241	17	may	may	MD	19	aux	36283	36286	_	_
241	18	be	be	VB	19	auxpass	36287	36289	_	_
241	19	evaluated	evaluate	VBN	0	ROOT	36290	36299	_	_
241	20	to	to	TO	21	mark	36300	36302	_	_
241	21	determine	determine	VB	19	xcomp	36303	36312	_	_
241	22	whether	whether	IN	29	mark	36314	36321	_	_
241	23	an	a	DT	25	det	36322	36324	_	_
241	24	additional	additional	JJ	25	amod	36325	36335	_	_
241	25	dose	dose	NN	29	nsubjpass	36336	36340	_	_
241	26	of	of	IN	27	case	36341	36343	_	_
241	27	vaccine	vaccine	NN	25	nmod	36344	36351	_	_
241	28	is	be	VBZ	29	auxpass	36352	36354	_	_
241	29	needed	need	VBN	21	ccomp	36355	36361	_	_
241	30	.	.	.	19	punct	36361	36362	_	_

242	1	The	the	DT	3	det	36363	36366	_	_
242	2	potential	potential	JJ	3	amod	36367	36376	_	_
242	3	risk	risk	NN	10	nsubjpass	36377	36381	_	_
242	4	to	to	TO	5	mark	36382	36384	_	_
242	5	benefit	benefit	VB	3	acl	36385	36392	_	_
242	6	ratio	ratio	NN	5	dobj	36394	36399	_	_
242	7	should	should	MD	10	aux	36400	36406	_	_
242	8	be	be	VB	10	auxpass	36407	36409	_	_
242	9	carefully	carefully	RB	10	advmod	36410	36419	_	_
242	10	evaluated	evaluate	VBN	0	ROOT	36420	36429	_	_
242	11	before	before	IN	12	mark	36430	36436	_	_
242	12	considering	consider	VBG	10	advcl	36437	36448	_	_
242	13	vaccination	vaccination	NN	12	dobj	36449	36460	_	_
242	14	in	in	IN	16	case	36461	36463	_	_
242	15	such	such	JJ	16	amod	36464	36468	B-persongroup-110156	_
242	16	cases	case	NNS	12	nmod	36470	36475	I-persongroup-110156	_
242	17	.	.	.	10	punct	36475	36476	I-persongroup-110156	_

243	1	Encephalitis	encephalitis	NN	2	compound	36478	36490	_	_
243	2	Encephalitis	encephalitis	NN	5	nsubjpass	36493	36505	_	_
243	3	has	have	VBZ	5	aux	36506	36509	_	_
243	4	been	be	VBN	5	auxpass	36510	36514	_	_
243	5	reported	report	VBN	0	ROOT	36515	36523	_	_
243	6	in	in	IN	7	case	36524	36526	_	_
243	7	association	association	NN	5	nmod	36527	36538	_	_
243	8	with	with	IN	9	case	36540	36544	_	_
243	9	administration	administration	NN	5	nmod	36545	36559	_	_
243	10	of	of	IN	12	case	36560	36562	_	_
243	11	measles	measles	NNS	12	compound	36563	36570	_	_
243	12	vaccine	vaccine	NN	9	nmod	36571	36578	_	_
243	13	in	in	IN	15	case	36579	36581	_	_
243	14	approximately	approximately	RB	15	advmod	36582	36595	_	_
243	15	1	1	CD	12	nmod	36596	36597	_	_
243	16	per	per	IN	18	case	36598	36601	_	_
243	17	million	million	CD	18	nummod	36602	36609	_	_
243	18	doses	dose	NNS	15	nmod	36610	36615	_	_
243	19	distributed	distribute	VBN	18	acl	36617	36628	_	_
243	20	in	in	IN	22	case	36629	36631	_	_
243	21	North	North	NNP	22	compound	36632	36637	B-persongroup-110158	_
243	22	America	America	NNP	19	nmod	36638	36645	I-persongroup-110158	_
243	23	which	which	WDT	26	nsubj	36646	36651	_	_
243	24	is	be	VBZ	26	cop	36652	36654	_	_
243	25	much	much	RB	26	advmod	36655	36659	_	_
243	26	lower	lower	JJR	22	acl:relcl	36661	36666	_	_
243	27	than	than	IN	29	mark	36667	36671	_	_
243	28	that	that	DT	29	nsubj	36672	36676	_	_
243	29	observed	observe	VBN	26	advcl	36677	36685	_	_
243	30	with	with	IN	33	case	36686	36690	_	_
243	31	natural	natural	JJ	33	amod	36691	36698	_	_
243	32	measles	measles	NNS	33	compound	36699	36706	_	_
243	33	disease	disease	NN	29	nmod	36707	36714	_	_
243	34	(	(	NN	29	dobj	36715	36716	_	_
243	35	1	1	CD	34	nummod	36716	36717	_	_
243	36	per	per	IN	38	case	36718	36721	_	_
243	37	1,000	1,000	CD	38	nummod	36722	36727	_	_
243	38	cases	case	NNS	34	nmod	36728	36733	_	_
243	39	)	)	CD	38	dep	36733	36734	_	_
243	40	.	.	.	5	punct	36734	36735	_	_

244	1	Febrile	febrile	JJ	2	amod	36737	36744	_	_
244	2	seizures	seizure	NNS	6	nsubj	36745	36753	_	_
244	3	Recent	recent	JJ	4	amod	36756	36762	_	_
244	4	studies	study	NNS	2	dep	36763	36770	_	_
244	5	have	have	VBP	6	aux	36771	36775	_	_
244	6	found	find	VBN	0	ROOT	36776	36781	_	_
244	7	a	a	DT	9	det	36782	36783	_	_
244	8	higher	higher	JJR	9	amod	36784	36790	_	_
244	9	risk	risk	NN	6	dobj	36791	36795	_	_
244	10	of	of	IN	12	case	36796	36798	_	_
244	11	febrile	febrile	JJ	12	amod	36799	36806	_	_
244	12	seizures	seizure	NNS	9	nmod	36807	36815	_	_
244	13	with	with	IN	16	case	36816	36820	_	_
244	14	the	the	DT	16	det	36821	36824	_	_
244	15	first	first	JJ	16	amod	36825	36830	_	_
244	16	dose	dose	NN	6	nmod	36831	36835	_	_
244	17	of	of	IN	20	case	36836	36838	_	_
244	18	a	a	DT	20	det	36839	36840	_	_
244	19	MMRV	mmrv	NN	20	compound	36841	36845	_	_
244	20	vaccine	vaccine	NN	16	nmod	36846	36853	_	_
244	21	(	(	CD	22	nummod	36854	36855	_	_
244	22	ProQuad	ProQuad	NNP	20	dep	36855	36862	_	_
244	23	®	®	CD	22	nummod	36862	36863	_	_
244	24	,	,	,	6	punct	36863	36864	_	_
244	25	not	not	RB	26	neg	36865	36868	_	_
244	26	authorized	authorize	VBN	6	dep	36869	36879	_	_
244	27	for	for	IN	28	case	36880	36883	_	_
244	28	use	use	NN	26	nmod	36884	36887	_	_
244	29	in	in	IN	30	case	36888	36890	_	_
244	30	Canada	Canada	NNP	28	nmod	36891	36897	B-persongroup-110159	_
244	31	)	)	CD	30	nummod	36897	36898	I-persongroup-110159	_
244	32	when	when	WRB	33	advmod	36899	36903	_	_
244	33	compared	compare	VBN	26	advcl	36904	36912	_	_
244	34	to	to	TO	37	case	36913	36915	_	_
244	35	the	the	DT	37	det	36916	36919	_	_
244	36	concomitant	concomitant	JJ	37	amod	36920	36931	_	_
244	37	administration	administration	NN	33	nmod	36932	36946	_	_
244	38	of	of	IN	43	case	36947	36949	_	_
244	39	MMR	mmr	NN	43	compound	36950	36953	_	_
244	40	and	and	CC	39	cc	36954	36957	_	_
244	41	univalent	univalent	JJ	39	conj	36958	36967	_	_
244	42	varicella	varicella	NN	43	compound	36968	36977	_	_
244	43	vaccine	vaccine	NN	37	nmod	36978	36985	_	_
244	44	.	.	.	6	punct	36985	36986	_	_

245	1	Data	datum	NNS	9	nsubj	36987	36991	_	_
245	2	from	from	IN	5	case	36992	36996	_	_
245	3	the	the	DT	5	det	36997	37000	_	_
245	4	United	United	NNP	5	compound	37001	37007	B-persongroup-110160	_
245	5	States	States	NNPS	1	nmod	37008	37014	I-persongroup-110160	_
245	6	(	(	CD	7	nummod	37015	37016	I-persongroup-110160	_
245	7	US	US	NNP	1	dep	37016	37018	I-persongroup-110160	_
245	8	)	)	CD	7	nummod	37018	37019	I-persongroup-110160	_
245	9	estimated	estimate	VBD	0	ROOT	37020	37029	_	_
245	10	that	that	IN	31	mark	37030	37034	_	_
245	11	the	the	DT	12	det	37035	37038	_	_
245	12	risk	risk	NN	31	nsubj	37039	37043	_	_
245	13	of	of	IN	15	case	37044	37046	_	_
245	14	febrile	febrile	JJ	15	amod	37047	37054	_	_
245	15	seizures	seizure	NNS	12	nmod	37055	37063	_	_
245	16	in	in	IN	21	case	37064	37066	_	_
245	17	the	the	DT	21	det	37067	37070	_	_
245	18	5	5	CD	20	compound	37071	37072	_	_
245	19	to	to	TO	20	dep	37073	37075	_	_
245	20	12	12	CD	21	nummod	37076	37078	_	_
245	21	days	day	NNS	15	nmod	37079	37083	_	_
245	22	following	follow	VBG	25	case	37084	37093	_	_
245	23	the	the	DT	25	det	37094	37097	_	_
245	24	first	first	JJ	25	amod	37098	37103	_	_
245	25	dose	dose	NN	21	nmod	37104	37108	_	_
245	26	of	of	IN	29	case	37109	37111	_	_
245	27	this	this	DT	29	det	37112	37116	_	_
245	28	MMRV	mmrv	NN	29	compound	37117	37121	_	_
245	29	vaccine	vaccine	NN	25	nmod	37122	37129	_	_
245	30	is	be	VBZ	31	cop	37130	37132	_	_
245	31	1	1	CD	9	ccomp	37133	37134	B-persongroup-110161	_
245	32	for	for	IN	34	case	37135	37138	I-persongroup-110161	_
245	33	every	every	DT	34	det	37139	37144	I-persongroup-110161	_
245	34	2,600	2,600	CD	31	nmod	37145	37150	I-persongroup-110161	_
245	35	vaccinated	vaccinate	VBN	34	acl	37151	37161	I-persongroup-110161	_
245	36	children	child	NNS	35	dobj	37162	37170	I-persongroup-110161	_
245	37	aged	aged	JJ	36	amod	37171	37175	_	_
245	38	12	12	CD	40	compound	37176	37178	_	_
245	39	to	to	TO	40	dep	37179	37181	_	_
245	40	23	23	CD	41	nummod	37182	37184	_	_
245	41	months	month	NNS	35	nmod:tmod	37185	37191	_	_
245	42	.	.	.	9	punct	37191	37192	_	_

246	1	Experience	experience	NN	11	nsubj	37193	37203	_	_
246	2	with	with	IN	5	case	37204	37208	_	_
246	3	the	the	DT	5	det	37209	37212	_	_
246	4	MMRV	mmrv	NN	5	compound	37213	37217	_	_
246	5	vaccine	vaccine	NN	1	nmod	37218	37225	_	_
246	6	available	available	JJ	5	amod	37226	37235	_	_
246	7	in	in	IN	8	case	37236	37238	_	_
246	8	Canada	Canada	NNP	6	nmod	37239	37245	B-persongroup-110162	_
246	9	is	be	VBZ	11	cop	37246	37248	_	_
246	10	more	more	RBR	11	advmod	37249	37253	_	_
246	11	limited	limited	JJ	0	ROOT	37254	37261	_	_
246	12	;	;	:	11	punct	37261	37262	_	_
246	13	however	however	RB	17	advmod	37263	37270	_	_
246	14	,	,	,	17	punct	37270	37271	_	_
246	15	one	one	CD	16	nummod	37272	37275	_	_
246	16	study	study	NN	17	nsubj	37276	37281	_	_
246	17	showed	show	VBD	11	parataxis	37282	37288	_	_
246	18	an	a	DT	20	det	37289	37291	_	_
246	19	additional	additional	JJ	20	amod	37292	37302	_	_
246	20	risk	risk	NN	17	dobj	37303	37307	_	_
246	21	of	of	IN	23	case	37308	37310	_	_
246	22	febrile	febrile	JJ	23	amod	37311	37318	_	_
246	23	seizures	seizure	NNS	20	nmod	37319	37327	_	_
246	24	with	with	IN	26	case	37328	37332	_	_
246	25	MMRV	mmrv	NN	26	compound	37333	37337	_	_
246	26	vaccine	vaccine	NN	23	nmod	37338	37345	_	_
246	27	compared	compare	VBN	29	case	37346	37354	_	_
246	28	to	to	TO	29	case	37355	37357	_	_
246	29	MMR	MMR	NNP	17	advcl	37358	37361	_	_
246	30	and	and	CC	29	cc	37362	37365	_	_
246	31	univalent	univalent	JJ	33	amod	37366	37375	_	_
246	32	varicella	varicella	NN	33	compound	37376	37385	_	_
246	33	vaccines	vaccine	NNS	29	conj	37386	37394	_	_
246	34	given	give	VBN	38	case	37395	37400	_	_
246	35	as	as	IN	38	case	37401	37403	_	_
246	36	two	two	CD	38	nummod	37404	37407	_	_
246	37	separate	separate	JJ	38	amod	37408	37416	_	_
246	38	products	product	NNS	17	advcl	37417	37425	_	_
246	39	administered	administer	VBN	38	acl	37426	37438	_	_
246	40	concomitantly	concomitantly	RB	39	advmod	37439	37452	_	_
246	41	.	.	.	11	punct	37452	37453	_	_

247	1	The	the	DT	2	det	37454	37457	_	_
247	2	risk	risk	NN	8	nsubj	37458	37462	_	_
247	3	with	with	IN	6	case	37463	37467	_	_
247	4	the	the	DT	6	det	37468	37471	_	_
247	5	Canadian	canadian	JJ	6	amod	37472	37480	_	_
247	6	vaccine	vaccine	NN	2	nmod	37481	37488	_	_
247	7	was	be	VBD	8	cop	37489	37492	_	_
247	8	smaller	smaller	JJR	0	ROOT	37493	37500	_	_
247	9	than	than	IN	11	case	37501	37505	_	_
247	10	the	the	DT	11	det	37506	37509	_	_
247	11	risk	risk	NN	8	nmod	37510	37514	_	_
247	12	found	find	VBN	11	acl	37515	37520	_	_
247	13	with	with	IN	16	case	37521	37525	_	_
247	14	the	the	DT	16	det	37526	37529	_	_
247	15	US	US	NNP	16	compound	37530	37532	_	_
247	16	product	product	NN	12	nmod	37533	37540	_	_
247	17	.	.	.	8	punct	37540	37541	_	_

248	1	Close	close	JJ	2	amod	37542	37547	_	_
248	2	surveillance	surveillance	NN	7	nsubj	37548	37560	_	_
248	3	and	and	CC	2	cc	37561	37564	_	_
248	4	further	further	JJ	5	amod	37565	37572	_	_
248	5	investigation	investigation	NN	2	conj	37573	37586	_	_
248	6	are	be	VBP	7	cop	37587	37590	_	_
248	7	underway	underway	NN	0	ROOT	37591	37599	_	_
248	8	.	.	.	7	punct	37599	37600	_	_

249	1	Anaphylactic	anaphylactic	JJ	2	amod	37602	37614	_	_
249	2	reactions	reaction	NNS	9	nsubjpass	37615	37624	_	_
249	3	,	,	,	9	punct	37624	37625	_	_
249	4	although	although	IN	5	mark	37626	37634	_	_
249	5	rare	rare	JJ	9	dep	37635	37639	_	_
249	6	,	,	,	9	punct	37639	37640	_	_
249	7	have	have	VBP	9	aux	37641	37645	_	_
249	8	been	be	VBN	9	auxpass	37647	37651	_	_
249	9	reported	report	VBN	0	ROOT	37652	37660	_	_
249	10	following	follow	VBG	12	case	37661	37670	_	_
249	11	the	the	DT	12	det	37671	37674	_	_
249	12	injection	injection	NN	9	nmod	37675	37684	_	_
249	13	of	of	IN	16	case	37685	37687	_	_
249	14	human	human	JJ	16	amod	37688	37693	_	_
249	15	immune	immune	JJ	16	amod	37694	37700	_	_
249	16	globulin	globulin	NN	12	nmod	37701	37709	_	_
249	17	.	.	.	9	punct	37709	37710	_	_

250	1	In	in	IN	3	case	37712	37714	_	_
250	2	the	the	DT	3	det	37715	37718	_	_
250	3	mid	mid	JJ	13	nmod	37719	37722	_	_
250	4	to	to	TO	6	case	37723	37725	_	_
250	5	late	late	JJ	6	amod	37726	37730	_	_
250	6	1990s	1990	NNS	3	nmod	37731	37736	_	_
250	7	,	,	,	13	punct	37736	37737	_	_
250	8	researchers	researcher	NNS	13	nsubj	37738	37749	B-persongroup-110163	_
250	9	from	from	IN	12	case	37750	37754	_	_
250	10	the	the	DT	12	det	37755	37758	B-persongroup-110164	_
250	11	United	United	NNP	12	compound	37759	37765	I-persongroup-110164	_
250	12	Kingdom	Kingdom	NNP	8	nmod	37766	37773	I-persongroup-110164	_
250	13	reported	report	VBD	0	ROOT	37774	37782	_	B-expressionNeg-110165:110163-persongroup
250	14	an	a	DT	15	det	37783	37785	_	I-expressionNeg-110165
250	15	association	association	NN	13	dobj	37786	37797	_	I-expressionNeg-110165
250	16	between	between	IN	18	case	37798	37805	_	I-expressionNeg-110165
250	17	MMR	MMR	NNP	18	compound	37806	37809	_	I-expressionNeg-110165
250	18	vaccine	vaccine	NN	15	nmod	37810	37817	_	I-expressionNeg-110165
250	19	and	and	CC	18	cc	37818	37821	_	I-expressionNeg-110165
250	20	inflammatory	inflammatory	JJ	22	amod	37822	37834	_	I-expressionNeg-110165
250	21	bowel	bowel	NN	22	compound	37835	37840	_	I-expressionNeg-110165
250	22	disease	disease	NN	18	conj	37841	37848	_	I-expressionNeg-110165
250	23	,	,	,	18	punct	37848	37849	_	I-expressionNeg-110165
250	24	and	and	CC	18	cc	37850	37853	_	I-expressionNeg-110165
250	25	MMR	mmr	NN	26	compound	37854	37857	_	I-expressionNeg-110165
250	26	vaccine	vaccine	NN	18	conj	37858	37865	_	I-expressionNeg-110165
250	27	and	and	CC	26	cc	37866	37869	_	I-expressionNeg-110165
250	28	autism	autism	NN	26	conj	37870	37876	_	I-expressionNeg-110165
250	29	.	.	.	13	punct	37876	37877	_	I-expressionNeg-110165

251	1	Rigorous	rigorous	JJ	3	amod	37878	37886	_	_
251	2	scientific	scientific	JJ	3	amod	37887	37897	_	_
251	3	studies	study	NNS	11	nsubjpass	37898	37905	_	_
251	4	and	and	CC	3	cc	37906	37909	_	_
251	5	reviews	review	NNS	3	conj	37910	37917	_	_
251	6	of	of	IN	8	case	37918	37920	_	_
251	7	the	the	DT	8	det	37921	37924	_	_
251	8	evidence	evidence	NN	3	nmod	37925	37933	_	_
251	9	have	have	VBP	11	aux	37934	37938	_	_
251	10	been	be	VBN	11	auxpass	37939	37943	_	_
251	11	done	do	VBN	0	ROOT	37944	37948	_	_
251	12	worldwide	worldwide	RB	11	advmod	37949	37958	_	_
251	13	,	,	,	11	punct	37958	37959	_	_
251	14	and	and	CC	11	cc	37960	37963	_	_
251	15	there	there	EX	16	expl	37964	37969	_	_
251	16	is	be	VBZ	11	conj	37970	37972	_	_
251	17	now	now	RB	16	advmod	37973	37976	_	_
251	18	considerable	considerable	JJ	19	amod	37977	37989	_	_
251	19	evidence	evidence	NN	16	nsubj	37990	37998	_	_
251	20	to	to	TO	21	mark	37999	38001	_	_
251	21	refute	refute	VB	19	acl	38002	38008	_	_
251	22	those	those	DT	23	det	38009	38014	_	_
251	23	claims	claim	NNS	21	dobj	38015	38021	_	_
251	24	.	.	.	11	punct	38021	38022	_	_

252	1	In	in	IN	2	case	38023	38025	_	_
252	2	2010	2010	CD	17	nmod	38026	38030	_	_
252	3	,	,	,	17	punct	38030	38031	_	_
252	4	the	the	DT	6	det	38032	38035	_	_
252	5	original	original	JJ	6	amod	38036	38044	_	_
252	6	study	study	NN	17	nsubjpass	38045	38050	_	_
252	7	suggesting	suggest	VBG	6	acl	38051	38061	_	_
252	8	a	a	DT	9	det	38062	38063	_	_
252	9	link	link	NN	7	dobj	38064	38068	_	_
252	10	between	between	IN	13	case	38069	38076	_	_
252	11	the	the	DT	13	det	38077	38080	_	_
252	12	MMR	mmr	NN	13	compound	38081	38084	_	_
252	13	vaccine	vaccine	NN	9	nmod	38085	38092	_	_
252	14	and	and	CC	13	cc	38093	38096	_	_
252	15	autism	autism	NN	13	conj	38097	38103	_	_
252	16	was	be	VBD	17	auxpass	38104	38107	_	_
252	17	found	find	VBN	0	ROOT	38108	38113	_	_
252	18	to	to	TO	20	mark	38114	38116	_	_
252	19	be	be	VB	20	cop	38117	38119	_	_
252	20	fraudulent	fraudulent	JJ	17	xcomp	38120	38130	_	_
252	21	and	and	CC	17	cc	38131	38134	_	_
252	22	was	be	VBD	23	auxpass	38135	38138	_	_
252	23	retracted	retract	VBN	17	conj	38139	38148	_	_
252	24	.	.	.	17	punct	38148	38149	_	_

253	1	Vaccine	vaccine	NN	2	compound	38150	38157	B-persongroup-110166	_
253	2	providers	provider	NNS	4	nsubjpass	38158	38167	I-persongroup-110166	_
253	3	are	be	VBP	4	auxpass	38169	38172	_	_
253	4	asked	ask	VBN	0	ROOT	38173	38178	_	_
253	5	to	to	TO	6	mark	38179	38181	_	_
253	6	report	report	VB	4	xcomp	38182	38188	_	_
253	7	the	the	DT	9	det	38189	38192	_	_
253	8	following	follow	VBG	9	amod	38193	38202	_	_
253	9	AEFI	aefi	NN	6	dobj	38203	38207	_	_
253	10	in	in	IN	11	case	38208	38210	_	_
253	11	particular	particular	JJ	9	nmod	38211	38221	_	_
253	12	,	,	,	9	punct	38221	38222	_	_
253	13	through	through	IN	17	case	38223	38230	_	_
253	14	local	local	JJ	17	amod	38231	38236	B-persongroup-110167	_
253	15	public	public	JJ	17	amod	38237	38243	I-persongroup-110167	_
253	16	health	health	NN	17	compound	38245	38251	I-persongroup-110167	_
253	17	officials	official	NNS	9	nmod	38252	38261	I-persongroup-110167	_
253	18	:	:	:	9	punct	38261	38262	I-persongroup-110167	_
253	19	Febrile	febrile	NN	20	compound	38263	38270	_	_
253	20	seizures	seizure	NNS	9	dep	38272	38280	_	_
253	21	within	within	IN	23	case	38281	38287	_	_
253	22	30	30	CD	23	nummod	38288	38290	_	_
253	23	days	day	NNS	20	nmod	38291	38295	_	_
253	24	after	after	IN	25	case	38296	38301	_	_
253	25	vaccination	vaccination	NN	6	nmod	38302	38313	_	_
253	26	with	with	IN	30	case	38314	38318	_	_
253	27	MMR	mmr	NN	30	compound	38319	38322	_	_
253	28	or	or	CC	27	cc	38323	38325	_	_
253	29	MMRV	mmrv	NN	27	conj	38326	38330	_	_
253	30	vaccine	vaccine	NN	6	nmod	38331	38338	_	_
253	31	.	.	.	4	punct	38338	38339	_	_

254	1	Varicella	varicella	NN	0	ROOT	38341	38350	_	_
254	2	that	that	WDT	5	nsubj	38352	38356	_	_
254	3	is	be	VBZ	5	cop	38357	38359	_	_
254	4	moderate	moderate	JJ	5	amod	38360	38368	_	_
254	5	(	(	NN	1	acl:relcl	38369	38370	_	_
254	6	50	50	CD	8	compound	38370	38372	_	_
254	7	to	to	TO	8	dep	38373	38375	_	_
254	8	500	500	CD	9	nummod	38376	38379	_	_
254	9	lesions	lesion	NNS	5	nmod	38380	38387	_	_
254	10	)	)	CD	9	dep	38387	38388	_	_
254	11	or	or	CC	10	cc	38389	38391	_	_
254	12	severe	severe	JJ	13	amod	38392	38398	_	_
254	13	(	(	NN	10	conj	38399	38400	_	_
254	14	more	more	RBR	16	advmod	38400	38404	_	_
254	15	than	than	IN	14	mwe	38405	38409	_	_
254	16	500	500	CD	18	nummod	38410	38413	_	_
254	17	vesicular	vesicular	JJ	18	amod	38414	38423	_	_
254	18	lesions	lesion	NNS	13	dep	38424	38431	_	_
254	19	or	or	CC	13	cc	38433	38435	_	_
254	20	associated	associate	VBN	21	amod	38436	38446	_	_
254	21	complications	complication	NNS	13	conj	38447	38460	_	_
254	22	or	or	CC	21	cc	38461	38463	_	_
254	23	hospital	hospital	NN	25	compound	38464	38472	_	_
254	24	admission	admission	NN	25	compound	38473	38482	_	_
254	25	)	)	NN	21	conj	38482	38483	_	_
254	26	and	and	CC	5	cc	38484	38487	_	_
254	27	occurs	occur	VBZ	5	conj	38488	38494	_	_
254	28	7	7	CD	30	compound	38495	38496	_	_
254	29	to	to	TO	30	dep	38497	38499	_	_
254	30	21	21	CD	31	nummod	38500	38502	_	_
254	31	days	day	NNS	27	nmod:tmod	38503	38507	_	_
254	32	after	after	IN	33	case	38509	38514	_	_
254	33	vaccination	vaccination	NN	27	nmod	38515	38526	_	_
254	34	with	with	IN	36	case	38527	38531	_	_
254	35	MMRV	mmrv	NN	36	compound	38532	38536	_	_
254	36	vaccine	vaccine	NN	33	nmod	38537	38544	_	_
254	37	.	.	.	1	punct	38544	38545	_	_

255	1	Any	any	DT	6	det	38546	38549	_	_
255	2	serious	serious	JJ	6	amod	38551	38558	_	_
255	3	or	or	CC	2	cc	38559	38561	_	_
255	4	unexpected	unexpected	JJ	2	conj	38562	38572	_	_
255	5	adverse	adverse	JJ	6	amod	38573	38580	_	_
255	6	event	event	NN	7	nsubj	38581	38586	_	_
255	7	felt	feel	VBD	0	ROOT	38587	38591	_	_
255	8	to	to	TO	11	mark	38592	38594	_	_
255	9	be	be	VB	11	cop	38595	38597	_	_
255	10	temporally	temporally	RB	11	advmod	38598	38608	_	_
255	11	related	related	JJ	7	xcomp	38609	38616	_	_
255	12	to	to	TO	13	case	38617	38619	_	_
255	13	vaccination	vaccination	NN	11	nmod	38621	38632	_	_
255	14	.	.	.	7	punct	38632	38633	_	_

256	1	An	a	DT	3	det	38634	38636	_	_
256	2	unexpected	unexpected	JJ	3	amod	38637	38647	_	_
256	3	AEFI	aefi	NN	6	nsubj	38648	38652	_	_
256	4	is	be	VBZ	6	cop	38653	38655	_	_
256	5	an	a	DT	6	det	38656	38658	_	_
256	6	event	event	NN	0	ROOT	38659	38664	_	_
256	7	that	that	WDT	10	nsubjpass	38665	38669	_	_
256	8	is	be	VBZ	10	auxpass	38670	38672	_	_
256	9	not	not	RB	10	neg	38673	38676	_	_
256	10	listed	list	VBN	6	acl:relcl	38677	38683	_	_
256	11	in	in	IN	14	case	38684	38686	_	_
256	12	available	available	JJ	14	amod	38687	38696	_	_
256	13	product	product	NN	14	compound	38698	38705	_	_
256	14	information	information	NN	10	nmod	38706	38717	_	_
256	15	but	but	CC	10	cc	38718	38721	_	_
256	16	may	may	MD	18	aux	38722	38725	_	_
256	17	be	be	VB	18	cop	38726	38728	_	_
256	18	due	due	JJ	10	conj	38729	38732	_	_
256	19	to	to	TO	21	case	38733	38735	_	_
256	20	the	the	DT	21	det	38736	38739	_	_
256	21	immunization	immunization	NN	18	nmod	38740	38752	_	_
256	22	,	,	,	6	punct	38752	38753	_	_
256	23	or	or	CC	6	cc	38754	38756	_	_
256	24	a	a	DT	25	det	38757	38758	_	_
256	25	change	change	NN	6	conj	38759	38765	_	_
256	26	in	in	IN	28	case	38766	38768	_	_
256	27	the	the	DT	28	det	38769	38772	_	_
256	28	frequency	frequency	NN	25	nmod	38774	38783	_	_
256	29	of	of	IN	32	case	38784	38786	_	_
256	30	a	a	DT	32	det	38787	38788	_	_
256	31	known	known	JJ	32	amod	38789	38794	_	_
256	32	AEFI	AEFI	NNP	28	nmod	38795	38799	_	_
256	33	.	.	.	6	punct	38799	38800	_	_

257	1	Refer	refer	VB	0	ROOT	38802	38807	_	_
257	2	to	to	TO	5	case	38808	38810	_	_
257	3	Reporting	Reporting	NNP	5	compound	38811	38820	_	_
257	4	Adverse	adverse	JJ	5	amod	38821	38828	_	_
257	5	Events	event	NNS	1	nmod	38829	38835	_	_
257	6	Following	follow	VBG	10	case	38836	38845	_	_
257	7	Immunization	immunization	NN	10	compound	38846	38858	_	_
257	8	(	(	NN	10	compound	38859	38860	_	_
257	9	AEFI	aefi	NN	10	compound	38860	38864	_	_
257	10	)	)	NN	5	nmod	38864	38865	_	_
257	11	in	in	IN	12	case	38866	38868	_	_
257	12	Canada	Canada	NNP	10	nmod	38869	38875	B-persongroup-110168	_
257	13	and	and	CC	10	cc	38876	38879	_	_
257	14	Vaccine	Vaccine	NNP	15	compound	38880	38887	_	_
257	15	Safety	Safety	NNP	10	conj	38888	38894	_	_
257	16	in	in	IN	17	case	38895	38897	_	_
257	17	Part	Part	NNP	15	nmod	38898	38902	_	_
257	18	2	2	CD	17	nummod	38903	38904	_	_
257	19	for	for	IN	21	case	38905	38908	_	_
257	20	additional	additional	JJ	21	amod	38909	38919	_	_
257	21	information	information	NN	1	nmod	38920	38931	_	_
257	22	about	about	IN	24	case	38932	38937	_	_
257	23	AEFI	AEFI	NNP	24	compound	38938	38942	_	_
257	24	reporting	reporting	NN	21	nmod	38943	38952	_	_
257	25	.	.	.	1	punct	38952	38953	_	_

258	1	MMR	mmr	NN	4	compound	38954	38957	_	_
258	2	and	and	CC	1	cc	38958	38961	_	_
258	3	MMRV	mmrv	NN	1	conj	38962	38966	_	_
258	4	vaccines	vaccine	NNS	8	nsubjpass	38967	38975	_	_
258	5	and	and	CC	4	cc	38976	38979	_	_
258	6	Ig	ig	NN	4	conj	38980	38982	_	_
258	7	are	be	VBP	8	auxpass	38983	38986	_	_
258	8	contraindicated	contraindicate	VBN	0	ROOT	38987	39002	_	_
258	9	in	in	IN	10	case	39003	39005	_	_
258	10	persons	person	NNS	8	nmod	39006	39013	B-persongroup-110169	_
258	11	with	with	IN	13	case	39014	39018	_	_
258	12	a	a	DT	13	det	39019	39020	_	_
258	13	history	history	NN	10	nmod	39021	39028	_	_
258	14	of	of	IN	15	case	39029	39031	_	_
258	15	anaphylaxis	anaphylaxis	NN	13	nmod	39032	39043	_	_
258	16	after	after	IN	18	case	39044	39049	_	_
258	17	previous	previous	JJ	18	amod	39050	39058	_	_
258	18	administration	administration	NN	8	nmod	39059	39073	_	_
258	19	of	of	IN	21	case	39074	39076	_	_
258	20	the	the	DT	21	det	39077	39080	_	_
258	21	product	product	NN	18	nmod	39081	39088	_	_
258	22	and	and	CC	18	cc	39089	39092	_	_
258	23	in	in	IN	24	case	39093	39095	_	_
258	24	persons	person	NNS	18	conj	39096	39103	_	_
258	25	with	with	IN	49	mark	39104	39108	_	_
258	26	proven	proven	JJ	27	amod	39109	39115	_	_
258	27	immediate	immediate	JJ	49	nsubj	39116	39125	_	_
258	28	or	or	CC	27	cc	39126	39128	_	_
258	29	anaphylactic	anaphylactic	JJ	30	amod	39129	39141	_	_
258	30	hypersensitivity	hypersensitivity	NN	27	conj	39142	39158	_	_
258	31	to	to	TO	33	case	39159	39161	_	_
258	32	any	any	DT	33	det	39162	39165	_	_
258	33	component	component	NN	27	nmod	39166	39175	_	_
258	34	of	of	IN	37	case	39176	39178	_	_
258	35	the	the	DT	37	det	39179	39182	_	_
258	36	product	product	NN	37	compound	39183	39190	_	_
258	37	(	(	NN	33	nmod	39191	39192	_	_
258	38	with	with	IN	40	case	39192	39196	_	_
258	39	the	the	DT	40	det	39197	39200	_	_
258	40	exception	exception	NN	33	nmod	39201	39210	_	_
258	41	of	of	IN	43	case	39211	39213	_	_
258	42	egg	egg	NN	43	compound	39214	39217	_	_
258	43	allergy	allergy	NN	40	nmod	39218	39225	_	_
258	44	for	for	IN	48	case	39226	39229	_	_
258	45	MMR	mmr	NN	48	compound	39230	39233	_	_
258	46	and	and	CC	45	cc	39234	39237	_	_
258	47	MMRV	mmrv	NN	45	conj	39238	39242	_	_
258	48	vaccines	vaccine	NNS	33	nmod	39243	39251	_	_
258	49	[	[	VBP	24	acl	39252	39253	_	_
258	50	refer	refer	VB	49	xcomp	39253	39258	_	_
258	51	below	below	IN	53	case	39259	39264	_	_
258	52	]	]	CD	53	compound	39264	39265	_	_
258	53	)	)	CD	50	nmod	39265	39266	_	_
258	54	,	,	,	53	punct	39266	39267	_	_
258	55	or	or	CC	53	cc	39268	39270	_	_
258	56	its	its	PRP$	57	nmod:poss	39271	39274	_	_
258	57	container	container	NN	53	conj	39275	39284	_	_
258	58	.	.	.	8	punct	39284	39285	_	_

259	1	Refer	refer	VB	0	ROOT	39286	39291	_	_
259	2	to	to	TO	3	case	39292	39294	_	_
259	3	Contents	Contents	NNP	1	nmod	39295	39303	_	_
259	4	of	of	IN	7	case	39304	39306	_	_
259	5	Immunizing	Immunizing	NNP	7	compound	39307	39317	_	_
259	6	Agents	Agents	NNPS	7	compound	39318	39324	_	_
259	7	Available	Available	NNP	3	nmod	39325	39334	_	_
259	8	for	for	IN	9	case	39335	39338	_	_
259	9	Use	Use	NNP	7	nmod	39339	39342	_	_
259	10	in	in	IN	11	case	39343	39345	_	_
259	11	Canada	Canada	NNP	1	nmod	39346	39352	B-persongroup-110170	_
259	12	in	in	IN	13	case	39353	39355	_	_
259	13	Part	Part	NNP	11	nmod	39356	39360	_	_
259	14	1	1	CD	13	nummod	39361	39362	_	_
259	15	for	for	IN	16	case	39363	39366	_	_
259	16	lists	list	NNS	1	nmod	39367	39372	_	_
259	17	of	of	IN	18	case	39373	39375	_	_
259	18	vaccines	vaccine	NNS	16	nmod	39376	39384	_	_
259	19	and	and	CC	16	cc	39385	39388	_	_
259	20	passive	passive	JJ	22	amod	39389	39396	_	_
259	21	immunizing	immunizing	JJ	22	amod	39397	39407	_	_
259	22	agents	agent	NNS	16	conj	39408	39414	_	_
259	23	available	available	JJ	22	amod	39415	39424	_	_
259	24	for	for	IN	25	case	39425	39428	_	_
259	25	use	use	NN	23	nmod	39429	39432	_	_
259	26	in	in	IN	27	case	39433	39435	_	_
259	27	Canada	Canada	NNP	25	nmod	39436	39442	B-persongroup-110171	_
259	28	and	and	CC	27	cc	39443	39446	_	_
259	29	their	they	PRP$	30	nmod:poss	39447	39452	_	_
259	30	contents	contents	NNS	27	conj	39453	39461	_	_
259	31	.	.	.	1	punct	39461	39462	_	_

260	1	For	for	IN	3	case	39463	39466	_	_
260	2	measles-containing	measles-containing	JJ	3	amod	39467	39485	_	_
260	3	vaccines	vaccine	NNS	7	nmod	39486	39494	_	_
260	4	,	,	,	7	punct	39494	39495	_	_
260	5	potential	potential	JJ	6	amod	39496	39505	_	_
260	6	allergens	allergen	NNS	7	nsubj	39506	39515	_	_
260	7	include	include	VBP	0	ROOT	39516	39523	_	_
260	8	:	:	:	7	punct	39523	39524	_	_
260	9	PRIORIX	PRIORIX	NNP	7	dobj	39527	39534	_	_
260	10	®	®	CD	9	nummod	39534	39535	_	_
260	11	:	:	:	9	punct	39535	39536	_	_
260	12	egg	egg	NN	13	compound	39536	39539	_	_
260	13	protein	protein	NN	9	dep	39540	39547	_	_
260	14	,	,	,	9	punct	39547	39548	_	_
260	15	neomycin	neomycin	NN	9	appos	39549	39557	_	_
260	16	In	in	IN	17	case	39559	39561	_	_
260	17	situations	situation	NNS	30	nmod	39562	39572	_	_
260	18	of	of	IN	20	case	39573	39575	_	_
260	19	suspected	suspect	VBN	20	amod	39576	39585	_	_
260	20	hypersensitivity	hypersensitivity	NN	17	nmod	39586	39602	_	_
260	21	or	or	CC	20	cc	39603	39605	_	_
260	22	non-anaphylactic	non-anaphylactic	JJ	23	amod	39606	39622	_	_
260	23	allergy	allergy	NN	20	conj	39623	39630	_	_
260	24	to	to	TO	26	case	39631	39633	_	_
260	25	vaccine	vaccine	NN	26	compound	39634	39641	_	_
260	26	components	component	NNS	23	nmod	39643	39653	_	_
260	27	,	,	,	30	punct	39653	39654	_	_
260	28	investigation	investigation	NN	30	nsubjpass	39655	39668	_	_
260	29	is	be	VBZ	30	auxpass	39669	39671	_	_
260	30	indicated	indicate	VBN	15	acl:relcl	39672	39681	_	_
260	31	which	which	WDT	33	nsubj	39682	39687	_	_
260	32	may	may	MD	33	aux	39688	39691	_	_
260	33	involve	involve	VB	9	acl:relcl	39692	39699	_	_
260	34	immunization	immunization	NN	33	dobj	39700	39712	_	_
260	35	in	in	IN	38	case	39713	39715	_	_
260	36	a	a	DT	38	det	39717	39718	_	_
260	37	controlled	controlled	JJ	38	amod	39719	39729	_	_
260	38	setting	setting	NN	33	nmod	39730	39737	_	_
260	39	.	.	.	7	punct	39737	39738	_	_

261	1	Consultation	consultation	NN	6	nsubjpass	39739	39751	_	_
261	2	with	with	IN	4	case	39752	39756	_	_
261	3	an	a	DT	4	det	39757	39759	B-persongroup-110172	_
261	4	allergist	allergist	NN	1	nmod	39760	39769	I-persongroup-110172	_
261	5	is	be	VBZ	6	auxpass	39770	39772	_	_
261	6	advised	advise	VBN	0	ROOT	39773	39780	_	_
261	7	.	.	.	6	punct	39780	39781	_	_

262	1	The	the	DT	2	det	39782	39785	_	_
262	2	measles	measles	NNS	12	nsubjpass	39786	39793	_	_
262	3	and	and	CC	2	cc	39794	39797	_	_
262	4	mumps	mumps	NNS	5	compound	39798	39803	_	_
262	5	components	component	NNS	2	conj	39804	39814	_	_
262	6	of	of	IN	10	case	39815	39817	_	_
262	7	MMR	mmr	NN	10	compound	39818	39821	_	_
262	8	and	and	CC	7	cc	39822	39825	_	_
262	9	MMRV	mmrv	NN	7	conj	39826	39830	_	_
262	10	vaccines	vaccine	NNS	2	nmod	39831	39839	_	_
262	11	are	be	VBP	12	auxpass	39840	39843	_	_
262	12	produced	produce	VBN	0	ROOT	39844	39852	_	_
262	13	in	in	IN	17	case	39853	39855	_	_
262	14	chick	chick	NN	17	compound	39856	39861	_	_
262	15	embryo	embryo	NN	17	compound	39862	39868	_	_
262	16	cell	cell	NN	17	compound	39869	39873	_	_
262	17	culture	culture	NN	12	nmod	39874	39881	_	_
262	18	and	and	CC	12	cc	39882	39885	_	_
262	19	may	may	MD	20	aux	39886	39889	_	_
262	20	contain	contain	VB	12	conj	39890	39897	_	_
262	21	traces	trace	NNS	20	dobj	39898	39904	_	_
262	22	of	of	IN	25	case	39905	39907	_	_
262	23	residual	residual	JJ	25	amod	39908	39916	_	_
262	24	egg	egg	NN	25	compound	39917	39920	_	_
262	25	protein	protein	NN	21	nmod	39921	39928	_	_
262	26	.	.	.	12	punct	39928	39929	_	_

263	1	The	the	DT	3	det	39930	39933	_	_
263	2	trace	trace	NN	3	compound	39934	39939	_	_
263	3	amount	amount	NN	10	nsubj	39940	39946	_	_
263	4	of	of	IN	6	case	39947	39949	_	_
263	5	egg	egg	NN	6	compound	39950	39953	_	_
263	6	protein	protein	NN	3	nmod	39954	39961	_	_
263	7	in	in	IN	9	case	39962	39964	_	_
263	8	the	the	DT	9	det	39965	39968	_	_
263	9	vaccine	vaccine	NN	6	nmod	39969	39976	_	_
263	10	appears	appear	VBZ	0	ROOT	39977	39984	_	_
263	11	to	to	TO	13	mark	39985	39987	_	_
263	12	be	be	VB	13	cop	39988	39990	_	_
263	13	insufficient	insufficient	JJ	10	xcomp	39991	40003	_	_
263	14	to	to	TO	15	mark	40004	40006	_	_
263	15	cause	cause	VB	13	xcomp	40007	40012	_	_
263	16	an	a	DT	18	det	40013	40015	_	_
263	17	allergic	allergic	JJ	18	amod	40016	40024	_	_
263	18	reaction	reaction	NN	15	dobj	40025	40033	_	_
263	19	in	in	IN	21	case	40034	40036	_	_
263	20	egg-allergic	egg-allergic	JJ	21	amod	40037	40049	B-persongroup-110173	_
263	21	individuals	individual	NNS	15	nmod	40050	40061	I-persongroup-110173	_
263	22	.	.	.	10	punct	40061	40062	I-persongroup-110173	_

264	1	Prior	prior	RB	2	advmod	40063	40068	_	_
264	2	egg	egg	NN	7	nmod	40069	40072	_	_
264	3	ingestion	ingestion	NN	7	nsubj	40073	40082	_	_
264	4	is	be	VBZ	7	cop	40083	40085	_	_
264	5	not	not	RB	7	neg	40086	40089	_	_
264	6	a	a	DT	7	det	40090	40091	_	_
264	7	prerequisite	prerequisite	NN	0	ROOT	40092	40104	_	_
264	8	for	for	IN	9	case	40105	40108	_	_
264	9	immunization	immunization	NN	7	nmod	40109	40121	_	_
264	10	with	with	IN	13	case	40122	40126	_	_
264	11	egg	egg	NN	13	compound	40127	40130	_	_
264	12	protein-containing	protein-containing	JJ	13	amod	40131	40149	_	_
264	13	vaccine	vaccine	NN	9	nmod	40150	40157	_	_
264	14	.	.	.	7	punct	40157	40158	_	_

265	1	Skin	skin	NN	2	compound	40159	40163	_	_
265	2	testing	testing	NN	5	nsubjpass	40164	40171	_	_
265	3	is	be	VBZ	5	auxpass	40172	40174	_	_
265	4	not	not	RB	5	neg	40175	40178	_	_
265	5	recommended	recommend	VBN	0	ROOT	40179	40190	_	_
265	6	prior	prior	RB	5	advmod	40191	40196	_	_
265	7	to	to	TO	8	case	40197	40199	_	_
265	8	vaccination	vaccination	NN	6	nmod	40200	40211	_	_
265	9	as	as	IN	13	mark	40212	40214	_	_
265	10	it	it	PRP	13	nsubj	40215	40217	_	_
265	11	does	do	VBZ	13	aux	40218	40222	_	_
265	12	not	not	RB	13	neg	40223	40226	_	_
265	13	predict	predict	VB	5	advcl	40227	40234	_	_
265	14	reaction	reaction	NN	13	dobj	40235	40243	_	_
265	15	to	to	TO	17	case	40244	40246	_	_
265	16	the	the	DT	17	det	40247	40250	_	_
265	17	vaccine	vaccine	NN	13	nmod	40251	40258	_	_
265	18	.	.	.	5	punct	40258	40259	_	_

266	1	MMR	mmr	NN	4	compound	40260	40263	_	_
266	2	or	or	CC	1	cc	40264	40266	_	_
266	3	MMRV	mmrv	NN	1	conj	40267	40271	_	_
266	4	vaccine	vaccine	NN	7	nsubjpass	40272	40279	_	_
266	5	can	can	MD	7	aux	40280	40283	_	_
266	6	be	be	VB	7	auxpass	40284	40286	_	_
266	7	administered	administer	VBN	0	ROOT	40287	40299	_	_
266	8	in	in	IN	11	case	40300	40302	_	_
266	9	the	the	DT	11	det	40303	40306	_	_
266	10	routine	routine	JJ	11	amod	40307	40314	_	_
266	11	manner	manner	NN	7	nmod	40315	40321	_	_
266	12	to	to	TO	13	case	40322	40324	_	_
266	13	people	people	NNS	7	nmod	40325	40331	B-persongroup-110174	_
266	14	who	who	WP	15	nsubj	40332	40335	_	_
266	15	have	have	VBP	13	acl:relcl	40336	40340	_	_
266	16	a	a	DT	17	det	40341	40342	_	_
266	17	history	history	NN	15	dobj	40343	40350	_	_
266	18	of	of	IN	20	case	40351	40353	_	_
266	19	anaphylactic	anaphylactic	JJ	20	amod	40354	40366	_	_
266	20	hypersensitivity	hypersensitivity	NN	17	nmod	40367	40383	_	_
266	21	to	to	TO	23	case	40384	40386	_	_
266	22	hensí	hensí	NN	23	compound	40387	40392	_	_
266	23	eggs	egg	NNS	15	nmod	40393	40397	_	_
266	24	.	.	.	7	punct	40397	40398	_	_

267	1	For	for	IN	3	case	40399	40402	_	_
267	2	all	all	DT	3	det	40403	40406	_	_
267	3	vaccines	vaccine	NNS	9	nmod	40407	40415	_	_
267	4	,	,	,	9	punct	40415	40416	_	_
267	5	immunization	immunization	NN	9	nsubjpass	40417	40429	_	_
267	6	should	should	MD	9	aux	40430	40436	_	_
267	7	always	always	RB	9	advmod	40437	40443	_	_
267	8	be	be	VB	9	auxpass	40444	40446	_	_
267	9	performed	perform	VBN	0	ROOT	40447	40456	_	_
267	10	by	by	IN	11	case	40457	40459	_	_
267	11	personnel	personnel	NNS	9	nmod	40460	40469	B-persongroup-110175	_
267	12	with	with	IN	14	case	40470	40474	_	_
267	13	the	the	DT	14	det	40475	40478	_	_
267	14	capability	capability	NN	11	nmod	40479	40489	_	_
267	15	and	and	CC	14	cc	40490	40493	_	_
267	16	facilities	facility	NNS	14	conj	40494	40504	_	_
267	17	to	to	TO	18	mark	40505	40507	_	_
267	18	manage	manage	VB	9	xcomp	40508	40514	_	_
267	19	adverse	adverse	JJ	20	amod	40515	40522	_	_
267	20	events	event	NNS	21	nsubj	40523	40529	_	_
267	21	post-vaccination	post-vaccination	JJ	18	xcomp	40530	40546	_	_
267	22	.	.	.	9	punct	40546	40547	_	_

268	1	Refer	refer	VB	0	ROOT	40548	40553	_	_
268	2	to	to	TO	4	case	40554	40556	_	_
268	3	Anaphylactic	Anaphylactic	NNP	4	compound	40557	40569	_	_
268	4	Hypersensitivity	hypersensitivity	NN	1	nmod	40570	40586	_	_
268	5	to	to	TO	9	case	40587	40589	_	_
268	6	Egg	Egg	NNP	9	compound	40590	40593	_	_
268	7	and	and	CC	6	cc	40594	40597	_	_
268	8	Egg-Related	Egg-Related	NNP	6	conj	40598	40609	_	_
268	9	Antigens	Antigens	NNPS	1	nmod	40610	40618	_	_
268	10	in	in	IN	11	case	40619	40621	_	_
268	11	Part	Part	NNP	9	nmod	40622	40626	_	_
268	12	2	2	CD	11	nummod	40627	40628	_	_
268	13	for	for	IN	15	case	40629	40632	_	_
268	14	additional	additional	JJ	15	amod	40633	40643	_	_
268	15	information	information	NN	1	nmod	40644	40655	_	_
268	16	.	.	.	1	punct	40655	40656	_	_

269	1	Children	child	NNS	25	nsubj	40657	40665	B-persongroup-110176	_
269	2	with	with	IN	4	case	40666	40670	_	_
269	3	a	a	DT	4	det	40671	40672	_	_
269	4	known	known	JJ	1	nmod	40674	40679	_	_
269	5	or	or	CC	4	cc	40680	40682	_	_
269	6	suspected	suspect	VBN	8	amod	40683	40692	_	_
269	7	family	family	NN	8	compound	40693	40699	_	_
269	8	history	history	NN	4	conj	40700	40707	_	_
269	9	of	of	IN	13	case	40708	40710	_	_
269	10	congenital	congenital	JJ	13	amod	40711	40721	_	_
269	11	or	or	CC	10	cc	40722	40724	_	_
269	12	hereditary	hereditary	JJ	10	conj	40725	40735	_	_
269	13	immunodeficiency	immunodeficiency	NN	8	nmod	40736	40752	_	_
269	14	that	that	WDT	17	nsubj	40754	40758	_	_
269	15	is	be	VBZ	17	cop	40759	40761	_	_
269	16	a	a	DT	17	det	40762	40763	_	_
269	17	contraindication	contraindication	NN	8	acl:relcl	40764	40780	_	_
269	18	to	to	TO	19	case	40781	40783	_	_
269	19	vaccination	vaccination	NN	17	nmod	40784	40795	_	_
269	20	with	with	IN	22	case	40796	40800	_	_
269	21	live	live	JJ	22	amod	40801	40805	_	_
269	22	vaccine	vaccine	NN	19	nmod	40806	40813	_	_
269	23	should	should	MD	25	aux	40814	40820	_	_
269	24	not	not	RB	25	neg	40821	40824	_	_
269	25	receive	receive	VB	0	ROOT	40825	40832	_	_
269	26	live	live	JJ	27	amod	40834	40838	_	_
269	27	vaccines	vaccine	NNS	25	dobj	40839	40847	_	_
269	28	unless	unless	IN	34	mark	40848	40854	_	_
269	29	their	they	PRP$	31	nmod:poss	40855	40860	_	_
269	30	immune	immune	JJ	31	amod	40861	40867	_	_
269	31	competence	competence	NN	34	nsubjpass	40868	40878	_	_
269	32	has	have	VBZ	34	aux	40879	40882	_	_
269	33	been	be	VBN	34	auxpass	40883	40887	_	_
269	34	established	establish	VBN	25	advcl	40888	40899	_	_
269	35	.	.	.	25	punct	40899	40900	_	_

270	1	MMRV	mmrv	NN	2	compound	40901	40905	_	_
270	2	vaccine	vaccine	NN	4	nsubjpass	40906	40913	_	_
270	3	is	be	VBZ	4	auxpass	40914	40916	_	_
270	4	contraindicated	contraindicate	VBN	0	ROOT	40917	40932	_	_
270	5	in	in	IN	6	case	40934	40936	_	_
270	6	persons	person	NNS	4	nmod	40937	40944	B-persongroup-110177	_
270	7	with	with	IN	10	case	40945	40949	_	_
270	8	impaired	impaired	JJ	9	amod	40950	40958	_	_
270	9	immune	immune	JJ	10	amod	40959	40965	_	_
270	10	function	function	NN	6	nmod	40966	40974	_	_
270	11	,	,	,	6	punct	40974	40975	_	_
270	12	including	include	VBG	17	case	40976	40985	_	_
270	13	primary	primary	JJ	17	amod	40986	40993	_	_
270	14	or	or	CC	13	cc	40994	40996	_	_
270	15	secondary	secondary	JJ	13	conj	40997	41006	_	_
270	16	immunodeficiency	immunodeficiency	NN	17	compound	41008	41024	_	_
270	17	disorders	disorder	NNS	6	nmod	41025	41034	_	_
270	18	.	.	.	4	punct	41034	41035	_	_

271	1	Refer	refer	VB	0	ROOT	41036	41041	_	_
271	2	to	to	TO	4	case	41042	41044	_	_
271	3	Immunocompromised	immunocompromised	JJ	4	amod	41045	41062	B-persongroup-110178	_
271	4	persons	person	NNS	1	nmod	41063	41070	I-persongroup-110178	_
271	5	.	.	.	1	punct	41070	41071	I-persongroup-110178	_

272	1	MMR	mmr	NN	4	compound	41072	41075	_	_
272	2	and	and	CC	1	cc	41076	41079	_	_
272	3	MMRV	mmrv	NN	1	conj	41080	41084	_	_
272	4	vaccines	vaccine	NNS	6	nsubjpass	41086	41094	_	_
272	5	are	be	VBP	6	auxpass	41095	41098	_	_
272	6	contraindicated	contraindicate	VBN	0	ROOT	41099	41114	_	_
272	7	during	during	IN	8	case	41115	41121	_	_
272	8	pregnancy	pregnancy	NN	6	nmod	41122	41131	_	_
272	9	.	.	.	6	punct	41131	41132	_	_

273	1	Refer	refer	VB	0	ROOT	41133	41138	_	_
273	2	to	to	TO	3	case	41139	41141	_	_
273	3	Pregnancy	Pregnancy	NNP	1	nmod	41142	41151	_	_
273	4	and	and	CC	3	cc	41152	41155	_	_
273	5	breastfeeding	breastfeeding	NN	3	conj	41156	41169	_	_
273	6	.	.	.	1	punct	41169	41170	_	_

274	1	MMR	mmr	NN	2	compound	41171	41174	_	_
274	2	vaccine	vaccine	NN	4	nsubjpass	41175	41182	_	_
274	3	is	be	VBZ	4	auxpass	41183	41185	_	_
274	4	contraindicated	contraindicate	VBN	0	ROOT	41186	41201	_	_
274	5	in	in	IN	6	case	41202	41204	_	_
274	6	individuals	individual	NNS	4	nmod	41206	41217	B-persongroup-110179	_
274	7	with	with	IN	11	case	41218	41222	_	_
274	8	active	active	JJ	10	amod	41223	41229	_	_
274	9	,	,	,	10	punct	41229	41230	_	_
274	10	untreated	untreated	JJ	11	amod	41231	41240	_	_
274	11	tuberculosis	tuberculosis	NN	6	nmod	41241	41253	_	_
274	12	.	.	.	4	punct	41253	41254	_	_

275	1	While	while	IN	5	mark	41255	41260	_	_
275	2	tuberculosis	tuberculosis	NN	5	nsubjpass	41261	41273	_	_
275	3	may	may	MD	5	aux	41274	41277	_	_
275	4	be	be	VB	5	auxpass	41278	41280	_	_
275	5	exacerbated	exacerbate	VBN	12	advcl	41281	41292	_	_
275	6	by	by	IN	9	case	41293	41295	_	_
275	7	natural	natural	JJ	9	amod	41296	41303	_	_
275	8	measles	measles	NNS	9	compound	41305	41312	_	_
275	9	infection	infection	NN	5	nmod	41313	41322	_	_
275	10	,	,	,	12	punct	41322	41323	_	_
275	11	there	there	EX	12	expl	41324	41329	_	_
275	12	is	be	VBZ	0	ROOT	41330	41332	_	_
275	13	no	no	DT	14	neg	41333	41335	_	_
275	14	evidence	evidence	NN	12	nsubj	41336	41344	_	_
275	15	that	that	IN	24	mark	41345	41349	_	_
275	16	measles-containing	measles-containing	JJ	17	amod	41350	41368	_	_
275	17	vaccines	vaccine	NNS	24	nsubj	41369	41377	_	_
275	18	,	,	,	17	punct	41377	41378	_	_
275	19	such	such	JJ	21	case	41379	41383	_	_
275	20	as	as	IN	19	mwe	41385	41387	_	_
275	21	MMR	mmr	NN	17	nmod	41388	41391	_	_
275	22	or	or	CC	21	cc	41392	41394	_	_
275	23	MMRV	mmrv	NN	21	conj	41395	41399	_	_
275	24	have	have	VBP	12	ccomp	41400	41404	_	_
275	25	such	such	JJ	27	amod	41405	41409	_	_
275	26	an	a	DT	27	det	41410	41412	_	_
275	27	effect	effect	NN	24	dobj	41413	41419	_	_
275	28	.	.	.	12	punct	41419	41420	_	_

276	1	A	a	DT	2	det	41422	41423	_	_
276	2	history	history	NN	15	nsubj	41424	41431	_	_
276	3	of	of	IN	5	case	41432	41434	_	_
276	4	febrile	febrile	JJ	5	amod	41436	41443	_	_
276	5	seizures	seizure	NNS	2	nmod	41444	41452	_	_
276	6	or	or	CC	2	cc	41453	41455	_	_
276	7	a	a	DT	9	det	41456	41457	_	_
276	8	family	family	NN	9	compound	41458	41464	_	_
276	9	history	history	NN	2	conj	41465	41472	_	_
276	10	of	of	IN	11	case	41473	41475	_	_
276	11	convulsions	convulsion	NNS	9	nmod	41476	41487	_	_
276	12	is	be	VBZ	15	cop	41488	41490	_	_
276	13	not	not	RB	15	neg	41491	41494	_	_
276	14	a	a	DT	15	det	41495	41496	_	_
276	15	contraindication	contraindication	NN	0	ROOT	41497	41513	_	_
276	16	for	for	IN	18	case	41515	41518	_	_
276	17	the	the	DT	18	det	41519	41522	_	_
276	18	use	use	NN	15	nmod	41523	41526	_	_
276	19	of	of	IN	21	case	41527	41529	_	_
276	20	MMRV	mmrv	NN	21	compound	41530	41534	_	_
276	21	vaccine	vaccine	NN	18	nmod	41535	41542	_	_
276	22	.	.	.	15	punct	41542	41543	_	_

277	1	Administration	administration	NN	9	nsubjpass	41545	41559	_	_
277	2	of	of	IN	6	case	41560	41562	_	_
277	3	MMR	mmr	NN	6	compound	41563	41566	_	_
277	4	or	or	CC	3	cc	41567	41569	_	_
277	5	MMRV	mmrv	NN	3	conj	41570	41574	_	_
277	6	vaccine	vaccine	NN	1	nmod	41575	41582	_	_
277	7	should	should	MD	9	aux	41583	41589	_	_
277	8	be	be	VB	9	auxpass	41590	41592	_	_
277	9	postponed	postpone	VBN	0	ROOT	41594	41603	_	_
277	10	in	in	IN	11	case	41604	41606	_	_
277	11	persons	person	NNS	9	nmod	41607	41614	B-persongroup-110180	_
277	12	with	with	IN	15	case	41615	41619	_	_
277	13	severe	severe	JJ	15	amod	41620	41626	_	_
277	14	acute	acute	JJ	15	amod	41627	41632	_	_
277	15	illness	illness	NN	11	nmod	41633	41640	_	_
277	16	.	.	.	9	punct	41640	41641	_	_

278	1	Persons	person	NNS	15	nsubjpass	41642	41649	B-persongroup-110181	_
278	2	with	with	IN	7	case	41650	41654	_	_
278	3	a	a	DT	7	det	41655	41656	_	_
278	4	minor	minor	JJ	5	amod	41658	41663	_	_
278	5	acute	acute	JJ	7	amod	41664	41669	_	_
278	6	illness	illness	NN	7	compound	41670	41677	_	_
278	7	(	(	NN	1	nmod	41678	41679	_	_
278	8	with	with	IN	12	case	41679	41683	_	_
278	9	or	or	CC	8	cc	41684	41686	_	_
278	10	without	without	IN	8	conj	41687	41694	_	_
278	11	fever	fever	NN	12	compound	41695	41700	_	_
278	12	)	)	NN	7	nmod	41700	41701	_	_
278	13	may	may	MD	15	aux	41702	41705	_	_
278	14	be	be	VB	15	auxpass	41706	41708	_	_
278	15	vaccinated	vaccinate	VBN	0	ROOT	41709	41719	_	_
278	16	.	.	.	15	punct	41719	41720	_	_

279	1	It	it	PRP	3	nsubjpass	41722	41724	_	_
279	2	is	be	VBZ	3	auxpass	41725	41727	_	_
279	3	recommended	recommend	VBN	0	ROOT	41728	41739	_	_
279	4	to	to	TO	5	mark	41740	41742	_	_
279	5	avoid	avoid	VB	3	xcomp	41743	41748	_	_
279	6	the	the	DT	7	det	41749	41752	_	_
279	7	use	use	NN	5	dobj	41753	41756	_	_
279	8	of	of	IN	9	case	41757	41759	_	_
279	9	salicylates	salicylate	NNS	7	nmod	41760	41771	_	_
279	10	(	(	CD	21	nummod	41772	41773	_	_
279	11	e.g.	e.g.	FW	21	amod	41773	41777	_	_
279	12	,	,	,	11	punct	41777	41778	_	_
279	13	acetylsalicylic	acetylsalicylic	JJ	16	amod	41779	41794	_	_
279	14	acid	acid	NN	16	compound	41796	41800	_	_
279	15	[	[	NN	16	compound	41801	41802	_	_
279	16	ASA	asa	NN	11	dep	41802	41805	_	_
279	17	]	]	CD	18	nummod	41805	41806	_	_
279	18	)	)	NN	16	dep	41806	41807	_	_
279	19	for	for	IN	20	case	41808	41811	_	_
279	20	6	6	CD	18	nmod	41812	41813	_	_
279	21	weeks	week	NNS	30	nmod	41814	41819	_	_
279	22	after	after	IN	21	case	41820	41825	_	_
279	23	immunization	immunization	NN	21	dep	41826	41838	_	_
279	24	with	with	IN	26	case	41839	41843	_	_
279	25	MMRV	mmrv	NN	26	compound	41844	41848	_	_
279	26	vaccine	vaccine	NN	23	nmod	41849	41856	_	_
279	27	because	because	IN	30	case	41857	41864	_	_
279	28	of	of	IN	27	mwe	41865	41867	_	_
279	29	an	a	DT	30	det	41869	41871	_	_
279	30	association	association	NN	5	nmod	41872	41883	_	_
279	31	between	between	IN	33	case	41884	41891	_	_
279	32	wild-type	wild-type	JJ	33	amod	41892	41901	_	_
279	33	varicella	varicella	NN	30	nmod	41902	41911	_	_
279	34	,	,	,	33	punct	41911	41912	_	_
279	35	salicylate	salicylate	NN	36	compound	41913	41923	_	_
279	36	therapy	therapy	NN	33	conj	41924	41931	_	_
279	37	and	and	CC	33	cc	41932	41935	_	_
279	38	Reye	Reye	NNP	40	nmod:poss	41936	41940	_	_
279	39	's	's	POS	38	case	41940	41942	_	_
279	40	syndrome	syndrome	NN	33	conj	41944	41952	_	_
279	41	.	.	.	3	punct	41952	41953	_	_

280	1	Refer	refer	VB	0	ROOT	41955	41960	_	_
280	2	to	to	TO	3	case	41961	41963	_	_
280	3	Contraindications	contraindication	NNS	1	nmod	41964	41981	_	_
280	4	,	,	,	3	punct	41981	41982	_	_
280	5	Precautions	precaution	NNS	3	conj	41983	41994	_	_
280	6	and	and	CC	3	cc	41995	41998	_	_
280	7	Concerns	concern	NNS	3	conj	41999	42007	_	_
280	8	in	in	IN	9	case	42008	42010	_	_
280	9	Part	part	NN	3	nmod	42011	42015	_	_
280	10	2	2	CD	9	nummod	42016	42017	_	_
280	11	and	and	CC	3	cc	42018	42021	_	_
280	12	Passive	Passive	NNP	15	compound	42022	42029	_	_
280	13	Immunizing	Immunizing	NNP	15	compound	42030	42040	_	_
280	14	Agents	Agents	NNPS	15	compound	42041	42047	_	_
280	15	Part	Part	NNP	3	conj	42048	42052	_	_
280	16	5	5	CD	15	dep	42053	42054	_	_
280	17	for	for	IN	20	case	42055	42058	_	_
280	18	additional	additional	JJ	20	amod	42059	42069	_	_
280	19	general	general	JJ	20	amod	42070	42077	_	_
280	20	information	information	NN	1	nmod	42078	42089	_	_
280	21	.	.	.	1	punct	42089	42090	_	_

281	1	Systemic	systemic	JJ	3	amod	42092	42100	_	_
281	2	antiviral	antiviral	JJ	3	amod	42101	42110	_	_
281	3	therapy	therapy	NN	15	nsubjpass	42111	42118	_	_
281	4	(	(	CD	3	nummod	42119	42120	_	_
281	5	such	such	JJ	12	case	42120	42124	_	_
281	6	as	as	IN	5	mwe	42126	42128	_	_
281	7	acyclovir	acyclovir	NN	12	compound	42129	42138	_	_
281	8	,	,	,	12	punct	42138	42139	_	_
281	9	valacyclovir	valacyclovir	NN	12	dep	42140	42152	_	_
281	10	,	,	,	12	punct	42152	42153	_	_
281	11	famciclovir	famciclovir	NN	12	dep	42154	42165	_	_
281	12	)	)	NN	3	nmod	42165	42166	_	_
281	13	should	should	MD	15	aux	42167	42173	_	_
281	14	be	be	VB	15	auxpass	42174	42176	_	_
281	15	avoided	avoid	VBN	0	ROOT	42177	42184	_	_
281	16	in	in	IN	19	case	42185	42187	_	_
281	17	the	the	DT	19	det	42188	42191	_	_
281	18	peri-immunization	peri-immunization	JJ	19	amod	42193	42210	_	_
281	19	period	period	NN	15	nmod	42211	42217	_	_
281	20	,	,	,	15	punct	42217	42218	_	_
281	21	as	as	IN	24	mark	42219	42221	_	_
281	22	it	it	PRP	24	nsubj	42222	42224	_	_
281	23	may	may	MD	24	aux	42225	42228	_	_
281	24	reduce	reduce	VB	15	advcl	42229	42235	_	_
281	25	the	the	DT	26	det	42236	42239	_	_
281	26	efficacy	efficacy	NN	24	dobj	42240	42248	_	_
281	27	of	of	IN	29	case	42249	42251	_	_
281	28	varicella-containing	varicella-containing	JJ	29	amod	42252	42272	_	_
281	29	vaccine	vaccine	NN	26	nmod	42274	42281	_	_
281	30	such	such	JJ	32	case	42282	42286	_	_
281	31	as	as	IN	30	mwe	42287	42289	_	_
281	32	MMRV	mmrv	NN	29	nmod	42290	42294	_	_
281	33	.	.	.	15	punct	42294	42295	_	_

282	1	On	on	IN	3	case	42296	42298	_	_
282	2	the	the	DT	3	det	42299	42302	_	_
282	3	basis	basis	NN	10	nmod	42303	42308	_	_
282	4	of	of	IN	6	case	42309	42311	_	_
282	5	expert	expert	JJ	6	amod	42312	42318	_	_
282	6	opinion	opinion	NN	3	nmod	42319	42326	_	_
282	7	,	,	,	10	punct	42326	42327	_	_
282	8	it	it	PRP	10	nsubjpass	42328	42330	_	_
282	9	is	be	VBZ	10	auxpass	42331	42333	_	_
282	10	recommended	recommend	VBN	0	ROOT	42334	42345	_	_
282	11	that	that	IN	18	mark	42346	42350	_	_
282	12	people	people	NNS	18	nsubj	42352	42358	B-persongroup-110182	_
282	13	taking	take	VBG	12	acl	42359	42365	_	_
282	14	long-term	long-term	JJ	16	amod	42366	42375	_	_
282	15	antiviral	antiviral	JJ	16	amod	42376	42385	_	_
282	16	therapy	therapy	NN	13	dobj	42386	42393	_	_
282	17	should	should	MD	18	aux	42394	42400	_	_
282	18	discontinue	discontinue	VB	10	ccomp	42401	42412	_	_
282	19	these	these	DT	20	det	42413	42418	_	_
282	20	drugs	drug	NNS	18	dobj	42419	42424	_	_
282	21	,	,	,	18	punct	42424	42425	_	_
282	22	if	if	IN	23	mark	42426	42428	_	_
282	23	possible	possible	JJ	18	advcl	42430	42438	_	_
282	24	,	,	,	18	punct	42438	42439	_	_
282	25	from	from	IN	29	case	42440	42444	_	_
282	26	at	at	IN	27	case	42445	42447	_	_
282	27	least	least	JJS	28	nmod:npmod	42448	42453	_	_
282	28	24	24	CD	29	nummod	42454	42456	_	_
282	29	hours	hour	NNS	18	nmod	42457	42462	_	_
282	30	before	before	IN	31	case	42463	42469	_	_
282	31	administration	administration	NN	29	nmod	42470	42484	_	_
282	32	of	of	IN	34	case	42485	42487	_	_
282	33	MMRV	mmrv	NN	34	compound	42488	42492	_	_
282	34	vaccine	vaccine	NN	31	nmod	42493	42500	_	_
282	35	and	and	CC	10	cc	42501	42504	_	_
282	36	should	should	MD	38	aux	42506	42512	_	_
282	37	not	not	RB	38	neg	42513	42516	_	_
282	38	restart	restart	VB	10	conj	42517	42524	_	_
282	39	antiviral	antiviral	JJ	40	amod	42525	42534	_	_
282	40	therapy	therapy	NN	38	dobj	42535	42542	_	_
282	41	until	until	IN	43	case	42543	42548	_	_
282	42	14	14	CD	43	nummod	42549	42551	_	_
282	43	days	day	NNS	38	nmod	42552	42556	_	_
282	44	after	after	IN	43	case	42557	42562	_	_
282	45	.	.	.	10	punct	42562	42563	_	_

283	1	The	the	DT	3	det	42564	42567	_	_
283	2	measles	measles	NNS	3	compound	42569	42576	_	_
283	3	component	component	NN	9	nsubj	42577	42586	_	_
283	4	in	in	IN	6	case	42587	42589	_	_
283	5	measles-containing	measles-containing	JJ	6	amod	42590	42608	_	_
283	6	vaccines	vaccine	NNS	3	nmod	42609	42617	_	_
283	7	can	can	MD	9	aux	42618	42621	_	_
283	8	temporarily	temporarily	RB	9	advmod	42622	42633	_	_
283	9	suppress	suppress	VB	0	ROOT	42634	42642	_	_
283	10	tuberculin	tuberculin	NN	11	compound	42644	42654	_	_
283	11	reactivity	reactivity	NN	9	dobj	42655	42665	_	_
283	12	,	,	,	9	punct	42665	42666	_	_
283	13	resulting	result	VBG	9	advcl	42667	42676	_	_
283	14	in	in	IN	16	case	42677	42679	_	_
283	15	false-negative	false-negative	JJ	16	amod	42680	42694	_	_
283	16	results	result	NNS	13	nmod	42695	42702	_	_
283	17	.	.	.	9	punct	42702	42703	_	_

284	1	If	if	IN	4	case	42704	42706	_	_
284	2	tuberculin	tuberculin	NN	4	compound	42707	42717	_	_
284	3	skin	skin	NN	4	compound	42718	42722	_	_
284	4	testing	testing	NN	16	nmod	42723	42730	_	_
284	5	or	or	CC	4	cc	42731	42733	_	_
284	6	an	a	DT	7	det	42734	42736	_	_
284	7	Interferon	interferon	NN	4	conj	42738	42748	_	_
284	8	Gamma	gamma	NN	14	compound	42749	42754	_	_
284	9	Release	Release	NNP	14	compound	42755	42762	_	_
284	10	Assay	assay	NN	14	compound	42763	42768	_	_
284	11	(	(	CD	14	nummod	42769	42770	_	_
284	12	IGRA	igra	NN	14	compound	42770	42774	_	_
284	13	)	)	CD	14	nummod	42774	42775	_	_
284	14	test	test	NN	16	nsubjpass	42776	42780	_	_
284	15	is	be	VBZ	16	auxpass	42781	42783	_	_
284	16	required	require	VBN	21	ccomp	42784	42792	_	_
284	17	,	,	,	21	punct	42792	42793	_	_
284	18	it	it	PRP	21	nsubjpass	42794	42796	_	_
284	19	should	should	MD	21	aux	42797	42803	_	_
284	20	be	be	VB	21	auxpass	42804	42806	_	_
284	21	done	do	VBN	0	ROOT	42807	42811	_	_
284	22	on	on	IN	25	case	42812	42814	_	_
284	23	the	the	DT	25	det	42816	42819	_	_
284	24	same	same	JJ	25	amod	42820	42824	_	_
284	25	day	day	NN	21	nmod	42825	42828	_	_
284	26	as	as	IN	27	case	42829	42831	_	_
284	27	immunization	immunization	NN	25	nmod	42832	42844	_	_
284	28	or	or	CC	21	cc	42845	42847	_	_
284	29	delayed	delay	VBN	21	conj	42848	42855	_	_
284	30	for	for	IN	34	case	42856	42859	_	_
284	31	at	at	IN	32	case	42860	42862	_	_
284	32	least	least	JJS	33	nmod:npmod	42863	42868	_	_
284	33	4	4	CD	34	nummod	42869	42870	_	_
284	34	weeks	week	NNS	29	nmod	42871	42876	_	_
284	35	after	after	IN	37	case	42877	42882	_	_
284	36	measles	measles	NNS	37	compound	42883	42890	_	_
284	37	vaccination	vaccination	NN	29	nmod	42892	42903	_	_
284	38	.	.	.	21	punct	42903	42904	_	_

285	1	Vaccination	vaccination	NN	6	nsubj	42905	42916	_	_
285	2	with	with	IN	4	case	42917	42921	_	_
285	3	measles-containing	measles-containing	JJ	4	amod	42922	42940	_	_
285	4	vaccine	vaccine	NN	1	nmod	42942	42949	_	_
285	5	may	may	MD	6	aux	42950	42953	_	_
285	6	take	take	VB	0	ROOT	42954	42958	_	_
285	7	place	place	NN	6	dobj	42959	42964	_	_
285	8	at	at	IN	10	case	42965	42967	_	_
285	9	any	any	DT	10	det	42968	42971	_	_
285	10	time	time	NN	6	nmod	42972	42976	_	_
285	11	after	after	IN	17	mark	42977	42982	_	_
285	12	tuberculin	tuberculin	NN	14	compound	42983	42993	_	_
285	13	skin	skin	NN	14	compound	42994	42998	_	_
285	14	testing	testing	NN	17	nsubjpass	42999	43006	_	_
285	15	has	have	VBZ	17	aux	43007	43010	_	_
285	16	been	be	VBN	17	auxpass	43011	43015	_	_
285	17	performed	perform	VBN	6	advcl	43017	43026	_	_
285	18	and/or	and/or	CC	17	cc	43027	43033	_	_
285	19	read	read	VBN	17	conj	43034	43038	_	_
285	20	.	.	.	6	punct	43038	43039	_	_

286	1	Passive	passive	JJ	2	amod	43040	43047	_	_
286	2	immunization	immunization	NN	13	nsubj	43048	43060	_	_
286	3	with	with	IN	5	case	43061	43065	_	_
286	4	human	human	JJ	5	amod	43066	43071	_	_
286	5	Ig	ig	NN	2	nmod	43072	43074	_	_
286	6	or	or	CC	5	cc	43075	43077	_	_
286	7	receipt	receipt	NN	5	conj	43078	43085	_	_
286	8	of	of	IN	11	case	43086	43088	_	_
286	9	most	most	JJS	11	amod	43089	43093	_	_
286	10	blood	blood	NN	11	compound	43094	43099	_	_
286	11	products	product	NNS	5	nmod	43100	43108	_	_
286	12	can	can	MD	13	aux	43109	43112	_	_
286	13	interfere	interfere	VB	0	ROOT	43113	43122	_	_
286	14	with	with	IN	17	case	43123	43127	_	_
286	15	the	the	DT	17	det	43128	43131	_	_
286	16	immune	immune	JJ	17	amod	43132	43138	_	_
286	17	response	response	NN	13	nmod	43139	43147	_	_
286	18	to	to	TO	22	case	43148	43150	_	_
286	19	MMR	mmr	NN	22	compound	43151	43154	_	_
286	20	and	and	CC	19	cc	43155	43158	_	_
286	21	MMRV	mmrv	NN	19	conj	43159	43163	_	_
286	22	vaccines	vaccine	NNS	13	nmod	43164	43172	_	_
286	23	.	.	.	13	punct	43172	43173	_	_

287	1	These	these	DT	2	det	43174	43179	_	_
287	2	vaccines	vaccine	NNS	5	nsubjpass	43180	43188	_	_
287	3	should	should	MD	5	aux	43189	43195	_	_
287	4	be	be	VB	5	auxpass	43196	43198	_	_
287	5	given	give	VBN	0	ROOT	43199	43204	_	_
287	6	at	at	IN	7	case	43205	43207	_	_
287	7	least	least	JJS	8	nmod:npmod	43208	43213	_	_
287	8	14	14	CD	9	nummod	43214	43216	_	_
287	9	days	day	NNS	10	nmod:npmod	43217	43221	_	_
287	10	prior	prior	RB	5	advmod	43222	43227	_	_
287	11	to	to	TO	12	case	43228	43230	_	_
287	12	administration	administration	NN	5	nmod	43231	43245	_	_
287	13	of	of	IN	16	case	43246	43248	_	_
287	14	an	a	DT	16	det	43249	43251	_	_
287	15	Ig	ig	NN	16	compound	43252	43254	_	_
287	16	preparation	preparation	NN	12	nmod	43255	43266	_	_
287	17	or	or	CC	16	cc	43267	43269	_	_
287	18	blood	blood	NN	19	compound	43270	43275	_	_
287	19	product	product	NN	16	conj	43276	43283	_	_
287	20	,	,	,	5	punct	43283	43284	_	_
287	21	or	or	CC	5	cc	43285	43287	_	_
287	22	delayed	delay	VBN	5	conj	43288	43295	_	_
287	23	until	until	IN	34	mark	43296	43301	_	_
287	24	the	the	DT	25	det	43302	43305	_	_
287	25	antibodies	antibody	NNS	34	nsubj	43306	43316	_	_
287	26	in	in	IN	29	case	43317	43319	_	_
287	27	the	the	DT	29	det	43320	43323	_	_
287	28	Ig	ig	NN	29	compound	43324	43326	_	_
287	29	preparation	preparation	NN	25	nmod	43327	43338	_	_
287	30	or	or	CC	29	cc	43339	43341	_	_
287	31	blood	blood	NN	32	compound	43342	43347	_	_
287	32	product	product	NN	29	conj	43348	43355	_	_
287	33	have	have	VBP	34	aux	43356	43360	_	_
287	34	degraded	degrade	VBN	22	advcl	43361	43369	_	_
287	35	.	.	.	5	punct	43369	43370	_	_

288	1	If	if	IN	22	mark	43371	43373	_	_
288	2	the	the	DT	3	det	43374	43377	_	_
288	3	interval	interval	NN	22	nsubj	43378	43386	_	_
288	4	between	between	IN	5	case	43387	43394	_	_
288	5	administration	administration	NN	3	nmod	43395	43409	_	_
288	6	of	of	IN	7	case	43410	43412	_	_
288	7	vaccine	vaccine	NN	5	nmod	43413	43420	_	_
288	8	and	and	CC	5	cc	43421	43424	_	_
288	9	subsequent	subsequent	JJ	10	amod	43425	43435	_	_
288	10	administration	administration	NN	5	conj	43436	43450	_	_
288	11	of	of	IN	14	case	43451	43453	_	_
288	12	an	a	DT	14	det	43454	43456	_	_
288	13	Ig	ig	NN	14	compound	43457	43459	_	_
288	14	preparation	preparation	NN	10	nmod	43460	43471	_	_
288	15	or	or	CC	14	cc	43472	43474	_	_
288	16	blood	blood	NN	17	compound	43475	43480	_	_
288	17	product	product	NN	14	conj	43481	43488	_	_
288	18	is	be	VBZ	22	cop	43489	43491	_	_
288	19	less	less	JJR	21	advmod	43492	43496	_	_
288	20	than	than	IN	19	mwe	43497	43501	_	_
288	21	14	14	CD	22	nummod	43502	43504	_	_
288	22	days	day	NNS	29	advcl	43505	43509	_	_
288	23	,	,	,	29	punct	43509	43510	_	_
288	24	the	the	DT	26	det	43511	43514	_	_
288	25	vaccine	vaccine	NN	26	compound	43515	43522	_	_
288	26	dose	dose	NN	29	nsubjpass	43523	43527	_	_
288	27	should	should	MD	29	aux	43528	43534	_	_
288	28	be	be	VB	29	auxpass	43535	43537	_	_
288	29	repeated	repeat	VBN	0	ROOT	43538	43546	_	_
288	30	after	after	IN	33	case	43547	43552	_	_
288	31	the	the	DT	33	det	43553	43556	_	_
288	32	recommended	recommend	VBN	33	amod	43557	43568	_	_
288	33	interval	interval	NN	29	nmod	43569	43577	_	_
288	34	.	.	.	29	punct	43577	43578	_	_

289	1	The	the	DT	3	det	43579	43582	_	_
289	2	recommended	recommend	VBN	3	amod	43583	43594	_	_
289	3	interval	interval	NN	16	nsubj	43595	43603	_	_
289	4	between	between	IN	5	case	43604	43611	_	_
289	5	administration	administration	NN	3	nmod	43612	43626	_	_
289	6	of	of	IN	9	case	43627	43629	_	_
289	7	an	a	DT	9	det	43630	43632	_	_
289	8	Ig	ig	NN	9	compound	43633	43635	_	_
289	9	preparation	preparation	NN	5	nmod	43636	43647	_	_
289	10	or	or	CC	9	cc	43648	43650	_	_
289	11	blood	blood	NN	12	compound	43651	43656	_	_
289	12	product	product	NN	9	conj	43657	43664	_	_
289	13	and	and	CC	9	cc	43665	43668	_	_
289	14	subsequent	subsequent	JJ	15	amod	43669	43679	_	_
289	15	immunization	immunization	NN	9	conj	43680	43692	_	_
289	16	varies	vary	VBZ	0	ROOT	43693	43699	_	_
289	17	,	,	,	16	punct	43699	43700	_	_
289	18	depending	depend	VBG	22	case	43701	43710	_	_
289	19	on	on	IN	22	case	43711	43713	_	_
289	20	the	the	DT	22	det	43714	43717	_	_
289	21	Ig	ig	NN	22	compound	43718	43720	_	_
289	22	preparation	preparation	NN	16	advcl	43721	43732	_	_
289	23	or	or	CC	22	cc	43733	43735	_	_
289	24	blood	blood	NN	25	compound	43736	43741	_	_
289	25	product	product	NN	22	conj	43742	43749	_	_
289	26	.	.	.	16	punct	43749	43750	_	_

290	1	If	if	IN	5	mark	43751	43753	_	_
290	2	the	the	DT	3	det	43754	43757	_	_
290	3	vaccine	vaccine	NN	5	nsubjpass	43758	43765	_	_
290	4	is	be	VBZ	5	auxpass	43766	43768	_	_
290	5	given	give	VBN	18	advcl	43769	43774	_	_
290	6	too	too	RB	8	advmod	43775	43778	_	_
290	7	early	early	RB	8	advmod	43779	43784	_	_
290	8	following	following	JJ	5	iobj	43785	43794	_	_
290	9	Ig	ig	NN	13	compound	43795	43797	_	_
290	10	or	or	CC	9	cc	43798	43800	_	_
290	11	blood	blood	NN	9	conj	43801	43806	_	_
290	12	product	product	NN	13	compound	43807	43814	_	_
290	13	administration	administration	NN	5	dobj	43815	43829	_	_
290	14	,	,	,	18	punct	43829	43830	_	_
290	15	it	it	PRP	18	nsubjpass	43831	43833	_	_
290	16	should	should	MD	18	aux	43834	43840	_	_
290	17	be	be	VB	18	auxpass	43841	43843	_	_
290	18	repeated	repeat	VBN	0	ROOT	43844	43852	_	_
290	19	after	after	IN	24	mark	43853	43858	_	_
290	20	the	the	DT	22	det	43859	43862	_	_
290	21	appropriate	appropriate	JJ	22	amod	43863	43874	_	_
290	22	interval	interval	NN	24	nsubj	43875	43883	_	_
290	23	has	have	VBZ	24	aux	43884	43887	_	_
290	24	passed	pass	VBN	18	advcl	43888	43894	_	_
290	25	.	.	.	18	punct	43894	43895	_	_

291	1	Palivizumab	Palivizumab	NNP	13	nsubj	43896	43907	_	_
291	2	(	(	CD	1	nummod	43908	43909	_	_
291	3	RSVAb	rsvab	NN	4	compound	43909	43914	_	_
291	4	)	)	NN	1	dep	43914	43915	_	_
291	5	and	and	CC	4	cc	43916	43919	_	_
291	6	washed	wash	VBN	4	acl	43920	43926	_	_
291	7	red	red	JJ	10	amod	43927	43930	_	_
291	8	blood	blood	NN	10	compound	43931	43936	_	_
291	9	cell	cell	NN	10	compound	43937	43941	_	_
291	10	transfusion	transfusion	NN	6	dobj	43942	43953	_	_
291	11	do	do	VBP	13	aux	43954	43956	_	_
291	12	not	not	RB	13	neg	43957	43960	_	_
291	13	interfere	interfere	VB	0	ROOT	43961	43970	_	_
291	14	with	with	IN	17	case	43971	43975	_	_
291	15	the	the	DT	17	det	43976	43979	_	_
291	16	antibody	antibody	NN	17	compound	43980	43988	_	_
291	17	response	response	NN	13	nmod	43989	43997	_	_
291	18	to	to	TO	22	case	43998	44000	_	_
291	19	MMR	mmr	NN	22	compound	44001	44004	_	_
291	20	or	or	CC	19	cc	44005	44007	_	_
291	21	MMRV	mmrv	NN	19	conj	44008	44012	_	_
291	22	vaccines	vaccine	NNS	13	nmod	44013	44021	_	_
291	23	.	.	.	13	punct	44021	44022	_	_

292	1	Refer	refer	VB	0	ROOT	44023	44028	_	_
292	2	to	to	TO	4	case	44029	44031	_	_
292	3	Blood	Blood	NNP	4	compound	44032	44037	_	_
292	4	Products	Products	NNPS	1	nmod	44038	44046	_	_
292	5	,	,	,	4	punct	44046	44047	_	_
292	6	Human	human	JJ	8	amod	44048	44053	_	_
292	7	Immune	immune	JJ	8	amod	44054	44060	_	_
292	8	Globulin	globulin	NN	4	conj	44061	44069	_	_
292	9	and	and	CC	4	cc	44070	44073	_	_
292	10	Timing	timing	NN	4	conj	44074	44080	_	_
292	11	of	of	IN	12	case	44081	44083	_	_
292	12	Immunization	immunization	NN	10	nmod	44084	44096	_	_
292	13	in	in	IN	14	case	44097	44099	_	_
292	14	Part	Part	NNP	12	nmod	44100	44104	_	_
292	15	1	1	CD	14	nummod	44105	44106	_	_
292	16	for	for	IN	19	case	44107	44110	_	_
292	17	additional	additional	JJ	19	amod	44111	44121	_	_
292	18	general	general	JJ	19	amod	44122	44129	_	_
292	19	information	information	NN	1	nmod	44130	44141	_	_
292	20	.	.	.	1	punct	44141	44142	_	_

293	1	On	on	IN	3	case	44144	44146	_	_
293	2	the	the	DT	3	det	44147	44150	_	_
293	3	basis	basis	NN	16	nmod	44151	44156	_	_
293	4	of	of	IN	6	case	44157	44159	_	_
293	5	expert	expert	JJ	6	amod	44160	44166	_	_
293	6	opinion	opinion	NN	3	nmod	44167	44174	_	_
293	7	,	,	,	16	punct	44174	44175	_	_
293	8	the	the	DT	10	det	44176	44179	_	_
293	9	MMR	mmr	NN	10	compound	44180	44183	_	_
293	10	vaccines	vaccine	NNS	16	nsubjpass	44184	44192	_	_
293	11	authorized	authorize	VBN	10	acl	44193	44203	_	_
293	12	in	in	IN	13	case	44204	44206	_	_
293	13	Canada	Canada	NNP	11	nmod	44207	44213	B-persongroup-110183	_
293	14	may	may	MD	16	aux	44214	44217	_	_
293	15	be	be	VB	16	auxpass	44218	44220	_	_
293	16	used	use	VBN	0	ROOT	44221	44225	_	_
293	17	interchangeably	interchangeably	RB	16	advmod	44226	44241	_	_
293	18	.	.	.	16	punct	44241	44242	_	_

294	1	Refer	refer	VB	0	ROOT	44243	44248	_	_
294	2	to	to	TO	3	case	44249	44251	_	_
294	3	Principles	principle	NNS	1	nmod	44252	44262	_	_
294	4	of	of	IN	6	case	44263	44265	_	_
294	5	Vaccine	Vaccine	NNP	6	compound	44266	44273	_	_
294	6	Interchangeability	Interchangeability	NNP	3	nmod	44274	44292	_	_
294	7	in	in	IN	8	case	44293	44295	_	_
294	8	Part	Part	NNP	6	nmod	44296	44300	_	_
294	9	1	1	CD	8	nummod	44301	44302	_	_
294	10	for	for	IN	13	case	44303	44306	_	_
294	11	additional	additional	JJ	13	amod	44307	44317	_	_
294	12	general	general	JJ	13	amod	44318	44325	_	_
294	13	information	information	NN	1	nmod	44326	44337	_	_
294	14	.	.	.	1	punct	44337	44338	_	_
